{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "8a486ea6",
   "metadata": {},
   "source": [
    "# BSML Project - Missing Knowledge Links"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4b302962",
   "metadata": {},
   "source": [
    "### Setup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "5d7111cf",
   "metadata": {},
   "outputs": [],
   "source": [
    "import time\n",
    "import mwclient\n",
    "import numpy as np\n",
    "import networkx as nx\n",
    "from sklearn.cluster import AffinityPropagation\n",
    "from sklearn.cluster import KMeans\n",
    "import scipy.sparse as sp\n",
    "from functools import lru_cache\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "13861cb7",
   "metadata": {},
   "source": [
    "### Part 1: given a link, find all connected links up to a certain depth, and create the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "f88d78b6",
   "metadata": {},
   "outputs": [],
   "source": [
    "# This function just returns a list of all links directly connected to the input link\n",
    "\n",
    "@lru_cache(maxsize=None)\n",
    "def get_links(title):\n",
    "    page = wikipedia_site.pages[title]\n",
    "    links = [link.name for link in page.links()]\n",
    "    time.sleep(1)  # da capire se necessario\n",
    "    return links"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "45c29d7b",
   "metadata": {},
   "outputs": [],
   "source": [
    "def build_graph_with_links(graph, starting_title, max_depth=1, visited_nodes=None):\n",
    "    \"\"\"\n",
    "    Adds links to a graph starting from a given title.\n",
    "\n",
    "    Parameters:\n",
    "    - graph: NetworkX Graph object\n",
    "    - starting_title: str, the starting title for link exploration\n",
    "    - max_depth: int, the maximum depth to explore links (default is 1)\n",
    "    - visited_nodes: set, a set to keep track of visited nodes (default is None)\n",
    "    \"\"\"\n",
    "    if visited_nodes is None:\n",
    "        visited_nodes = set()\n",
    "\n",
    "    # We decided to filter out certain links\n",
    "    link_filter_keywords = ['Wikipedia', 'Category', 'identifier', 'Help', 'Template', ':']\n",
    "\n",
    "    # This is the base case: if depth is 0 or the title has already been visited, return\n",
    "    if max_depth == 0 or starting_title in visited_nodes:\n",
    "        return\n",
    "\n",
    "    # The current title is marked as visited\n",
    "    visited_nodes.add(starting_title)\n",
    "\n",
    "    # Get links for the current title\n",
    "    links = get_links(starting_title)\n",
    "\n",
    "    # By iterating through links, we actually build the graph\n",
    "    for link in links:\n",
    "        # Check if the link contains any filter keywords\n",
    "        if  not any(keyword in link for keyword in link_filter_keywords):\n",
    "            # If the link is not already in the graph, add it and explore further\n",
    "            if link not in graph:\n",
    "                graph.add_edge(starting_title, link)\n",
    "                build_graph_with_links(graph, link, max_depth-1, visited_nodes)\n",
    "            else:\n",
    "                # If the link is already in the graph, just add the edge\n",
    "                graph.add_edge(starting_title, link)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0efd0f8d",
   "metadata": {},
   "source": [
    "### Part 2: Perform Clustering Analysis on Graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "7bfca7eb",
   "metadata": {},
   "outputs": [],
   "source": [
    "# With this function the aim is to start from an adjacency matrix (which represents the graph\n",
    "# created with the function above), store it in a more memory-efficient format, and transform\n",
    "# it into a matrix in which nodes that are not directly connected, but are anyway \"near to each\n",
    "# other\" in the original graph, are now connected (the smaller the distance between two nodes\n",
    "# in the original graph, the stronger the link between them that we create here). We also make \n",
    "# sure the resulting matrix stays symmetric. This new matrix allow us to later perform \n",
    "# some clustering\n",
    "\n",
    "\n",
    "def apply_depth(adjacency_matrix, additional_depth = 2):\n",
    "    \"\"\"\n",
    "    Applies depth-based transformations to an adjacency matrix and normalizes the result.\n",
    "\n",
    "    Parameters:\n",
    "    - adjacency_matrix: 2D array-like, the original adjacency matrix\n",
    "    - depth: int, the depth of transformations to apply\n",
    "\n",
    "    Returns:\n",
    "    - 2D array, the transformed and normalized adjacency matrix\n",
    "    \"\"\"\n",
    "    # Convert the adjacency matrix to a Compressed Sparse Row (CSR) matrix\n",
    "    adj_matrix = sp.csr_matrix(adjacency_matrix)\n",
    "\n",
    "    if additional_depth == 0:\n",
    "        return adj_matrix.toarray() #return it as an array\n",
    "\n",
    "    # Now we apply a series of depth-based transformations to the adjacency matrix:\n",
    "    # each iteration updates the adjacency matrix by adding a fraction of\n",
    "    # the matrix multiplied by itself (adj_matrix @ adj_matrix).\n",
    "    # The fraction is determined by the term 1 / (2 ** (i + 1)), which\n",
    "    # decreases with each iteration, effectively diminishing the influence\n",
    "    # of higher powers in the matrix multiplication.\n",
    "    # This process creates weaker links between nodes that aren't connected\n",
    "    # at depth=1 but are connected at a higher depth. The higher the depth,\n",
    "    # the lower the strength of their new connection.\n",
    "\n",
    "    for i in range(0, additional_depth):\n",
    "        adj_matrix = adj_matrix + 1 / (2 ** (i+1)) * adj_matrix @ adj_matrix\n",
    "\n",
    "    # Here we compute the transpose of the adjacency matrix and we sum the original matrix \n",
    "    # with its transpose to obtain a symmetric matrix\n",
    "    adj_matrix_transpose = adj_matrix.transpose()\n",
    "    symmetric_matrix = adj_matrix + adj_matrix_transpose\n",
    "    \n",
    "    # Here we normalize the matrix by setting the diagonal values to a scaled maximum value\n",
    "    max_value = adj_matrix.max()\n",
    "    normalized_matrix = 0.9 * (symmetric_matrix / max_value)\n",
    "    normalized_matrix.setdiag(1)\n",
    "\n",
    "    # The algorithm returns the normalized transformed matrix as an array\n",
    "    return normalized_matrix.toarray()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "9e29e1fc",
   "metadata": {},
   "outputs": [],
   "source": [
    "def perform_affinity_propagation_clustering(similarity_matrix):\n",
    "    \"\"\"\n",
    "    Clusters nodes in a graph based on the given similarity matrix using Affinity Propagation.\n",
    "\n",
    "    Parameters:\n",
    "    - similarity_matrix: 2D array-like, a matrix representing pairwise similarities between nodes\n",
    "\n",
    "    Returns:\n",
    "    - 1D array, representing cluster assignments for each node\n",
    "    \"\"\"\n",
    "    \n",
    "    affinity_propagation_model = AffinityPropagation(affinity='precomputed', damping=0.98)\n",
    "\n",
    "    # This line performs the actual clustering\n",
    "    cluster_assignments = affinity_propagation_model.fit_predict(similarity_matrix)\n",
    "    \n",
    "    return np.array(cluster_assignments)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "0d372fe7",
   "metadata": {},
   "outputs": [],
   "source": [
    "# This is a more efficient way to perform the clustering, although slighty less accurate than \n",
    "# the previous one\n",
    "\n",
    "def perform_kmeans_clustering(similarity_matrix, num_clusters):\n",
    "    \"\"\"\n",
    "    Clusters nodes in a graph based on the given similarity matrix using K-Means.\n",
    "\n",
    "    Parameters:\n",
    "    - similarity_matrix: 2D array-like, a matrix representing pairwise similarities between nodes\n",
    "    - num_clusters: int, the number of clusters to form\n",
    "\n",
    "    Returns:\n",
    "    - 1D array, representing cluster assignments for each node\n",
    "    \"\"\"\n",
    "    \n",
    "    distance_matrix = 1 - similarity_matrix # this is a simple way to convert a similarity \n",
    "                                            # matrix to a distance one (which is what we need \n",
    "                                            # for K-Means)\n",
    "\n",
    "    kmeans_model = KMeans(n_clusters=num_clusters, random_state=0)\n",
    "\n",
    "    # This line performs the actual clustering\n",
    "    cluster_assignments = kmeans_model.fit_predict(distance_matrix)\n",
    "\n",
    "    return np.array(cluster_assignments)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "f93462f6",
   "metadata": {},
   "outputs": [],
   "source": [
    "# We use the well-known Elbow method to estimate the optimal number of clusters\n",
    "\n",
    "def elbow_method(similarity_matrix, min_k=10, max_k=100, step=10):\n",
    "    \"\"\"\n",
    "    Estimates the optimal number of clusters for K-Means clustering using the Elbow Method.\n",
    "\n",
    "    Parameters:\n",
    "    - similarity_matrix: 2D array-like, a matrix representing pairwise similarities between nodes\n",
    "    - max_k: int, the minimum number of clusters to consider\n",
    "    - max_k: int, the maximum number of clusters to consider\n",
    "\n",
    "    Returns:\n",
    "    - int, an estimated optimal number of clusters\n",
    "    \"\"\"\n",
    "    \n",
    "    distance_matrix = 1 - similarity_matrix\n",
    "    inertia_values = []\n",
    "\n",
    "    for k in range(min_k, max_k+1, step):\n",
    "        kmeans = KMeans(n_clusters=k, random_state=0)\n",
    "        kmeans.fit(distance_matrix)\n",
    "        inertia_values.append(kmeans.inertia_)\n",
    "        \n",
    "    plt.figure(figsize=(8, 4))\n",
    "    plt.plot(range(min_k, max_k+1, step), inertia_values, marker='o')\n",
    "    plt.title('Elbow Method For Optimal k')\n",
    "    plt.xlabel('Number of clusters')\n",
    "    plt.ylabel('Inertia')\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4b1d2cc6",
   "metadata": {},
   "source": [
    "### Part 3 - Find Potential Missing Links"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "8c83b2c2",
   "metadata": {},
   "outputs": [],
   "source": [
    "def find_missing_links(graph, similarity_matrix, clusters_array):\n",
    "    \"\"\"\n",
    "    Identifies missing links between nodes in the same cluster based on the given graph,\n",
    "    similarity matrix, and cluster assignments.\n",
    "\n",
    "    Parameters:\n",
    "    - graph: NetworkX Graph object, the input graph\n",
    "    - similarity_matrix: 2D array-like, a matrix representing pairwise similarities between nodes\n",
    "    - clusters: 1D array-like, representing cluster assignments for each node\n",
    "\n",
    "    Returns:\n",
    "    - dict, a dictionary of missing links and their associated similarity scores\n",
    "    \"\"\"\n",
    "    # We create an array of node indices\n",
    "    nodes_list = list(graph.nodes)\n",
    "    nodes_indices = np.arange(len(nodes_list))\n",
    "\n",
    "    max_cluster_index = np.max(clusters_array)\n",
    "    adjacency_matrix = np.array(nx.adjacency_matrix(graph).todense())\n",
    "    missing_links = {} # the keys are the potentially missing links, while the \n",
    "                       # values are their similarity scores\n",
    "\n",
    "    # Iterate through each cluster\n",
    "    for cluster_index in range(max_cluster_index + 1):\n",
    "        cluster_mask = (clusters_array == cluster_index)\n",
    "        nodes_in_cluster = nodes_indices[cluster_mask]\n",
    "        # We iterate through pairs of nodes in the current cluster\n",
    "        for i1, node1 in enumerate(nodes_in_cluster):\n",
    "            for node2 in nodes_in_cluster[i1+1:]:\n",
    "                # There must be no edge between the nodes in the graph\n",
    "                if adjacency_matrix[node1, node2] == 0 and adjacency_matrix[node2, node1] == 0:\n",
    "                    # There must be a positive similarity score in the similarity matrix\n",
    "                    if similarity_matrix[node1, node2] > 0:\n",
    "                        \n",
    "                        first_node, second_node = nodes_list[node1], nodes_list[node2]\n",
    "                        missing_links[(first_node, second_node)] = np.round(similarity_matrix[node1, node2], 2)\n",
    "                        \n",
    "    return missing_links # we return the dictionary of missing links"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "c5bb5613",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_top_n_links(link_scores, n):\n",
    "    \"\"\"\n",
    "    Retrieves the top n links based on their scores from a dictionary.\n",
    "\n",
    "    Parameters:\n",
    "    - link_scores: dict, a dictionary where keys are link identifiers and values are scores\n",
    "    - n: int, the number of top links to retrieve\n",
    "\n",
    "    Returns:\n",
    "    - dict, a new dictionary containing the top n links and their scores\n",
    "    \"\"\"\n",
    "    \n",
    "    sorted_link_scores = sorted(link_scores.items(), key=lambda x: x[1], reverse=True)\n",
    "    top_n_items = sorted_link_scores[:n]\n",
    "    top_n_links_dict = dict(top_n_items)\n",
    "    return top_n_links_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6734db0f",
   "metadata": {},
   "source": [
    "### Test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "e3f41a97",
   "metadata": {},
   "outputs": [],
   "source": [
    "wikipedia_site = mwclient.Site('en.wikipedia.org', path='/w/')\n",
    "wikipedia_site.connection.headers.update({'User-Agent': 'WikipediaNetworkResearch (er.pupone@gmail.com)'})\n",
    "\n",
    "# Initialize a directed graph for storing Wikipedia network information\n",
    "wikipedia_graph = nx.DiGraph()\n",
    "\n",
    "# Examples of an interesting starting page with many links (these are pages with plenty of links)\n",
    "#start_node_fourier_transform = \"Fourier transform\" # (approximately 4 min to build graph)\n",
    "start_node_cure_of_cancer = \"Cancer treatment\" # (approximately 2 min and 10s to build graph)\n",
    "\n",
    "# Examples of fun starting nodes\n",
    "#start_node_bocconi = \"Bocconi University\"\n",
    "#start_node_acmilan = \"AC Milan\"\n",
    "\n",
    "build_graph_with_links(wikipedia_graph, start_node_cure_of_cancer, max_depth=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "793ce9f7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of nodes in the graph: 12145\n"
     ]
    }
   ],
   "source": [
    "print(\"Number of nodes in the graph:\", len(wikipedia_graph.nodes()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "65bd5120",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/Giulio/opt/anaconda3/lib/python3.9/site-packages/scipy/sparse/_index.py:125: SparseEfficiencyWarning: Changing the sparsity structure of a csr_matrix is expensive. lil_matrix is more efficient.\n",
      "  self._set_arrayXarray(i, j, x)\n"
     ]
    }
   ],
   "source": [
    "adjacency_matrix = nx.adjacency_matrix(wikipedia_graph)\n",
    "transformed_matrix = apply_depth(adjacency_matrix, additional_depth=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "577cd527",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/Giulio/opt/anaconda3/lib/python3.9/site-packages/sklearn/cluster/_affinity_propagation.py:148: FutureWarning: 'random_state' has been introduced in 0.23. It will be set to None starting from 1.0 (renaming of 0.25) which means that results will differ at every function call. Set 'random_state' to None to silence this warning, or to 0 to keep the behavior of versions <0.23.\n",
      "  warnings.warn(\n"
     ]
    }
   ],
   "source": [
    "# This is the clustering performed with Affinity Propagation. \n",
    "# After careful consideration, we opted for this method over K-Means\n",
    "clusters = perform_affinity_propagation_clustering(transformed_matrix)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "2da6dfad",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of clusters:  34\n",
      "Sizes of clusters:  [4369, 23, 244, 36, 31, 38, 51, 222, 502, 355, 70, 763, 875, 110, 73, 191, 1570, 85, 60, 29, 36, 109, 1026, 62, 274, 59, 170, 136, 176, 20, 50, 196, 42, 92]\n"
     ]
    }
   ],
   "source": [
    "num_clusters = np.max(clusters)+1    # only for clusters created with Propagation Clustering\n",
    "print('Number of clusters: ', num_clusters)\n",
    "\n",
    "sizes = []\n",
    "for i in range(num_clusters):\n",
    "    mask = (clusters == i)\n",
    "    cluster_size = np.sum(mask)\n",
    "    sizes.append(cluster_size)\n",
    "print('Sizes of clusters: ', sizes)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "7d51d8b4",
   "metadata": {},
   "outputs": [],
   "source": [
    "missing_links = find_missing_links(wikipedia_graph, transformed_matrix, clusters)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "c84f4f6e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{('Cancer treatment', 'Acute lymphoblastic leukemia'): 0.09, ('Cancer treatment', 'Acute myeloid leukaemia'): 0.03, ('Cancer treatment', 'Acute myeloid leukemia'): 0.08, ('Cancer treatment', 'Adjuvant'): 0.06, ('Cancer treatment', 'Adverse events'): 0.03, ('Cancer treatment', 'Alkylating agents'): 0.03, ('Cancer treatment', 'Alopecia'): 0.03, ('Cancer treatment', 'Analgesic adjuvant'): 0.06, ('Cancer treatment', 'Bernard Fisher (scientist)'): 0.06, ('Cancer treatment', 'Biological response modifiers'): 0.06, ('Cancer treatment', 'Bladder'): 0.06, ('Cancer treatment', 'Brain'): 0.08, ('Cancer treatment', 'Brain cancer'): 0.06, ('Cancer treatment', 'Breast cancer'): 0.59, ('Cancer treatment', 'Cancer therapy'): 0.03, ('Cancer treatment', 'Carboplatin'): 0.08, ('Cancer treatment', 'Central nervous system'): 0.18, ('Cancer treatment', 'Chemotherapy-induced peripheral neuropathy'): 0.06, ('Cancer treatment', 'Cisplatin'): 0.08, ('Cancer treatment', 'Colon cancer'): 0.13, ('Cancer treatment', 'Colorectal carcinoma'): 0.03, ('Cancer treatment', 'Constipation'): 0.12, ('Cancer treatment', 'Cyclophosphamide'): 0.08, ('Cancer treatment', 'Cyclophosphamide Methotrexate Fluorouracil'): 0.03, ('Cancer treatment', 'Cystectomy'): 0.03, ('Cancer treatment', 'Cytotoxic'): 0.08, ('Cancer treatment', 'Dacarbazine'): 0.06, ('Cancer treatment', 'Dementia'): 0.08, ('Cancer treatment', 'Developmental disability'): 0.03, ('Cancer treatment', 'Diarrhea'): 0.15, ('Cancer treatment', 'Docetaxel'): 0.08, ('Cancer treatment', 'Doxorubicin'): 0.1, ('Cancer treatment', 'Dysphagia'): 0.03, ('Cancer treatment', 'Dysuria'): 0.03, ('Cancer treatment', 'Endometrial cancer'): 0.08, ('Cancer treatment', 'Epirubicin'): 0.06, ('Cancer treatment', 'Fluorouracil'): 0.08, ('Cancer treatment', 'Food and Drug Administration (United States)'): 0.06, ('Cancer treatment', 'Gemcitabine'): 0.12, ('Cancer treatment', 'Glioblastoma multiforme'): 0.03, ('Cancer treatment', 'Gompertz curve'): 0.03, ('Cancer treatment', 'Headache'): 0.06, ('Cancer treatment', 'Hemorrhage'): 0.03, ('Cancer treatment', 'Hormonal therapy'): 0.06, ('Cancer treatment', 'Hormone therapy'): 0.03, ('Cancer treatment', 'Human brain'): 0.18, ('Cancer treatment', 'Hydrocortisone'): 0.06, ('Cancer treatment', 'Hyperthermia therapy'): 0.06, ('Cancer treatment', 'Interferon type I'): 0.07, ('Cancer treatment', 'Intrathecal'): 0.03, ('Cancer treatment', 'Ipilimumab'): 0.19, ('Cancer treatment', 'Late effect'): 0.03, ('Cancer treatment', 'Leukoencephalopathy'): 0.03, ('Cancer treatment', 'Lung'): 0.06, ('Cancer treatment', 'Medical Subject Headings'): 0.56, ('Cancer treatment', 'Medulloblastoma'): 0.03, ('Cancer treatment', 'Memory loss'): 0.03, ('Cancer treatment', 'Metastases'): 0.03, ('Cancer treatment', 'Methotrexate'): 0.08, ('Cancer treatment', 'Metritis'): 0.03, ('Cancer treatment', 'Micrometastatic'): 0.03, ('Cancer treatment', 'Microsatellite instability'): 0.03, ('Cancer treatment', 'Mucositis'): 0.03, ('Cancer treatment', 'Myelosuppression'): 0.03, ('Cancer treatment', 'Myelosuppressive'): 0.03, ('Cancer treatment', 'Nausea'): 0.15, ('Cancer treatment', 'Neoadjuvant therapy'): 0.06, ('Cancer treatment', 'Neoplasm'): 0.3, ('Cancer treatment', 'Neutropenia'): 0.07, ('Cancer treatment', 'Neutropenic'): 0.03, ('Cancer treatment', 'Oncologist'): 0.09, ('Cancer treatment', 'Orchidectomy'): 0.03, ('Cancer treatment', 'Paclitaxel'): 0.11, ('Cancer treatment', 'Pancreatic cancer'): 0.21, ('Cancer treatment', 'Post-chemotherapy cognitive impairment'): 0.03, ('Cancer treatment', 'Primary tumor'): 0.18, ('Cancer treatment', 'Proctitis'): 0.06, ('Cancer treatment', 'Prostate'): 0.11, ('Cancer treatment', 'Radiation'): 0.06, ('Cancer treatment', 'Radiation dermatitis'): 0.03, ('Cancer treatment', 'Radiotherapy'): 0.12, ('Cancer treatment', 'Septicaemia'): 0.03, ('Cancer treatment', 'Side effect'): 0.03, ('Cancer treatment', 'Small cell lung carcinoma'): 0.03, ('Cancer treatment', 'Surgeries'): 0.03, ('Cancer treatment', 'Temozolomide'): 0.06, ('Cancer treatment', 'Testicular cancer'): 0.08, ('Cancer treatment', 'Therapy'): 0.23, ('Cancer treatment', 'University of Pittsburgh'): 0.03, ('Cancer treatment', 'Vomiting'): 0.17, ('Cancer treatment', '7S seed storage protein'): 0.04, ('Cancer treatment', '11S globulin family'): 0.04, ('Cancer treatment', '2S albumin'): 0.04, ('Cancer treatment', 'Afamin'): 0.04, ('Cancer treatment', 'Albumin (disambiguation)'): 0.04, ('Cancer treatment', 'Alpha-2-Macroglobulin'): 0.04, ('Cancer treatment', 'Alpha-fetoprotein'): 0.11, ('Cancer treatment', 'Alpha-lactalbumin'): 0.04, ('Cancer treatment', 'Alpha 1-antichymotrypsin'): 0.04, ('Cancer treatment', 'Alpha 1-antitrypsin'): 0.04, ('Cancer treatment', 'Alpha 2-antiplasmin'): 0.04, ('Cancer treatment', 'Alpha globulin'): 0.04, ('Cancer treatment', 'Angiostatin'): 0.04, ('Cancer treatment', 'Antithrombin'): 0.06, ('Cancer treatment', 'Avidin'): 0.04, ('Cancer treatment', 'Beta-2 microglobulin'): 0.06, ('Cancer treatment', 'Beta-lactoglobulin'): 0.04, ('Cancer treatment', 'Beta globulins'): 0.04, ('Cancer treatment', 'Biliprotein'): 0.04, ('Cancer treatment', 'Bilirubin'): 0.04, ('Cancer treatment', 'Blood plasma'): 0.06, ('Cancer treatment', 'Blood proteins'): 0.04, ('Cancer treatment', 'Bovine serum albumin'): 0.04, ('Cancer treatment', 'C-reactive protein'): 0.04, ('Cancer treatment', 'CITES'): 0.04, ('Cancer treatment', 'Carrier protein'): 0.04, ('Cancer treatment', 'Ceruloplasmin'): 0.04, ('Cancer treatment', 'Chromoprotein'): 0.04, ('Cancer treatment', 'Chromosome 4'): 0.04, ('Cancer treatment', 'Coagulate'): 0.04, ('Cancer treatment', 'Cohn process'): 0.04, ('Cancer treatment', 'Conalbumin'): 0.04, ('Cancer treatment', 'Denaturation (biochemistry)'): 0.06, ('Cancer treatment', 'Edestin'): 0.04, ('Cancer treatment', 'Egg white'): 0.04, ('Cancer treatment', 'Encyclopædia Britannica Eleventh Edition'): 0.04, ('Cancer treatment', 'Extracellular matrix protein 1'): 0.04, ('Cancer treatment', 'Factor H'): 0.04, ('Cancer treatment', 'Fatty acid'): 0.04, ('Cancer treatment', 'Fetal fibronectin'): 0.04, ('Cancer treatment', 'Fibronectin'): 0.04, ('Cancer treatment', 'Gamma globulin'): 0.04, ('Cancer treatment', 'Genetically modified rice'): 0.04, ('Cancer treatment', 'Globular protein'): 0.04, ('Cancer treatment', 'Globulin'): 0.04, ('Cancer treatment', 'Glycosylation'): 0.04, ('Cancer treatment', 'Haptoglobin'): 0.04, ('Cancer treatment', 'Hemopexin'): 0.04, ('Cancer treatment', 'Hemp protein'): 0.04, ('Cancer treatment', 'Heparin cofactor II'): 0.04, ('Cancer treatment', 'Human serum albumin'): 0.06, ('Cancer treatment', 'InterPro'): 0.08, ('Cancer treatment', 'Isoelectric point'): 0.04, ('Cancer treatment', 'Lactalbumin'): 0.04, ('Cancer treatment', 'Lactoferrin'): 0.04, ('Cancer treatment', 'Latin'): 0.13, ('Cancer treatment', 'Ligand'): 0.04, ('Cancer treatment', 'Lipocalin'): 0.04, ('Cancer treatment', 'List of proteins'): 0.04, ('Cancer treatment', 'Macroglobulin'): 0.04, ('Cancer treatment', 'Membrane protein'): 0.11, ('Cancer treatment', 'Microglobulin'): 0.04, ('Cancer treatment', 'Oncotic pressure'): 0.04, ('Cancer treatment', 'Orosomucoid'): 0.04, ('Cancer treatment', 'Ovalbumin'): 0.04, ('Cancer treatment', 'PDBsum'): 0.04, ('Cancer treatment', 'PROSITE'): 0.04, ('Cancer treatment', 'Parvalbumin'): 0.04, ('Cancer treatment', 'Pfam'): 0.04, ('Cancer treatment', 'Photoreceptor protein'): 0.04, ('Cancer treatment', 'Phycobiliprotein'): 0.04, ('Cancer treatment', 'Phylogeny'): 0.04, ('Cancer treatment', 'Phytochrome'): 0.04, ('Cancer treatment', 'Plasmin'): 0.04, ('Cancer treatment', 'Post-translational modification'): 0.04, ('Cancer treatment', 'Properdin'): 0.04, ('Cancer treatment', 'Proteasome'): 0.07, ('Cancer treatment', 'Protein'): 0.3, ('Cancer treatment', 'Protein Data Bank'): 0.31, ('Cancer treatment', 'Protein biosynthesis'): 0.04, ('Cancer treatment', 'Protein domain'): 0.04, ('Cancer treatment', 'Protein family'): 0.09, ('Cancer treatment', 'Protein folding'): 0.04, ('Cancer treatment', 'Protein methods'): 0.04, ('Cancer treatment', 'Protein structure'): 0.04, ('Cancer treatment', 'Protein targeting'): 0.04, ('Cancer treatment', 'Proteome'): 0.04, ('Cancer treatment', 'Retinol binding protein'): 0.04, ('Cancer treatment', 'Ricin'): 0.04, ('Cancer treatment', 'Scleroprotein'): 0.04, ('Cancer treatment', 'Seed'): 0.04, ('Cancer treatment', 'Serpin'): 0.04, ('Cancer treatment', 'Serum albumin'): 0.04, ('Cancer treatment', 'Sex hormone-binding globulin'): 0.06, ('Cancer treatment', 'Simple Modular Architecture Research Tool'): 0.04, ('Cancer treatment', 'Solubility'): 0.04, ('Cancer treatment', 'Storage protein'): 0.04, ('Cancer treatment', 'Structural Classification of Proteins'): 0.04, ('Cancer treatment', 'Thyroglobulin'): 0.06, ('Cancer treatment', 'Traditional Chinese medicine'): 0.09, ('Cancer treatment', 'Transcobalamin'): 0.04, ('Cancer treatment', 'Transcortin'): 0.04, ('Cancer treatment', 'Transferrin'): 0.04, ('Cancer treatment', 'Transthyretin'): 0.04, ('Cancer treatment', 'Unified atomic mass unit'): 0.04, ('Cancer treatment', 'Vertebrates'): 0.04, ('Cancer treatment', 'Vitamin D-binding protein'): 0.04, ('Cancer treatment', 'Whey protein'): 0.04, ('Cancer treatment', 'Wikisource'): 0.04, ('Cancer treatment', 'Wnt protein'): 0.08, ('Cancer treatment', 'Allotransplantation'): 0.06, ('Cancer treatment', 'Traditional, complementary, and integrative medicine'): 0.03, ('Cancer treatment', '2012 phenomenon'): 0.03, ('Cancer treatment', '5G'): 0.03, ('Cancer treatment', '9/11 conspiracy theories'): 0.03, ('Cancer treatment', 'AYUSH'): 0.03, ('Cancer treatment', 'Activated charcoal cleanse'): 0.06, ('Cancer treatment', 'Acupressure'): 0.08, ('Cancer treatment', 'Acupuncture'): 0.06, ('Cancer treatment', 'Adrenal fatigue'): 0.06, ('Cancer treatment', 'Adrian Hayday'): 0.03, ('Cancer treatment', 'Advance-fee scam'): 0.03, ('Cancer treatment', 'Aerotoxic syndrome'): 0.06, ('Cancer treatment', 'Affinity fraud'): 0.03, ('Cancer treatment', 'Alchemy'): 0.03, ('Cancer treatment', 'Alkaline diet'): 0.06, ('Cancer treatment', 'Alternative veterinary medicine'): 0.06, ('Cancer treatment', 'American Cancer Society Cancer Action Network'): 0.03, ('Cancer treatment', 'American Cancer Society Center'): 0.03, ('Cancer treatment', 'American Cancer Society Classic'): 0.03, ('Cancer treatment', 'An Encyclopedia of Claims, Frauds, and Hoaxes of the Occult and Supernatural'): 0.03, ('Cancer treatment', 'Ancient astronauts'): 0.03, ('Cancer treatment', 'Andrew Wakefield'): 0.03, ('Cancer treatment', 'Animal magnetism'): 0.06, ('Cancer treatment', \"Anne O'Garra\"): 0.03, ('Cancer treatment', 'Anthroposophic medicine'): 0.06, ('Cancer treatment', 'Anti-gravity'): 0.03, ('Cancer treatment', 'Anti-vaccinationism in chiropractic'): 0.06, ('Cancer treatment', 'Anti-vaccine activism'): 0.06, ('Cancer treatment', 'Antiscience'): 0.06, ('Cancer treatment', 'Anxiety'): 0.1, ('Cancer treatment', 'Apitherapy'): 0.06, ('Cancer treatment', 'Applied kinesiology'): 0.06, ('Cancer treatment', 'Aquatic ape hypothesis'): 0.03, ('Cancer treatment', 'Aromatherapy'): 0.06, ('Cancer treatment', 'Aryan race'): 0.03, ('Cancer treatment', 'Association for Research and Enlightenment'): 0.06, ('Cancer treatment', 'Astrology'): 0.03, ('Cancer treatment', 'Auditing (Scientology)'): 0.03, ('Cancer treatment', 'Auriculotherapy'): 0.06, ('Cancer treatment', 'Australia'): 0.08, ('Cancer treatment', 'Ayurveda'): 0.06, ('Cancer treatment', 'Baby boomers'): 0.03, ('Cancer treatment', 'Bach flower remedies'): 0.06, ('Cancer treatment', 'Balneotherapy'): 0.06, ('Cancer treatment', 'Bank fraud'): 0.03, ('Cancer treatment', 'Bankruptcy fraud'): 0.03, ('Cancer treatment', 'Bates method'): 0.06, ('Cancer treatment', 'Benefit finding'): 0.03, ('Cancer treatment', 'Benefit fraud in the United Kingdom'): 0.03, ('Cancer treatment', 'Big Pharma conspiracy theories'): 0.06, ('Cancer treatment', 'Biodynamic agriculture'): 0.03, ('Cancer treatment', 'Bioelectromagnetic'): 0.03, ('Cancer treatment', 'Biofeedback'): 0.08, ('Cancer treatment', 'Biological terrain assessment'): 0.06, ('Cancer treatment', 'Biological transmutation'): 0.03, ('Cancer treatment', 'Biorhythm (pseudoscience)'): 0.03, ('Cancer treatment', 'Black salve'): 0.06, ('Cancer treatment', 'Blood stasis'): 0.06, ('Cancer treatment', 'Bloodletting'): 0.03, ('Cancer treatment', 'Body cleansing'): 0.03, ('Cancer treatment', 'Body memory'): 0.03, ('Cancer treatment', 'Bodywork (alternative medicine)'): 0.06, ('Cancer treatment', 'Bogdanov affair'): 0.03, ('Cancer treatment', 'Bourgeois pseudoscience'): 0.03, ('Cancer treatment', 'Bowen technique'): 0.06, ('Cancer treatment', 'Brazilian traditional medicine'): 0.06, ('Cancer treatment', 'Breathwork'): 0.06, ('Cancer treatment', 'Bride scam'): 0.03, ('Cancer treatment', 'Brigitte Boisselier'): 0.03, ('Cancer treatment', 'Bufo'): 0.03, ('Cancer treatment', 'Bush medicine'): 0.06, ('Cancer treatment', 'CA (journal)'): 0.03, ('Cancer treatment', 'COVID-19 misinformation'): 0.06, ('Cancer treatment', 'Camel urine'): 0.06, ('Cancer treatment', 'Cancer (journal)'): 0.03, ('Cancer treatment', 'Cancer Act 1939'): 0.03, ('Cancer treatment', 'Cancer Cytopathology'): 0.03, ('Cancer treatment', 'Cancer Research UK'): 0.03, ('Cancer treatment', 'Cancers'): 0.03, ('Cancer treatment', 'Candida hypersensitivity'): 0.06, ('Cancer treatment', 'Carding (fraud)'): 0.03, ('Cancer treatment', 'Cargo cult science'): 0.03, ('Cancer treatment', 'Caroline S. Hill'): 0.03, ('Cancer treatment', 'Catastrophism'): 0.03, ('Cancer treatment', \"Cattle Baron's Ball\"): 0.03, ('Cancer treatment', 'Chargeback fraud'): 0.03, ('Cancer treatment', 'Charity fraud'): 0.03, ('Cancer treatment', 'Charlatan'): 0.03, ('Cancer treatment', 'Charles Swanton'): 0.03, ('Cancer treatment', 'Chelation therapy'): 0.06, ('Cancer treatment', 'Chemotherapeutic'): 0.03, ('Cancer treatment', 'Chemtrail conspiracy theory'): 0.03, ('Cancer treatment', 'Cheque fraud'): 0.03, ('Cancer treatment', 'Chinese herbology'): 0.06, ('Cancer treatment', 'Chiropractic'): 0.06, ('Cancer treatment', 'Chiropractic treatment techniques'): 0.06, ('Cancer treatment', 'Christian Science'): 0.06, ('Cancer treatment', 'Chromotherapy'): 0.06, ('Cancer treatment', 'Chronic Lyme disease'): 0.06, ('Cancer treatment', 'Chumash traditional medicine'): 0.06, ('Cancer treatment', 'Claude Vorilhon'): 0.03, ('Cancer treatment', 'Climate change denial'): 0.03, ('Cancer treatment', 'Clonaid'): 0.03, ('Cancer treatment', 'Coffee enema'): 0.06, ('Cancer treatment', 'Cognitive therapy'): 0.06, ('Cancer treatment', 'Cold fusion'): 0.03, ('Cancer treatment', 'Colloidal silver'): 0.06, ('Cancer treatment', 'Colon cleansing'): 0.06, ('Cancer treatment', 'Colorpuncture'): 0.06, ('Cancer treatment', 'Columbia University'): 0.03, ('Cancer treatment', 'Committee for Skeptical Inquiry'): 0.03, ('Cancer treatment', 'Competition Bureau'): 0.03, ('Cancer treatment', 'Complementary and alternative medicine'): 0.03, ('Cancer treatment', 'Confidence trick'): 0.03, ('Cancer treatment', 'Conspiracy theory'): 0.06, ('Cancer treatment', 'Conversion therapy'): 0.06, ('Cancer treatment', 'Corentin Louis Kervran'): 0.03, ('Cancer treatment', 'Correactology'): 0.06, ('Cancer treatment', 'Counterfeit'): 0.03, ('Cancer treatment', 'Cramming (fraud)'): 0.03, ('Cancer treatment', 'Craniosacral therapy'): 0.06, ('Cancer treatment', 'Crank (person)'): 0.03, ('Cancer treatment', 'Creation science'): 0.03, ('Cancer treatment', 'Credit card fraud'): 0.03, ('Cancer treatment', 'Cryonics'): 0.03, ('Cancer treatment', 'Cryptozoology'): 0.03, ('Cancer treatment', 'Crystal healing'): 0.06, ('Cancer treatment', 'Cults of Unreason'): 0.03, ('Cancer treatment', 'Cupping therapy'): 0.06, ('Cancer treatment', 'Curandero'): 0.06, ('Cancer treatment', 'Curcumin'): 0.03, ('Cancer treatment', 'DNA repair'): 0.3, ('Cancer treatment', 'DNA replication'): 0.27, ('Cancer treatment', 'David Cooksey'): 0.03, ('Cancer treatment', 'David Icke'): 0.03, ('Cancer treatment', 'David Willetts'): 0.03, ('Cancer treatment', 'Dean drive'): 0.03, ('Cancer treatment', 'Deepak Chopra'): 0.03, ('Cancer treatment', 'Del Bigtree'): 0.03, ('Cancer treatment', 'Demarcation problem'): 0.03, ('Cancer treatment', 'Dental amalgam controversy'): 0.06, ('Cancer treatment', 'Detoxification (alternative medicine)'): 0.06, ('Cancer treatment', 'Detoxification foot baths'): 0.06, ('Cancer treatment', 'Dianetics'): 0.03, ('Cancer treatment', 'Diet and cancer'): 0.16, ('Cancer treatment', 'Diets'): 0.03, ('Cancer treatment', 'Disability fraud'): 0.03, ('Cancer treatment', 'Dit da'): 0.06, ('Cancer treatment', 'Divination'): 0.03, ('Cancer treatment', 'Doctrine of signatures'): 0.03, ('Cancer treatment', \"Doktor Koster's Antigaspills\"): 0.03, ('Cancer treatment', 'Doreen Cantrell'): 0.03, ('Cancer treatment', 'Dosha'): 0.06, ('Cancer treatment', 'Dowsing'): 0.03, ('Cancer treatment', 'Drug fraud'): 0.03, ('Cancer treatment', 'Dry needling'): 0.06, ('Cancer treatment', 'Ear candling'): 0.06, ('Cancer treatment', 'Electoral fraud'): 0.03, ('Cancer treatment', 'Electromagnetic hypersensitivity'): 0.06, ('Cancer treatment', 'Electronic voice phenomenon'): 0.03, ('Cancer treatment', 'EmDrive'): 0.03, ('Cancer treatment', 'Email fraud'): 0.03, ('Cancer treatment', 'Employment fraud'): 0.03, ('Cancer treatment', 'Energy (esotericism)'): 0.06, ('Cancer treatment', 'Energy medicine'): 0.06, ('Cancer treatment', 'Epigenetics'): 0.24, ('Cancer treatment', 'Estrogen dominance'): 0.06, ('Cancer treatment', 'Eugenics'): 0.03, ('Cancer treatment', 'European Journal of Cancer'): 0.03, ('Cancer treatment', 'Evidence-based medicine'): 0.03, ('Cancer treatment', 'Fabunan Antiviral Injection'): 0.06, ('Cancer treatment', 'Facilitated communication'): 0.06, ('Cancer treatment', 'Fad diet'): 0.03, ('Cancer treatment', 'Fads and Fallacies in the Name of Science'): 0.03, ('Cancer treatment', 'Faith healing'): 0.06, ('Cancer treatment', 'Faked death'): 0.03, ('Cancer treatment', 'False billing'): 0.03, ('Cancer treatment', 'Faster-than-light'): 0.03, ('Cancer treatment', 'Federal Trade Commission'): 0.06, ('Cancer treatment', 'Feldenkrais Method'): 0.06, ('Cancer treatment', 'Feng shui'): 0.03, ('Cancer treatment', 'Fertility fraud'): 0.03, ('Cancer treatment', 'Flat Earth'): 0.03, ('Cancer treatment', 'Foreign exchange fraud'): 0.03, ('Cancer treatment', 'Forgery'): 0.03, ('Cancer treatment', 'Fortean Times'): 0.03, ('Cancer treatment', 'Francis Crick Institute'): 0.03, ('Cancer treatment', 'Frank Uhlmann'): 0.03, ('Cancer treatment', 'Fraud'): 0.03, ('Cancer treatment', 'Fringe science'): 0.03, ('Cancer treatment', 'Fringe theory'): 0.03, ('Cancer treatment', 'Functional medicine'): 0.06, ('Cancer treatment', 'Gaia, Inc.'): 0.03, ('Cancer treatment', 'Generation'): 0.06, ('Cancer treatment', 'Generationism'): 0.03, ('Cancer treatment', 'Genocide denial'): 0.03, ('Cancer treatment', 'Georgetown University'): 0.03, ('Cancer treatment', 'Geraint Rees'): 0.03, ('Cancer treatment', 'Germ theory denialism'): 0.03, ('Cancer treatment', 'Gill plate trade'): 0.06, ('Cancer treatment', 'Goop (company)'): 0.03, ('Cancer treatment', 'Graham Hancock'): 0.03, ('Cancer treatment', 'Graphology'): 0.03, ('Cancer treatment', 'Great American Smokeout'): 0.03, ('Cancer treatment', 'Gua sha'): 0.06, ('Cancer treatment', 'HIV/AIDS denialism'): 0.06, ('Cancer treatment', 'Hair analysis (alternative medicine)'): 0.06, ('Cancer treatment', 'Hans Alfred Nieper'): 0.03, ('Cancer treatment', 'Harpal Kumar'): 0.03, ('Cancer treatment', 'Harvard University'): 0.03, ('Cancer treatment', 'Health care fraud'): 0.03, ('Cancer treatment', 'Heavy legs'): 0.06, ('Cancer treatment', 'Herb'): 0.03, ('Cancer treatment', 'Herbal medicine'): 0.06, ('Cancer treatment', 'Herbology'): 0.03, ('Cancer treatment', 'Hilot'): 0.06, ('Cancer treatment', 'Historical negationism'): 0.03, ('Cancer treatment', 'History of alternative medicine'): 0.06, ('Cancer treatment', 'History of cancer chemotherapy'): 0.08, ('Cancer treatment', 'History of medicine'): 0.22, ('Cancer treatment', 'Hoax'): 0.03, ('Cancer treatment', 'Holistic dentistry'): 0.06, ('Cancer treatment', 'Hollow Earth'): 0.03, ('Cancer treatment', 'Holocaust denial'): 0.03, ('Cancer treatment', 'Hologram bracelet'): 0.06, ('Cancer treatment', 'Homeopathy'): 0.06, ('Cancer treatment', 'Honest services fraud'): 0.03, ('Cancer treatment', 'Hope Lodge (American Cancer Society)'): 0.03, ('Cancer treatment', 'HuaChanSu'): 0.03, ('Cancer treatment', 'Humorism'): 0.03, ('Cancer treatment', 'Hydrotherapy'): 0.06, ('Cancer treatment', 'Hypnosis'): 0.03, ('Cancer treatment', 'Hypnotherapy'): 0.08, ('Cancer treatment', 'Identity theft'): 0.03, ('Cancer treatment', 'Ignatius L. Donnelly'): 0.03, ('Cancer treatment', 'Igor and Grichka Bogdanoff'): 0.03, ('Cancer treatment', 'Immune tolerance'): 0.09, ('Cancer treatment', 'Imperial College London'): 0.03, ('Cancer treatment', 'Indigo children'): 0.03, ('Cancer treatment', 'Insurance fraud'): 0.03, ('Cancer treatment', 'Intelligent design'): 0.03, ('Cancer treatment', 'Internet fraud'): 0.03, ('Cancer treatment', 'Ionized jewelry'): 0.06, ('Cancer treatment', 'Iranian traditional medicine'): 0.06, ('Cancer treatment', 'Iridology'): 0.06, ('Cancer treatment', 'James Randi Educational Foundation'): 0.03, ('Cancer treatment', 'Jamu'): 0.06, ('Cancer treatment', 'Japhetic theory'): 0.03, ('Cancer treatment', 'Jean-Paul Vincent'): 0.03, ('Cancer treatment', 'Jenny McCarthy'): 0.03, ('Cancer treatment', 'Jeremy Farrar'): 0.03, ('Cancer treatment', 'Jilly Juice'): 0.06, ('Cancer treatment', 'Jim Cuthbert Smith'): 0.03, ('Cancer treatment', 'Job fraud'): 0.03, ('Cancer treatment', 'John Skehel'): 0.03, ('Cancer treatment', 'Joseph Mercola'): 0.03, ('Cancer treatment', 'Julian Downward'): 0.03, ('Cancer treatment', 'Junk science'): 0.03, ('Cancer treatment', 'Kambo cleanse'): 0.06, ('Cancer treatment', 'Kampo'): 0.06, ('Cancer treatment', 'Kayakalpa'): 0.06, ('Cancer treatment', 'Keith Peters (physician)'): 0.03, ('Cancer treatment', \"King's College London\"): 0.06, ('Cancer treatment', 'Laundry ball'): 0.03, ('Cancer treatment', 'Law of attraction (New Thought)'): 0.03, ('Cancer treatment', 'Leaky gut syndrome'): 0.06, ('Cancer treatment', 'Levitation (paranormal)'): 0.03, ('Cancer treatment', 'Library of Congress'): 0.03, ('Cancer treatment', 'List of topics characterized as pseudoscience'): 0.03, ('Cancer treatment', 'List of types of fraud'): 0.03, ('Cancer treatment', 'List of unproven methods against COVID-19'): 0.06, ('Cancer treatment', 'London Research Institute'): 0.03, ('Cancer treatment', 'Long firm fraud'): 0.03, ('Cancer treatment', 'Long gu'): 0.06, ('Cancer treatment', 'Lottery fraud'): 0.03, ('Cancer treatment', 'Lottery scam'): 0.03, ('Cancer treatment', 'Lunar effect'): 0.03, ('Cancer treatment', 'Lymphotherapy'): 0.06, ('Cancer treatment', 'Lysenkoism'): 0.03, ('Cancer treatment', 'MMR vaccine and autism'): 0.06, ('Cancer treatment', 'Macrobiotic diet'): 0.03, ('Cancer treatment', 'Magnet therapy'): 0.06, ('Cancer treatment', 'Maharishi Vedic Approach to Health'): 0.06, ('Cancer treatment', 'Mail and wire fraud'): 0.03, ('Cancer treatment', 'Management of cancer'): 0.03, ('Cancer treatment', 'Manual therapy'): 0.06, ('Cancer treatment', 'Massage therapy'): 0.03, ('Cancer treatment', 'Max Gerson'): 0.03, ('Cancer treatment', 'Medical Research Council (United Kingdom)'): 0.03, ('Cancer treatment', 'Medical cannabis'): 0.12, ('Cancer treatment', 'Medical intuitive'): 0.06, ('Cancer treatment', 'Medical massage'): 0.03, ('Cancer treatment', 'Medical schools'): 0.03, ('Cancer treatment', 'Medicare fraud'): 0.03, ('Cancer treatment', 'Medicine'): 0.25, ('Cancer treatment', 'Meditation'): 0.06, ('Cancer treatment', 'Mediumship'): 0.03, ('Cancer treatment', 'Megavitamin therapy'): 0.06, ('Cancer treatment', 'Mehmet Oz'): 0.03, ('Cancer treatment', 'Melanin theory'): 0.03, ('Cancer treatment', 'Meridian (Chinese medicine)'): 0.06, ('Cancer treatment', 'Mien Shiang'): 0.06, ('Cancer treatment', 'Mike Lindell'): 0.03, ('Cancer treatment', 'Mind-body intervention'): 0.03, ('Cancer treatment', 'Mind–body intervention'): 0.03, ('Cancer treatment', 'Mind–body interventions'): 0.06, ('Cancer treatment', 'Ministry of Ayush'): 0.03, ('Cancer treatment', 'Miracle Mineral Supplement'): 0.06, ('Cancer treatment', 'Mismarking'): 0.03, ('Cancer treatment', 'Moon landing conspiracy theories'): 0.03, ('Cancer treatment', 'Mortgage fraud'): 0.03, ('Cancer treatment', 'Moxibustion'): 0.06, ('Cancer treatment', 'Multiple chemical sensitivity'): 0.06, ('Cancer treatment', 'Music therapy'): 0.08, ('Cancer treatment', 'Mutational'): 0.12, ('Cancer treatment', 'Muti'): 0.06, ('Cancer treatment', 'Myofascial release'): 0.06, ('Cancer treatment', \"Nambudripad's Allergy Elimination Techniques\"): 0.06, ('Cancer treatment', 'National Center for Complementary and Alternative Medicine'): 0.03, ('Cancer treatment', 'National Institute for Medical Research'): 0.03, ('Cancer treatment', 'National Institutes of Health'): 0.1, ('Cancer treatment', 'Naturopathy'): 0.06, ('Cancer treatment', 'Nazi archaeology'): 0.03, ('Cancer treatment', 'Nibiru cataclysm'): 0.03, ('Cancer treatment', 'Nicholas Gonzalez (physician)'): 0.03, ('Cancer treatment', 'Numerology'): 0.03, ('Cancer treatment', 'Nutritional supplement'): 0.03, ('Cancer treatment', 'Nutritional supplements'): 0.03, ('Cancer treatment', 'Odometer fraud'): 0.03, ('Cancer treatment', 'Office of Cancer Complementary and Alternative Medicine'): 0.06, ('Cancer treatment', 'Oil pulling'): 0.06, ('Cancer treatment', 'Oncosurgery'): 0.03, ('Cancer treatment', 'Oral polio vaccine AIDS hypothesis'): 0.06, ('Cancer treatment', 'Orgone'): 0.06, ('Cancer treatment', 'Orthomolecular medicine'): 0.06, ('Cancer treatment', 'Orthopathy'): 0.06, ('Cancer treatment', 'Osteomyology'): 0.06, ('Cancer treatment', 'Osteopathy'): 0.06, ('Cancer treatment', 'Overpayment scam'): 0.03, ('Cancer treatment', 'Ozone therapy'): 0.06, ('Cancer treatment', 'Palmistry'): 0.03, ('Cancer treatment', 'Panchagavya'): 0.03, ('Cancer treatment', 'Paranormal'): 0.03, ('Cancer treatment', 'Parapsychology'): 0.06, ('Cancer treatment', 'Parotoid gland'): 0.03, ('Cancer treatment', 'Past life regression'): 0.03, ('Cancer treatment', 'Patent medicine'): 0.03, ('Cancer treatment', 'Paternity fraud'): 0.03, ('Cancer treatment', 'Pathological science'): 0.03, ('Cancer treatment', 'Paul Joseph Watson'): 0.03, ('Cancer treatment', 'Paul Nurse'): 0.03, ('Cancer treatment', 'Perpetual motion'): 0.03, ('Cancer treatment', 'Personal growth'): 0.03, ('Cancer treatment', 'Peter Gruss'): 0.03, ('Cancer treatment', 'Pharmaceutical fraud'): 0.03, ('Cancer treatment', 'Philip Yea'): 0.03, ('Cancer treatment', 'Phone fraud'): 0.03, ('Cancer treatment', 'Phrenology'): 0.06, ('Cancer treatment', 'Placebo effect'): 0.03, ('Cancer treatment', 'Polygraph'): 0.03, ('Cancer treatment', 'Postural Integration'): 0.06, ('Cancer treatment', 'Praying'): 0.03, ('Cancer treatment', 'Pressure point'): 0.06, ('Cancer treatment', 'Price fixing'): 0.03, ('Cancer treatment', 'Primal therapy'): 0.03, ('Cancer treatment', 'Prophetic medicine'): 0.06, ('Cancer treatment', 'Pseudoarchaeology'): 0.03, ('Cancer treatment', 'Pseudohistory'): 0.03, ('Cancer treatment', 'Pseudolaw'): 0.03, ('Cancer treatment', 'Pseudomathematics'): 0.03, ('Cancer treatment', 'Pseudoscience'): 0.06, ('Cancer treatment', 'Pseudoscientific metrology'): 0.03, ('Cancer treatment', 'Psilocybin'): 0.06, ('Cancer treatment', 'Psychic surgery'): 0.06, ('Cancer treatment', 'Psychodermatology'): 0.06, ('Cancer treatment', 'Psychotherapy'): 0.06, ('Cancer treatment', 'Public health'): 0.22, ('Cancer treatment', 'Qi'): 0.06, ('Cancer treatment', 'Quackery'): 0.06, ('Cancer treatment', 'Quackwatch'): 0.06, ('Cancer treatment', 'Quantum healing'): 0.06, ('Cancer treatment', 'Quantum mysticism'): 0.03, ('Cancer treatment', 'Racket (crime)'): 0.03, ('Cancer treatment', 'Radionics'): 0.06, ('Cancer treatment', 'Randolph Stone'): 0.03, ('Cancer treatment', 'Rapid prompting method'): 0.06, ('Cancer treatment', 'Raël'): 0.03, ('Cancer treatment', 'Reactionless drive'): 0.03, ('Cancer treatment', 'Recovered-memory therapy'): 0.03, ('Cancer treatment', 'Reflexology'): 0.06, ('Cancer treatment', 'Regulatory agency'): 0.03, ('Cancer treatment', 'Reichian body-oriented psychotherapy'): 0.06, ('Cancer treatment', 'Reiki'): 0.06, ('Cancer treatment', 'Relaxation technique'): 0.03, ('Cancer treatment', 'Relay For Life'): 0.03, ('Cancer treatment', 'Return fraud'): 0.03, ('Cancer treatment', 'Rhonda Byrne'): 0.03, ('Cancer treatment', 'Richard Treisman'): 0.03, ('Cancer treatment', 'Robert Charroux'): 0.03, ('Cancer treatment', 'Robert F. Kennedy Jr'): 0.03, ('Cancer treatment', 'Robin Lovell-Badge'): 0.03, ('Cancer treatment', 'Rolfing'): 0.06, ('Cancer treatment', 'Romance scam'): 0.03, ('Cancer treatment', 'San Jiao'): 0.06, ('Cancer treatment', 'Scams in intellectual property'): 0.03, ('Cancer treatment', 'Scientific method'): 0.03, ('Cancer treatment', 'Scientific misconduct'): 0.03, ('Cancer treatment', 'Scientific racism'): 0.06, ('Cancer treatment', 'Scientific skepticism'): 0.06, ('Cancer treatment', 'Secretariat of Health'): 0.03, ('Cancer treatment', 'Securities fraud'): 0.03, ('Cancer treatment', 'Selenium'): 0.03, ('Cancer treatment', 'Self-hypnosis'): 0.06, ('Cancer treatment', 'Sense of control'): 0.03, ('Cancer treatment', 'Sham marriage'): 0.03, ('Cancer treatment', 'Shamanism'): 0.06, ('Cancer treatment', 'Shiatsu'): 0.06, ('Cancer treatment', 'Shill'): 0.03, ('Cancer treatment', 'Siddha medicine'): 0.06, ('Cancer treatment', 'Simon Boulton'): 0.03, ('Cancer treatment', 'Skeptical Inquirer'): 0.06, ('Cancer treatment', 'Skepticism'): 0.06, ('Cancer treatment', 'Snake oil'): 0.03, ('Cancer treatment', 'Soursop'): 0.03, ('Cancer treatment', 'Spiritual growth'): 0.03, ('Cancer treatment', 'Spiritual practices'): 0.03, ('Cancer treatment', 'Spiritualism'): 0.03, ('Cancer treatment', 'Spyware'): 0.03, ('Cancer treatment', 'Sri Lankan traditional medicine'): 0.06, ('Cancer treatment', 'Statement analysis'): 0.03, ('Cancer treatment', 'Strauss–Howe generational theory'): 0.03, ('Cancer treatment', 'Sucharit Bhakdi'): 0.03, ('Cancer treatment', 'Superseded theories in science'): 0.03, ('Cancer treatment', 'Supportive psychotherapy'): 0.03, ('Cancer treatment', 'Suppressed research in the Soviet Union'): 0.03, ('Cancer treatment', 'Targeted therapies'): 0.03, ('Cancer treatment', 'Tax evasion'): 0.03, ('Cancer treatment', 'Technical support scam'): 0.03, ('Cancer treatment', 'Telemarketing fraud'): 0.03, ('Cancer treatment', 'Telephone slamming'): 0.03, ('Cancer treatment', 'Teleportation'): 0.03, ('Cancer treatment', 'Terminology of alternative medicine'): 0.06, ('Cancer treatment', 'Thai massage'): 0.06, ('Cancer treatment', 'The Daily Telegraph'): 0.03, ('Cancer treatment', 'The Light (newspaper)'): 0.03, ('Cancer treatment', 'The Lightning Process'): 0.06, ('Cancer treatment', 'The Natural History of Quackery'): 0.03, ('Cancer treatment', 'The Psychology of the Occult'): 0.03, ('Cancer treatment', 'The Ragged Edge of Science'): 0.03, ('Cancer treatment', \"The Skeptic's Dictionary\"): 0.03, ('Cancer treatment', 'The Skeptic Encyclopedia of Pseudoscience'): 0.03, ('Cancer treatment', 'The Truth About Cancer'): 0.03, ('Cancer treatment', 'Theodor Morell'): 0.06, ('Cancer treatment', 'Therapeutic nihilism'): 0.06, ('Cancer treatment', 'Therapeutic touch'): 0.06, ('Cancer treatment', 'ThetaHealing'): 0.06, ('Cancer treatment', 'Thought Field Therapy'): 0.06, ('Cancer treatment', 'Tim Hunt'): 0.03, ('Cancer treatment', 'Tomas Lindahl'): 0.03, ('Cancer treatment', 'Tractor beam'): 0.03, ('Cancer treatment', 'Traditional African medicine'): 0.06, ('Cancer treatment', 'Traditional Cambodian medicine'): 0.06, ('Cancer treatment', 'Traditional Korean medicine'): 0.06, ('Cancer treatment', 'Traditional Mongolian medicine'): 0.06, ('Cancer treatment', 'Traditional Tibetan medicine'): 0.06, ('Cancer treatment', 'Traditional Vietnamese medicine'): 0.06, ('Cancer treatment', 'Traditional bone-setting'): 0.06, ('Cancer treatment', 'Traditional healers of Southern Africa'): 0.06, ('Cancer treatment', 'Traditional medicine'): 0.22, ('Cancer treatment', 'Trepanning'): 0.03, ('Cancer treatment', 'True-believer syndrome'): 0.03, ('Cancer treatment', 'Tui na'): 0.06, ('Cancer treatment', 'Turmeric'): 0.03, ('Cancer treatment', 'U.S. Congress'): 0.03, ('Cancer treatment', 'Ufology'): 0.03, ('Cancer treatment', 'Unani medicine'): 0.06, ('Cancer treatment', 'United Kingdom'): 0.15, ('Cancer treatment', 'United States'): 0.08, ('Cancer treatment', 'United States Federal Trade Commission'): 0.03, ('Cancer treatment', 'University College London'): 0.03, ('Cancer treatment', 'Urophagia'): 0.06, ('Cancer treatment', 'Vaccines and autism'): 0.06, ('Cancer treatment', 'Vaginal steaming'): 0.06, ('Cancer treatment', 'Vassilis Pachnis'): 0.03, ('Cancer treatment', 'Vegetotherapy'): 0.06, ('Cancer treatment', 'Vernon Coleman'): 0.03, ('Cancer treatment', 'Vertebral subluxation'): 0.06, ('Cancer treatment', 'Visa fraud'): 0.03, ('Cancer treatment', 'Vision therapy'): 0.06, ('Cancer treatment', 'Vitalism'): 0.06, ('Cancer treatment', 'Voice stress analysis'): 0.03, ('Cancer treatment', 'Vomit fraud'): 0.03, ('Cancer treatment', 'Voodoo Science'): 0.03, ('Cancer treatment', 'Water-fueled car'): 0.03, ('Cancer treatment', 'Water fluoridation controversy'): 0.06, ('Cancer treatment', 'Water memory'): 0.03, ('Cancer treatment', 'Welfare fraud'): 0.03, ('Cancer treatment', 'Wellcome Trust'): 0.03, ('Cancer treatment', 'White-collar crime'): 0.03, ('Cancer treatment', 'William Donald Kelley'): 0.03, ('Cancer treatment', \"Wilson's temperature syndrome\"): 0.06, ('Cancer treatment', 'Wind turbine syndrome'): 0.03, ('Cancer treatment', 'Wine fraud'): 0.03, ('Cancer treatment', 'Young blood transfusion'): 0.06, ('Cancer treatment', 'Zang-fu'): 0.06, ('Cancer treatment', 'Zero balancing'): 0.06, ('Cancer treatment', 'Pain management'): 0.21, ('Cancer treatment', 'Phrase'): 0.02, ('Cancer treatment', 'Terminology'): 0.02, ('Cancer treatment', 'AmeriPath'): 0.05, ('Cancer treatment', 'Addiction medicine'): 0.23, ('Cancer treatment', 'Addiction psychiatry'): 0.17, ('Cancer treatment', 'Adolescent medicine'): 0.17, ('Cancer treatment', 'Allergy'): 0.25, ('Cancer treatment', 'Allied health professions'): 0.19, ('Cancer treatment', 'American Board of Pathology'): 0.05, ('Cancer treatment', 'American Osteopathic Board of Pathology'): 0.05, ('Cancer treatment', 'Andrology'): 0.17, ('Cancer treatment', 'Anesthesiology'): 0.17, ('Cancer treatment', 'Angiology'): 0.17, ('Cancer treatment', 'Apoptosis'): 0.39, ('Cancer treatment', 'Atrophy'): 0.05, ('Cancer treatment', 'Autopsy'): 0.05, ('Cancer treatment', 'Aviation medicine'): 0.17, ('Cancer treatment', 'Bachelor of Medical Sciences'): 0.17, ('Cancer treatment', 'Bachelor of Medicine, Bachelor of Surgery'): 0.17, ('Cancer treatment', 'Basic research'): 0.05, ('Cancer treatment', 'Biopsy'): 0.19, ('Cancer treatment', 'Blood bank'): 0.05, ('Cancer treatment', 'Blood banking'): 0.05, ('Cancer treatment', 'Bodily fluid'): 0.05, ('Cancer treatment', 'Cardiac surgery'): 0.17, ('Cancer treatment', 'Cardiology'): 0.17, ('Cancer treatment', 'Cardiothoracic surgery'): 0.19, ('Cancer treatment', 'Caseous necrosis'): 0.05, ('Cancer treatment', 'Cause (medicine)'): 0.05, ('Cancer treatment', 'Cell biology'): 0.05, ('Cancer treatment', 'Cell damage'): 0.05, ('Cancer treatment', 'Cell death'): 0.08, ('Cancer treatment', 'Cellular adaptation'): 0.05, ('Cancer treatment', 'Chief physician'): 0.17, ('Cancer treatment', 'Chromatography'): 0.05, ('Cancer treatment', 'Chromosomal translocation'): 0.05, ('Cancer treatment', 'Clinical Pathology'): 0.05, ('Cancer treatment', 'Clinical chemistry'): 0.17, ('Cancer treatment', 'Clinical neurophysiology'): 0.17, ('Cancer treatment', 'Clinical pathology'): 0.17, ('Cancer treatment', 'Clinical research'): 0.05, ('Cancer treatment', 'Coagulative necrosis'): 0.05, ('Cancer treatment', 'Colon (anatomy)'): 0.08, ('Cancer treatment', 'Colorectal polyp'): 0.05, ('Cancer treatment', 'Colorectal surgery'): 0.17, ('Cancer treatment', 'Cytogenetics'): 0.05, ('Cancer treatment', 'Cytopathology'): 0.17, ('Cancer treatment', 'Dentistry'): 0.19, ('Cancer treatment', 'Dermatologist'): 0.05, ('Cancer treatment', 'Dermatology'): 0.17, ('Cancer treatment', 'Digestive system surgery'): 0.17, ('Cancer treatment', 'Digital pathology'): 0.05, ('Cancer treatment', 'Disaster medicine'): 0.17, ('Cancer treatment', 'Disease'): 0.05, ('Cancer treatment', 'Diving medicine'): 0.19, ('Cancer treatment', 'Doctor of Medicine'): 0.17, ('Cancer treatment', 'Doctor of Osteopathic Medicine'): 0.17, ('Cancer treatment', 'Ductal carcinoma'): 0.05, ('Cancer treatment', 'Dura Mater'): 0.05, ('Cancer treatment', 'Dysplasia'): 0.27, ('Cancer treatment', 'Economies of scale'): 0.05, ('Cancer treatment', 'Electron microscope'): 0.05, ('Cancer treatment', 'Electron microscopy'): 0.05, ('Cancer treatment', 'Emergency medicine'): 0.17, ('Cancer treatment', 'Endocrine surgery'): 0.17, ('Cancer treatment', 'Endocrinology'): 0.17, ('Cancer treatment', 'Enzyme assay'): 0.05, ('Cancer treatment', 'Eosin'): 0.05, ('Cancer treatment', 'Evolutionary medicine'): 0.17, ('Cancer treatment', 'Eye surgery'): 0.17, ('Cancer treatment', 'Family medicine'): 0.17, ('Cancer treatment', 'Fat necrosis'): 0.05, ('Cancer treatment', 'Fibrinoid necrosis'): 0.05, ('Cancer treatment', 'Fine-needle aspiration'): 0.05, ('Cancer treatment', 'Flow cytometry'): 0.08, ('Cancer treatment', 'Fluorescence in situ hybridization'): 0.05, ('Cancer treatment', 'Fluorescent'): 0.05, ('Cancer treatment', 'Fluorescent in situ hybridization'): 0.05, ('Cancer treatment', 'Forensic pathology'): 0.05, ('Cancer treatment', 'Forlì'): 0.05, ('Cancer treatment', 'Gangrene'): 0.05, ('Cancer treatment', 'Gastroenterology'): 0.17, ('Cancer treatment', 'Genentech'): 0.05, ('Cancer treatment', 'General pathology'): 0.05, ('Cancer treatment', 'General practice'): 0.17, ('Cancer treatment', 'General surgery'): 0.19, ('Cancer treatment', 'Genetic testing'): 0.14, ('Cancer treatment', 'Geriatrics'): 0.17, ('Cancer treatment', 'Giovan Battista Morgagni'): 0.05, ('Cancer treatment', 'Glandular metaplasia'): 0.05, ('Cancer treatment', 'Gross examination'): 0.05, ('Cancer treatment', 'Gross processing'): 0.05, ('Cancer treatment', 'Gynaecology'): 0.17, ('Cancer treatment', 'Gynecologic oncology'): 0.17, ('Cancer treatment', 'HMO'): 0.05, ('Cancer treatment', 'Haematoxylin'): 0.05, ('Cancer treatment', 'Hand surgery'): 0.17, ('Cancer treatment', 'Hematology'): 0.17, ('Cancer treatment', 'Hematopathology'): 0.08, ('Cancer treatment', 'Hemodynamics'): 0.05, ('Cancer treatment', 'Hemosiderin'): 0.05, ('Cancer treatment', 'Hepatology'): 0.17, ('Cancer treatment', 'Her2neu'): 0.05, ('Cancer treatment', 'Histochemistry'): 0.05, ('Cancer treatment', 'Histology'): 0.11, ('Cancer treatment', 'Histopathology'): 0.05, ('Cancer treatment', 'History of pathology'): 0.05, ('Cancer treatment', 'Hospital medicine'): 0.17, ('Cancer treatment', 'Human lung'): 0.05, ('Cancer treatment', 'Hyperplasia'): 0.27, ('Cancer treatment', 'Hypertrophy'): 0.05, ('Cancer treatment', 'Immotile cilia syndrome'): 0.05, ('Cancer treatment', 'Immunoassay'): 0.05, ('Cancer treatment', 'Immunofluorescence'): 0.05, ('Cancer treatment', 'Immunohistochemistry'): 0.05, ('Cancer treatment', 'Immunology'): 0.17, ('Cancer treatment', 'Immunopathology'): 0.05, ('Cancer treatment', 'Immunophenotype'): 0.05, ('Cancer treatment', 'In situ hybridization'): 0.05, ('Cancer treatment', 'Infection'): 0.18, ('Cancer treatment', 'Infectious diseases (medical specialty)'): 0.17, ('Cancer treatment', 'Inflammation'): 0.28, ('Cancer treatment', 'Intensive care medicine'): 0.17, ('Cancer treatment', 'Internal medicine'): 0.17, ('Cancer treatment', 'Interventional radiologist'): 0.05, ('Cancer treatment', 'Interventional radiology'): 0.17, ('Cancer treatment', 'Ischemia'): 0.12, ('Cancer treatment', 'Italy'): 0.08, ('Cancer treatment', 'Karyolysis'): 0.05, ('Cancer treatment', 'Karyorrhexis'): 0.05, ('Cancer treatment', 'Laser capture microdissection'): 0.05, ('Cancer treatment', 'Lipochrome'): 0.05, ('Cancer treatment', 'Lipofuscin'): 0.05, ('Cancer treatment', 'Liquefactive necrosis'): 0.05, ('Cancer treatment', 'List of pathologists'): 0.05, ('Cancer treatment', 'MD–PhD'): 0.17, ('Cancer treatment', 'Magnifying glass'): 0.05, ('Cancer treatment', 'Mass gathering medicine'): 0.17, ('Cancer treatment', 'Mass spectrometry'): 0.08, ('Cancer treatment', 'Master of Medicine'): 0.17, ('Cancer treatment', 'Master of Surgery'): 0.17, ('Cancer treatment', 'Maternal–fetal medicine'): 0.17, ('Cancer treatment', 'Medical Scientist Training Program'): 0.17, ('Cancer treatment', 'Medical diagnosis'): 0.26, ('Cancer treatment', 'Medical education'): 0.19, ('Cancer treatment', 'Medical genetics'): 0.17, ('Cancer treatment', 'Medical laboratory'): 0.05, ('Cancer treatment', 'Medical license'): 0.05, ('Cancer treatment', 'Medical microbiology'): 0.17, ('Cancer treatment', 'Medical school'): 0.19, ('Cancer treatment', 'Medical specialty'): 0.26, ('Cancer treatment', 'Medical students'): 0.05, ('Cancer treatment', 'Medicare (United States)'): 0.08, ('Cancer treatment', 'Melanin'): 0.08, ('Cancer treatment', 'Meningitis'): 0.08, ('Cancer treatment', 'Metaplasia'): 0.05, ('Cancer treatment', 'Microbiological culture'): 0.05, ('Cancer treatment', 'Microscope'): 0.08, ('Cancer treatment', 'Molecular oncology'): 0.17, ('Cancer treatment', 'Molecular pathology'): 0.05, ('Cancer treatment', 'Myocytolysis'): 0.05, ('Cancer treatment', 'Nanomedicine'): 0.21, ('Cancer treatment', 'Narcology'): 0.17, ('Cancer treatment', 'Necrosis'): 0.08, ('Cancer treatment', 'Neonatology'): 0.17, ('Cancer treatment', 'Nephrology'): 0.17, ('Cancer treatment', 'Neurology'): 0.17, ('Cancer treatment', 'Neuroradiology'): 0.17, ('Cancer treatment', 'Neurosurgery'): 0.19, ('Cancer treatment', 'Neurosurgical anesthesia'): 0.17, ('Cancer treatment', 'Nuclear medicine'): 0.2, ('Cancer treatment', 'Obstetric anesthesiology'): 0.17, ('Cancer treatment', 'Obstetrics'): 0.17, ('Cancer treatment', 'Obstetrics and gynaecology'): 0.17, ('Cancer treatment', 'Occupational medicine'): 0.17, ('Cancer treatment', 'Ophthalmology'): 0.21, ('Cancer treatment', 'Optical microscope'): 0.05, ('Cancer treatment', 'Oral and maxillofacial pathology'): 0.05, ('Cancer treatment', 'Oral and maxillofacial surgery'): 0.17, ('Cancer treatment', 'Oral medicine'): 0.17, ('Cancer treatment', 'Organ (anatomy)'): 0.05, ('Cancer treatment', 'Organ transplantation'): 0.19, ('Cancer treatment', 'Organelles'): 0.05, ('Cancer treatment', 'Orthopedic surgery'): 0.19, ('Cancer treatment', 'Otorhinolaryngology'): 0.17, ('Cancer treatment', 'Outline of medicine'): 0.19, ('Cancer treatment', 'Pap smear'): 0.05, ('Cancer treatment', 'Pap test'): 0.05, ('Cancer treatment', 'Pathogenesis'): 0.09, ('Cancer treatment', 'Pathological Society'): 0.05, ('Cancer treatment', 'Pathology'): 0.19, ('Cancer treatment', 'Pediatric surgery'): 0.17, ('Cancer treatment', 'Pediatrics'): 0.17, ('Cancer treatment', 'Personalized medicine'): 0.19, ('Cancer treatment', 'Pharmacy'): 0.19, ('Cancer treatment', 'Phlebologist'): 0.17, ('Cancer treatment', 'Physical medicine and rehabilitation'): 0.17, ('Cancer treatment', 'Physical therapy'): 0.19, ('Cancer treatment', 'Physician'): 0.19, ('Cancer treatment', 'Pigment'): 0.05, ('Cancer treatment', 'Plastic surgery'): 0.17, ('Cancer treatment', 'Podiatry'): 0.17, ('Cancer treatment', 'Preventive healthcare'): 0.17, ('Cancer treatment', 'Prison healthcare'): 0.17, ('Cancer treatment', 'Programmed cell death'): 0.08, ('Cancer treatment', 'Psychiatry'): 0.19, ('Cancer treatment', 'Pulmonary fibrosis'): 0.05, ('Cancer treatment', 'Pulmonology'): 0.17, ('Cancer treatment', 'Pyknosis'): 0.05, ('Cancer treatment', 'RCPA'): 0.05, ('Cancer treatment', 'RNA'): 0.08, ('Cancer treatment', 'Radiology'): 0.19, ('Cancer treatment', 'Reproductive endocrinology and infertility'): 0.17, ('Cancer treatment', 'Reproductive medicine'): 0.17, ('Cancer treatment', 'Reproductive surgery'): 0.17, ('Cancer treatment', 'Residency (medicine)'): 0.05, ('Cancer treatment', 'Rheumatology'): 0.17, ('Cancer treatment', 'Rural health'): 0.17, ('Cancer treatment', 'Serology'): 0.05, ('Cancer treatment', 'Sexual medicine'): 0.17, ('Cancer treatment', 'Sleep medicine'): 0.17, ('Cancer treatment', 'Sports medicine'): 0.17, ('Cancer treatment', 'Squamous metaplasia'): 0.05, ('Cancer treatment', 'Steatosis'): 0.05, ('Cancer treatment', 'Subspecialty'): 0.17, ('Cancer treatment', 'Surgeon'): 0.05, ('Cancer treatment', 'Surgical oncology'): 0.17, ('Cancer treatment', 'Surgical pathology'): 0.05, ('Cancer treatment', 'Telepathology'): 0.05, ('Cancer treatment', 'Tissue (biology)'): 0.1, ('Cancer treatment', 'Transfusion medicine'): 0.17, ('Cancer treatment', 'Translational research'): 0.05, ('Cancer treatment', 'Trauma surgery'): 0.17, ('Cancer treatment', 'Travel medicine'): 0.17, ('Cancer treatment', 'Tropical medicine'): 0.17, ('Cancer treatment', 'United States and Canadian Academy of Pathology'): 0.05, ('Cancer treatment', 'Urogynecology'): 0.17, ('Cancer treatment', 'Urology'): 0.17, ('Cancer treatment', 'Vascular surgery'): 0.17, ('Cancer treatment', 'Venereology'): 0.17, ('Cancer treatment', 'Veterinary medicine'): 0.17, ('Cancer treatment', 'Veterinary pathology'): 0.05, ('Cancer treatment', 'Wound healing'): 0.12, ('Cancer treatment', 'German Chemical Society'): 0.05, ('Cancer treatment', 'AC133'): 0.04, ('Cancer treatment', 'Aerobic exercise'): 0.04, ('Cancer treatment', 'Alpha-5 beta-1'): 0.04, ('Cancer treatment', 'Alpha-v beta-3'): 0.04, ('Cancer treatment', 'Alpha-v beta-5'): 0.04, ('Cancer treatment', \"Alzheimer's disease\"): 0.15, ('Cancer treatment', 'Anatomical terminology'): 0.14, ('Cancer treatment', 'Ang1'): 0.04, ('Cancer treatment', 'Ang2'): 0.04, ('Cancer treatment', 'Angioblast'): 0.04, ('Cancer treatment', 'Angiogenin'): 0.07, ('Cancer treatment', 'Angiopoietins'): 0.04, ('Cancer treatment', 'Anterior cardinal vein'): 0.04, ('Cancer treatment', 'Aorta'): 0.04, ('Cancer treatment', 'Aortic arches'): 0.04, ('Cancer treatment', 'Aortic sac'): 0.04, ('Cancer treatment', 'Aorticopulmonary septum'): 0.04, ('Cancer treatment', 'Arteriogenesis'): 0.04, ('Cancer treatment', 'Atrioventricular canal'): 0.04, ('Cancer treatment', 'BFGF'): 0.04, ('Cancer treatment', 'Basement membrane'): 0.07, ('Cancer treatment', 'Bilayer'): 0.04, ('Cancer treatment', 'Blood islands'): 0.04, ('Cancer treatment', 'Blood vessel'): 0.13, ('Cancer treatment', 'Blood vessels'): 0.04, ('Cancer treatment', 'Bulbus cordis'): 0.04, ('Cancer treatment', 'CCL2'): 0.08, ('Cancer treatment', 'CD31'): 0.07, ('Cancer treatment', 'COX-2'): 0.04, ('Cancer treatment', 'Capillaries'): 0.04, ('Cancer treatment', 'Cardiovascular diseases'): 0.04, ('Cancer treatment', 'Cell growth'): 0.04, ('Cancer treatment', 'Cell junction'): 0.04, ('Cancer treatment', 'Cell signaling'): 0.11, ('Cancer treatment', 'Chorion'): 0.04, ('Cancer treatment', 'Circulating tumor cell'): 0.09, ('Cancer treatment', 'Circulatory system'): 0.2, ('Cancer treatment', 'Coalescent angiogenesis'): 0.04, ('Cancer treatment', 'Collagen'): 0.1, ('Cancer treatment', 'Collagen, type IV, alpha 1'): 0.04, ('Cancer treatment', 'Common cardinal veins'): 0.04, ('Cancer treatment', 'Concentration'): 0.04, ('Cancer treatment', 'Connecting stalk'): 0.04, ('Cancer treatment', 'DLL4'): 0.04, ('Cancer treatment', 'Diet (nutrition)'): 0.04, ('Cancer treatment', 'Dorsal aorta'): 0.04, ('Cancer treatment', 'Drug resistance'): 0.04, ('Cancer treatment', 'Ductus arteriosus'): 0.04, ('Cancer treatment', 'Ductus venosus'): 0.04, ('Cancer treatment', 'Edema'): 0.07, ('Cancer treatment', 'Embryo'): 0.07, ('Cancer treatment', 'Embryogenesis'): 0.07, ('Cancer treatment', 'Endocardial cushions'): 0.04, ('Cancer treatment', 'Endoglin'): 0.07, ('Cancer treatment', 'Endothelial'): 0.04, ('Cancer treatment', 'Endothelial cell'): 0.04, ('Cancer treatment', 'Endothelial cells'): 0.11, ('Cancer treatment', 'Endothelium'): 0.2, ('Cancer treatment', 'Endurance exercise'): 0.04, ('Cancer treatment', 'Ephrin'): 0.12, ('Cancer treatment', 'FGF-1'): 0.04, ('Cancer treatment', 'FGF-2'): 0.04, ('Cancer treatment', 'Fetal circulation'): 0.04, ('Cancer treatment', 'Fibroblast growth factor'): 0.14, ('Cancer treatment', 'Fibrosis'): 0.04, ('Cancer treatment', 'Foramen ovale (heart)'): 0.04, ('Cancer treatment', 'Foramen secundum'): 0.04, ('Cancer treatment', 'Gene knockout'): 0.07, ('Cancer treatment', 'Granulation tissue'): 0.07, ('Cancer treatment', 'Growth factor'): 0.22, ('Cancer treatment', 'Growth factors'): 0.07, ('Cancer treatment', 'Haematopoiesis'): 0.13, ('Cancer treatment', 'Heart'): 0.07, ('Cancer treatment', 'Heart development'): 0.04, ('Cancer treatment', 'Heart disease'): 0.09, ('Cancer treatment', 'Histamine'): 0.07, ('Cancer treatment', 'Hyperaemia'): 0.04, ('Cancer treatment', 'Hypoxia (medical)'): 0.11, ('Cancer treatment', 'ID1'): 0.07, ('Cancer treatment', 'ID3 (gene)'): 0.07, ('Cancer treatment', 'Immunogenicity'): 0.04, ('Cancer treatment', 'Inferior vena cava'): 0.04, ('Cancer treatment', 'Integrin'): 0.11, ('Cancer treatment', 'Intussusceptive angiogenesis'): 0.04, ('Cancer treatment', 'John Hunter (surgeon)'): 0.04, ('Cancer treatment', 'Judah Folkman'): 0.04, ('Cancer treatment', 'Junctional molecule'): 0.04, ('Cancer treatment', 'Lumen (anatomy)'): 0.07, ('Cancer treatment', 'Lymph sacs'): 0.04, ('Cancer treatment', 'Lymphangiogenesis'): 0.04, ('Cancer treatment', 'Lymphocyte'): 0.2, ('Cancer treatment', 'MRNA'): 0.1, ('Cancer treatment', 'Macular degeneration'): 0.04, ('Cancer treatment', 'Maggot therapy'): 0.04, ('Cancer treatment', 'Malignant'): 0.13, ('Cancer treatment', 'Malignant tumor'): 0.1, ('Cancer treatment', 'Matrix (biology)'): 0.04, ('Cancer treatment', 'Matrix macromolecules'): 0.04, ('Cancer treatment', 'Matrix metalloproteinase'): 0.07, ('Cancer treatment', 'Mechanism of action'): 0.04, ('Cancer treatment', 'Mesoderm'): 0.07, ('Cancer treatment', 'Microcirculation'): 0.04, ('Cancer treatment', 'Mutation'): 0.31, ('Cancer treatment', 'Myofibroblast'): 0.04, ('Cancer treatment', 'NRP-1'): 0.04, ('Cancer treatment', 'Neonatal'): 0.04, ('Cancer treatment', 'Neovascularization'): 0.04, ('Cancer treatment', 'Neuroangiogenesis'): 0.04, ('Cancer treatment', 'Neuropilin'): 0.07, ('Cancer treatment', 'Nitric oxide'): 0.04, ('Cancer treatment', 'Nitric oxide synthase'): 0.07, ('Cancer treatment', 'Notch family of receptors'): 0.04, ('Cancer treatment', 'Oncogenesis'): 0.04, ('Cancer treatment', 'Oxygen'): 0.07, ('Cancer treatment', 'PDGFR'): 0.11, ('Cancer treatment', 'Perforated'): 0.04, ('Cancer treatment', 'Perfusion'): 0.04, ('Cancer treatment', 'Pericyte'): 0.04, ('Cancer treatment', 'Phosphorylation'): 0.07, ('Cancer treatment', 'Placenta'): 0.09, ('Cancer treatment', 'Plasminogen activator'): 0.04, ('Cancer treatment', 'Plasminogen activator inhibitor-1'): 0.04, ('Cancer treatment', 'Platelet-derived growth factor'): 0.21, ('Cancer treatment', 'Platelet derived growth factor'): 0.04, ('Cancer treatment', 'Posterior cardinal vein'): 0.04, ('Cancer treatment', 'Presentation (medical)'): 0.04, ('Cancer treatment', 'Primary interatrial foramen'): 0.04, ('Cancer treatment', 'Primary interventricular foramen'): 0.04, ('Cancer treatment', 'Primitive atrium'): 0.04, ('Cancer treatment', 'Primitive ventricle'): 0.04, ('Cancer treatment', 'Protease'): 0.07, ('Cancer treatment', 'Proteases in angiogenesis'): 0.04, ('Cancer treatment', 'Protein replacement therapy'): 0.04, ('Cancer treatment', 'Protein signalling in heart development'): 0.04, ('Cancer treatment', 'Proteinase'): 0.04, ('Cancer treatment', 'Proteolysis'): 0.04, ('Cancer treatment', 'Proteolytic'): 0.04, ('Cancer treatment', 'Pulmonary artery'): 0.04, ('Cancer treatment', 'Receptor (biochemistry)'): 0.2, ('Cancer treatment', 'Retina'): 0.04, ('Cancer treatment', 'Scar'): 0.04, ('Cancer treatment', 'Semaphorin'): 0.08, ('Cancer treatment', 'Septum intermedium'): 0.04, ('Cancer treatment', 'Septum primum'): 0.04, ('Cancer treatment', 'Septum secundum'): 0.04, ('Cancer treatment', 'Shear stress'): 0.04, ('Cancer treatment', 'Sinus venosus'): 0.04, ('Cancer treatment', 'Smooth muscle cell'): 0.07, ('Cancer treatment', 'Space'): 0.04, ('Cancer treatment', 'Stem cell'): 0.22, ('Cancer treatment', 'Tandem'): 0.04, ('Cancer treatment', 'The Angiogenesis Foundation'): 0.04, ('Cancer treatment', 'Tie-1'): 0.04, ('Cancer treatment', 'Tie-2'): 0.04, ('Cancer treatment', 'Time'): 0.04, ('Cancer treatment', 'Transdifferentiation'): 0.04, ('Cancer treatment', 'Transforming growth factor beta'): 0.04, ('Cancer treatment', 'Transforming growth factor beta receptor'): 0.12, ('Cancer treatment', 'Truncus arteriosus'): 0.04, ('Cancer treatment', 'Tubular heart'): 0.04, ('Cancer treatment', 'Tumor'): 0.23, ('Cancer treatment', 'Tyrosine kinases'): 0.04, ('Cancer treatment', 'Umbilical artery'): 0.04, ('Cancer treatment', 'Umbilical cord'): 0.11, ('Cancer treatment', 'Umbilical vein'): 0.04, ('Cancer treatment', 'VE-cadherin'): 0.07, ('Cancer treatment', 'VEGF-A'): 0.04, ('Cancer treatment', 'VEGFR'): 0.04, ('Cancer treatment', 'Vascular endothelial growth factor'): 0.19, ('Cancer treatment', 'Vascular remodelling in the embryo'): 0.04, ('Cancer treatment', 'Vasculature'): 0.11, ('Cancer treatment', 'Vasculogenesis'): 0.04, ('Cancer treatment', 'Vasculogenic mimicry'): 0.04, ('Cancer treatment', 'Vitelline arteries'): 0.04, ('Cancer treatment', 'Vitelline veins'): 0.04, ('Cancer treatment', 'Western world'): 0.04, ('Cancer treatment', 'Yolk sac'): 0.07, ('Cancer treatment', '5-HT3 antagonist'): 0.07, ('Cancer treatment', 'ACE inhibitor'): 0.04, ('Cancer treatment', 'ATC code A'): 0.04, ('Cancer treatment', 'ATC code A04'): 0.07, ('Cancer treatment', 'ATC code B'): 0.04, ('Cancer treatment', 'ATC code C'): 0.04, ('Cancer treatment', 'ATC code D'): 0.04, ('Cancer treatment', 'ATC code D09'): 0.04, ('Cancer treatment', 'ATC code G'): 0.04, ('Cancer treatment', 'ATC code H'): 0.04, ('Cancer treatment', 'ATC code J'): 0.04, ('Cancer treatment', 'ATC code L'): 0.04, ('Cancer treatment', 'ATC code M'): 0.04, ('Cancer treatment', 'ATC code N'): 0.04, ('Cancer treatment', 'ATC code P'): 0.04, ('Cancer treatment', 'ATC code R'): 0.04, ('Cancer treatment', 'ATC code S'): 0.04, ('Cancer treatment', 'ATC code V'): 0.04, ('Cancer treatment', 'ATCvet code QI'): 0.04, ('Cancer treatment', 'Adverse effect (medicine)'): 0.04, ('Cancer treatment', 'Agonist'): 0.09, ('Cancer treatment', 'Ajwain'): 0.04, ('Cancer treatment', 'Alizapride'): 0.07, ('Cancer treatment', 'Alkylating antineoplastic agent'): 0.07, ('Cancer treatment', 'Alosetron'): 0.07, ('Cancer treatment', 'Amisulpride'): 0.07, ('Cancer treatment', 'Anabolic steroid'): 0.09, ('Cancer treatment', 'Analgesic'): 0.09, ('Cancer treatment', 'Anatomical Therapeutic Chemical Classification System'): 0.13, ('Cancer treatment', 'Anesthetic'): 0.04, ('Cancer treatment', 'Angiotensin II receptor antagonist'): 0.04, ('Cancer treatment', 'Anorectic'): 0.04, ('Cancer treatment', 'Antacid'): 0.04, ('Cancer treatment', 'Anthelmintic'): 0.04, ('Cancer treatment', 'Anti-inflammatory'): 0.08, ('Cancer treatment', 'Anti-obesity medication'): 0.04, ('Cancer treatment', 'Antianginal'): 0.04, ('Cancer treatment', 'Antiarrhythmic agent'): 0.04, ('Cancer treatment', 'Antibacterial'): 0.04, ('Cancer treatment', 'Anticholinergic'): 0.09, ('Cancer treatment', 'Anticoagulant'): 0.04, ('Cancer treatment', 'Anticonvulsant'): 0.04, ('Cancer treatment', 'Antidementia drug'): 0.04, ('Cancer treatment', 'Antidepressant'): 0.07, ('Cancer treatment', 'Antidiarrhoeal'): 0.04, ('Cancer treatment', 'Antidote'): 0.04, ('Cancer treatment', 'Antifibrinolytic'): 0.04, ('Cancer treatment', 'Antifungal drug'): 0.04, ('Cancer treatment', 'Antihemorrhagic'): 0.04, ('Cancer treatment', 'Antihistamine'): 0.07, ('Cancer treatment', 'Antihyperkinetic'): 0.04, ('Cancer treatment', 'Antihypertensive drug'): 0.04, ('Cancer treatment', 'Antimetabolite'): 0.07, ('Cancer treatment', 'Antimicrobial'): 0.04, ('Cancer treatment', 'Antimigraine drug'): 0.04, ('Cancer treatment', 'Antimycobacterial'): 0.04, ('Cancer treatment', 'Antineoplastic'): 0.13, ('Cancer treatment', 'Antiparasitic'): 0.04, ('Cancer treatment', 'Antiplatelet drug'): 0.04, ('Cancer treatment', 'Antipropulsive'): 0.04, ('Cancer treatment', 'Antiprotozoal agent'): 0.04, ('Cancer treatment', 'Antipruritic'): 0.04, ('Cancer treatment', 'Antipsoriatic'): 0.04, ('Cancer treatment', 'Antipsychotic'): 0.04, ('Cancer treatment', 'Antisemitism'): 0.04, ('Cancer treatment', 'Antithrombotic'): 0.04, ('Cancer treatment', 'Antithyroid agent'): 0.04, ('Cancer treatment', 'Antiviral drug'): 0.04, ('Cancer treatment', 'Anxiolytic'): 0.04, ('Cancer treatment', 'Aphrodisiac'): 0.04, ('Cancer treatment', 'Atropine'): 0.09, ('Cancer treatment', 'Azasetron'): 0.07, ('Cancer treatment', 'Bemesetron'): 0.07, ('Cancer treatment', 'Benzodiazepines'): 0.04, ('Cancer treatment', 'Beta blocker'): 0.04, ('Cancer treatment', 'Bile acid sequestrant'): 0.04, ('Cancer treatment', 'Bisphosphonate'): 0.04, ('Cancer treatment', 'Blood'): 0.1, ('Cancer treatment', 'Bone'): 0.16, ('Cancer treatment', 'Bromopride'): 0.07, ('Cancer treatment', 'Bronchodilator'): 0.04, ('Cancer treatment', 'CB1 receptor'): 0.07, ('Cancer treatment', 'Cachexia'): 0.07, ('Cancer treatment', 'Calcium channel blocker'): 0.07, ('Cancer treatment', 'Cannabinoid'): 0.09, ('Cancer treatment', 'Cannabis (drug)'): 0.09, ('Cancer treatment', 'Cardiac glycoside'): 0.04, ('Cancer treatment', 'Cardiac stimulant'): 0.04, ('Cancer treatment', 'Casopitant'): 0.04, ('Cancer treatment', 'Cerium oxalate'): 0.07, ('Cancer treatment', 'Chemoreceptor trigger zone'): 0.07, ('Cancer treatment', 'Chlorpromazine'): 0.09, ('Cancer treatment', 'Cicatrizant'): 0.04, ('Cancer treatment', 'Cilansetron'): 0.07, ('Cancer treatment', 'Cinnarizine'): 0.04, ('Cancer treatment', 'Clebopride'): 0.07, ('Cancer treatment', 'Clozapine'): 0.07, ('Cancer treatment', 'Coagulation'): 0.1, ('Cancer treatment', 'Compazine'): 0.04, ('Cancer treatment', 'Controlled Substances Act'): 0.07, ('Cancer treatment', 'Corticosteroid'): 0.07, ('Cancer treatment', 'Cough medicine'): 0.04, ('Cancer treatment', 'Cyclizine'): 0.07, ('Cancer treatment', 'Cyproheptadine'): 0.07, ('Cancer treatment', 'Dazopride'): 0.07, ('Cancer treatment', 'Decongestant'): 0.04, ('Cancer treatment', 'Deliriant'): 0.07, ('Cancer treatment', 'Depressant'): 0.09, ('Cancer treatment', 'Dexamethasone'): 0.15, ('Cancer treatment', 'Diabetes medication'): 0.04, ('Cancer treatment', 'Dietary mineral'): 0.04, ('Cancer treatment', 'Dimenhydrinate'): 0.09, ('Cancer treatment', 'Diphenhydramine'): 0.09, ('Cancer treatment', 'Disease-modifying antirheumatic drug'): 0.04, ('Cancer treatment', 'Dissociative'): 0.07, ('Cancer treatment', 'Diuretic'): 0.04, ('Cancer treatment', 'Dolasetron'): 0.07, ('Cancer treatment', 'Domperidone'): 0.09, ('Cancer treatment', 'Dopamine antagonist'): 0.09, ('Cancer treatment', 'Doxylamine'): 0.04, ('Cancer treatment', 'Dressing (medical)'): 0.04, ('Cancer treatment', 'Dronabinol'): 0.07, ('Cancer treatment', 'Droperidol'): 0.04, ('Cancer treatment', 'Ectoparasiticide'): 0.04, ('Cancer treatment', 'Emetic'): 0.04, ('Cancer treatment', 'Emetrol'): 0.04, ('Cancer treatment', 'Emollient'): 0.04, ('Cancer treatment', 'Endocrine system'): 0.08, ('Cancer treatment', 'Entactogen'): 0.04, ('Cancer treatment', 'Entheogen'): 0.07, ('Cancer treatment', 'Eritrea'): 0.04, ('Cancer treatment', 'Ethiopia'): 0.04, ('Cancer treatment', 'Euphoria'): 0.07, ('Cancer treatment', 'Eur J Pharmacol'): 0.04, ('Cancer treatment', 'Extrapyramidal system'): 0.07, ('Cancer treatment', 'Fatigue (medical)'): 0.04, ('Cancer treatment', 'Fertility medication'): 0.04, ('Cancer treatment', 'Fibrate'): 0.04, ('Cancer treatment', 'Fosaprepitant'): 0.07, ('Cancer treatment', 'Galanolactone'): 0.04, ('Cancer treatment', 'Gastroenteritis'): 0.07, ('Cancer treatment', 'Gastrointestinal tract'): 0.09, ('Cancer treatment', 'General anaesthetic'): 0.07, ('Cancer treatment', 'Genitourinary system'): 0.04, ('Cancer treatment', 'Ginger'): 0.07, ('Cancer treatment', 'Gingerol'): 0.04, ('Cancer treatment', 'Glucocorticoid'): 0.11, ('Cancer treatment', 'Granisetron'): 0.07, ('Cancer treatment', 'H1 antagonist'): 0.07, ('Cancer treatment', 'H2 antagonist'): 0.04, ('Cancer treatment', 'Haloperidol'): 0.09, ('Cancer treatment', 'Histamine antagonist'): 0.07, ('Cancer treatment', 'Histamine receptor'): 0.04, ('Cancer treatment', 'Hormonal contraception'): 0.07, ('Cancer treatment', 'Human gastrointestinal tract'): 0.04, ('Cancer treatment', 'Human skin'): 0.04, ('Cancer treatment', 'Hydroxyzine'): 0.07, ('Cancer treatment', 'Hyoscine hydrobromide'): 0.07, ('Cancer treatment', 'Hyoscyamine'): 0.07, ('Cancer treatment', 'Hyperemesis gravidarum'): 0.04, ('Cancer treatment', 'Hypnotic'): 0.04, ('Cancer treatment', 'Hypolipidemic agent'): 0.04, ('Cancer treatment', 'Hypothalamic–pituitary hormone'): 0.07, ('Cancer treatment', 'Immunomodulator'): 0.07, ('Cancer treatment', 'Immunostimulant'): 0.04, ('Cancer treatment', 'Immunosuppressive drug'): 0.07, ('Cancer treatment', 'India'): 0.09, ('Cancer treatment', 'Intravenous immunoglobulin'): 0.04, ('Cancer treatment', 'Itopride'): 0.07, ('Cancer treatment', 'JWH cannabinoids'): 0.04, ('Cancer treatment', 'Joint'): 0.04, ('Cancer treatment', 'Laxative'): 0.04, ('Cancer treatment', 'Lerisetron'): 0.07, ('Cancer treatment', 'Local anesthetic'): 0.07, ('Cancer treatment', 'Lorazepam'): 0.09, ('Cancer treatment', \"Management of Parkinson's disease\"): 0.04, ('Cancer treatment', 'Maropitant'): 0.07, ('Cancer treatment', 'Meclizine'): 0.07, ('Cancer treatment', 'Metabolism'): 0.12, ('Cancer treatment', 'Metoclopramide'): 0.09, ('Cancer treatment', 'Metopimazine'): 0.07, ('Cancer treatment', 'Mianserin'): 0.09, ('Cancer treatment', 'Midazolam'): 0.09, ('Cancer treatment', 'Mineralocorticoid'): 0.07, ('Cancer treatment', 'Mirtazapine'): 0.09, ('Cancer treatment', 'Mood stabilizer'): 0.04, ('Cancer treatment', 'Morning sickness'): 0.04, ('Cancer treatment', 'Motion sickness'): 0.07, ('Cancer treatment', 'Muscarinic acetylcholine receptor'): 0.07, ('Cancer treatment', 'Muscimol'): 0.07, ('Cancer treatment', 'Muscle'): 0.07, ('Cancer treatment', 'Muscle relaxant'): 0.07, ('Cancer treatment', 'Muscle spasms'): 0.04, ('Cancer treatment', 'NK1 receptor antagonist'): 0.07, ('Cancer treatment', 'Nabilone'): 0.09, ('Cancer treatment', 'Nervous system'): 0.07, ('Cancer treatment', 'Netupitant'): 0.07, ('Cancer treatment', 'Netupitant/palonosetron'): 0.07, ('Cancer treatment', 'Neuroprotective'): 0.04, ('Cancer treatment', 'Neurotoxin'): 0.04, ('Cancer treatment', 'Non-steroidal anti-inflammatory drug'): 0.07, ('Cancer treatment', 'Nootropic'): 0.07, ('Cancer treatment', 'Olanzapine'): 0.07, ('Cancer treatment', 'Opioid'): 0.14, ('Cancer treatment', 'Orexigenic'): 0.04, ('Cancer treatment', 'Otology'): 0.04, ('Cancer treatment', 'Palonosetron'): 0.07, ('Cancer treatment', 'Peppermint'): 0.04, ('Cancer treatment', 'Platelet'): 0.13, ('Cancer treatment', 'Prochlorperazine'): 0.07, ('Cancer treatment', 'Promethazine'): 0.07, ('Cancer treatment', 'Propofol'): 0.09, ('Cancer treatment', 'Proton-pump inhibitor'): 0.04, ('Cancer treatment', 'Psychedelic drug'): 0.07, ('Cancer treatment', 'Psychedelics, dissociatives and deliriants'): 0.04, ('Cancer treatment', 'Psychomotor agitation'): 0.04, ('Cancer treatment', 'Quetiapine'): 0.07, ('Cancer treatment', 'Radiopharmacology'): 0.07, ('Cancer treatment', 'Ramosetron'): 0.07, ('Cancer treatment', 'Receptor Antagonist'): 0.07, ('Cancer treatment', 'Renin inhibitor'): 0.04, ('Cancer treatment', 'Renin–angiotensin system'): 0.04, ('Cancer treatment', 'Respiratory system'): 0.04, ('Cancer treatment', 'Ricasetron'): 0.07, ('Cancer treatment', 'Risperidone'): 0.09, ('Cancer treatment', 'Rolapitant'): 0.07, ('Cancer treatment', 'Sativex'): 0.04, ('Cancer treatment', 'Schedule II Controlled Substance'): 0.07, ('Cancer treatment', 'Scopolamine'): 0.09, ('Cancer treatment', 'Sedative'): 0.07, ('Cancer treatment', 'Selective estrogen receptor modulator'): 0.09, ('Cancer treatment', 'Senotherapeutics'): 0.04, ('Cancer treatment', 'Sense'): 0.04, ('Cancer treatment', 'Serenic'): 0.04, ('Cancer treatment', 'Serotonin'): 0.07, ('Cancer treatment', 'Serotonin antagonist'): 0.07, ('Cancer treatment', 'Sex steroid'): 0.09, ('Cancer treatment', 'Shogaol'): 0.04, ('Cancer treatment', 'Spindle poison'): 0.07, ('Cancer treatment', 'Statin'): 0.04, ('Cancer treatment', 'Steroid'): 0.07, ('Cancer treatment', 'Stimulant'): 0.07, ('Cancer treatment', 'Synthetic cannabinoids'): 0.04, ('Cancer treatment', 'Tetrahydrocannabinol'): 0.09, ('Cancer treatment', 'The New York Times'): 0.25, ('Cancer treatment', 'Thiethylperazine'): 0.07, ('Cancer treatment', 'Thrombolytic drug'): 0.04, ('Cancer treatment', 'Thyroid hormone'): 0.04, ('Cancer treatment', 'Topoisomerase inhibitor'): 0.12, ('Cancer treatment', 'Trimethobenzamide'): 0.07, ('Cancer treatment', 'Tropisetron'): 0.07, ('Cancer treatment', 'Vaccine'): 0.11, ('Cancer treatment', 'Vasodilation'): 0.07, ('Cancer treatment', 'Vitamin'): 0.07, ('Cancer treatment', 'Wakefulness-promoting agent'): 0.04, ('Cancer treatment', 'Xerostomia'): 0.1, ('Cancer treatment', 'Zatosetron'): 0.07, ('Cancer treatment', 'Ziprasidone'): 0.07, ('Cancer treatment', \"3,7,8,2'-Tetrahydroxyflavone\"): 0.04, ('Cancer treatment', '3,7-Dihydroxyflavone'): 0.04, ('Cancer treatment', '7,3′-Dihydroxyflavone'): 0.04, ('Cancer treatment', \"7,8,2'-Trihydroxyflavone\"): 0.04, ('Cancer treatment', 'ABT-110'): 0.04, ('Cancer treatment', 'ALE-0540'): 0.04, ('Cancer treatment', 'AM7 (drug)'): 0.04, ('Cancer treatment', 'AMG-458'): 0.04, ('Cancer treatment', 'ASP-6294'): 0.04, ('Cancer treatment', 'AVE-1642'): 0.04, ('Cancer treatment', 'AZD-6918'): 0.04, ('Cancer treatment', 'Agerafenib'): 0.08, ('Cancer treatment', 'Altiratinib'): 0.04, ('Cancer treatment', 'Amuvatinib'): 0.04, ('Cancer treatment', 'Angiopoietin 3'): 0.04, ('Cancer treatment', 'Aprutumab'): 0.04, ('Cancer treatment', 'Aprutumab ixadotin'): 0.04, ('Cancer treatment', 'Axitinib (data page)'): 0.04, ('Cancer treatment', 'BMS-754807'): 0.04, ('Cancer treatment', 'BMS-777607'): 0.04, ('Cancer treatment', 'CE-245677'): 0.04, ('Cancer treatment', 'CH-7057288'): 0.04, ('Cancer treatment', 'DMAQ-B1'): 0.04, ('Cancer treatment', 'DS-6051'): 0.04, ('Cancer treatment', 'Dapiclermin'): 0.04, ('Cancer treatment', 'Depatuxizumab'): 0.04, ('Cancer treatment', 'EVT-901'): 0.04, ('Cancer treatment', 'Ersofermin'): 0.04, ('Cancer treatment', 'Fosgonimeton'): 0.04, ('Cancer treatment', 'GBR-900'): 0.04, ('Cancer treatment', 'GZ-389988'): 0.04, ('Cancer treatment', 'Gambogic amide'): 0.04, ('Cancer treatment', 'Glypromate'): 0.04, ('Cancer treatment', 'Golvatinib'): 0.04, ('Cancer treatment', 'INCB28060'): 0.04, ('Cancer treatment', 'JNJ-38877605'): 0.04, ('Cancer treatment', 'LEVI-04'): 0.04, ('Cancer treatment', 'Liatermin'): 0.04, ('Cancer treatment', 'MEDI-578'): 0.04, ('Cancer treatment', 'MK-2461'): 0.04, ('Cancer treatment', 'Milciclib'): 0.04, ('Cancer treatment', 'NVP-ADW742'): 0.04, ('Cancer treatment', 'NVP-AEW541'): 0.04, ('Cancer treatment', 'ONO-4474'): 0.04, ('Cancer treatment', 'ONO-5390556'): 0.04, ('Cancer treatment', 'OSl-906'): 0.04, ('Cancer treatment', 'Oncologic Drugs Advisory Committee'): 0.04, ('Cancer treatment', 'PF-04217903'): 0.04, ('Cancer treatment', 'PF-2341066'): 0.04, ('Cancer treatment', 'PHA-665752'): 0.04, ('Cancer treatment', 'PLX-7486'): 0.04, ('Cancer treatment', 'R1507'): 0.04, ('Cancer treatment', 'RBM-004'): 0.04, ('Cancer treatment', 'Ranevetmab'): 0.04, ('Cancer treatment', 'ReN-1820'): 0.04, ('Cancer treatment', 'Repifermin'): 0.04, ('Cancer treatment', 'SNA-120'): 0.04, ('Cancer treatment', 'SU-11274'): 0.04, ('Cancer treatment', 'TDP6'): 0.04, ('Cancer treatment', 'Telbermin'): 0.04, ('Cancer treatment', 'Telisotuzumab'): 0.04, ('Cancer treatment', 'Telisotuzumab vedotin'): 0.04, ('Cancer treatment', 'Tomoregulin'): 0.04, ('Cancer treatment', 'Trastuzumab duocarmazine'): 0.04, ('Cancer treatment', \"4'-Dimethylamino-7,8-dihydroxyflavone\"): 0.04, ('Cancer treatment', \"7,8,3'-Trihydroxyflavone\"): 0.04, ('Cancer treatment', '7,8-Dihydroxyflavone'): 0.06, ('Cancer treatment', 'ALK1 inhibitor'): 0.04, ('Cancer treatment', 'ANA-12'): 0.04, ('Cancer treatment', 'ANXA2'): 0.09, ('Cancer treatment', 'ATC code L01'): 0.09, ('Cancer treatment', 'Abemaciclib'): 0.09, ('Cancer treatment', 'Acalabrutinib'): 0.09, ('Cancer treatment', 'Adagrasib'): 0.09, ('Cancer treatment', 'Adipotide'): 0.09, ('Cancer treatment', 'Adrenomedullin'): 0.04, ('Cancer treatment', 'Afatinib'): 0.09, ('Cancer treatment', 'Aflibercept'): 0.09, ('Cancer treatment', 'Alacizumab pegol'): 0.04, ('Cancer treatment', 'Alectinib'): 0.09, ('Cancer treatment', 'Alemtuzumab'): 0.09, ('Cancer treatment', 'American Society of Health-System Pharmacists'): 0.06, ('Cancer treatment', 'Amitriptyline'): 0.06, ('Cancer treatment', 'Amivantamab'): 0.09, ('Cancer treatment', 'Amphiregulin'): 0.04, ('Cancer treatment', 'Anaplastic lymphoma kinase'): 0.13, ('Cancer treatment', 'Ancestim'): 0.04, ('Cancer treatment', 'Angiopoietin 1'): 0.04, ('Cancer treatment', 'Angiopoietin 2'): 0.04, ('Cancer treatment', 'Angiopoietin 4'): 0.04, ('Cancer treatment', 'Angiopoietin receptor'): 0.04, ('Cancer treatment', 'Area under the curve (pharmacokinetics)'): 0.06, ('Cancer treatment', 'Artemin'): 0.04, ('Cancer treatment', 'Asciminib'): 0.09, ('Cancer treatment', 'Atezolizumab'): 0.09, ('Cancer treatment', 'Autophagy'): 0.04, ('Cancer treatment', 'Avapritinib'): 0.09, ('Cancer treatment', 'Avelumab'): 0.09, ('Cancer treatment', 'Axokine'): 0.04, ('Cancer treatment', 'BNN-20'): 0.04, ('Cancer treatment', 'BNN-27'): 0.04, ('Cancer treatment', 'Bangladesh'): 0.06, ('Cancer treatment', 'Baricitinib'): 0.13, ('Cancer treatment', 'Bcr-abl fusion protein'): 0.09, ('Cancer treatment', 'Becaplermin'): 0.04, ('Cancer treatment', 'Belantamab mafodotin'): 0.09, ('Cancer treatment', 'Bermekimab'): 0.09, ('Cancer treatment', 'Betacellulin'): 0.04, ('Cancer treatment', 'Binimetinib'): 0.09, ('Cancer treatment', 'Bioavailability'): 0.06, ('Cancer treatment', 'Biological half-life'): 0.06, ('Cancer treatment', 'Blinatumomab'): 0.09, ('Cancer treatment', 'Bosutinib'): 0.09, ('Cancer treatment', 'Brain-derived neurotrophic factor'): 0.09, ('Cancer treatment', 'Brentuximab vedotin'): 0.09, ('Cancer treatment', 'Brigatinib'): 0.09, ('Cancer treatment', \"Bruton's tyrosine kinase\"): 0.09, ('Cancer treatment', 'Burosumab'): 0.04, ('Cancer treatment', 'C-KIT'): 0.06, ('Cancer treatment', 'C-Met'): 0.18, ('Cancer treatment', 'CAS Registry Number'): 0.06, ('Cancer treatment', 'CD117'): 0.22, ('Cancer treatment', 'CD135'): 0.2, ('Cancer treatment', 'CD20'): 0.13, ('Cancer treatment', 'CD30'): 0.2, ('Cancer treatment', 'CD33'): 0.11, ('Cancer treatment', 'CD3 (immunology)'): 0.13, ('Cancer treatment', 'CD52'): 0.11, ('Cancer treatment', 'CDK inhibitor'): 0.12, ('Cancer treatment', 'CSPG5'): 0.04, ('Cancer treatment', 'CYP1A2'): 0.04, ('Cancer treatment', 'CYP2C19'): 0.04, ('Cancer treatment', 'CYP3A4'): 0.09, ('Cancer treatment', 'CYP3A5'): 0.04, ('Cancer treatment', 'Canertinib'): 0.04, ('Cancer treatment', 'Capmatinib'): 0.09, ('Cancer treatment', 'Catumaxomab'): 0.09, ('Cancer treatment', 'Cediranib'): 0.09, ('Cancer treatment', 'Cemiplimab'): 0.09, ('Cancer treatment', 'Cenegermin'): 0.04, ('Cancer treatment', 'Cerebrolysin'): 0.04, ('Cancer treatment', 'Ceritinib'): 0.09, ('Cancer treatment', 'Cetuximab'): 0.09, ('Cancer treatment', 'ChEBI'): 0.06, ('Cancer treatment', 'ChEMBL'): 0.06, ('Cancer treatment', 'ChemSpider'): 0.06, ('Cancer treatment', 'Chemical formula'): 0.06, ('Cancer treatment', 'Chronic myeloid leukemia'): 0.06, ('Cancer treatment', 'Ciliary neurotrophic factor receptor'): 0.04, ('Cancer treatment', 'Cixutumumab'): 0.04, ('Cancer treatment', 'Cmax (pharmacology)'): 0.06, ('Cancer treatment', 'Cobimetinib'): 0.09, ('Cancer treatment', 'Colony-stimulating factor'): 0.08, ('Cancer treatment', 'CompTox Chemicals Dashboard'): 0.06, ('Cancer treatment', 'Connective tissue growth factor'): 0.08, ('Cancer treatment', 'Crenolanib'): 0.04, ('Cancer treatment', 'Crizotinib'): 0.09, ('Cancer treatment', 'Cyclotraxin B'): 0.04, ('Cancer treatment', 'Dacomitinib'): 0.09, ('Cancer treatment', 'DailyMed'): 0.06, ('Cancer treatment', 'Dalotuzumab'): 0.04, ('Cancer treatment', 'Daratumumab'): 0.09, ('Cancer treatment', 'Dasatinib'): 0.09, ('Cancer treatment', 'Dehydroepiandrosterone'): 0.06, ('Cancer treatment', 'Dehydroepiandrosterone sulfate'): 0.06, ('Cancer treatment', 'Denileukin diftitox'): 0.09, ('Cancer treatment', 'Deoxygedunin'): 0.04, ('Cancer treatment', 'Depatuxizumab mafodotin'): 0.04, ('Cancer treatment', 'Deprenyl'): 0.04, ('Cancer treatment', 'Des(1-3)IGF-1'): 0.04, ('Cancer treatment', 'Dihexa'): 0.04, ('Cancer treatment', 'Dinutuximab beta'): 0.09, ('Cancer treatment', 'Diosmetin'): 0.04, ('Cancer treatment', 'Dostarlimab'): 0.09, ('Cancer treatment', 'DrugBank'): 0.06, ('Cancer treatment', 'Drug metabolism'): 0.06, ('Cancer treatment', 'Drug nomenclature'): 0.06, ('Cancer treatment', 'Drugs.com'): 0.06, ('Cancer treatment', 'Duligotumab'): 0.04, ('Cancer treatment', 'Durvalumab'): 0.09, ('Cancer treatment', 'Dusigitumab'): 0.04, ('Cancer treatment', 'ECHA InfoCard'): 0.06, ('Cancer treatment', 'EFNA1'): 0.08, ('Cancer treatment', 'EFNA2'): 0.08, ('Cancer treatment', 'EFNA3'): 0.08, ('Cancer treatment', 'EFNA4'): 0.08, ('Cancer treatment', 'EFNA5'): 0.08, ('Cancer treatment', 'EFNB1'): 0.08, ('Cancer treatment', 'EFNB2'): 0.08, ('Cancer treatment', 'EFNB3'): 0.08, ('Cancer treatment', 'EML4'): 0.11, ('Cancer treatment', 'Edrecolomab'): 0.09, ('Cancer treatment', 'Elotuzumab'): 0.09, ('Cancer treatment', 'Emibetuzumab'): 0.04, ('Cancer treatment', 'Enfortumab vedotin'): 0.09, ('Cancer treatment', 'Entrectinib'): 0.09, ('Cancer treatment', 'EpCAM'): 0.09, ('Cancer treatment', 'Epidermal growth factor'): 0.1, ('Cancer treatment', 'Epidermal growth factor receptor'): 0.23, ('Cancer treatment', 'Epigen'): 0.04, ('Cancer treatment', 'Epiregulin'): 0.04, ('Cancer treatment', 'ErbB'): 0.18, ('Cancer treatment', 'Erdafitinib'): 0.09, ('Cancer treatment', 'Erlotinib'): 0.11, ('Cancer treatment', 'Ertumaxomab'): 0.04, ('Cancer treatment', 'Erythropoietin'): 0.13, ('Cancer treatment', 'European Medicines Agency'): 0.06, ('Cancer treatment', 'Everolimus'): 0.09, ('Cancer treatment', 'Evinacumab'): 0.04, ('Cancer treatment', 'Excretion'): 0.06, ('Cancer treatment', 'Exotoxin'): 0.09, ('Cancer treatment', 'FGF1'): 0.04, ('Cancer treatment', 'FGF10'): 0.04, ('Cancer treatment', 'FGF15/19'): 0.04, ('Cancer treatment', 'FGF17'): 0.04, ('Cancer treatment', 'FGF18'): 0.04, ('Cancer treatment', 'FGF19'): 0.04, ('Cancer treatment', 'FGF2'): 0.04, ('Cancer treatment', 'FGF20'): 0.04, ('Cancer treatment', 'FGF22'): 0.04, ('Cancer treatment', 'FGF23'): 0.04, ('Cancer treatment', 'FGF3'): 0.04, ('Cancer treatment', 'FGF4'): 0.04, ('Cancer treatment', 'FGF5'): 0.04, ('Cancer treatment', 'FGF6'): 0.04, ('Cancer treatment', 'FGF7'): 0.04, ('Cancer treatment', 'FGF8'): 0.04, ('Cancer treatment', 'FGF9'): 0.04, ('Cancer treatment', 'FX007'): 0.04, ('Cancer treatment', 'Fasinumab'): 0.04, ('Cancer treatment', 'Fedratinib'): 0.09, ('Cancer treatment', 'Fibroblast growth factor receptor'): 0.04, ('Cancer treatment', 'Fibroblast growth factor receptor 1'): 0.09, ('Cancer treatment', 'Fibroblast growth factor receptor 2'): 0.06, ('Cancer treatment', 'Fibroblast growth factor receptor 3'): 0.06, ('Cancer treatment', 'Fibroblast growth factor receptor 4'): 0.06, ('Cancer treatment', 'Ficlatuzumab'): 0.04, ('Cancer treatment', 'Figitumumab'): 0.04, ('Cancer treatment', 'Filgotinib'): 0.13, ('Cancer treatment', 'Flanvotumab'): 0.04, ('Cancer treatment', 'Food and Drug Administration'): 0.13, ('Cancer treatment', 'Foretinib'): 0.04, ('Cancer treatment', 'Frunevetmab'): 0.06, ('Cancer treatment', 'Fruquintinib'): 0.09, ('Cancer treatment', 'Fulranumab'): 0.04, ('Cancer treatment', 'Fusion protein'): 0.11, ('Cancer treatment', 'Futibatinib'): 0.09, ('Cancer treatment', 'Futuximab'): 0.04, ('Cancer treatment', 'GFRα1'): 0.04, ('Cancer treatment', 'GFRα2'): 0.04, ('Cancer treatment', 'GFRα3'): 0.04, ('Cancer treatment', 'GFRα4'): 0.04, ('Cancer treatment', 'Ganitumab'): 0.04, ('Cancer treatment', 'Gemtuzumab ozogamicin'): 0.09, ('Cancer treatment', 'Germany'): 0.09, ('Cancer treatment', 'Gilteritinib'): 0.09, ('Cancer treatment', 'Glasdegib'): 0.09, ('Cancer treatment', 'Glia maturation factor'): 0.04, ('Cancer treatment', 'Glial cell line-derived neurotrophic factor'): 0.04, ('Cancer treatment', 'Glofitamab'): 0.09, ('Cancer treatment', 'Glucose-6-phosphate isomerase'): 0.06, ('Cancer treatment', 'Gossypetin'): 0.04, ('Cancer treatment', 'Grandinin'): 0.04, ('Cancer treatment', 'Growth factor receptor'): 0.04, ('Cancer treatment', 'Guide to Pharmacology'): 0.06, ('Cancer treatment', 'HER3'): 0.04, ('Cancer treatment', 'HER4'): 0.04, ('Cancer treatment', 'HIOC'): 0.04, ('Cancer treatment', 'Hand-foot syndrome'): 0.04, ('Cancer treatment', 'Hedgehog signaling pathway'): 0.18, ('Cancer treatment', 'Heparin-binding EGF-like growth factor'): 0.04, ('Cancer treatment', 'Hepatocyte growth factor'): 0.18, ('Cancer treatment', 'Hepatocyte growth factor receptor'): 0.06, ('Cancer treatment', 'Hepatoma-derived growth factor'): 0.04, ('Cancer treatment', 'IC50'): 0.04, ('Cancer treatment', 'IGF-1 LR3'): 0.04, ('Cancer treatment', 'IGFBP1'): 0.04, ('Cancer treatment', 'IGFBP2'): 0.04, ('Cancer treatment', 'IGFBP3'): 0.04, ('Cancer treatment', 'IGFBP4'): 0.04, ('Cancer treatment', 'IGFBP5'): 0.04, ('Cancer treatment', 'IGFBP6'): 0.04, ('Cancer treatment', 'IGFBP7'): 0.04, ('Cancer treatment', 'IUPAC nomenclature of chemistry'): 0.06, ('Cancer treatment', 'Ibritumomab tiuxetan'): 0.12, ('Cancer treatment', 'Ibrutinib'): 0.09, ('Cancer treatment', 'Icotinib'): 0.09, ('Cancer treatment', 'Icrucumab'): 0.04, ('Cancer treatment', 'Imgatuzumab'): 0.04, ('Cancer treatment', 'Infigratinib'): 0.09, ('Cancer treatment', 'Inotuzumab ozogamicin'): 0.09, ('Cancer treatment', 'Insulin'): 0.13, ('Cancer treatment', 'Insulin-like growth factor-binding protein'): 0.04, ('Cancer treatment', 'Insulin-like growth factor 1'): 0.09, ('Cancer treatment', 'Insulin-like growth factor 1 receptor'): 0.06, ('Cancer treatment', 'Insulin-like growth factor 2'): 0.06, ('Cancer treatment', 'Insulin-like growth factor 2 receptor'): 0.06, ('Cancer treatment', 'Interleukin'): 0.1, ('Cancer treatment', 'Interleukin 2'): 0.17, ('Cancer treatment', 'International Chemical Identifier'): 0.06, ('Cancer treatment', 'Isatuximab'): 0.09, ('Cancer treatment', 'JSmol'): 0.06, ('Cancer treatment', 'Janus kinase'): 0.16, ('Cancer treatment', 'K252a'): 0.04, ('Cancer treatment', 'KEGG'): 0.06, ('Cancer treatment', 'KRAS'): 0.11, ('Cancer treatment', 'Keratinocyte growth factor'): 0.04, ('Cancer treatment', 'LM22A-4'): 0.04, ('Cancer treatment', 'Lapatinib'): 0.09, ('Cancer treatment', 'Larotrectinib'): 0.09, ('Cancer treatment', 'Lenvatinib'): 0.09, ('Cancer treatment', 'Lestaurtinib'): 0.13, ('Cancer treatment', 'Leukemia inhibitory factor'): 0.08, ('Cancer treatment', 'Linsitinib'): 0.04, ('Cancer treatment', 'List of adverse effects of axitinib'): 0.04, ('Cancer treatment', 'Liver'): 0.09, ('Cancer treatment', 'Lorlatinib'): 0.09, ('Cancer treatment', 'Low-affinity nerve growth factor receptor'): 0.06, ('Cancer treatment', 'Lymphatic system'): 0.18, ('Cancer treatment', 'MTOR inhibitor'): 0.09, ('Cancer treatment', 'Macrophage-stimulating protein'): 0.04, ('Cancer treatment', 'Masitinib'): 0.09, ('Cancer treatment', 'Matuzumab'): 0.04, ('Cancer treatment', 'Mecasermin'): 0.04, ('Cancer treatment', 'Mecasermin rinfabate'): 0.04, ('Cancer treatment', 'Medicines and Healthcare products Regulatory Agency'): 0.04, ('Cancer treatment', 'MedlinePlus'): 0.09, ('Cancer treatment', 'Midkine'): 0.04, ('Cancer treatment', 'Midostaurin'): 0.13, ('Cancer treatment', 'Migration-stimulating factor'): 0.04, ('Cancer treatment', 'Mirvetuximab soravtansine'): 0.09, ('Cancer treatment', 'Mitogen-activated protein kinase kinase'): 0.14, ('Cancer treatment', 'Mobocertinib'): 0.09, ('Cancer treatment', 'Mogamulizumab'): 0.09, ('Cancer treatment', 'Molar mass'): 0.06, ('Cancer treatment', 'Momelotinib'): 0.13, ('Cancer treatment', 'Mosunetuzumab'): 0.09, ('Cancer treatment', 'Motesanib'): 0.04, ('Cancer treatment', 'Moxetumomab pasudotox'): 0.09, ('Cancer treatment', 'Mubritinib'): 0.04, ('Cancer treatment', 'Murodermin'): 0.04, ('Cancer treatment', 'Myeloid'): 0.09, ('Cancer treatment', 'N-Acetylserotonin'): 0.04, ('Cancer treatment', 'NRG2'): 0.04, ('Cancer treatment', 'NRG3'): 0.04, ('Cancer treatment', 'NRG4'): 0.04, ('Cancer treatment', 'Necitumumab'): 0.09, ('Cancer treatment', 'Nepidermin'): 0.04, ('Cancer treatment', 'Neratinib'): 0.09, ('Cancer treatment', 'Nerve growth factor'): 0.11, ('Cancer treatment', 'Nesvacumab'): 0.04, ('Cancer treatment', 'Neuregulin'): 0.04, ('Cancer treatment', 'Neuregulin-1'): 0.04, ('Cancer treatment', 'Neurotrophin-3'): 0.04, ('Cancer treatment', 'Neurotrophin-4'): 0.04, ('Cancer treatment', 'Neurturin'): 0.04, ('Cancer treatment', 'Nilotinib'): 0.09, ('Cancer treatment', 'Nimotuzumab'): 0.04, ('Cancer treatment', 'Nintedanib'): 0.09, ('Cancer treatment', 'Nivolumab'): 0.09, ('Cancer treatment', 'Non-receptor tyrosine kinase'): 0.09, ('Cancer treatment', 'Norwogonin'): 0.04, ('Cancer treatment', 'Obinutuzumab'): 0.09, ('Cancer treatment', 'Ofatumumab'): 0.09, ('Cancer treatment', 'Olaratumab'): 0.09, ('Cancer treatment', 'Olmutinib'): 0.09, ('Cancer treatment', 'Onartuzumab'): 0.04, ('Cancer treatment', 'Oncomodulin'): 0.04, ('Cancer treatment', 'Oral administration'): 0.06, ('Cancer treatment', 'Osimertinib'): 0.09, ('Cancer treatment', 'PDGFA'): 0.04, ('Cancer treatment', 'PDGFB'): 0.04, ('Cancer treatment', 'PDGFC'): 0.04, ('Cancer treatment', 'PDGFD'): 0.04, ('Cancer treatment', 'Pacritinib'): 0.13, ('Cancer treatment', 'Palbociclib'): 0.11, ('Cancer treatment', 'Palifermin'): 0.04, ('Cancer treatment', 'Panitumumab'): 0.09, ('Cancer treatment', 'Patritumab'): 0.04, ('Cancer treatment', 'Pazopanib'): 0.09, ('Cancer treatment', 'Pegaptanib'): 0.04, ('Cancer treatment', 'Pembrolizumab'): 0.09, ('Cancer treatment', 'Pemigatinib'): 0.09, ('Cancer treatment', 'Persephin'): 0.04, ('Cancer treatment', 'Pertuzumab'): 0.09, ('Cancer treatment', 'Pexidartinib'): 0.09, ('Cancer treatment', 'Pfizer'): 0.06, ('Cancer treatment', 'Pharmacokinetics'): 0.06, ('Cancer treatment', 'Philadelphia chromosome'): 0.09, ('Cancer treatment', 'Pirtobrutinib'): 0.09, ('Cancer treatment', 'Pituitary adenylate cyclase-activating peptide'): 0.04, ('Cancer treatment', 'Placental growth factor'): 0.04, ('Cancer treatment', 'Plasma protein binding'): 0.09, ('Cancer treatment', 'Platelet-derived growth factor receptor'): 0.09, ('Cancer treatment', 'Pleiotrophin'): 0.04, ('Cancer treatment', 'Polatuzumab vedotin'): 0.09, ('Cancer treatment', 'Ponatinib'): 0.09, ('Cancer treatment', 'Pralsetinib'): 0.09, ('Cancer treatment', 'Pregnancy category'): 0.06, ('Cancer treatment', 'Prescription drug'): 0.04, ('Cancer treatment', 'Proapoptotic'): 0.09, ('Cancer treatment', 'Progression-free survival'): 0.04, ('Cancer treatment', 'Prohibitin'): 0.09, ('Cancer treatment', 'PubChem'): 0.06, ('Cancer treatment', 'Quizartinib'): 0.13, ('Cancer treatment', 'R13 (drug)'): 0.04, ('Cancer treatment', 'R7 (drug)'): 0.04, ('Cancer treatment', 'RET proto-oncogene'): 0.18, ('Cancer treatment', 'RTK class III'): 0.09, ('Cancer treatment', 'Radotinib'): 0.09, ('Cancer treatment', 'Ramucirumab'): 0.09, ('Cancer treatment', 'Ranibizumab'): 0.04, ('Cancer treatment', 'Rebastinib'): 0.04, ('Cancer treatment', 'Receptor modulator'): 0.13, ('Cancer treatment', 'Receptor tyrosine kinase'): 0.22, ('Cancer treatment', 'Regorafenib'): 0.09, ('Cancer treatment', 'Regulation of therapeutic goods'): 0.06, ('Cancer treatment', 'Renalase'): 0.04, ('Cancer treatment', 'Repotrectinib'): 0.09, ('Cancer treatment', 'Retifanlimab'): 0.09, ('Cancer treatment', 'Ribociclib'): 0.09, ('Cancer treatment', 'Ridaforolimus'): 0.09, ('Cancer treatment', 'Rilotumumab'): 0.04, ('Cancer treatment', 'Ripretinib'): 0.09, ('Cancer treatment', 'Robatumumab'): 0.04, ('Cancer treatment', 'Rociletinib'): 0.09, ('Cancer treatment', 'Route of administration'): 0.06, ('Cancer treatment', 'Ruxolitinib'): 0.13, ('Cancer treatment', 'Selpercatinib'): 0.09, ('Cancer treatment', 'Selumetinib'): 0.09, ('Cancer treatment', 'Semaxanib'): 0.09, ('Cancer treatment', 'Seribantumab'): 0.04, ('Cancer treatment', 'Simplified molecular-input line-entry system'): 0.06, ('Cancer treatment', 'Somatomedin receptor'): 0.04, ('Cancer treatment', 'Sonidegib'): 0.09, ('Cancer treatment', 'Sorafenib'): 0.15, ('Cancer treatment', 'Sotorasib'): 0.09, ('Cancer treatment', 'Sprifermin'): 0.04, ('Cancer treatment', 'Src (gene)'): 0.09, ('Cancer treatment', 'Standard for the Uniform Scheduling of Medicines and Poisons'): 0.06, ('Cancer treatment', 'Stem cell factor'): 0.08, ('Cancer treatment', 'Sunitinib'): 0.13, ('Cancer treatment', 'Switzerland'): 0.06, ('Cancer treatment', 'T-cell growth factor'): 0.04, ('Cancer treatment', 'Tafasitamab'): 0.09, ('Cancer treatment', 'Tanezumab'): 0.06, ('Cancer treatment', 'Targeted cancer therapy'): 0.09, ('Cancer treatment', 'Tavilermide'): 0.04, ('Cancer treatment', 'Tebentafusp'): 0.09, ('Cancer treatment', 'Temsirolimus'): 0.09, ('Cancer treatment', 'Tepotinib'): 0.09, ('Cancer treatment', 'Teprotumumab'): 0.04, ('Cancer treatment', 'Therapeutic Goods Administration'): 0.04, ('Cancer treatment', 'Thrombopoietin'): 0.08, ('Cancer treatment', 'Tivantinib'): 0.04, ('Cancer treatment', 'Tivozanib'): 0.09, ('Cancer treatment', 'Toceranib'): 0.09, ('Cancer treatment', 'Tositumomab'): 0.09, ('Cancer treatment', 'Tovetumab'): 0.04, ('Cancer treatment', 'Trafermin'): 0.04, ('Cancer treatment', 'Trametinib'): 0.09, ('Cancer treatment', 'Transforming growth factor alpha'): 0.04, ('Cancer treatment', 'Trastuzumab/hyaluronidase'): 0.09, ('Cancer treatment', 'Trastuzumab deruxtecan'): 0.09, ('Cancer treatment', 'Trastuzumab emtansine'): 0.09, ('Cancer treatment', 'Trilaciclib'): 0.09, ('Cancer treatment', 'TrkA receptor'): 0.04, ('Cancer treatment', 'VM-902A'): 0.04, ('Cancer treatment', 'Velafermin'): 0.04, ('Cancer treatment', 'WHI-P 154'): 0.08, ('Cancer treatment', 'Xentuzumab'): 0.04, ('Cancer treatment', 'TrkB receptor'): 0.04, ('Cancer treatment', 'TrkC receptor'): 0.04, ('Cancer treatment', 'Trk receptor'): 0.04, ('Cancer treatment', 'Trofinetide'): 0.04, ('Cancer treatment', 'Tucatinib'): 0.09, ('Cancer treatment', 'Tyrosine kinase inhibitors'): 0.04, ('Cancer treatment', 'UGT1A1'): 0.06, ('Cancer treatment', 'Unique Ingredient Identifier'): 0.06, ('Cancer treatment', 'V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog'): 0.04, ('Cancer treatment', 'VEGFR1'): 0.06, ('Cancer treatment', 'VEGFR2'): 0.06, ('Cancer treatment', 'VEGFR3'): 0.04, ('Cancer treatment', 'VEGF receptor'): 0.04, ('Cancer treatment', 'VEGF receptors'): 0.09, ('Cancer treatment', 'Vandetanib'): 0.09, ('Cancer treatment', 'Vascular endothelial growth factor A'): 0.09, ('Cancer treatment', 'Vascular endothelial growth factor B'): 0.04, ('Cancer treatment', 'Vascular endothelial growth factor C'): 0.04, ('Cancer treatment', 'Vascular endothelial growth factor D'): 0.04, ('Cancer treatment', 'Vascular endothelial growth factor receptor'): 0.04, ('Cancer treatment', 'Venetoclax'): 0.09, ('Cancer treatment', 'Vismodegib'): 0.09, ('Cancer treatment', 'Volitinib'): 0.04, ('Cancer treatment', 'Volume of distribution'): 0.06, ('Cancer treatment', 'Wnt signaling pathway'): 0.17, ('Cancer treatment', 'Xenograft'): 0.06, ('Cancer treatment', 'Zalutumumab'): 0.04, ('Cancer treatment', 'Zanubrutinib'): 0.09, ('Cancer treatment', 'B cell'): 0.18, ('Cancer treatment', 'AKT'): 0.11, ('Cancer treatment', 'AKT1'): 0.11, ('Cancer treatment', 'AP-1 transcription factor'): 0.11, ('Cancer treatment', 'ATF1'): 0.11, ('Cancer treatment', 'Abl gene'): 0.09, ('Cancer treatment', 'Acetaldehyde'): 0.11, ('Cancer treatment', 'Adenomatosis polyposis coli'): 0.09, ('Cancer treatment', 'Akt/PKB signaling pathway'): 0.13, ('Cancer treatment', 'Allele'): 0.09, ('Cancer treatment', 'Alpha-helices'): 0.09, ('Cancer treatment', 'Alpha helix'): 0.13, ('Cancer treatment', 'Androgen receptor'): 0.14, ('Cancer treatment', 'Ashkenazi Jews'): 0.09, ('Cancer treatment', 'Association for Molecular Pathology v. Myriad Genetics'): 0.09, ('Cancer treatment', 'Ataxia telangiectasia and Rad3 related'): 0.09, ('Cancer treatment', 'Ataxia telangiectasia mutated'): 0.17, ('Cancer treatment', 'BACH1'): 0.11, ('Cancer treatment', 'BARD1'): 0.09, ('Cancer treatment', 'BRCA1 protein'): 0.09, ('Cancer treatment', 'BRCA mutation'): 0.09, ('Cancer treatment', 'BRCC3'): 0.09, ('Cancer treatment', 'BRCT domain'): 0.09, ('Cancer treatment', 'BRE (gene)'): 0.09, ('Cancer treatment', 'BRIP1'): 0.14, ('Cancer treatment', 'Base pair'): 0.23, ('Cancer treatment', 'Bcl-2'): 0.09, ('Cancer treatment', 'Beta-catenin'): 0.09, ('Cancer treatment', 'Beta-sheet'): 0.09, ('Cancer treatment', 'Biological patent'): 0.09, ('Cancer treatment', 'Breast'): 0.17, ('Cancer treatment', 'Breast cancer classification'): 0.09, ('Cancer treatment', 'C-Fos'): 0.14, ('Cancer treatment', 'C-Raf'): 0.11, ('Cancer treatment', 'C-jun'): 0.11, ('Cancer treatment', 'C-terminus'): 0.09, ('Cancer treatment', 'CBL (gene)'): 0.09, ('Cancer treatment', 'CDH1 (gene)'): 0.14, ('Cancer treatment', 'CHEK2'): 0.11, ('Cancer treatment', 'CLSPN'): 0.09, ('Cancer treatment', 'CREB-binding protein'): 0.09, ('Cancer treatment', 'CSNK2B'): 0.09, ('Cancer treatment', 'CSTF2'): 0.09, ('Cancer treatment', 'Caretaker gene'): 0.09, ('Cancer treatment', 'Cell cycle'): 0.17, ('Cancer treatment', 'Cell nucleus'): 0.22, ('Cancer treatment', 'Chelation'): 0.09, ('Cancer treatment', 'Chromosome 17 (human)'): 0.09, ('Cancer treatment', 'Cofactor of BRCA1'): 0.09, ('Cancer treatment', 'Comparative genomic hybridization'): 0.09, ('Cancer treatment', 'Cyclin-dependent kinase 2'): 0.11, ('Cancer treatment', 'Cyclin-dependent kinase 4'): 0.11, ('Cancer treatment', 'Cyclin D'): 0.09, ('Cancer treatment', 'Cyclin E'): 0.09, ('Cancer treatment', 'Cysteine'): 0.13, ('Cancer treatment', 'DHX9'): 0.09, ('Cancer treatment', 'DNA mismatch repair'): 0.19, ('Cancer treatment', 'Double-strand break repair model'): 0.09, ('Cancer treatment', 'Double-strand breaks'): 0.09, ('Cancer treatment', 'ELK4'): 0.11, ('Cancer treatment', 'EP300'): 0.09, ('Cancer treatment', 'ERBB3'): 0.11, ('Cancer treatment', 'Ensembl'): 0.28, ('Cancer treatment', 'Ensembl genome database project'): 0.23, ('Cancer treatment', 'Entrez'): 0.28, ('Cancer treatment', 'Estrogen receptor'): 0.16, ('Cancer treatment', 'Estrogen receptor alpha'): 0.11, ('Cancer treatment', 'Eva Y.-H. P. Lee'): 0.09, ('Cancer treatment', 'FANCA'): 0.14, ('Cancer treatment', 'FANCD2'): 0.17, ('Cancer treatment', 'FHL2'): 0.11, ('Cancer treatment', 'Fallopian tube'): 0.09, ('Cancer treatment', 'Fanconi anemia'): 0.11, ('Cancer treatment', 'Federal Court of Australia'): 0.09, ('Cancer treatment', 'Formaldehyde'): 0.14, ('Cancer treatment', 'Gene'): 0.32, ('Cancer treatment', 'GeneCards'): 0.28, ('Cancer treatment', 'Gene expression'): 0.28, ('Cancer treatment', 'Gene nomenclature'): 0.28, ('Cancer treatment', 'Gene ontology'): 0.23, ('Cancer treatment', 'H2AFX'): 0.09, ('Cancer treatment', 'HRAS'): 0.09, ('Cancer treatment', 'Hereditary breast–ovarian cancer syndrome'): 0.09, ('Cancer treatment', 'Heterodimerization'): 0.09, ('Cancer treatment', 'High Court of Australia'): 0.09, ('Cancer treatment', 'Hippo signaling pathway'): 0.13, ('Cancer treatment', 'Histidine'): 0.09, ('Cancer treatment', 'Histone deacetylase'): 0.09, ('Cancer treatment', 'HomoloGene'): 0.23, ('Cancer treatment', 'Homology directed repair'): 0.14, ('Cancer treatment', 'Human genome'): 0.23, ('Cancer treatment', 'Hypomorphic'): 0.09, ('Cancer treatment', 'In vitro'): 0.26, ('Cancer treatment', 'In vivo'): 0.23, ('Cancer treatment', 'Inhibitor of apoptosis'): 0.09, ('Cancer treatment', 'Intracellular signaling peptides and proteins'): 0.09, ('Cancer treatment', 'Invasive lobular carcinoma'): 0.09, ('Cancer treatment', 'Invertebrate'): 0.09, ('Cancer treatment', 'JAK-STAT signaling pathway'): 0.15, ('Cancer treatment', 'JUNB'): 0.11, ('Cancer treatment', 'James G. Herman'): 0.11, ('Cancer treatment', 'JunD'): 0.11, ('Cancer treatment', 'KLF6'): 0.11, ('Cancer treatment', 'LMO4'): 0.09, ('Cancer treatment', 'Laboratory mouse'): 0.23, ('Cancer treatment', 'Ligand (biochemistry)'): 0.15, ('Cancer treatment', 'Locus (genetics)'): 0.23, ('Cancer treatment', 'MAP3K3'): 0.11, ('Cancer treatment', 'MED1'): 0.09, ('Cancer treatment', 'MED17'): 0.09, ('Cancer treatment', 'MED21'): 0.09, ('Cancer treatment', 'MED24'): 0.09, ('Cancer treatment', 'MRE11A'): 0.15, ('Cancer treatment', 'MSH2'): 0.14, ('Cancer treatment', 'MSH3'): 0.09, ('Cancer treatment', 'MSH6'): 0.09, ('Cancer treatment', 'Mary-Claire King'): 0.09, ('Cancer treatment', 'Maspin'): 0.09, ('Cancer treatment', 'Mdm2'): 0.09, ('Cancer treatment', 'Meiosis'): 0.17, ('Cancer treatment', 'Mendelian Inheritance in Man'): 0.23, ('Cancer treatment', 'Merlin (protein)'): 0.09, ('Cancer treatment', 'Methylation'): 0.09, ('Cancer treatment', 'MiRNA'): 0.12, ('Cancer treatment', 'MicroRNA'): 0.17, ('Cancer treatment', 'Mir-17 microRNA precursor family'): 0.09, ('Cancer treatment', 'Mir-30 microRNA precursor'): 0.09, ('Cancer treatment', 'Missense mutation'): 0.09, ('Cancer treatment', 'Mitochondrion'): 0.18, ('Cancer treatment', 'Mothers against decapentaplegic homolog 2'): 0.11, ('Cancer treatment', 'Mothers against decapentaplegic homolog 4'): 0.11, ('Cancer treatment', 'Mouse Genome Informatics'): 0.23, ('Cancer treatment', 'Mre11-Rad50-Nbs1'): 0.09, ('Cancer treatment', 'Multiplex ligation-dependent probe amplification'): 0.09, ('Cancer treatment', 'Myc'): 0.14, ('Cancer treatment', 'Myriad Genetics'): 0.09, ('Cancer treatment', 'N-myc-interactor'): 0.09, ('Cancer treatment', 'NPM1'): 0.09, ('Cancer treatment', 'NUFIP1'): 0.09, ('Cancer treatment', 'Negative elongation factor'): 0.09, ('Cancer treatment', 'Neurofibromin 1'): 0.09, ('Cancer treatment', 'Nibrin'): 0.09, ('Cancer treatment', 'Non-homologous end joining'): 0.19, ('Cancer treatment', 'Notch signaling'): 0.09, ('Cancer treatment', 'Nuclear export signal'): 0.09, ('Cancer treatment', 'Nuclear localization signal'): 0.09, ('Cancer treatment', 'Nuclear receptor coactivator 2'): 0.09, ('Cancer treatment', 'Oncogene'): 0.29, ('Cancer treatment', 'Ortholog'): 0.09, ('Cancer treatment', 'Orthologs'): 0.28, ('Cancer treatment', 'P14arf'): 0.11, ('Cancer treatment', 'P16 (gene)'): 0.11, ('Cancer treatment', 'P53'): 0.29, ('Cancer treatment', 'PALB2'): 0.17, ('Cancer treatment', 'POLR2A'): 0.09, ('Cancer treatment', 'PPP1CA'): 0.09, ('Cancer treatment', 'PTCH1'): 0.09, ('Cancer treatment', 'PTEN (gene)'): 0.11, ('Cancer treatment', 'Paralogy'): 0.09, ('Cancer treatment', 'Penetrance'): 0.11, ('Cancer treatment', 'Poly (ADP-ribose) polymerase'): 0.09, ('Cancer treatment', 'Progesterone receptor'): 0.16, ('Cancer treatment', 'Promoter (biology)'): 0.11, ('Cancer treatment', 'Prophylactic surgery'): 0.09, ('Cancer treatment', 'Protein–protein interaction'): 0.11, ('Cancer treatment', 'Proto-oncogene tyrosine-protein kinase Src'): 0.09, ('Cancer treatment', 'PubMed'): 0.28, ('Cancer treatment', 'Quantitative PCR'): 0.09, ('Cancer treatment', 'RAD51'): 0.17, ('Cancer treatment', 'RBBP4'): 0.09, ('Cancer treatment', 'RBBP7'): 0.09, ('Cancer treatment', 'RBBP8'): 0.09, ('Cancer treatment', 'RELA'): 0.16, ('Cancer treatment', 'RING finger domain'): 0.09, ('Cancer treatment', 'RNA polymerase II'): 0.12, ('Cancer treatment', 'RPL31'): 0.09, ('Cancer treatment', 'Rad50'): 0.09, ('Cancer treatment', 'Ras (protein)'): 0.09, ('Cancer treatment', 'Retinoblastoma-like protein 1'): 0.11, ('Cancer treatment', 'Retinoblastoma-like protein 2'): 0.11, ('Cancer treatment', 'Retinoblastoma protein'): 0.14, ('Cancer treatment', 'SDHB'): 0.09, ('Cancer treatment', 'SDHD'): 0.09, ('Cancer treatment', 'SMARCA4'): 0.09, ('Cancer treatment', 'SMARCB1'): 0.09, ('Cancer treatment', 'STAT1'): 0.11, ('Cancer treatment', 'Sequence homology'): 0.09, ('Cancer treatment', 'Signal transduction'): 0.18, ('Cancer treatment', 'Sister chromatid'): 0.09, ('Cancer treatment', 'Stathmin'): 0.09, ('Cancer treatment', 'Stephen B. Baylin'): 0.11, ('Cancer treatment', 'Supreme Court of the United States'): 0.09, ('Cancer treatment', 'Sydney Morning Herald'): 0.09, ('Cancer treatment', 'TGF beta receptor 2'): 0.09, ('Cancer treatment', 'TGF beta signaling pathway'): 0.13, ('Cancer treatment', 'TOPBP1'): 0.09, ('Cancer treatment', 'Tandem repeat'): 0.14, ('Cancer treatment', 'The Guardian'): 0.09, ('Cancer treatment', 'Three prime untranslated region'): 0.11, ('Cancer treatment', 'Transcription factor'): 0.25, ('Cancer treatment', 'Transcriptional regulation'): 0.09, ('Cancer treatment', 'Triple-negative breast cancer'): 0.09, ('Cancer treatment', 'Tumor suppressor gene'): 0.24, ('Cancer treatment', 'UBE2D1'): 0.09, ('Cancer treatment', 'USF2'): 0.09, ('Cancer treatment', 'Ubiquitin'): 0.09, ('Cancer treatment', 'Ubiquitin ligase'): 0.09, ('Cancer treatment', 'UniProt'): 0.28, ('Cancer treatment', 'University of California, Berkeley'): 0.09, ('Cancer treatment', 'Valosin-containing protein'): 0.09, ('Cancer treatment', 'Vertebrate'): 0.09, ('Cancer treatment', 'Von Hippel–Lindau tumor suppressor'): 0.09, ('Cancer treatment', 'WT1'): 0.14, ('Cancer treatment', 'Wikidata'): 0.28, ('Cancer treatment', 'XIST (gene)'): 0.09, ('Cancer treatment', 'ZNF350'): 0.11, ('Cancer treatment', 'Zn finger'): 0.09, ('Cancer treatment', 'BCG vaccine'): 0.06, ('Cancer treatment', 'Basal-cell carcinoma'): 0.06, ('Cancer treatment', '3-methyladenine'): 0.05, ('Cancer treatment', 'APE1'): 0.05, ('Cancer treatment', 'APE2'): 0.05, ('Cancer treatment', 'Apn1'): 0.05, ('Cancer treatment', 'Apn2'): 0.05, ('Cancer treatment', 'Endonuclease IV'): 0.05, ('Cancer treatment', '5-Methylcytosine'): 0.05, ('Cancer treatment', '5-hydroxymethylcytosine'): 0.05, ('Cancer treatment', '5-methylcytosine'): 0.05, ('Cancer treatment', '7-methylguanosine'): 0.05, ('Cancer treatment', \"8-Oxo-2'-deoxyguanosine\"): 0.05, ('Cancer treatment', '8-Oxoguanine'): 0.05, ('Cancer treatment', '8-oxoguanine'): 0.05, ('Cancer treatment', 'APOBEC3G'): 0.05, ('Cancer treatment', 'AP endonuclease'): 0.05, ('Cancer treatment', 'AP lyase'): 0.05, ('Cancer treatment', 'AP site'): 0.05, ('Cancer treatment', 'Adaptive response'): 0.05, ('Cancer treatment', 'Adenine'): 0.05, ('Cancer treatment', 'Biochemistry'): 0.08, ('Cancer treatment', 'Bloom syndrome protein'): 0.05, ('Cancer treatment', 'CRY1'): 0.05, ('Cancer treatment', 'CRY2'): 0.05, ('Cancer treatment', 'Carcinogenesis'): 0.22, ('Cancer treatment', 'Cognition'): 0.1, ('Cancer treatment', 'CpG site'): 0.07, ('Cancer treatment', 'Cytosine'): 0.05, ('Cancer treatment', 'DDB1'): 0.05, ('Cancer treatment', 'DNA-3-methyladenine glycosylase'): 0.05, ('Cancer treatment', 'DNA Polymerase'): 0.05, ('Cancer treatment', 'DNA base flipping'): 0.05, ('Cancer treatment', 'DNA demethylation'): 0.05, ('Cancer treatment', 'DNA glycosylase'): 0.05, ('Cancer treatment', 'DNA ligase'): 0.05, ('Cancer treatment', 'DNA oxidation'): 0.05, ('Cancer treatment', 'DNA polymerase'): 0.08, ('Cancer treatment', 'DNA polymerase beta'): 0.08, ('Cancer treatment', 'DNA polymerase lambda'): 0.08, ('Cancer treatment', 'Deamination'): 0.05, ('Cancer treatment', 'Deletion (genetics)'): 0.05, ('Cancer treatment', 'Directionality (molecular biology)'): 0.05, ('Cancer treatment', 'Downregulation and upregulation'): 0.07, ('Cancer treatment', 'ERCC1'): 0.07, ('Cancer treatment', 'ERCC2'): 0.05, ('Cancer treatment', 'ERCC4'): 0.05, ('Cancer treatment', 'ERCC5'): 0.05, ('Cancer treatment', 'ERCC6'): 0.05, ('Cancer treatment', 'ERCC8 (gene)'): 0.05, ('Cancer treatment', 'Excinuclease'): 0.05, ('Cancer treatment', 'Excision repair'): 0.05, ('Cancer treatment', 'Excision repair cross-complementing'): 0.05, ('Cancer treatment', 'Exonuclease III'): 0.05, ('Cancer treatment', 'FANCB'): 0.07, ('Cancer treatment', 'FANCE'): 0.05, ('Cancer treatment', 'FANCF'): 0.05, ('Cancer treatment', 'FANCG'): 0.05, ('Cancer treatment', 'FANCI'): 0.05, ('Cancer treatment', 'FANCL'): 0.05, ('Cancer treatment', 'FANCM'): 0.05, ('Cancer treatment', 'FANC proteins'): 0.05, ('Cancer treatment', 'FEN1'): 0.05, ('Cancer treatment', 'Fanconi anemia, complementation group C'): 0.05, ('Cancer treatment', 'Fear conditioning'): 0.05, ('Cancer treatment', 'Flap endonuclease'): 0.05, ('Cancer treatment', 'Gene promoter'): 0.05, ('Cancer treatment', 'Gene silencing'): 0.05, ('Cancer treatment', 'Genetics'): 0.07, ('Cancer treatment', 'Glycosidic bond'): 0.05, ('Cancer treatment', 'Helicase'): 0.05, ('Cancer treatment', 'Hippocampus'): 0.07, ('Cancer treatment', 'Hoogsteen base pair'): 0.05, ('Cancer treatment', 'Host-cell reactivation'): 0.05, ('Cancer treatment', 'Hydantoin'): 0.05, ('Cancer treatment', 'Hypoxanthine'): 0.05, ('Cancer treatment', 'Intron'): 0.05, ('Cancer treatment', 'Ku (protein)'): 0.05, ('Cancer treatment', 'MBD4'): 0.05, ('Cancer treatment', 'MLH1'): 0.07, ('Cancer treatment', 'MUTYH'): 0.05, ('Cancer treatment', 'Meiotic recombination checkpoint'): 0.05, ('Cancer treatment', 'Memory'): 0.05, ('Cancer treatment', 'Messenger RNA'): 0.05, ('Cancer treatment', 'NEIL1'): 0.07, ('Cancer treatment', 'Neurobiological effects of physical exercise'): 0.1, ('Cancer treatment', 'Non-small-cell lung carcinoma'): 0.18, ('Cancer treatment', 'Nucleotide excision repair'): 0.12, ('Cancer treatment', 'O-6-methylguanine-DNA methyltransferase'): 0.13, ('Cancer treatment', 'Okazaki fragment'): 0.05, ('Cancer treatment', 'Oxoguanine glycosylase'): 0.07, ('Cancer treatment', 'PCNA'): 0.05, ('Cancer treatment', 'PNKP'): 0.05, ('Cancer treatment', 'PcrA'): 0.05, ('Cancer treatment', 'Photolyase'): 0.05, ('Cancer treatment', 'Poly ADP ribose polymerase'): 0.1, ('Cancer treatment', 'Postreplication repair'): 0.05, ('Cancer treatment', 'Proliferating cell nuclear antigen'): 0.07, ('Cancer treatment', 'Protein O-GlcNAc transferase'): 0.05, ('Cancer treatment', 'Pyrimidine'): 0.05, ('Cancer treatment', 'RAD23A'): 0.05, ('Cancer treatment', 'RAD23B'): 0.05, ('Cancer treatment', 'RecA'): 0.05, ('Cancer treatment', 'RecF pathway'): 0.05, ('Cancer treatment', 'Replication protein A'): 0.05, ('Cancer treatment', 'SMUG1'): 0.05, ('Cancer treatment', 'SOS box'): 0.05, ('Cancer treatment', 'SOS response'): 0.05, ('Cancer treatment', 'Saccharomyces cerevisiae'): 0.1, ('Cancer treatment', 'Sgs1'): 0.05, ('Cancer treatment', 'Single-nucleotide polymorphism'): 0.05, ('Cancer treatment', 'Slx4'): 0.05, ('Cancer treatment', 'TRAMP complex'): 0.05, ('Cancer treatment', 'Tet methylcytosine dioxygenase 1'): 0.05, ('Cancer treatment', 'Tet methylcytosine dioxygenase 2'): 0.05, ('Cancer treatment', 'Tet methylcytosine dioxygenase 3'): 0.05, ('Cancer treatment', 'Thymidine'): 0.08, ('Cancer treatment', 'Thymine'): 0.05, ('Cancer treatment', 'Thymine-DNA glycosylase'): 0.05, ('Cancer treatment', 'Thymine glycol'): 0.05, ('Cancer treatment', 'Transcription-coupled repair'): 0.05, ('Cancer treatment', 'Transition (genetics)'): 0.05, ('Cancer treatment', 'Uracil'): 0.05, ('Cancer treatment', 'Uracil-DNA glycosylase'): 0.05, ('Cancer treatment', 'White blood cell'): 0.2, ('Cancer treatment', 'XPA'): 0.05, ('Cancer treatment', 'XPB'): 0.05, ('Cancer treatment', 'XPC (gene)'): 0.05, ('Cancer treatment', 'XRCC1'): 0.13, ('Cancer treatment', 'Xanthine'): 0.05, ('Cancer treatment', 'Adipocyte'): 0.07, ('Cancer treatment', 'Adipose tissue'): 0.12, ('Cancer treatment', 'Allogenic'): 0.07, ('Cancer treatment', 'Anemia'): 0.16, ('Cancer treatment', 'Antiretroviral'): 0.07, ('Cancer treatment', 'Aplastic anemia'): 0.07, ('Cancer treatment', 'Appendicular skeleton'): 0.07, ('Cancer treatment', 'Aquaporin'): 0.07, ('Cancer treatment', 'Autologous'): 0.09, ('Cancer treatment', 'Axial skeleton'): 0.07, ('Cancer treatment', 'Band cell'): 0.07, ('Cancer treatment', 'Basophil granulocyte'): 0.07, ('Cancer treatment', 'Basophilic normoblast'): 0.07, ('Cancer treatment', 'Beta cell'): 0.12, ('Cancer treatment', 'Biological tissue'): 0.09, ('Cancer treatment', 'Blood cell'): 0.09, ('Cancer treatment', 'Bone canaliculus'): 0.07, ('Cancer treatment', 'Bone marrow (food)'): 0.07, ('Cancer treatment', 'Bone marrow aspiration'): 0.07, ('Cancer treatment', 'Bone marrow examination'): 0.07, ('Cancer treatment', 'Bone mineral'): 0.07, ('Cancer treatment', 'Cartilage'): 0.12, ('Cancer treatment', 'Cellular compartment'): 0.07, ('Cancer treatment', 'Cellular differentiation'): 0.09, ('Cancer treatment', 'Chemical precursor'): 0.07, ('Cancer treatment', 'Chondroblast'): 0.07, ('Cancer treatment', 'Chondrocyte'): 0.07, ('Cancer treatment', 'Colony stimulating factors'): 0.11, ('Cancer treatment', 'Condyle'): 0.07, ('Cancer treatment', 'Cords of Billroth'): 0.07, ('Cancer treatment', 'Devonian'): 0.07, ('Cancer treatment', 'Diaphysis'): 0.07, ('Cancer treatment', 'Elastic cartilage'): 0.07, ('Cancer treatment', 'Endochondral ossification'): 0.07, ('Cancer treatment', 'Endosteum'): 0.07, ('Cancer treatment', 'Endothelial stem cell'): 0.09, ('Cancer treatment', 'Enthesis'): 0.07, ('Cancer treatment', 'Eosinophil'): 0.12, ('Cancer treatment', 'Eosinophil granulocyte'): 0.07, ('Cancer treatment', 'Eosinophilic band cell'): 0.07, ('Cancer treatment', 'Eosinophilic metamyelocyte'): 0.07, ('Cancer treatment', 'Eosinophilic myelocyte'): 0.07, ('Cancer treatment', 'Epicondyle'): 0.07, ('Cancer treatment', 'Epiphyseal line'): 0.07, ('Cancer treatment', 'Epiphyseal plate'): 0.07, ('Cancer treatment', 'Epiphysis'): 0.07, ('Cancer treatment', 'Erythrocytes'): 0.09, ('Cancer treatment', 'Erythroid'): 0.07, ('Cancer treatment', 'Erythropoiesis'): 0.07, ('Cancer treatment', 'European Synchrotron Radiation Facility'): 0.07, ('Cancer treatment', 'Eusthenopteron'): 0.07, ('Cancer treatment', 'Femur'): 0.07, ('Cancer treatment', 'Fibroblasts'): 0.07, ('Cancer treatment', 'Fibrocartilage'): 0.07, ('Cancer treatment', 'Fibrocartilage callus'): 0.07, ('Cancer treatment', 'Flat bone'): 0.07, ('Cancer treatment', 'Foundational Model of Anatomy'): 0.07, ('Cancer treatment', 'General anesthesia'): 0.09, ('Cancer treatment', 'Germinal center'): 0.07, ('Cancer treatment', 'Gift of Life Marrow Registry'): 0.09, ('Cancer treatment', 'Glycophorin'): 0.07, ('Cancer treatment', 'Granulocytes'): 0.07, ('Cancer treatment', 'Gut-associated lymphoid tissue'): 0.07, ('Cancer treatment', 'HIV'): 0.18, ('Cancer treatment', \"Hassall's corpuscles\"): 0.07, ('Cancer treatment', 'Haversian canal'): 0.07, ('Cancer treatment', 'Hematopoiesis'): 0.12, ('Cancer treatment', 'Hematopoietic stem cell'): 0.14, ('Cancer treatment', 'Hematopoietic system'): 0.07, ('Cancer treatment', 'Hemoglobin'): 0.07, ('Cancer treatment', 'High endothelial venules'): 0.07, ('Cancer treatment', 'Human skull'): 0.07, ('Cancer treatment', 'Human sternum'): 0.07, ('Cancer treatment', 'Humerus'): 0.07, ('Cancer treatment', 'Hyaline cartilage'): 0.07, ('Cancer treatment', 'Iliac crest'): 0.07, ('Cancer treatment', 'Inflammatory bowel disease'): 0.09, ('Cancer treatment', 'Intramembranous ossification'): 0.07, ('Cancer treatment', 'Intravenous therapy'): 0.12, ('Cancer treatment', 'Iron'): 0.07, ('Cancer treatment', 'Irregular bone'): 0.07, ('Cancer treatment', 'LOC100272216'): 0.07, ('Cancer treatment', 'Lacuna (histology)'): 0.07, ('Cancer treatment', 'Latin language'): 0.07, ('Cancer treatment', 'Lingual tonsils'): 0.07, ('Cancer treatment', 'List of distinct cell types in the adult human body'): 0.09, ('Cancer treatment', 'Lizard'): 0.07, ('Cancer treatment', 'Lobe-finned fish'): 0.07, ('Cancer treatment', 'Local anesthesia'): 0.07, ('Cancer treatment', 'Long bone'): 0.07, ('Cancer treatment', 'Long bones'): 0.09, ('Cancer treatment', 'Lymphatic fluid'): 0.07, ('Cancer treatment', 'Lymphatic vessel'): 0.07, ('Cancer treatment', 'Lymphocytes'): 0.07, ('Cancer treatment', 'Macrophages'): 0.12, ('Cancer treatment', 'Mammal'): 0.09, ('Cancer treatment', 'Mantle zone'): 0.07, ('Cancer treatment', 'Marginal zone'): 0.07, ('Cancer treatment', 'Marrow Adipose Tissue'): 0.07, ('Cancer treatment', 'Marrow adipose tissue'): 0.07, ('Cancer treatment', 'Mast cell'): 0.11, ('Cancer treatment', 'Medullary cavity'): 0.07, ('Cancer treatment', 'Megakaryocyte'): 0.07, ('Cancer treatment', 'Mesenchymal stem cell'): 0.12, ('Cancer treatment', 'Mesenchymal stem cells'): 0.09, ('Cancer treatment', 'Metamyelocyte'): 0.07, ('Cancer treatment', 'Metaphysis'): 0.07, ('Cancer treatment', 'Milan'): 0.07, ('Cancer treatment', 'Monash University'): 0.07, ('Cancer treatment', 'Monocyte'): 0.07, ('Cancer treatment', 'Mucosa-associated lymphoid tissue'): 0.07, ('Cancer treatment', 'Multiple myeloma'): 0.19, ('Cancer treatment', 'Multipotent'): 0.07, ('Cancer treatment', 'Myeloblast'): 0.07, ('Cancer treatment', 'Myelofibrosis'): 0.07, ('Cancer treatment', 'Myelogenous leukemia'): 0.07, ('Cancer treatment', 'Myeloid cell'): 0.07, ('Cancer treatment', 'Myeloid tissue'): 0.07, ('Cancer treatment', 'Myelomonocyte'): 0.07, ('Cancer treatment', 'Myelonecrosis'): 0.07, ('Cancer treatment', 'Myelopoiesis'): 0.07, ('Cancer treatment', 'Myocyte'): 0.07, ('Cancer treatment', 'National Marrow Donor Program'): 0.09, ('Cancer treatment', 'Nature Publishing Group'): 0.07, ('Cancer treatment', 'Neutrophilic band cell'): 0.07, ('Cancer treatment', 'Neutrophilic metamyelocyte'): 0.07, ('Cancer treatment', 'Neutrophilic myelocyte'): 0.07, ('Cancer treatment', 'Organ system'): 0.07, ('Cancer treatment', 'Orthochromatic'): 0.07, ('Cancer treatment', 'Orthochromatic normoblast'): 0.07, ('Cancer treatment', 'Ossein'): 0.07, ('Cancer treatment', 'Ossification'): 0.07, ('Cancer treatment', 'Ossobuco'): 0.07, ('Cancer treatment', 'Osteoblast'): 0.07, ('Cancer treatment', 'Osteoblasts'): 0.07, ('Cancer treatment', 'Osteoclast'): 0.07, ('Cancer treatment', 'Osteoclasts'): 0.07, ('Cancer treatment', 'Osteocyte'): 0.07, ('Cancer treatment', 'Osteoid'): 0.07, ('Cancer treatment', 'Osteon'): 0.07, ('Cancer treatment', 'Outpatient surgery'): 0.07, ('Cancer treatment', 'Palatine tonsil'): 0.07, ('Cancer treatment', 'Pancytopenia'): 0.07, ('Cancer treatment', 'Pelvis'): 0.07, ('Cancer treatment', 'Periarteriolar lymphoid sheaths'): 0.07, ('Cancer treatment', 'Perichondrium'): 0.07, ('Cancer treatment', 'Periosteum'): 0.07, ('Cancer treatment', 'Peripheral blood'): 0.07, ('Cancer treatment', 'Peripheral venous catheter'): 0.07, ('Cancer treatment', \"Peyer's patch\"): 0.07, ('Cancer treatment', 'Pharyngeal tonsil'): 0.07, ('Cancer treatment', 'Plasma cell'): 0.09, ('Cancer treatment', 'Platelets'): 0.09, ('Cancer treatment', 'Pluripotential hematopoietic stem cell'): 0.07, ('Cancer treatment', 'Polychromatic normoblast'): 0.07, ('Cancer treatment', 'Polycythemia'): 0.07, ('Cancer treatment', 'Primary bone'): 0.07, ('Cancer treatment', 'Primary lymphoid organs'): 0.07, ('Cancer treatment', 'Progenitor cell'): 0.09, ('Cancer treatment', 'Promyelocyte'): 0.07, ('Cancer treatment', 'Pronormoblast'): 0.07, ('Cancer treatment', 'Prussian blue'): 0.07, ('Cancer treatment', 'Radiation poisoning'): 0.09, ('Cancer treatment', 'Radiograph'): 0.07, ('Cancer treatment', 'Red blood cell'): 0.1, ('Cancer treatment', 'Red pulp'): 0.07, ('Cancer treatment', 'Reference range'): 0.07, ('Cancer treatment', 'Reticular cell'): 0.07, ('Cancer treatment', 'Reticular connective tissue'): 0.07, ('Cancer treatment', 'Rib cage'): 0.07, ('Cancer treatment', 'Ribs'): 0.07, ('Cancer treatment', 'Scapulae'): 0.07, ('Cancer treatment', 'Secondary lymphoid organs'): 0.07, ('Cancer treatment', 'Segmented neutrophil'): 0.07, ('Cancer treatment', 'Sesamoid bone'): 0.07, ('Cancer treatment', \"Sharpey's fibres\"): 0.07, ('Cancer treatment', 'Short bone'): 0.07, ('Cancer treatment', 'Sinusoid blood vessel'): 0.07, ('Cancer treatment', 'Sinusoids'): 0.07, ('Cancer treatment', 'Spleen'): 0.09, ('Cancer treatment', 'Splenic hilum'): 0.07, ('Cancer treatment', 'Spongy bone'): 0.07, ('Cancer treatment', 'Sternum'): 0.07, ('Cancer treatment', 'Stromal cell'): 0.16, ('Cancer treatment', 'Suction (medicine)'): 0.07, ('Cancer treatment', 'T1-weighted MRI'): 0.07, ('Cancer treatment', 'T cell'): 0.19, ('Cancer treatment', 'Terminologia Anatomica'): 0.07, ('Cancer treatment', 'Tetrapod'): 0.07, ('Cancer treatment', 'Thalassemia'): 0.07, ('Cancer treatment', 'Thymus'): 0.12, ('Cancer treatment', 'Tibia'): 0.07, ('Cancer treatment', 'Tonsil'): 0.07, ('Cancer treatment', 'Tonsillar crypts'): 0.07, ('Cancer treatment', 'Trabecula'): 0.07, ('Cancer treatment', 'Trabeculae of spleen'): 0.07, ('Cancer treatment', 'Trabecular arteries'): 0.07, ('Cancer treatment', 'Trabecular veins'): 0.07, ('Cancer treatment', 'Tubal tonsil'): 0.07, ('Cancer treatment', 'Tuberculosis'): 0.14, ('Cancer treatment', 'Uppsala University'): 0.07, ('Cancer treatment', 'Valve'): 0.07, ('Cancer treatment', 'Venipuncture'): 0.07, ('Cancer treatment', 'Vertebra'): 0.07, ('Cancer treatment', 'Vertebrae'): 0.07, ('Cancer treatment', \"Volkmann's canals\"): 0.07, ('Cancer treatment', 'Wake Forest Baptist Medical Center'): 0.07, ('Cancer treatment', \"Waldeyer's tonsillar ring\"): 0.07, ('Cancer treatment', 'White pulp'): 0.07, ('Cancer treatment', \"Wright's stain\"): 0.07, ('Cancer treatment', 'X-ray microtomography'): 0.07, ('Cancer treatment', 'Abdominal pain'): 0.05, ('Cancer treatment', 'Acute pancreatitis'): 0.06, ('Cancer treatment', 'Bile duct'): 0.06, ('Cancer treatment', 'Bowel perforation'): 0.05, ('Cancer treatment', 'Catheter'): 0.05, ('Cancer treatment', 'Chagas disease'): 0.06, ('Cancer treatment', 'Coeliac disease'): 0.05, ('Cancer treatment', 'Complication (medicine)'): 0.07, ('Cancer treatment', 'Dehydration'): 0.05, ('Cancer treatment', 'Differential diagnosis'): 0.07, ('Cancer treatment', 'Digestion'): 0.05, ('Cancer treatment', 'Diseases Database'): 0.07, ('Cancer treatment', 'Duodenum'): 0.05, ('Cancer treatment', 'EMedicine'): 0.11, ('Cancer treatment', 'Ebers Papyrus'): 0.1, ('Cancer treatment', 'Enema'): 0.05, ('Cancer treatment', 'Enteropathy'): 0.05, ('Cancer treatment', 'Gastrinoma'): 0.05, ('Cancer treatment', 'Gastroparesis'): 0.05, ('Cancer treatment', 'Hepatic encephalopathy'): 0.05, ('Cancer treatment', 'ICD-10'): 0.1, ('Cancer treatment', 'Ileum'): 0.05, ('Cancer treatment', 'International Statistical Classification of Diseases and Related Health Problems'): 0.1, ('Cancer treatment', 'Laparoscopy'): 0.05, ('Cancer treatment', 'List of ICD-9 codes'): 0.07, ('Cancer treatment', 'Medical imaging'): 0.06, ('Cancer treatment', 'Medical ultrasonography'): 0.05, ('Cancer treatment', 'Multiple sclerosis'): 0.16, ('Cancer treatment', 'Neoplasia'): 0.05, ('Cancer treatment', 'Pain'): 0.07, ('Cancer treatment', 'Primary biliary cirrhosis'): 0.05, ('Cancer treatment', 'Radiation proctitis'): 0.06, ('Cancer treatment', 'Rectum'): 0.06, ('Cancer treatment', 'Sepsis'): 0.06, ('Cancer treatment', 'Signs and symptoms'): 0.07, ('Cancer treatment', 'Spinal cord'): 0.05, ('Cancer treatment', 'Ultrasound'): 0.05, ('Cancer treatment', 'X-ray'): 0.05, ('Cancer treatment', 'Afterloader'): 0.03, ('Cancer treatment', 'Arbus-reactor'): 0.03, ('Cancer treatment', 'HWGCR'): 0.03, ('Cancer treatment', 'HWLWR'): 0.03, ('Cancer treatment', 'Kernkraftwerk Niederaichbach'): 0.03, ('Cancer treatment', 'MHR-T'): 0.03, ('Cancer treatment', 'MZFR'): 0.03, ('Cancer treatment', 'Prismatic block reactor'): 0.03, ('Cancer treatment', 'ACP1000'): 0.03, ('Cancer treatment', 'ACPR1000'): 0.03, ('Cancer treatment', 'ACR-1000'): 0.03, ('Cancer treatment', 'AP1000'): 0.03, ('Cancer treatment', 'APR+'): 0.03, ('Cancer treatment', 'APR-1400'): 0.03, ('Cancer treatment', 'APWR'): 0.03, ('Cancer treatment', 'ATMEA1'): 0.03, ('Cancer treatment', 'AVR reactor'): 0.03, ('Cancer treatment', 'Abscopal effect'): 0.03, ('Cancer treatment', 'Actinide'): 0.03, ('Cancer treatment', 'Actinide chemistry'): 0.03, ('Cancer treatment', 'Activation product'): 0.03, ('Cancer treatment', 'Advanced Gas-cooled Reactor'): 0.03, ('Cancer treatment', 'Advanced boiling water reactor'): 0.03, ('Cancer treatment', 'Advanced heavy-water reactor'): 0.03, ('Cancer treatment', 'Aircraft Nuclear Propulsion'): 0.03, ('Cancer treatment', 'Alexander Graham Bell'): 0.03, ('Cancer treatment', 'Alpha decay'): 0.03, ('Cancer treatment', 'American Association of Physicists in Medicine'): 0.03, ('Cancer treatment', 'Ancient Greek'): 0.06, ('Cancer treatment', 'Anti-nuclear movement'): 0.03, ('Cancer treatment', 'Anus'): 0.03, ('Cancer treatment', 'Aqueous homogeneous reactor'): 0.03, ('Cancer treatment', 'Atomic gardening'): 0.03, ('Cancer treatment', 'Atomic nucleus'): 0.03, ('Cancer treatment', 'Atrial fibrillation'): 0.03, ('Cancer treatment', 'Autoradiograph'): 0.03, ('Cancer treatment', 'BEAMnrc'): 0.03, ('Cancer treatment', 'BN-1200 reactor'): 0.03, ('Cancer treatment', 'BN-350 reactor'): 0.03, ('Cancer treatment', 'BN-600 reactor'): 0.03, ('Cancer treatment', 'BN-800 reactor'): 0.03, ('Cancer treatment', 'Beloyarsk Nuclear Power Station'): 0.03, ('Cancer treatment', 'Beta decay'): 0.03, ('Cancer treatment', 'Beta ray'): 0.03, ('Cancer treatment', \"Blue Ribbon Commission on America's Nuclear Future\"): 0.03, ('Cancer treatment', 'Boiling water reactor'): 0.03, ('Cancer treatment', 'Bolus (radiation therapy)'): 0.03, ('Cancer treatment', 'Bragg peak'): 0.03, ('Cancer treatment', 'Breasts'): 0.06, ('Cancer treatment', 'Bremsstrahlung'): 0.03, ('Cancer treatment', 'Brennilis Nuclear Power Plant'): 0.03, ('Cancer treatment', 'Bronchi'): 0.03, ('Cancer treatment', 'Bubble fusion'): 0.03, ('Cancer treatment', 'Bystander effect (radiobiology)'): 0.03, ('Cancer treatment', 'CANDU reactor'): 0.03, ('Cancer treatment', 'CAP1400'): 0.03, ('Cancer treatment', 'CFR-600'): 0.03, ('Cancer treatment', 'CPR-1000'): 0.03, ('Cancer treatment', 'Caesium-131'): 0.03, ('Cancer treatment', 'Caesium-137'): 0.03, ('Cancer treatment', 'Carbon dioxide'): 0.03, ('Cancer treatment', 'Carolinas–Virginia Tube Reactor'): 0.03, ('Cancer treatment', 'Cervical cancer'): 0.13, ('Cancer treatment', 'Cervix'): 0.03, ('Cancer treatment', 'China Experimental Fast Reactor'): 0.03, ('Cancer treatment', 'Cobalt'): 0.03, ('Cancer treatment', 'Cobalt-60'): 0.03, ('Cancer treatment', 'Cobalt therapy'): 0.03, ('Cancer treatment', 'Coronary stent'): 0.03, ('Cancer treatment', 'Cyberknife (device)'): 0.03, ('Cancer treatment', 'D50 (radiotherapy)'): 0.03, ('Cancer treatment', 'Deep geological repository'): 0.03, ('Cancer treatment', 'Dense plasma focus'): 0.03, ('Cancer treatment', 'Depleted uranium'): 0.03, ('Cancer treatment', 'Deuterium'): 0.03, ('Cancer treatment', 'Deuterium oxide'): 0.03, ('Cancer treatment', 'Dose-volume histogram'): 0.03, ('Cancer treatment', 'Dose profile'): 0.03, ('Cancer treatment', 'Dose verification system'): 0.03, ('Cancer treatment', 'Dosimetry'): 0.03, ('Cancer treatment', 'Dounreay'): 0.03, ('Cancer treatment', 'Dry cask storage'): 0.03, ('Cancer treatment', 'Dual fluid reactor'): 0.03, ('Cancer treatment', 'EGP-6'): 0.03, ('Cancer treatment', 'EPR (nuclear reactor)'): 0.03, ('Cancer treatment', 'Economic Simplified Boiling Water Reactor'): 0.03, ('Cancer treatment', 'Economics of nuclear power plants'): 0.03, ('Cancer treatment', 'Effects of nuclear explosions'): 0.03, ('Cancer treatment', 'Electron'): 0.03, ('Cancer treatment', 'Electron-beam processing'): 0.03, ('Cancer treatment', 'Electron capture'): 0.03, ('Cancer treatment', 'Electron therapy'): 0.03, ('Cancer treatment', 'Energy Multiplier Module'): 0.03, ('Cancer treatment', 'Enriched uranium'): 0.03, ('Cancer treatment', 'Esophageal cancer'): 0.06, ('Cancer treatment', 'Esophagus'): 0.03, ('Cancer treatment', 'FBR-600'): 0.03, ('Cancer treatment', 'FLiBe'): 0.03, ('Cancer treatment', 'Fast-neutron reactor'): 0.03, ('Cancer treatment', 'Fast Breeder Test Reactor'): 0.03, ('Cancer treatment', 'Fast breeder reactor'): 0.03, ('Cancer treatment', 'Fast neutron'): 0.03, ('Cancer treatment', 'Fast neutron therapy'): 0.03, ('Cancer treatment', 'Fertile material'): 0.03, ('Cancer treatment', 'Field-reversed configuration'): 0.03, ('Cancer treatment', 'Fissile material'): 0.03, ('Cancer treatment', 'Floor of mouth'): 0.03, ('Cancer treatment', 'Food irradiation'): 0.03, ('Cancer treatment', 'Fugen Nuclear Power Plant'): 0.03, ('Cancer treatment', 'Fuji Molten Salt Reactor'): 0.03, ('Cancer treatment', 'Fusion neutron'): 0.03, ('Cancer treatment', 'Fusion power'): 0.03, ('Cancer treatment', 'Fusor'): 0.03, ('Cancer treatment', 'GE BWR'): 0.03, ('Cancer treatment', 'Gall bladder'): 0.03, ('Cancer treatment', 'Gamma Knife'): 0.03, ('Cancer treatment', 'Gamma ray'): 0.03, ('Cancer treatment', 'Gas-cooled fast reactor'): 0.03, ('Cancer treatment', 'Gas-cooled reactor'): 0.03, ('Cancer treatment', 'Gas turbine modular helium reactor'): 0.03, ('Cancer treatment', 'Gemstone irradiation'): 0.03, ('Cancer treatment', 'Generation IV reactor'): 0.03, ('Cancer treatment', 'Gentilly Nuclear Generating Station'): 0.03, ('Cancer treatment', 'Glioblastoma'): 0.16, ('Cancer treatment', 'Gold'): 0.03, ('Cancer treatment', 'Graphite-moderated reactor'): 0.03, ('Cancer treatment', 'Gray (unit)'): 0.06, ('Cancer treatment', 'Greek language'): 0.12, ('Cancer treatment', 'H2O'): 0.03, ('Cancer treatment', 'HTR-10'): 0.03, ('Cancer treatment', 'HTR-PM'): 0.03, ('Cancer treatment', 'Hadron'): 0.03, ('Cancer treatment', 'Heavy-water reactor'): 0.03, ('Cancer treatment', 'Helium'): 0.03, ('Cancer treatment', 'Helium-3'): 0.03, ('Cancer treatment', 'Henri-Alexandre Danlos'): 0.03, ('Cancer treatment', 'Henri Becquerel'): 0.03, ('Cancer treatment', 'High-altitude nuclear explosion'): 0.03, ('Cancer treatment', 'High-level waste'): 0.03, ('Cancer treatment', 'Historical nuclear weapons stockpiles and nuclear tests by country'): 0.03, ('Cancer treatment', 'History of nuclear weapons'): 0.03, ('Cancer treatment', 'Hualong One'): 0.03, ('Cancer treatment', 'Human eye'): 0.03, ('Cancer treatment', 'ICD-9-CM Volume 3'): 0.06, ('Cancer treatment', 'IPHWR'): 0.03, ('Cancer treatment', 'IPHWR-220'): 0.03, ('Cancer treatment', 'IPHWR-700'): 0.03, ('Cancer treatment', 'IPWR-900'): 0.03, ('Cancer treatment', 'Impotence'): 0.03, ('Cancer treatment', 'Inertial confinement fusion'): 0.03, ('Cancer treatment', 'Inertial electrostatic confinement'): 0.03, ('Cancer treatment', 'Integral Molten Salt Reactor'): 0.03, ('Cancer treatment', 'Integral fast reactor'): 0.03, ('Cancer treatment', 'Intraoperative electron radiation therapy'): 0.03, ('Cancer treatment', 'Intraoperative radiation therapy'): 0.03, ('Cancer treatment', 'Iobenguane'): 0.03, ('Cancer treatment', 'Iodine-125'): 0.03, ('Cancer treatment', 'Iodine-131'): 0.03, ('Cancer treatment', 'Iridium-192'): 0.03, ('Cancer treatment', 'Irradiation'): 0.03, ('Cancer treatment', 'Isocenter'): 0.03, ('Cancer treatment', 'Isotope separation'): 0.03, ('Cancer treatment', 'KS 150'): 0.03, ('Cancer treatment', 'Kerena boiling water reactor'): 0.03, ('Cancer treatment', 'Kerma (physics)'): 0.03, ('Cancer treatment', 'Kiloelectronvolt'): 0.03, ('Cancer treatment', 'Lead-cooled fast reactor'): 0.03, ('Cancer treatment', 'Levitated dipole'): 0.03, ('Cancer treatment', 'Light-water reactor'): 0.03, ('Cancer treatment', 'Liquid fluoride thorium reactor'): 0.03, ('Cancer treatment', 'Liquid metal cooled reactor'): 0.03, ('Cancer treatment', 'List of nuclear weapons'): 0.03, ('Cancer treatment', 'List of nuclear weapons tests'): 0.03, ('Cancer treatment', 'List of nuclear weapons tests of the United States'): 0.03, ('Cancer treatment', 'List of states with nuclear weapons'): 0.03, ('Cancer treatment', 'List of weapons of mass destruction treaties'): 0.03, ('Cancer treatment', 'Long-lived fission product'): 0.03, ('Cancer treatment', 'Low-level waste'): 0.03, ('Cancer treatment', 'Lucens reactor'): 0.03, ('Cancer treatment', 'Lungs'): 0.03, ('Cancer treatment', 'Magnetic confinement fusion'): 0.03, ('Cancer treatment', 'Magnetized target fusion'): 0.03, ('Cancer treatment', 'Magnox'): 0.03, ('Cancer treatment', 'Megaelectronvolt'): 0.03, ('Cancer treatment', 'Megavoltage X-rays'): 0.03, ('Cancer treatment', 'Migma'): 0.03, ('Cancer treatment', 'Minor actinide'): 0.03, ('Cancer treatment', 'Mobetron'): 0.03, ('Cancer treatment', 'Molten-Salt Reactor Experiment'): 0.03, ('Cancer treatment', 'Molten salt reactor'): 0.03, ('Cancer treatment', 'Monitor unit'): 0.03, ('Cancer treatment', 'Multi-mission radioisotope thermoelectric generator'): 0.03, ('Cancer treatment', 'Multileaf collimator'): 0.03, ('Cancer treatment', 'Muon-catalyzed fusion'): 0.03, ('Cancer treatment', 'Nanoimpellers'): 0.03, ('Cancer treatment', 'Nasopharynx'): 0.03, ('Cancer treatment', 'Natural nuclear fission reactor'): 0.03, ('Cancer treatment', 'Neutron'): 0.03, ('Cancer treatment', 'Neutron activation'): 0.03, ('Cancer treatment', 'Neutron capture'): 0.03, ('Cancer treatment', 'Neutron capture therapy of cancer'): 0.03, ('Cancer treatment', 'Neutron cross section'): 0.03, ('Cancer treatment', 'Neutron generator'): 0.03, ('Cancer treatment', 'Neutron moderator'): 0.03, ('Cancer treatment', 'Neutron poison'): 0.03, ('Cancer treatment', 'Neutron radiation'): 0.03, ('Cancer treatment', 'Neutron reflector'): 0.03, ('Cancer treatment', 'Neutron temperature'): 0.03, ('Cancer treatment', 'Nuclear-weapon-free zone'): 0.03, ('Cancer treatment', 'Nuclear and radiation accidents and incidents'): 0.03, ('Cancer treatment', 'Nuclear arms race'): 0.03, ('Cancer treatment', 'Nuclear chemistry'): 0.03, ('Cancer treatment', 'Nuclear decommissioning'): 0.03, ('Cancer treatment', 'Nuclear disarmament'): 0.03, ('Cancer treatment', 'Nuclear energy in Argentina'): 0.03, ('Cancer treatment', 'Nuclear energy policy'): 0.03, ('Cancer treatment', 'Nuclear engineering'): 0.03, ('Cancer treatment', 'Nuclear ethics'): 0.03, ('Cancer treatment', 'Nuclear explosion'): 0.03, ('Cancer treatment', 'Nuclear fission'): 0.03, ('Cancer treatment', 'Nuclear fission product'): 0.03, ('Cancer treatment', 'Nuclear fuel'): 0.03, ('Cancer treatment', 'Nuclear fuel cycle'): 0.03, ('Cancer treatment', 'Nuclear fusion'): 0.03, ('Cancer treatment', 'Nuclear material'): 0.03, ('Cancer treatment', 'Nuclear physics'): 0.03, ('Cancer treatment', 'Nuclear power'): 0.03, ('Cancer treatment', 'Nuclear power by country'): 0.03, ('Cancer treatment', 'Nuclear power debate'): 0.03, ('Cancer treatment', 'Nuclear power phase-out'): 0.03, ('Cancer treatment', 'Nuclear power plant'): 0.03, ('Cancer treatment', 'Nuclear proliferation'): 0.03, ('Cancer treatment', 'Nuclear propulsion'): 0.03, ('Cancer treatment', 'Nuclear reactor'): 0.03, ('Cancer treatment', 'Nuclear reactor coolant'): 0.03, ('Cancer treatment', 'Nuclear reprocessing'): 0.03, ('Cancer treatment', 'Nuclear safety and security'): 0.03, ('Cancer treatment', 'Nuclear technology'): 0.03, ('Cancer treatment', 'Nuclear thermal rocket'): 0.03, ('Cancer treatment', 'Nuclear transmutation'): 0.03, ('Cancer treatment', 'Nuclear warfare'): 0.03, ('Cancer treatment', 'Nuclear weapon'): 0.03, ('Cancer treatment', 'Nuclear weapon design'): 0.03, ('Cancer treatment', 'Nuclear weapon yield'): 0.03, ('Cancer treatment', 'Nuclear weapons debate'): 0.03, ('Cancer treatment', 'Nuclear weapons delivery'): 0.03, ('Cancer treatment', 'Nuclear weapons testing'): 0.03, ('Cancer treatment', 'Obninsk Nuclear Power Plant'): 0.03, ('Cancer treatment', 'Oesophagus'): 0.03, ('Cancer treatment', 'Organic matter'): 0.03, ('Cancer treatment', 'Organic nuclear reactor'): 0.03, ('Cancer treatment', 'Oropharynx'): 0.03, ('Cancer treatment', 'Orphaned source'): 0.03, ('Cancer treatment', 'Orthovoltage X-rays'): 0.03, ('Cancer treatment', 'Oxygen enhancement ratio'): 0.03, ('Cancer treatment', 'PRISM (reactor)'): 0.03, ('Cancer treatment', 'Palladium-103'): 0.03, ('Cancer treatment', 'Particle therapy'): 0.03, ('Cancer treatment', 'Pebble-bed reactor'): 0.03, ('Cancer treatment', 'Pencil-beam scanning'): 0.03, ('Cancer treatment', 'Pencil (optics)'): 0.03, ('Cancer treatment', 'Penis'): 0.03, ('Cancer treatment', 'Percentage depth dose curve'): 0.03, ('Cancer treatment', 'Peripheral vascular disease'): 0.03, ('Cancer treatment', 'Photon'): 0.03, ('Cancer treatment', 'Phénix'): 0.03, ('Cancer treatment', 'Pierre Curie'): 0.03, ('Cancer treatment', 'Piqua Nuclear Generating Station'): 0.03, ('Cancer treatment', 'Plaque radiotherapy'): 0.03, ('Cancer treatment', 'Plutonium'): 0.06, ('Cancer treatment', 'Polywell'): 0.03, ('Cancer treatment', 'Positron emission tomography'): 0.06, ('Cancer treatment', 'Pressurized heavy-water reactor'): 0.03, ('Cancer treatment', 'Pressurized water reactor'): 0.03, ('Cancer treatment', 'Prostate brachytherapy'): 0.06, ('Cancer treatment', 'Proton therapy'): 0.03, ('Cancer treatment', 'Prototype Fast Breeder Reactor'): 0.03, ('Cancer treatment', 'Pyroelectric fusion'): 0.03, ('Cancer treatment', 'R4 nuclear reactor'): 0.03, ('Cancer treatment', 'RBMK'): 0.03, ('Cancer treatment', 'RadBall'): 0.03, ('Cancer treatment', 'Radiation-induced lung injury'): 0.06, ('Cancer treatment', 'Radiation burn'): 0.06, ('Cancer treatment', 'Radiation oncologist'): 0.03, ('Cancer treatment', 'Radiation therapist'): 0.03, ('Cancer treatment', 'Radiation treatment planning'): 0.03, ('Cancer treatment', 'Radical prostatectomy'): 0.03, ('Cancer treatment', 'Radioactive waste'): 0.03, ('Cancer treatment', 'Radioimmunotherapy'): 0.03, ('Cancer treatment', 'Radioisotope'): 0.03, ('Cancer treatment', 'Radioisotope thermoelectric generator'): 0.03, ('Cancer treatment', 'Radionuclide'): 0.03, ('Cancer treatment', 'Radium-226'): 0.03, ('Cancer treatment', 'Radium sulfate'): 0.03, ('Cancer treatment', 'Radon'): 0.03, ('Cancer treatment', 'Reactor-grade plutonium'): 0.03, ('Cancer treatment', 'Reduced moderation water reactor'): 0.03, ('Cancer treatment', 'Reprocessed uranium'): 0.03, ('Cancer treatment', 'Reversed field pinch'): 0.03, ('Cancer treatment', 'Rhenium'): 0.03, ('Cancer treatment', 'Robert Abbe'): 0.03, ('Cancer treatment', 'Ruthenium-106'): 0.03, ('Cancer treatment', 'SIR-Spheres'): 0.03, ('Cancer treatment', 'Samarium-153'): 0.03, ('Cancer treatment', 'Samarium (153Sm) lexidronam'): 0.03, ('Cancer treatment', 'Sarcomas'): 0.03, ('Cancer treatment', 'Scintigraphy'): 0.03, ('Cancer treatment', 'Selective internal radiation therapy'): 0.03, ('Cancer treatment', 'Single-photon emission computed tomography'): 0.03, ('Cancer treatment', 'Skin'): 0.08, ('Cancer treatment', 'Skin cancer'): 0.21, ('Cancer treatment', 'Small, sealed, transportable, autonomous reactor'): 0.03, ('Cancer treatment', 'Sodium-cooled fast reactor'): 0.03, ('Cancer treatment', 'Spent fuel pool'): 0.03, ('Cancer treatment', 'Spent nuclear fuel'): 0.03, ('Cancer treatment', 'Spheromak'): 0.03, ('Cancer treatment', 'Squamous cell carcinoma'): 0.08, ('Cancer treatment', 'Stable salt reactor'): 0.03, ('Cancer treatment', 'Steam-generating heavy water reactor'): 0.03, ('Cancer treatment', 'Stellarator'): 0.03, ('Cancer treatment', 'Stereotactic radiation therapy'): 0.03, ('Cancer treatment', 'Strontium-89'): 0.03, ('Cancer treatment', 'Supercritical water reactor'): 0.03, ('Cancer treatment', 'Superficial X-rays'): 0.03, ('Cancer treatment', 'Superphénix'): 0.03, ('Cancer treatment', 'TARGIT'): 0.03, ('Cancer treatment', 'THTR-300'): 0.03, ('Cancer treatment', 'TMSR-500'): 0.03, ('Cancer treatment', 'TMSR-LF1'): 0.03, ('Cancer treatment', 'TNT equivalent'): 0.03, ('Cancer treatment', 'Tantalum'): 0.03, ('Cancer treatment', 'Targeted alpha-particle therapy'): 0.03, ('Cancer treatment', 'Targeted intra-operative radiotherapy'): 0.03, ('Cancer treatment', 'TheraSphere'): 0.03, ('Cancer treatment', 'Thermal neutron'): 0.03, ('Cancer treatment', 'Thermonuclear fusion'): 0.03, ('Cancer treatment', 'Thorium'): 0.03, ('Cancer treatment', 'Tissue-to-air ratio'): 0.03, ('Cancer treatment', 'Tokamak'): 0.03, ('Cancer treatment', 'Tomotherapy'): 0.03, ('Cancer treatment', 'Traveling wave reactor'): 0.03, ('Cancer treatment', 'Tritium'): 0.03, ('Cancer treatment', 'UHTREX'): 0.03, ('Cancer treatment', 'UNGG reactor'): 0.03, ('Cancer treatment', 'Underground nuclear weapons testing'): 0.03, ('Cancer treatment', 'Unsealed source radiotherapy'): 0.03, ('Cancer treatment', 'Uranium'): 0.06, ('Cancer treatment', 'Uranium mining debate'): 0.03, ('Cancer treatment', 'Urethra'): 0.06, ('Cancer treatment', 'Urinary incontinence'): 0.08, ('Cancer treatment', 'VVER'): 0.03, ('Cancer treatment', 'Vagina'): 0.06, ('Cancer treatment', 'Vertebrate trachea'): 0.03, ('Cancer treatment', 'Very-high-temperature reactor'): 0.03, ('Cancer treatment', 'Viagra'): 0.03, ('Cancer treatment', 'Vulva'): 0.03, ('Cancer treatment', 'WR-1'): 0.03, ('Cancer treatment', 'William Duane (physicist)'): 0.03, ('Cancer treatment', 'Yttrium-90'): 0.03, ('Cancer treatment', 'Z-pinch'): 0.03, ('Cancer treatment', 'Ågestaverket'): 0.03, ('Cancer treatment', 'Alcohol (drug)'): 0.1, ('Cancer treatment', 'Chronic fatigue syndrome'): 0.05, ('Cancer treatment', 'Dyspnea'): 0.05, ('Cancer treatment', 'Insomnia'): 0.07, ('Cancer treatment', 'Interleukin 6'): 0.13, ('Cancer treatment', 'Menopause'): 0.07, ('Cancer treatment', 'Methylphenidate'): 0.07, ('Cancer treatment', 'National Cancer Institute'): 0.14, ('Cancer treatment', 'Physical activity'): 0.05, ('Cancer treatment', 'Physical fitness'): 0.05, ('Cancer treatment', 'Psychosocial'): 0.05, ('Cancer treatment', 'Screening (medicine)'): 0.05, ('Cancer treatment', 'Substance abuse'): 0.05, ('Cancer treatment', 'BRAF (gene)'): 0.07, ('Cancer treatment', 'Biomarker'): 0.05, ('Cancer treatment', 'CA-125'): 0.05, ('Cancer treatment', 'Carcinoembryonic antigen'): 0.1, ('Cancer treatment', 'Chronic myelogenous leukemia'): 0.05, ('Cancer treatment', 'Gastrointestinal stromal tumor'): 0.05, ('Cancer treatment', 'Gene duplication'): 0.08, ('Cancer treatment', 'HER2'): 0.05, ('Cancer treatment', 'KIT (gene)'): 0.05, ('Cancer treatment', 'Liver cancer'): 0.1, ('Cancer treatment', 'Mercaptopurine'): 0.07, ('Cancer treatment', 'Merkel cell polyomavirus'): 0.05, ('Cancer treatment', 'MyoD'): 0.05, ('Cancer treatment', 'Oral cancer'): 0.15, ('Cancer treatment', 'Prostate-specific antigen'): 0.05, ('Cancer treatment', 'Proteomics'): 0.06, ('Cancer treatment', 'Relapse'): 0.05, ('Cancer treatment', 'Tumor marker'): 0.08, ('Cancer treatment', 'Tyrosine kinase'): 0.08, ('Cancer treatment', 'Urine'): 0.1, ('Cancer treatment', 'Abiogenesis'): 0.05, ('Cancer treatment', 'Adenoma'): 0.13, ('Cancer treatment', 'Adnaviria'): 0.05, ('Cancer treatment', 'Age of Discovery'): 0.05, ('Cancer treatment', 'Alphasatellitidae'): 0.05, ('Cancer treatment', 'Ampullaviridae'): 0.05, ('Cancer treatment', 'Ancient Egypt'): 0.05, ('Cancer treatment', 'Anelloviridae'): 0.05, ('Cancer treatment', 'Animal'): 0.05, ('Cancer treatment', 'Animalia'): 0.05, ('Cancer treatment', 'Ann Arbor staging'): 0.13, ('Cancer treatment', 'Apicoplast'): 0.05, ('Cancer treatment', 'Archaea'): 0.05, ('Cancer treatment', 'Artificial cell'): 0.05, ('Cancer treatment', 'Avsunviroidae'): 0.05, ('Cancer treatment', 'Bacteria'): 0.15, ('Cancer treatment', 'Bacteriome'): 0.05, ('Cancer treatment', 'Benign tumor'): 0.17, ('Cancer treatment', 'Bicaudaviridae'): 0.05, ('Cancer treatment', 'Bio-like structure'): 0.05, ('Cancer treatment', 'Biological dark matter'): 0.05, ('Cancer treatment', 'Biologist'): 0.05, ('Cancer treatment', 'Blastoma'): 0.13, ('Cancer treatment', 'Blood cells'): 0.05, ('Cancer treatment', 'Bone tumor'): 0.13, ('Cancer treatment', 'Bortezomib'): 0.1, ('Cancer treatment', 'Cancer Cell (journal)'): 0.05, ('Cancer treatment', 'Cancer research'): 0.13, ('Cancer treatment', 'Cancer stem cell'): 0.08, ('Cancer treatment', 'Carcinogen'): 0.15, ('Cancer treatment', 'Carcinogenic bacteria'): 0.15, ('Cancer treatment', 'Carcinoma'): 0.17, ('Cancer treatment', 'Carcinoma in situ'): 0.13, ('Cancer treatment', 'Cell (biology)'): 0.11, ('Cancer treatment', 'Cell division'): 0.05, ('Cancer treatment', 'Chloroplast'): 0.09, ('Cancer treatment', 'Chordoma'): 0.05, ('Cancer treatment', 'Chromatin'): 0.08, ('Cancer treatment', 'Chromoplast'): 0.09, ('Cancer treatment', 'Circular chromosome'): 0.05, ('Cancer treatment', 'Clavaviridae'): 0.05, ('Cancer treatment', 'Clivus (anatomy)'): 0.05, ('Cancer treatment', 'Clonally transmissible cancer'): 0.13, ('Cancer treatment', 'Coacervate'): 0.05, ('Cancer treatment', 'Colicin'): 0.05, ('Cancer treatment', 'Connective tissue'): 0.08, ('Cancer treatment', 'Cosmid'): 0.05, ('Cancer treatment', 'Cranium'): 0.05, ('Cancer treatment', 'Cyst'): 0.13, ('Cancer treatment', 'Cytoplasm'): 0.15, ('Cancer treatment', 'DMC1 (gene)'): 0.05, ('Cancer treatment', 'DNA repair-deficiency disorder'): 0.08, ('Cancer treatment', 'DNA transcription'): 0.05, ('Cancer treatment', 'DNA transposon'): 0.05, ('Cancer treatment', 'DNA virus'): 0.05, ('Cancer treatment', 'Defective interfering particle'): 0.05, ('Cancer treatment', 'Digestive system neoplasm'): 0.13, ('Cancer treatment', 'Dinodnavirus'): 0.05, ('Cancer treatment', 'Diversity-generating retroelement'): 0.05, ('Cancer treatment', 'Double-stranded RNA viruses'): 0.05, ('Cancer treatment', 'DsDNA-RT virus'): 0.05, ('Cancer treatment', 'Dukes classification'): 0.13, ('Cancer treatment', 'Duplodnaviria'): 0.05, ('Cancer treatment', 'Earliest known life forms'): 0.05, ('Cancer treatment', 'Endocrine gland neoplasm'): 0.15, ('Cancer treatment', 'Endogenous retrovirus'): 0.05, ('Cancer treatment', 'Endogenous viral element'): 0.05, ('Cancer treatment', 'Endosymbiont'): 0.09, ('Cancer treatment', 'Epidemiology of cancer'): 0.05, ('Cancer treatment', 'Epithelial'): 0.05, ('Cancer treatment', 'Eukaryota'): 0.05, ('Cancer treatment', 'Eukaryote'): 0.09, ('Cancer treatment', 'Extrachromosomal DNA'): 0.05, ('Cancer treatment', 'Fertility factor (bacteria)'): 0.05, ('Cancer treatment', 'Finnlakeviridae'): 0.05, ('Cancer treatment', 'Fosmid'): 0.05, ('Cancer treatment', 'Fungal prion'): 0.05, ('Cancer treatment', 'Fungi'): 0.05, ('Cancer treatment', 'Fungus'): 0.05, ('Cancer treatment', 'Fuselloviridae'): 0.05, ('Cancer treatment', 'Genome'): 0.05, ('Cancer treatment', 'Genomic island'): 0.05, ('Cancer treatment', 'Germ-line'): 0.05, ('Cancer treatment', 'Gerontoplast'): 0.09, ('Cancer treatment', 'Giant virus'): 0.05, ('Cancer treatment', 'Gleason grading system'): 0.13, ('Cancer treatment', 'Globuloviridae'): 0.05, ('Cancer treatment', 'Group II intron'): 0.05, ('Cancer treatment', 'Group I catalytic intron'): 0.05, ('Cancer treatment', 'Guttaviridae'): 0.05, ('Cancer treatment', 'Halspiviridae'): 0.05, ('Cancer treatment', 'Hamartoma'): 0.13, ('Cancer treatment', 'HeLa'): 0.05, ('Cancer treatment', 'Head and neck cancer'): 0.2, ('Cancer treatment', 'Histological'): 0.05, ('Cancer treatment', 'History of cancer'): 0.13, ('Cancer treatment', 'Hominin'): 0.05, ('Cancer treatment', 'Horizontal gene transfer'): 0.05, ('Cancer treatment', 'Hydrogenosome'): 0.05, ('Cancer treatment', 'Incertae sedis'): 0.05, ('Cancer treatment', 'Index of oncology articles'): 0.13, ('Cancer treatment', 'Integrative and conjugative element'): 0.05, ('Cancer treatment', 'Interspersed repeat'): 0.05, ('Cancer treatment', 'Jeewanu'): 0.05, ('Cancer treatment', 'John Hughes Bennett'): 0.05, ('Cancer treatment', 'Kappa organism'): 0.05, ('Cancer treatment', 'LUCA'): 0.05, ('Cancer treatment', 'Last universal common ancestor'): 0.05, ('Cancer treatment', 'Leucoplast'): 0.09, ('Cancer treatment', 'Life'): 0.05, ('Cancer treatment', 'Linear chromosome'): 0.05, ('Cancer treatment', 'MHC class I polypeptide-related sequence B'): 0.05, ('Cancer treatment', 'MIC-A'): 0.05, ('Cancer treatment', 'Malignant cells'): 0.05, ('Cancer treatment', 'Mesothelioma'): 0.1, ('Cancer treatment', 'Mesothelium'): 0.05, ('Cancer treatment', 'Microbial dark matter'): 0.05, ('Cancer treatment', 'Microparticle'): 0.05, ('Cancer treatment', 'Mitosome'): 0.05, ('Cancer treatment', 'Mobile genetic elements'): 0.05, ('Cancer treatment', 'Mobilome'): 0.05, ('Cancer treatment', 'Model lipid bilayer'): 0.05, ('Cancer treatment', 'Monodnaviria'): 0.05, ('Cancer treatment', 'Myeloma'): 0.05, ('Cancer treatment', 'Naldaviricetes'): 0.05, ('Cancer treatment', 'Nanobacterium'): 0.05, ('Cancer treatment', 'Nanobe'): 0.05, ('Cancer treatment', 'Nasopharyngeal carcinoma'): 0.13, ('Cancer treatment', 'Nervous system neoplasm'): 0.13, ('Cancer treatment', 'Non-cellular life'): 0.05, ('Cancer treatment', 'Non-coding DNA'): 0.05, ('Cancer treatment', 'Nucleic acid'): 0.08, ('Cancer treatment', 'Nucleolus'): 0.09, ('Cancer treatment', 'Oncovirus'): 0.17, ('Cancer treatment', 'Organism'): 0.05, ('Cancer treatment', 'Origin of replication'): 0.05, ('Cancer treatment', 'Osteosarcoma'): 0.08, ('Cancer treatment', 'Ovaliviridae'): 0.05, ('Cancer treatment', 'Papilloma'): 0.13, ('Cancer treatment', 'Parakaryon myojinensis'): 0.05, ('Cancer treatment', 'Paraneoplastic syndrome'): 0.13, ('Cancer treatment', 'Phagemid'): 0.05, ('Cancer treatment', 'Plant'): 0.05, ('Cancer treatment', 'Plasmaviridae'): 0.05, ('Cancer treatment', 'Plasmid'): 0.05, ('Cancer treatment', 'Plastid'): 0.09, ('Cancer treatment', 'Politician'): 0.05, ('Cancer treatment', 'Polydnaviridae'): 0.05, ('Cancer treatment', 'Portogloboviridae'): 0.05, ('Cancer treatment', 'Pospiviroidae'): 0.05, ('Cancer treatment', 'Precancerous condition'): 0.13, ('Cancer treatment', 'Prion'): 0.05, ('Cancer treatment', 'Prokaryota'): 0.05, ('Cancer treatment', 'Prophage'): 0.05, ('Cancer treatment', 'Prostate cancer staging'): 0.13, ('Cancer treatment', 'Proteinoid'): 0.05, ('Cancer treatment', 'Protist'): 0.05, ('Cancer treatment', 'Protista'): 0.05, ('Cancer treatment', 'Protocell'): 0.05, ('Cancer treatment', 'Provirus'): 0.05, ('Cancer treatment', 'Pseudocyst'): 0.13, ('Cancer treatment', 'R-factor'): 0.05, ('Cancer treatment', 'RNA-dependent RNA polymerase'): 0.09, ('Cancer treatment', 'RNA virus'): 0.05, ('Cancer treatment', 'RNA world'): 0.05, ('Cancer treatment', 'Renaissance period'): 0.05, ('Cancer treatment', 'Repeated sequence (DNA)'): 0.05, ('Cancer treatment', 'Replicon (genetics)'): 0.05, ('Cancer treatment', 'Retron'): 0.05, ('Cancer treatment', 'Retroposon'): 0.05, ('Cancer treatment', 'Retrotransposon'): 0.05, ('Cancer treatment', 'Retrovirus'): 0.05, ('Cancer treatment', 'Retrozyme'): 0.05, ('Cancer treatment', 'Reverse transcriptase-related cellular gene'): 0.05, ('Cancer treatment', 'Rhizidiovirus'): 0.05, ('Cancer treatment', 'Riboviria'): 0.05, ('Cancer treatment', 'Ribozyme'): 0.05, ('Cancer treatment', 'Ribozyviria'): 0.05, ('Cancer treatment', 'Rudolf Virchow'): 0.05, ('Cancer treatment', 'Sarcoma'): 0.22, ('Cancer treatment', 'Satellite (biology)'): 0.05, ('Cancer treatment', 'Secondary chromosome'): 0.05, ('Cancer treatment', 'Self-replication'): 0.05, ('Cancer treatment', 'Sentinel lymph node'): 0.13, ('Cancer treatment', 'Siddhartha Mukherjee'): 0.05, ('Cancer treatment', 'Sp2 transcription factor'): 0.05, ('Cancer treatment', \"Spiegelman's Monster\"): 0.05, ('Cancer treatment', 'Spiraviridae'): 0.05, ('Cancer treatment', 'Stem cells'): 0.08, ('Cancer treatment', 'Subviral agents'): 0.05, ('Cancer treatment', 'Sulphobes'): 0.05, ('Cancer treatment', 'Synthetic virology'): 0.05, ('Cancer treatment', 'T-cells'): 0.08, ('Cancer treatment', 'TNM staging system'): 0.13, ('Cancer treatment', 'Telomerase'): 0.11, ('Cancer treatment', 'Telomerase reverse transcriptase'): 0.05, ('Cancer treatment', 'Thaspiviridae'): 0.05, ('Cancer treatment', 'Ti plasmid'): 0.05, ('Cancer treatment', 'Tolecusatellitidae'): 0.05, ('Cancer treatment', 'Transposable element'): 0.05, ('Cancer treatment', 'Transpoviron'): 0.05, ('Cancer treatment', 'Trophosome'): 0.05, ('Cancer treatment', 'Tumour'): 0.05, ('Cancer treatment', 'Tumour heterogeneity'): 0.05, ('Cancer treatment', 'University of the Witwatersrand'): 0.05, ('Cancer treatment', 'Urogenital neoplasm'): 0.13, ('Cancer treatment', 'Varidnaviria'): 0.05, ('Cancer treatment', 'Viral vector'): 0.05, ('Cancer treatment', 'Viroid'): 0.05, ('Cancer treatment', 'Virome'): 0.05, ('Cancer treatment', 'Virophage'): 0.05, ('Cancer treatment', 'Virulence factor'): 0.05, ('Cancer treatment', 'Virus'): 0.13, ('Cancer treatment', 'Virusoid'): 0.05, ('Cancer treatment', 'Xenobot'): 0.05, ('Cancer treatment', 'Arsenic'): 0.05, ('Cancer treatment', 'Aspirin'): 0.07, ('Cancer treatment', 'Brazil'): 0.05, ('Cancer treatment', 'COX-2 inhibitor'): 0.05, ('Cancer treatment', 'China'): 0.07, ('Cancer treatment', 'Cigarette'): 0.05, ('Cancer treatment', 'Coffee'): 0.05, ('Cancer treatment', 'Diethylstilbestrol'): 0.05, ('Cancer treatment', 'Epstein–Barr virus'): 0.05, ('Cancer treatment', 'HPV vaccine'): 0.05, ('Cancer treatment', 'Helicobacter pylori'): 0.1, ('Cancer treatment', 'Hepatitis B vaccine'): 0.05, ('Cancer treatment', 'Hepatitis B virus'): 0.05, ('Cancer treatment', 'International Agency for Research on Cancer'): 0.05, ('Cancer treatment', 'Obesity'): 0.05, ('Cancer treatment', 'Physical exercise'): 0.05, ('Cancer treatment', 'Radiation-induced cancer'): 0.05, ('Cancer treatment', 'Raloxifene'): 0.05, ('Cancer treatment', 'Tamoxifen'): 0.1, ('Cancer treatment', 'Tobacco'): 0.05, ('Cancer treatment', 'Tobacco smoking'): 0.05, ('Cancer treatment', 'Ultraviolet'): 0.05, ('Cancer treatment', 'Vitamin D'): 0.05, ('Cancer treatment', 'Adaptive immune system'): 0.09, ('Cancer treatment', 'Antigen'): 0.09, ('Cancer treatment', 'Antigen presentation'): 0.09, ('Cancer treatment', 'CimaVax-EGF'): 0.05, ('Cancer treatment', 'Dendritic cells'): 0.08, ('Cancer treatment', 'Epitope'): 0.09, ('Cancer treatment', 'Hormone-refractory prostate cancer'): 0.05, ('Cancer treatment', 'Immune checkpoint blockade'): 0.05, ('Cancer treatment', 'In situ'): 0.05, ('Cancer treatment', 'Kinase insert domain receptor'): 0.05, ('Cancer treatment', 'Lymph nodes'): 0.05, ('Cancer treatment', 'MUC1'): 0.05, ('Cancer treatment', 'Non-Hodgkin lymphoma'): 0.1, ('Cancer treatment', 'Oncolytic viruses'): 0.05, ('Cancer treatment', 'Stomach cancer'): 0.08, ('Cancer treatment', 'Talimogene laherparepvec'): 0.05, ('Cancer treatment', 'Vemurafenib'): 0.05, ('Cancer treatment', 'Caesarean section'): 0.03, ('Cancer treatment', 'Aminopterin'): 0.05, ('Cancer treatment', 'Amrubicin'): 0.05, ('Cancer treatment', 'Anorexia (symptom)'): 0.05, ('Cancer treatment', 'Anthracycline'): 0.05, ('Cancer treatment', 'Bleomycin'): 0.05, ('Cancer treatment', 'Camptothecin'): 0.07, ('Cancer treatment', 'Celecoxib'): 0.05, ('Cancer treatment', 'Cyclin-dependent kinase'): 0.08, ('Cancer treatment', 'Daunorubicin'): 0.05, ('Cancer treatment', 'Desensitization (psychology)'): 0.05, ('Cancer treatment', 'Diazepam'): 0.05, ('Cancer treatment', 'Enzyme inhibitor'): 0.14, ('Cancer treatment', 'Estramustine phosphate'): 0.05, ('Cancer treatment', 'Idarubicin'): 0.05, ('Cancer treatment', 'Injection (medicine)'): 0.05, ('Cancer treatment', 'List of withdrawn drugs'): 0.07, ('Cancer treatment', 'Mechlorethamine'): 0.05, ('Cancer treatment', 'Megestrol acetate'): 0.05, ('Cancer treatment', 'Microtubule'): 0.06, ('Cancer treatment', 'Neuroleptic'): 0.05, ('Cancer treatment', 'Niraparib'): 0.05, ('Cancer treatment', 'Nitrogen mustard'): 0.05, ('Cancer treatment', 'Opioid receptor'): 0.05, ('Cancer treatment', 'Phases of clinical research'): 0.15, ('Cancer treatment', 'Proteasome inhibitor'): 0.05, ('Cancer treatment', 'Retinoid X receptor'): 0.05, ('Cancer treatment', 'Rucaparib'): 0.05, ('Cancer treatment', 'S phase'): 0.05, ('Cancer treatment', 'Syndrome'): 0.06, ('Cancer treatment', 'Testolactone'): 0.05, ('Cancer treatment', 'Topotecan'): 0.07, ('Cancer treatment', 'Type I topoisomerase'): 0.05, ('Cancer treatment', 'Vinblastine'): 0.07, ('Cancer treatment', 'Vincristine'): 0.07, ('Cancer treatment', 'WHO Model List of Essential Medicines'): 0.07, ('Cancer treatment', 'Addiction'): 0.05, ('Cancer treatment', 'Amphetamine'): 0.05, ('Cancer treatment', 'Benzodiazepine'): 0.05, ('Cancer treatment', 'CREB'): 0.05, ('Cancer treatment', 'Depression (mood)'): 0.05, ('Cancer treatment', 'Diabetes'): 0.05, ('Cancer treatment', 'Drug checking'): 0.05, ('Cancer treatment', 'Drug withdrawal'): 0.05, ('Cancer treatment', 'FOSB'): 0.05, ('Cancer treatment', 'Harm reduction'): 0.05, ('Cancer treatment', 'Mania'): 0.05, ('Cancer treatment', 'Mental health'): 0.07, ('Cancer treatment', 'Methamphetamine'): 0.05, ('Cancer treatment', 'National Health Service'): 0.05, ('Cancer treatment', 'Nonbenzodiazepine'): 0.05, ('Cancer treatment', 'Reagent testing'): 0.05, ('Cancer treatment', 'Responsible drug use'): 0.05, ('Cancer treatment', 'Schizophrenia'): 0.06, ('Cancer treatment', 'Spinal cord injury'): 0.07, ('Cancer treatment', 'Sport psychology'): 0.05, ('Cancer treatment', 'Substance dependence'): 0.05, ('Cancer treatment', 'Supervised injection site'): 0.07, ('Cancer treatment', 'DMOZ'): 0.02, ('Cancer treatment', 'ARA-290'): 0.04, ('Cancer treatment', 'AZD-1480'): 0.04, ('Cancer treatment', 'Asialo erythropoietin'): 0.04, ('Cancer treatment', 'Bifarcept'): 0.04, ('Cancer treatment', 'CHZ868'): 0.04, ('Cancer treatment', 'CNTO-530'): 0.04, ('Cancer treatment', 'Carbamylated erythropoietin'): 0.04, ('Cancer treatment', 'Cercosporamide'): 0.04, ('Cancer treatment', 'Cilmostim'): 0.04, ('Cancer treatment', 'Ecogramostim'): 0.04, ('Cancer treatment', 'Emfilermin'): 0.04, ('Cancer treatment', 'Epoetin delta'): 0.04, ('Cancer treatment', 'Epoetin epsilon'): 0.04, ('Cancer treatment', 'Epoetin gamma'): 0.04, ('Cancer treatment', 'Epoetin kappa'): 0.04, ('Cancer treatment', 'Epoetin omega'): 0.04, ('Cancer treatment', 'Erythropoietin-Fc'): 0.04, ('Cancer treatment', 'IFNB3'): 0.04, ('Cancer treatment', 'IL12 family'): 0.04, ('Cancer treatment', 'Interferon alfa n1'): 0.04, ('Cancer treatment', 'Lanimostim'): 0.04, ('Cancer treatment', 'Leridistim'): 0.04, ('Cancer treatment', 'MEDI-545'): 0.04, ('Cancer treatment', 'Milodistim'): 0.04, ('Cancer treatment', 'Mirimostim'): 0.04, ('Cancer treatment', 'NSC-33994'): 0.04, ('Cancer treatment', 'NSC-7908'): 0.04, ('Cancer treatment', 'Nartograstim'): 0.04, ('Cancer treatment', 'Pegacaristim'): 0.04, ('Cancer treatment', 'Pegnartograstim'): 0.04, ('Cancer treatment', 'Pegol sihematide'): 0.04, ('Cancer treatment', 'Regramostim'): 0.04, ('Cancer treatment', 'SD-1008'): 0.04, ('Cancer treatment', '1918 flu pandemic'): 0.04, ('Cancer treatment', '4-1BB ligand'): 0.04, ('Cancer treatment', '7TM Receptor'): 0.04, ('Cancer treatment', 'A proliferation-inducing ligand'): 0.04, ('Cancer treatment', 'Abrocitinib'): 0.04, ('Cancer treatment', 'Adipokine'): 0.04, ('Cancer treatment', 'Affinity maturation'): 0.06, ('Cancer treatment', 'Agouti-related protein'): 0.04, ('Cancer treatment', 'Agouti signaling protein'): 0.04, ('Cancer treatment', 'Albinterferon'): 0.04, ('Cancer treatment', 'Allergen'): 0.06, ('Cancer treatment', 'Alloimmunity'): 0.06, ('Cancer treatment', 'Allotype (immunology)'): 0.06, ('Cancer treatment', 'Alpha-taxilin'): 0.04, ('Cancer treatment', 'Amino-acid'): 0.04, ('Cancer treatment', 'Angiogenic protein'): 0.04, ('Cancer treatment', 'Anifrolumab'): 0.04, ('Cancer treatment', 'Antigen-presenting cell'): 0.09, ('Cancer treatment', 'Antigenic variation'): 0.06, ('Cancer treatment', 'Aqueous solution'): 0.06, ('Cancer treatment', 'Atiprimod'): 0.04, ('Cancer treatment', 'Autoantibody'): 0.06, ('Cancer treatment', 'Autocrine'): 0.04, ('Cancer treatment', 'Autocrine signaling'): 0.04, ('Cancer treatment', 'Autocrine signalling'): 0.04, ('Cancer treatment', 'Autoimmune disorder'): 0.04, ('Cancer treatment', 'Autoimmunity'): 0.06, ('Cancer treatment', 'B-cell activating factor'): 0.06, ('Cancer treatment', 'Biochemical cascade'): 0.04, ('Cancer treatment', 'Biologic medical product'): 0.04, ('Cancer treatment', 'Blastocyst'): 0.06, ('Cancer treatment', 'Bone morphogenetic protein'): 0.04, ('Cancer treatment', 'C-C motif chemokine ligand 27'): 0.04, ('Cancer treatment', 'CAMP-dependent pathway'): 0.04, ('Cancer treatment', 'CCL1'): 0.04, ('Cancer treatment', 'CCL11'): 0.04, ('Cancer treatment', 'CCL12'): 0.04, ('Cancer treatment', 'CCL13'): 0.04, ('Cancer treatment', 'CCL14'): 0.04, ('Cancer treatment', 'CCL15'): 0.04, ('Cancer treatment', 'CCL16'): 0.04, ('Cancer treatment', 'CCL17'): 0.04, ('Cancer treatment', 'CCL18'): 0.06, ('Cancer treatment', 'CCL19'): 0.04, ('Cancer treatment', 'CCL20'): 0.04, ('Cancer treatment', 'CCL21'): 0.04, ('Cancer treatment', 'CCL22'): 0.04, ('Cancer treatment', 'CCL23'): 0.04, ('Cancer treatment', 'CCL24'): 0.04, ('Cancer treatment', 'CCL25'): 0.04, ('Cancer treatment', 'CCL26'): 0.04, ('Cancer treatment', 'CCL28'): 0.04, ('Cancer treatment', 'CCL3'): 0.04, ('Cancer treatment', 'CCL4'): 0.04, ('Cancer treatment', 'CCL5'): 0.04, ('Cancer treatment', 'CCL6'): 0.04, ('Cancer treatment', 'CCL7'): 0.04, ('Cancer treatment', 'CCL8'): 0.04, ('Cancer treatment', 'CCL9'): 0.04, ('Cancer treatment', 'CCN intercellular signaling protein'): 0.04, ('Cancer treatment', 'CCR5'): 0.09, ('Cancer treatment', 'CD153'): 0.06, ('Cancer treatment', 'CD154'): 0.06, ('Cancer treatment', 'CD27'): 0.06, ('Cancer treatment', 'CD4'): 0.09, ('Cancer treatment', 'CD40'): 0.04, ('Cancer treatment', 'CD70'): 0.06, ('Cancer treatment', 'COVID-19 pandemic'): 0.04, ('Cancer treatment', 'CSF2RB'): 0.06, ('Cancer treatment', 'CX3CL1'): 0.04, ('Cancer treatment', 'CXCL1'): 0.04, ('Cancer treatment', 'CXCL10'): 0.04, ('Cancer treatment', 'CXCL11'): 0.04, ('Cancer treatment', 'CXCL13'): 0.06, ('Cancer treatment', 'CXCL14'): 0.04, ('Cancer treatment', 'CXCL15'): 0.04, ('Cancer treatment', 'CXCL16'): 0.04, ('Cancer treatment', 'CXCL17'): 0.04, ('Cancer treatment', 'CXCL2'): 0.04, ('Cancer treatment', 'CXCL3'): 0.04, ('Cancer treatment', 'CXCL5'): 0.04, ('Cancer treatment', 'CXCL6'): 0.04, ('Cancer treatment', 'CXCL7'): 0.04, ('Cancer treatment', 'CXCL9'): 0.04, ('Cancer treatment', 'CYT387'): 0.04, ('Cancer treatment', 'Calcium signaling'): 0.04, ('Cancer treatment', 'Cardiotrophin 1'): 0.04, ('Cancer treatment', 'Cell-mediated immunity'): 0.06, ('Cancer treatment', 'Cell-surface receptor'): 0.04, ('Cancer treatment', 'Cell adhesion molecule'): 0.04, ('Cancer treatment', 'Cell surface receptor'): 0.04, ('Cancer treatment', 'Cellular immune response'): 0.04, ('Cancer treatment', 'Central tolerance'): 0.06, ('Cancer treatment', 'Chemical synapse'): 0.04, ('Cancer treatment', 'Chemokine'): 0.09, ('Cancer treatment', 'Chemokine receptor'): 0.04, ('Cancer treatment', 'Chemokinesis'): 0.04, ('Cancer treatment', 'Chemotaxis'): 0.06, ('Cancer treatment', 'Chronic granulomatous disease'): 0.04, ('Cancer treatment', 'Ciliary neurotrophic factor'): 0.04, ('Cancer treatment', 'Clonal anergy'): 0.06, ('Cancer treatment', 'Clonal deletion'): 0.06, ('Cancer treatment', 'Clonal selection'): 0.06, ('Cancer treatment', 'Co-receptor'): 0.06, ('Cancer treatment', 'Co-stimulation'): 0.06, ('Cancer treatment', 'Colony-stimulating factor receptor'): 0.04, ('Cancer treatment', 'Common gamma chain'): 0.06, ('Cancer treatment', 'Complement system'): 0.06, ('Cancer treatment', 'Conformational epitope'): 0.06, ('Cancer treatment', 'Coronavirus disease 2019'): 0.04, ('Cancer treatment', 'Cross-reactivity'): 0.06, ('Cancer treatment', 'Cucurbitacin I'): 0.04, ('Cancer treatment', 'Cysteine-rich protein 61'): 0.04, ('Cancer treatment', 'Cysteine knot'): 0.04, ('Cancer treatment', 'Cytokine receptor'): 0.04, ('Cancer treatment', 'Cytokine redundancy'): 0.04, ('Cancer treatment', 'Cytokine release syndrome'): 0.04, ('Cancer treatment', 'Cytokine storm syndrome'): 0.04, ('Cancer treatment', 'Cytokinin'): 0.04, ('Cancer treatment', 'Cytolysin'): 0.06, ('Cancer treatment', 'Darbepoetin alfa'): 0.04, ('Cancer treatment', 'Decernotinib'): 0.04, ('Cancer treatment', 'Deucravacitinib'): 0.04, ('Cancer treatment', 'EDA (gene)'): 0.04, ('Cancer treatment', 'EDN1'): 0.04, ('Cancer treatment', 'EDN2'): 0.04, ('Cancer treatment', 'EDN3'): 0.04, ('Cancer treatment', 'ELISA'): 0.04, ('Cancer treatment', 'Eltrombopag'): 0.04, ('Cancer treatment', 'Emapalumab'): 0.04, ('Cancer treatment', 'Embryonic development'): 0.06, ('Cancer treatment', 'Endocrine'): 0.04, ('Cancer treatment', 'Endocrine signaling'): 0.04, ('Cancer treatment', 'Endometrium'): 0.06, ('Cancer treatment', 'Endothelin'): 0.04, ('Cancer treatment', 'Epoetin alfa'): 0.04, ('Cancer treatment', 'Epoetin beta'): 0.04, ('Cancer treatment', 'Epoetin theta'): 0.04, ('Cancer treatment', 'Epoetin zeta'): 0.04, ('Cancer treatment', 'Erythropoietin receptor'): 0.04, ('Cancer treatment', 'Exocrine gland'): 0.04, ('Cancer treatment', 'FMS-like tyrosine kinase 3 ligand'): 0.04, ('Cancer treatment', 'Faralimomab'): 0.04, ('Cancer treatment', 'Fas ligand'): 0.06, ('Cancer treatment', 'Fever'): 0.09, ('Cancer treatment', 'Fibroblast'): 0.06, ('Cancer treatment', 'Filgrastim'): 0.04, ('Cancer treatment', 'Fontolizumab'): 0.04, ('Cancer treatment', 'Foxp3'): 0.04, ('Cancer treatment', 'Fungal infections'): 0.04, ('Cancer treatment', 'G protein-coupled receptor'): 0.07, ('Cancer treatment', 'G protein-coupled receptors'): 0.04, ('Cancer treatment', 'Gap junction'): 0.06, ('Cancer treatment', 'Gastric cancer'): 0.09, ('Cancer treatment', 'General transcription factor'): 0.06, ('Cancer treatment', 'Genes'): 0.04, ('Cancer treatment', 'Gland'): 0.04, ('Cancer treatment', 'Glycoprotein 130'): 0.06, ('Cancer treatment', 'Granulocyte colony-stimulating factor'): 0.04, ('Cancer treatment', 'Granulocyte colony-stimulating factor receptor'): 0.06, ('Cancer treatment', 'Granulocyte macrophage colony-stimulating factor'): 0.04, ('Cancer treatment', 'Granulocyte macrophage colony-stimulating factor receptor'): 0.06, ('Cancer treatment', 'Hapten'): 0.06, ('Cancer treatment', 'Hedgehog protein'): 0.04, ('Cancer treatment', 'Helix bundle'): 0.04, ('Cancer treatment', 'Hematopoietic'): 0.04, ('Cancer treatment', 'Hemopoietic growth factor'): 0.04, ('Cancer treatment', 'Hemorrhagic stroke'): 0.04, ('Cancer treatment', 'Hepatitis C'): 0.06, ('Cancer treatment', 'Hormone'): 0.06, ('Cancer treatment', 'Human leukocyte antigen'): 0.06, ('Cancer treatment', 'Humoral immunity'): 0.06, ('Cancer treatment', 'Hypersensitivity'): 0.09, ('Cancer treatment', 'IFNA10'): 0.04, ('Cancer treatment', 'IFNA13'): 0.04, ('Cancer treatment', 'IFNA14'): 0.04, ('Cancer treatment', 'IFNA16'): 0.04, ('Cancer treatment', 'IFNA17'): 0.04, ('Cancer treatment', 'IFNA2'): 0.04, ('Cancer treatment', 'IFNA21'): 0.04, ('Cancer treatment', 'IFNA4'): 0.04, ('Cancer treatment', 'IFNA5'): 0.04, ('Cancer treatment', 'IFNA6'): 0.04, ('Cancer treatment', 'IFNA7'): 0.04, ('Cancer treatment', 'IFNA8'): 0.04, ('Cancer treatment', 'IFNB1'): 0.04, ('Cancer treatment', 'IFNK'): 0.04, ('Cancer treatment', 'IFNW1'): 0.04, ('Cancer treatment', 'IL-35'): 0.04, ('Cancer treatment', 'IL10 family'): 0.04, ('Cancer treatment', 'IL17A'): 0.04, ('Cancer treatment', 'IL17 family'): 0.04, ('Cancer treatment', 'IL1A'): 0.04, ('Cancer treatment', 'IL1F10'): 0.04, ('Cancer treatment', 'IL1F5'): 0.04, ('Cancer treatment', 'IL1F7'): 0.04, ('Cancer treatment', 'IL1F9'): 0.04, ('Cancer treatment', 'IL36A'): 0.04, ('Cancer treatment', 'IL36B'): 0.04, ('Cancer treatment', 'Idiotype'): 0.06, ('Cancer treatment', 'Immune complex'): 0.06, ('Cancer treatment', 'Immune privilege'): 0.06, ('Cancer treatment', 'Immune tolerance in pregnancy'): 0.06, ('Cancer treatment', 'Immunity (medical)'): 0.06, ('Cancer treatment', 'Immunodeficiency'): 0.06, ('Cancer treatment', 'Immunogen'): 0.06, ('Cancer treatment', 'Immunogenetics'): 0.06, ('Cancer treatment', 'Immunoglobulin class switching'): 0.06, ('Cancer treatment', 'Immunoglobulin superfamily'): 0.06, ('Cancer treatment', 'Immunomodulation'): 0.04, ('Cancer treatment', 'Implantation (embryology)'): 0.04, ('Cancer treatment', 'Inflammaging'): 0.04, ('Cancer treatment', 'Inflammatory cytokine'): 0.06, ('Cancer treatment', 'Injury'): 0.04, ('Cancer treatment', 'Interferon-alpha/beta receptor'): 0.04, ('Cancer treatment', 'Interferon-gamma receptor'): 0.04, ('Cancer treatment', 'Interferon-lambda receptor'): 0.04, ('Cancer treatment', 'Interferon alfa'): 0.04, ('Cancer treatment', 'Interferon alfa 2a'): 0.04, ('Cancer treatment', 'Interferon alfa 2b'): 0.04, ('Cancer treatment', 'Interferon alfacon-1'): 0.04, ('Cancer treatment', 'Interferon alpha'): 0.04, ('Cancer treatment', 'Interferon alpha-n3'): 0.04, ('Cancer treatment', 'Interferon alpha 1'): 0.04, ('Cancer treatment', 'Interferon beta'): 0.04, ('Cancer treatment', 'Interferon beta 1a'): 0.04, ('Cancer treatment', 'Interferon beta 1b'): 0.04, ('Cancer treatment', 'Interferon gamma'): 0.06, ('Cancer treatment', 'Interferon gamma 1b'): 0.04, ('Cancer treatment', 'Interferon kappa'): 0.04, ('Cancer treatment', 'Interferon omega'): 0.04, ('Cancer treatment', 'Interferon receptor'): 0.04, ('Cancer treatment', 'Interferon type II'): 0.04, ('Cancer treatment', 'Interferon type III'): 0.04, ('Cancer treatment', 'Interleukin-17 receptor'): 0.04, ('Cancer treatment', 'Interleukin-34'): 0.04, ('Cancer treatment', 'Interleukin-6'): 0.04, ('Cancer treatment', 'Interleukin 1'): 0.04, ('Cancer treatment', 'Interleukin 10'): 0.04, ('Cancer treatment', 'Interleukin 11'): 0.04, ('Cancer treatment', 'Interleukin 12'): 0.04, ('Cancer treatment', 'Interleukin 12 receptor, beta 1 subunit'): 0.06, ('Cancer treatment', 'Interleukin 13'): 0.04, ('Cancer treatment', 'Interleukin 15'): 0.04, ('Cancer treatment', 'Interleukin 16'): 0.04, ('Cancer treatment', 'Interleukin 17'): 0.04, ('Cancer treatment', 'Interleukin 18'): 0.04, ('Cancer treatment', 'Interleukin 19'): 0.04, ('Cancer treatment', 'Interleukin 1 beta'): 0.04, ('Cancer treatment', 'Interleukin 1 family'): 0.04, ('Cancer treatment', 'Interleukin 1 receptor antagonist'): 0.04, ('Cancer treatment', 'Interleukin 20'): 0.04, ('Cancer treatment', 'Interleukin 21'): 0.06, ('Cancer treatment', 'Interleukin 22'): 0.04, ('Cancer treatment', 'Interleukin 23'): 0.04, ('Cancer treatment', 'Interleukin 24'): 0.04, ('Cancer treatment', 'Interleukin 25'): 0.04, ('Cancer treatment', 'Interleukin 26'): 0.04, ('Cancer treatment', 'Interleukin 27'): 0.04, ('Cancer treatment', 'Interleukin 28'): 0.04, ('Cancer treatment', 'Interleukin 29'): 0.04, ('Cancer treatment', 'Interleukin 3'): 0.04, ('Cancer treatment', 'Interleukin 30'): 0.04, ('Cancer treatment', 'Interleukin 31'): 0.04, ('Cancer treatment', 'Interleukin 32'): 0.04, ('Cancer treatment', 'Interleukin 33'): 0.04, ('Cancer treatment', 'Interleukin 34'): 0.04, ('Cancer treatment', 'Interleukin 35'): 0.04, ('Cancer treatment', 'Interleukin 4'): 0.06, ('Cancer treatment', 'Interleukin 5'): 0.04, ('Cancer treatment', 'Interleukin 7'): 0.04, ('Cancer treatment', 'Interleukin 8'): 0.04, ('Cancer treatment', 'Interleukin 9'): 0.04, ('Cancer treatment', 'Interleukin receptor'): 0.04, ('Cancer treatment', 'Intracellular receptor'): 0.06, ('Cancer treatment', 'Intracrine'): 0.04, ('Cancer treatment', 'Ion channel'): 0.04, ('Cancer treatment', 'Isotype (immunology)'): 0.06, ('Cancer treatment', 'JAK1'): 0.04, ('Cancer treatment', 'JAK2'): 0.04, ('Cancer treatment', 'JAK3'): 0.04, ('Cancer treatment', 'Janus kinase inhibitor'): 0.06, ('Cancer treatment', 'Junctional diversity'): 0.06, ('Cancer treatment', 'Juxtacrine signalling'): 0.04, ('Cancer treatment', 'KDa'): 0.04, ('Cancer treatment', 'Kinin'): 0.04, ('Cancer treatment', 'Lenograstim'): 0.04, ('Cancer treatment', 'Ligands'): 0.04, ('Cancer treatment', 'Linear epitope'): 0.06, ('Cancer treatment', 'Lipegfilgrastim'): 0.04, ('Cancer treatment', 'Lipid bilayer'): 0.04, ('Cancer treatment', 'Lipid signaling'): 0.04, ('Cancer treatment', 'Lymphokine'): 0.04, ('Cancer treatment', 'Lymphotoxin'): 0.04, ('Cancer treatment', 'Lymphotoxin alpha'): 0.04, ('Cancer treatment', 'Lymphotoxin beta'): 0.04, ('Cancer treatment', 'Macrophage'): 0.11, ('Cancer treatment', 'Macrophage colony-stimulating factor'): 0.04, ('Cancer treatment', 'Macrophage colony-stimulating factor receptor'): 0.04, ('Cancer treatment', 'Macrophage migration inhibitory factor'): 0.04, ('Cancer treatment', 'Major depression'): 0.04, ('Cancer treatment', 'Major histocompatibility complex'): 0.06, ('Cancer treatment', 'Major trauma'): 0.04, ('Cancer treatment', 'Mavrilimumab'): 0.04, ('Cancer treatment', 'Mechanotransduction'): 0.04, ('Cancer treatment', 'Medical animation'): 0.04, ('Cancer treatment', 'Methoxy polyethylene glycol-epoetin beta'): 0.04, ('Cancer treatment', 'Microantibody'): 0.06, ('Cancer treatment', 'Mimotope'): 0.06, ('Cancer treatment', 'Molar concentration'): 0.04, ('Cancer treatment', 'Molgramostim'): 0.04, ('Cancer treatment', 'Monoclonal antibody'): 0.14, ('Cancer treatment', 'Monocytes'): 0.04, ('Cancer treatment', 'Monokine'): 0.04, ('Cancer treatment', 'Multi organ dysfunction'): 0.04, ('Cancer treatment', 'Myokine'): 0.04, ('Cancer treatment', 'Namilumab'): 0.04, ('Cancer treatment', 'Nephroblastoma overexpressed protein'): 0.04, ('Cancer treatment', 'Neuroendocrine cell'): 0.04, ('Cancer treatment', 'Neurohormone'): 0.04, ('Cancer treatment', 'Neuropeptide'): 0.06, ('Cancer treatment', 'Neurotransmitter'): 0.06, ('Cancer treatment', 'Notch signaling pathway'): 0.04, ('Cancer treatment', 'OX40L'): 0.06, ('Cancer treatment', 'Oclacitinib'): 0.04, ('Cancer treatment', 'Oncostatin M'): 0.04, ('Cancer treatment', 'Opsonin'): 0.06, ('Cancer treatment', 'Order of magnitude'): 0.04, ('Cancer treatment', 'Osteopetrosis'): 0.04, ('Cancer treatment', 'Osteopontin'): 0.04, ('Cancer treatment', 'Otilimab'): 0.04, ('Cancer treatment', 'Oxidative stress'): 0.07, ('Cancer treatment', 'Pancreas'): 0.12, ('Cancer treatment', 'Papule'): 0.04, ('Cancer treatment', 'Paracrine'): 0.04, ('Cancer treatment', 'Paracrine signaling'): 0.07, ('Cancer treatment', 'Paracrine signalling'): 0.06, ('Cancer treatment', 'Parathyroid hormone-related protein'): 0.04, ('Cancer treatment', 'Paratope'): 0.06, ('Cancer treatment', 'Peficitinib'): 0.04, ('Cancer treatment', 'Pegfilgrastim'): 0.04, ('Cancer treatment', 'Peginesatide'): 0.04, ('Cancer treatment', 'Peginterferon alfa-2a'): 0.04, ('Cancer treatment', 'Peginterferon alfa-2b'): 0.04, ('Cancer treatment', 'Peripheral tolerance'): 0.06, ('Cancer treatment', 'Pheromone'): 0.06, ('Cancer treatment', 'Platelet factor 4'): 0.04, ('Cancer treatment', 'Pleiotropy'): 0.04, ('Cancer treatment', 'Polyclonal B cell response'): 0.06, ('Cancer treatment', 'Polyclonal antibodies'): 0.06, ('Cancer treatment', 'Programmed cell death 1'): 0.04, ('Cancer treatment', 'Proinflammatory cytokine'): 0.04, ('Cancer treatment', 'Promegapoietin'): 0.04, ('Cancer treatment', 'RANKL'): 0.06, ('Cancer treatment', 'Recombinant DNA'): 0.04, ('Cancer treatment', 'Ritlecitinib'): 0.04, ('Cancer treatment', 'Romiplostim'): 0.04, ('Cancer treatment', 'Rontalizumab'): 0.04, ('Cancer treatment', 'SDF-1 (biology)'): 0.04, ('Cancer treatment', 'Sargramostim'): 0.04, ('Cancer treatment', 'Scaffold protein'): 0.04, ('Cancer treatment', 'Second messenger system'): 0.04, ('Cancer treatment', 'Secretion assay'): 0.04, ('Cancer treatment', 'Severe Combined Immunodeficiency'): 0.04, ('Cancer treatment', 'Sifalimumab'): 0.04, ('Cancer treatment', 'Signal transducing adaptor protein'): 0.04, ('Cancer treatment', 'Somatic hypermutation'): 0.06, ('Cancer treatment', 'Somatomedin'): 0.04, ('Cancer treatment', 'TCS-21311'): 0.04, ('Cancer treatment', 'ZM-39923'): 0.04, ('Cancer treatment', 'ZM-449829'): 0.04, ('Cancer treatment', 'Stanley Cohen (biochemist)'): 0.04, ('Cancer treatment', 'Structural biology'): 0.04, ('Cancer treatment', 'Structural homology'): 0.04, ('Cancer treatment', 'Superantigen'): 0.06, ('Cancer treatment', 'Synaptic transmission'): 0.04, ('Cancer treatment', 'Systemic inflammatory response syndrome'): 0.04, ('Cancer treatment', 'T-helper cell'): 0.04, ('Cancer treatment', 'TGF-β'): 0.06, ('Cancer treatment', 'TGF beta 1'): 0.04, ('Cancer treatment', 'TGF beta 2'): 0.04, ('Cancer treatment', 'TGF beta 3'): 0.04, ('Cancer treatment', 'TGN1412'): 0.04, ('Cancer treatment', 'TNF-α'): 0.06, ('Cancer treatment', 'TRAIL'): 0.06, ('Cancer treatment', 'Thrombocytopenia'): 0.06, ('Cancer treatment', 'Thrombopoietin receptor'): 0.04, ('Cancer treatment', 'Thymic stromal lymphopoietin'): 0.04, ('Cancer treatment', 'Tofacitinib'): 0.06, ('Cancer treatment', 'Tolloid-like metalloproteinase'): 0.04, ('Cancer treatment', 'Transcription factor II D'): 0.06, ('Cancer treatment', 'Transcription factor II H'): 0.06, ('Cancer treatment', 'Transcription factors'): 0.04, ('Cancer treatment', 'Transcription preinitiation complex'): 0.04, ('Cancer treatment', 'Transforming growth factor beta superfamily'): 0.04, ('Cancer treatment', 'Treg'): 0.04, ('Cancer treatment', 'Tregs'): 0.04, ('Cancer treatment', 'Tumor necrosis factor'): 0.11, ('Cancer treatment', 'Tumor necrosis factor alpha'): 0.04, ('Cancer treatment', 'Tumor necrosis factor beta'): 0.04, ('Cancer treatment', 'Tumor necrosis factor receptor'): 0.04, ('Cancer treatment', 'Tumor necrosis factors'): 0.04, ('Cancer treatment', 'Tumour necrosis factor'): 0.04, ('Cancer treatment', 'Type II cytokine receptor'): 0.04, ('Cancer treatment', 'Type I cytokine receptor'): 0.04, ('Cancer treatment', 'Tyrosine kinase 2'): 0.04, ('Cancer treatment', 'Upadacitinib'): 0.04, ('Cancer treatment', 'V(D)J recombination'): 0.06, ('Cancer treatment', 'Virokine'): 0.04, ('Cancer treatment', 'Visual phototransduction'): 0.04, ('Cancer treatment', 'Vox (website)'): 0.04, ('Cancer treatment', 'X-SCID'): 0.04, ('Cancer treatment', 'XCL1'): 0.04, ('Cancer treatment', 'XCL2'): 0.04, ('Cancer treatment', 'Zona hatching'): 0.04, ('Cancer treatment', 'Angiotensin-converting enzyme'): 0.05, ('Cancer treatment', 'Arthritis'): 0.05, ('Cancer treatment', 'Autoimmune disease'): 0.07, ('Cancer treatment', 'BMPR1A'): 0.05, ('Cancer treatment', 'BMPR1B'): 0.05, ('Cancer treatment', 'CD28'): 0.05, ('Cancer treatment', 'CD40 (protein)'): 0.05, ('Cancer treatment', 'CD79A'): 0.05, ('Cancer treatment', 'CD8'): 0.05, ('Cancer treatment', 'CD80'): 0.05, ('Cancer treatment', 'CD86'): 0.05, ('Cancer treatment', 'CXCR4'): 0.07, ('Cancer treatment', 'CXCR5'): 0.05, ('Cancer treatment', 'Fas receptor'): 0.05, ('Cancer treatment', 'Integrin beta 1'): 0.05, ('Cancer treatment', 'Neprilysin'): 0.05, ('Cancer treatment', 'PDBe-KB'): 0.05, ('Cancer treatment', 'PI3K'): 0.06, ('Cancer treatment', 'Phosphoinositide 3-kinase'): 0.06, ('Cancer treatment', 'Protein-protein interaction'): 0.12, ('Cancer treatment', 'Public domain'): 0.05, ('Cancer treatment', 'Regulatory T cell'): 0.05, ('Cancer treatment', 'T cell receptor'): 0.05, ('Cancer treatment', 'Type 1 diabetes'): 0.05, ('Cancer treatment', 'United States National Library of Medicine'): 0.07, ('Cancer treatment', 'Affinity (pharmacology)'): 0.05, ('Cancer treatment', 'Differentiation (cellular)'): 0.05, ('Cancer treatment', 'Eomesodermin'): 0.05, ('Cancer treatment', 'Serine protease'): 0.05, ('Cancer treatment', 'T helper cell'): 0.05, ('Cancer treatment', 'Transplant rejection'): 0.05, ('Cancer treatment', 'ARID1A'): 0.06, ('Cancer treatment', 'ETS1'): 0.05, ('Cancer treatment', 'FOXO3'): 0.05, ('Cancer treatment', 'Glucocorticoid receptor'): 0.05, ('Cancer treatment', 'HMGB1'): 0.05, ('Cancer treatment', 'High-mobility group'): 0.05, ('Cancer treatment', 'Homeobox protein NANOG'): 0.05, ('Cancer treatment', 'MYBL2'): 0.05, ('Cancer treatment', 'Mineralocorticoid receptor'): 0.05, ('Cancer treatment', 'NDRG1'): 0.05, ('Cancer treatment', 'NFATC1'): 0.05, ('Cancer treatment', 'PRRX1'): 0.05, ('Cancer treatment', 'STAT3'): 0.08, ('Cancer treatment', 'STAT5'): 0.05, ('Cancer treatment', 'TMPRSS2'): 0.05, ('Cancer treatment', 'ZEB1'): 0.05, ('Cancer treatment', 'ZEB2'): 0.05, ('Cancer treatment', 'ZNF423'): 0.05, ('Cancer treatment', 'Zinc finger'): 0.05, ('Cancer treatment', 'Activator protein 1'): 0.05, ('Cancer treatment', 'Adrenal gland'): 0.05, ('Cancer treatment', 'Anastrozole'): 0.05, ('Cancer treatment', 'Apigenin'): 0.05, ('Cancer treatment', 'Binding affinity'): 0.05, ('Cancer treatment', 'Biological target'): 0.05, ('Cancer treatment', 'Cadmium'): 0.05, ('Cancer treatment', 'Calcitonin'): 0.05, ('Cancer treatment', 'Catechin'): 0.05, ('Cancer treatment', 'Cell membrane'): 0.06, ('Cancer treatment', 'Conjugation (biochemistry)'): 0.05, ('Cancer treatment', 'Cyproterone acetate'): 0.05, ('Cancer treatment', 'Cytochrome P450'): 0.05, ('Cancer treatment', 'Cytosol'): 0.06, ('Cancer treatment', 'Endogenous'): 0.07, ('Cancer treatment', 'Epicatechin'): 0.05, ('Cancer treatment', 'Epicatechin gallate'): 0.05, ('Cancer treatment', 'Etacstil'): 0.05, ('Cancer treatment', 'Glucuronidation'): 0.05, ('Cancer treatment', 'Half-maximal effective concentration'): 0.05, ('Cancer treatment', 'Human chorionic gonadotropin'): 0.07, ('Cancer treatment', 'Hypogonadism'): 0.05, ('Cancer treatment', 'Hypothalamus'): 0.05, ('Cancer treatment', 'Ligament'): 0.05, ('Cancer treatment', 'Lipid'): 0.06, ('Cancer treatment', 'Lipotropin'): 0.05, ('Cancer treatment', 'Metabolic pathway'): 0.05, ('Cancer treatment', 'Metabolite'): 0.05, ('Cancer treatment', 'N,N-Dimethyltryptamine'): 0.05, ('Cancer treatment', 'Naringenin'): 0.05, ('Cancer treatment', 'Ovary'): 0.05, ('Cancer treatment', 'Oxandrolone'): 0.05, ('Cancer treatment', 'Oxytocin'): 0.05, ('Cancer treatment', 'Parathyroid gland'): 0.05, ('Cancer treatment', 'Pineal gland'): 0.05, ('Cancer treatment', 'Potency (pharmacology)'): 0.05, ('Cancer treatment', 'Prolactin'): 0.05, ('Cancer treatment', 'Proopiomelanocortin'): 0.05, ('Cancer treatment', 'Pulmonary alveolus'): 0.05, ('Cancer treatment', 'RNA polymerase'): 0.06, ('Cancer treatment', 'Resveratrol'): 0.05, ('Cancer treatment', 'Sperm'): 0.05, ('Cancer treatment', 'Steroid sulfatase'): 0.05, ('Cancer treatment', 'Subcutaneous injection'): 0.05, ('Cancer treatment', 'Tendon'): 0.05, ('Cancer treatment', 'Testicle'): 0.07, ('Cancer treatment', 'Thyroid'): 0.05, ('Cancer treatment', 'Thyroxine'): 0.05, ('Cancer treatment', 'Transcription (biology)'): 0.05, ('Cancer treatment', 'Exercise physiology'): 0.05, ('Cancer treatment', 'Back pain'): 0.05, ('Cancer treatment', 'Clinic'): 0.05, ('Cancer treatment', 'Glossary of medicine'): 0.05, ('Cancer treatment', 'Hospital'): 0.07, ('Cancer treatment', 'Osteoarthritis'): 0.05, ('Cancer treatment', 'Acrosome'): 0.03, ('Cancer treatment', 'Adaptive immunity'): 0.03, ('Cancer treatment', 'Akt'): 0.03, ('Cancer treatment', 'Alpha-synuclein'): 0.03, ('Cancer treatment', 'Amyloplast'): 0.03, ('Cancer treatment', 'Antonio Vidal-Puig'): 0.03, ('Cancer treatment', 'Atomic force microscopy'): 0.03, ('Cancer treatment', 'Autophagosome'): 0.03, ('Cancer treatment', 'Axoneme'): 0.03, ('Cancer treatment', 'B cells'): 0.03, ('Cancer treatment', 'Basal body'): 0.03, ('Cancer treatment', 'Caenorhabditis elegans'): 0.06, ('Cancer treatment', 'Cell culture'): 0.06, ('Cancer treatment', 'Cell wall'): 0.03, ('Cancer treatment', 'Centriole'): 0.03, ('Cancer treatment', 'Centrosome'): 0.06, ('Cancer treatment', 'Cerebrospinal fluid'): 0.08, ('Cancer treatment', 'Cilium'): 0.03, ('Cancer treatment', 'Clinical trials'): 0.06, ('Cancer treatment', 'Cytoplasmic inclusion'): 0.03, ('Cancer treatment', 'Cytoskeleton'): 0.03, ('Cancer treatment', 'Differential centrifugation'): 0.03, ('Cancer treatment', 'Elaioplast'): 0.03, ('Cancer treatment', 'Endomembrane system'): 0.03, ('Cancer treatment', 'Endoplasmic reticulum'): 0.03, ('Cancer treatment', 'Endosome'): 0.03, ('Cancer treatment', 'Erythrocyte'): 0.03, ('Cancer treatment', 'Eukaryotes'): 0.03, ('Cancer treatment', 'ExoCarta'): 0.03, ('Cancer treatment', 'Exosome complex'): 0.03, ('Cancer treatment', 'Extracellular signal-regulated kinases'): 0.06, ('Cancer treatment', 'Extracellular vesicle'): 0.03, ('Cancer treatment', 'Filopodium'): 0.03, ('Cancer treatment', 'Flagellum'): 0.03, ('Cancer treatment', 'Glyoxysome'): 0.03, ('Cancer treatment', 'Golgi apparatus'): 0.03, ('Cancer treatment', 'Granule (cell biology)'): 0.03, ('Cancer treatment', 'Growth medium'): 0.03, ('Cancer treatment', 'Heat shock protein 90kDa alpha (cytosolic), member A1'): 0.06, ('Cancer treatment', 'Insulin-like growth factor-1'): 0.03, ('Cancer treatment', 'Intermediate filament'): 0.03, ('Cancer treatment', 'International Society for Extracellular Vesicles'): 0.03, ('Cancer treatment', 'Intraluminal vesicle'): 0.03, ('Cancer treatment', 'Journal of Extracellular Vesicles'): 0.03, ('Cancer treatment', 'Lamellipodium'): 0.03, ('Cancer treatment', 'Lipoprotein'): 0.03, ('Cancer treatment', 'Lysosome'): 0.03, ('Cancer treatment', 'MHC I'): 0.03, ('Cancer treatment', 'MHC II'): 0.03, ('Cancer treatment', 'Magnetosome'): 0.03, ('Cancer treatment', 'Melanosome'): 0.03, ('Cancer treatment', 'Membrane vesicle trafficking'): 0.03, ('Cancer treatment', 'Microbody'): 0.03, ('Cancer treatment', 'Microfilament'): 0.03, ('Cancer treatment', 'Microtubule organizing center'): 0.03, ('Cancer treatment', 'Microvesicles'): 0.03, ('Cancer treatment', 'Multicellular organism'): 0.03, ('Cancer treatment', 'Multivesicular body'): 0.03, ('Cancer treatment', 'Myofibril'): 0.03, ('Cancer treatment', 'Nanometre'): 0.03, ('Cancer treatment', 'Nanoparticle tracking analysis'): 0.03, ('Cancer treatment', 'Organelle'): 0.03, ('Cancer treatment', 'Parenthesome'): 0.03, ('Cancer treatment', 'Pathogens'): 0.03, ('Cancer treatment', 'Peroxisome'): 0.03, ('Cancer treatment', 'Phagosome'): 0.03, ('Cancer treatment', 'Plasma membrane'): 0.03, ('Cancer treatment', 'Prokaryotic cytoskeleton'): 0.03, ('Cancer treatment', 'Prostasomes'): 0.03, ('Cancer treatment', 'Proteinoplast'): 0.03, ('Cancer treatment', 'Pseudopodium'): 0.03, ('Cancer treatment', 'RNA-induced silencing complex'): 0.08, ('Cancer treatment', 'Radial spoke'): 0.03, ('Cancer treatment', 'Reactive oxygen species'): 0.06, ('Cancer treatment', 'Refractive index'): 0.03, ('Cancer treatment', 'Reticulocyte'): 0.03, ('Cancer treatment', 'Ribosome'): 0.03, ('Cancer treatment', 'Saliva'): 0.06, ('Cancer treatment', 'Signaling pathways'): 0.03, ('Cancer treatment', 'Small interfering RNA'): 0.06, ('Cancer treatment', 'Spindle pole body'): 0.03, ('Cancer treatment', 'Spliceosome'): 0.03, ('Cancer treatment', 'Stromal cell-derived factor 1'): 0.06, ('Cancer treatment', 'Superoxide dismutase'): 0.03, ('Cancer treatment', 'Tannosome'): 0.03, ('Cancer treatment', 'Transcriptomics'): 0.03, ('Cancer treatment', 'Transferrin receptor'): 0.03, ('Cancer treatment', 'Transmission electron microscopy'): 0.03, ('Cancer treatment', 'Trypanosoma cruzi'): 0.03, ('Cancer treatment', 'Tunable resistive pulse sensing'): 0.03, ('Cancer treatment', 'Undulipodium'): 0.03, ('Cancer treatment', 'Vaccination'): 0.03, ('Cancer treatment', 'Vacuole'): 0.03, ('Cancer treatment', 'Vault (organelle)'): 0.03, ('Cancer treatment', 'Vesicle (biology)'): 0.03, ('Cancer treatment', 'Vesicle (biology and chemistry)'): 0.03, ('Cancer treatment', 'Weibel–Palade body'): 0.03, ('Cancer treatment', 'Western blot'): 0.03, ('Cancer treatment', 'Wound'): 0.03, ('Cancer treatment', 'Zeta potential'): 0.03, ('Cancer treatment', 'Doctoral advisor'): 0.05, ('Cancer treatment', 'Laser'): 0.05, ('Cancer treatment', 'Nature (journal)'): 0.05, ('Cancer treatment', 'Radical (chemistry)'): 0.02, ('Cancer treatment', 'Dana–Farber Cancer Institute'): 0.02, ('Cancer treatment', 'Fred Hutchinson Cancer Research Center'): 0.02, ('Cancer treatment', 'Harvard Medical School'): 0.05, ('Cancer treatment', 'Harvard School of Public Health'): 0.02, ('Cancer treatment', 'Julio Frenk'): 0.02, ('Cancer treatment', 'Lance Armstrong'): 0.02, ('Cancer treatment', 'Lawrence Corey'): 0.02, ('Cancer treatment', 'Princess Dina Mired of Jordan'): 0.02, ('Cancer treatment', 'University of Washington'): 0.07, ('Cancer treatment', 'Canada'): 0.05, ('Cancer treatment', 'Egypt'): 0.05, ('Cancer treatment', 'France'): 0.05, ('Cancer treatment', 'Health insurance'): 0.05, ('Cancer treatment', 'Health system'): 0.05, ('Cancer treatment', 'Japan'): 0.05, ('Cancer treatment', 'New York Times'): 0.05, ('Cancer treatment', 'South Africa'): 0.05, ('Cancer treatment', 'Spain'): 0.05, ('Cancer treatment', 'The New Yorker'): 0.05, ('Cancer treatment', 'Zimbabwe'): 0.05, ('Cancer treatment', 'Cocaine'): 0.05, ('Cancer treatment', 'Delirium'): 0.05, ('Cancer treatment', 'Dextromethorphan'): 0.05, ('Cancer treatment', 'Dizziness'): 0.05, ('Cancer treatment', 'Halothane'): 0.05, ('Cancer treatment', 'Intravenous'): 0.05, ('Cancer treatment', 'MDMA'): 0.05, ('Cancer treatment', 'Medical emergency'): 0.05, ('Cancer treatment', 'Neuroleptic malignant syndrome'): 0.05, ('Cancer treatment', 'Organ failure'): 0.05, ('Cancer treatment', 'Perspiration'): 0.05, ('Cancer treatment', 'Phencyclidine'): 0.05, ('Cancer treatment', 'Pheochromocytoma'): 0.07, ('Cancer treatment', 'Renal'): 0.05, ('Cancer treatment', 'Risk assessment'): 0.05, ('Cancer treatment', 'Status epilepticus'): 0.05, ('Cancer treatment', 'Traumatic brain injury'): 0.05, ('Cancer treatment', 'MAPK'): 0.06, ('Cancer treatment', 'Medullary thyroid cancer'): 0.07, ('Cancer treatment', 'Rac (GTPase)'): 0.06, ('Cancer treatment', 'Rhabdomyosarcoma'): 0.05, ('Cancer treatment', 'Vimentin'): 0.05, ('Cancer treatment', 'American Statistical Association'): 0.02, ('Cancer treatment', 'Biometry'): 0.02, ('Cancer treatment', 'Biostatistics'): 0.05, ('Cancer treatment', 'Caucus for Women in Statistics'): 0.02, ('Cancer treatment', 'Fellow of the American Statistical Association'): 0.07, ('Cancer treatment', 'Fellow of the Royal Statistical Society'): 0.02, ('Cancer treatment', 'International Statistical Institute'): 0.02, ('Cancer treatment', 'Missing data'): 0.02, ('Cancer treatment', 'Oklahoma State University'): 0.02, ('Cancer treatment', 'Sociology'): 0.02, ('Cancer treatment', 'Treatment of cancer'): 0.12, ('Cancer treatment', 'UTHealth School of Public Health'): 0.02, ('Cancer treatment', 'University of Texas MD Anderson Cancer Center'): 0.02, ('Cancer treatment', 'Pseudokinases'): 0.03, ('Cancer treatment', 'ADP—thymidine kinase'): 0.03, ('Cancer treatment', 'Activation loop'): 0.03, ('Cancer treatment', 'Active site'): 0.08, ('Cancer treatment', 'Adenosine diphosphate'): 0.03, ('Cancer treatment', 'Adenosine monophosphate'): 0.06, ('Cancer treatment', 'Adenosine triphosphate'): 0.06, ('Cancer treatment', 'Adenylate kinase'): 0.03, ('Cancer treatment', 'Agammaglobulinaemia'): 0.03, ('Cancer treatment', 'Alcohol (chemistry)'): 0.03, ('Cancer treatment', 'Allosteric regulation'): 0.06, ('Cancer treatment', 'Amino acid'): 0.03, ('Cancer treatment', 'Anhydride'): 0.03, ('Cancer treatment', 'Aspartate kinase'): 0.03, ('Cancer treatment', 'Autophosphorylation'): 0.03, ('Cancer treatment', 'Binding site'): 0.06, ('Cancer treatment', 'CDK-activating kinase'): 0.03, ('Cancer treatment', 'CDP-diacylglycerol—glycerol-3-phosphate 3-phosphatidyltransferase'): 0.03, ('Cancer treatment', 'CDP-diacylglycerol—inositol 3-phosphatidyltransferase'): 0.03, ('Cancer treatment', 'CDP-diacylglycerol—serine O-phosphatidyltransferase'): 0.03, ('Cancer treatment', 'Ca2+/calmodulin-dependent protein kinase'): 0.06, ('Cancer treatment', 'Calorie'): 0.03, ('Cancer treatment', 'Carbohydrate'): 0.03, ('Cancer treatment', 'Carboxy'): 0.03, ('Cancer treatment', 'Catalysis'): 0.03, ('Cancer treatment', 'Catalytic triad'): 0.06, ('Cancer treatment', 'Cation'): 0.03, ('Cancer treatment', 'Cdc25'): 0.06, ('Cancer treatment', 'Cell differentiation'): 0.03, ('Cancer treatment', 'Cell signalling'): 0.03, ('Cancer treatment', 'Cellular metabolism'): 0.03, ('Cancer treatment', 'Cellular signalling'): 0.03, ('Cancer treatment', 'Cellular transport'): 0.03, ('Cancer treatment', 'Citrate'): 0.03, ('Cancer treatment', 'Class II PI 3-kinases'): 0.03, ('Cancer treatment', 'Class I PI 3-kinases'): 0.03, ('Cancer treatment', 'Cofactor (biochemistry)'): 0.06, ('Cancer treatment', 'Cooperativity'): 0.06, ('Cancer treatment', 'Covalent modulation'): 0.03, ('Cancer treatment', 'Creatine'): 0.03, ('Cancer treatment', 'Creatine kinase'): 0.03, ('Cancer treatment', 'Cyclin'): 0.03, ('Cancer treatment', 'Cyclin dependent kinase'): 0.03, ('Cancer treatment', 'DNA polymerase I'): 0.03, ('Cancer treatment', 'DNA polymerase II'): 0.03, ('Cancer treatment', 'DNA polymerase III holoenzyme'): 0.03, ('Cancer treatment', 'DNA polymerase IV'): 0.03, ('Cancer treatment', 'DNA polymerase V'): 0.03, ('Cancer treatment', 'DNA polymerase alpha'): 0.03, ('Cancer treatment', 'DNA polymerase delta'): 0.03, ('Cancer treatment', 'DNA polymerase epsilon'): 0.03, ('Cancer treatment', 'DNA polymerase eta'): 0.03, ('Cancer treatment', 'DNA polymerase mu'): 0.03, ('Cancer treatment', 'DNA polymerase nu'): 0.03, ('Cancer treatment', 'DNA synthesis'): 0.03, ('Cancer treatment', 'Deoxycytidine kinase'): 0.03, ('Cancer treatment', 'Dephosphorylation'): 0.03, ('Cancer treatment', 'Deprotonate'): 0.03, ('Cancer treatment', 'Diacylglycerol kinase'): 0.03, ('Cancer treatment', 'Dictionary.com'): 0.03, ('Cancer treatment', 'Diffusion-limited enzyme'): 0.06, ('Cancer treatment', 'Dihydroxyacetone'): 0.03, ('Cancer treatment', 'Diphosphate'): 0.03, ('Cancer treatment', 'Diphosphotransferase'): 0.03, ('Cancer treatment', 'Divalent'): 0.03, ('Cancer treatment', 'EGF receptor'): 0.03, ('Cancer treatment', 'Eadie–Hofstee diagram'): 0.06, ('Cancer treatment', 'Edmond H. Fischer'): 0.03, ('Cancer treatment', 'Edwin G. Krebs'): 0.03, ('Cancer treatment', 'Edwin Krebs'): 0.03, ('Cancer treatment', 'Endocytosis'): 0.03, ('Cancer treatment', 'Enzyme Commission number'): 0.08, ('Cancer treatment', 'Enzyme activator'): 0.06, ('Cancer treatment', 'Enzyme catalysis'): 0.06, ('Cancer treatment', 'Enzyme kinetics'): 0.06, ('Cancer treatment', 'Enzyme promiscuity'): 0.06, ('Cancer treatment', 'Eugene P. Kennedy'): 0.03, ('Cancer treatment', 'Exocytosis'): 0.03, ('Cancer treatment', 'Exoribonuclease'): 0.06, ('Cancer treatment', 'Flavin adenine dinucleotide'): 0.03, ('Cancer treatment', 'Flavin mononucleotide'): 0.03, ('Cancer treatment', 'Fructokinase'): 0.03, ('Cancer treatment', 'GPCR'): 0.03, ('Cancer treatment', 'Galactokinase'): 0.03, ('Cancer treatment', 'Galactose-1-phosphate uridylyltransferase'): 0.03, ('Cancer treatment', 'Glucokinase'): 0.03, ('Cancer treatment', 'Glucose-1,6-bisphosphate synthase'): 0.03, ('Cancer treatment', 'Glycerol kinase'): 0.03, ('Cancer treatment', 'Glycogen'): 0.03, ('Cancer treatment', 'Glycogen synthase'): 0.03, ('Cancer treatment', 'Glycolysis'): 0.03, ('Cancer treatment', 'Guanosine diphosphate'): 0.03, ('Cancer treatment', 'Guanosine triphosphate'): 0.03, ('Cancer treatment', 'Guanylate kinase'): 0.03, ('Cancer treatment', 'Guanylyltransferase'): 0.03, ('Cancer treatment', 'HDAC'): 0.03, ('Cancer treatment', 'Hanes–Woolf plot'): 0.06, ('Cancer treatment', 'Hepatic fructokinase'): 0.03, ('Cancer treatment', 'Hexokinase'): 0.03, ('Cancer treatment', 'Hexokinase deficiency'): 0.03, ('Cancer treatment', 'High-energy phosphate'): 0.03, ('Cancer treatment', 'Histidine kinase'): 0.03, ('Cancer treatment', 'Hydrolase'): 0.08, ('Cancer treatment', 'Insulin resistance'): 0.03, ('Cancer treatment', 'Integrase'): 0.03, ('Cancer treatment', 'Isomerase'): 0.06, ('Cancer treatment', 'Ligase'): 0.06, ('Cancer treatment', 'Lineweaver–Burk plot'): 0.06, ('Cancer treatment', 'List of EC numbers (EC 1)'): 0.06, ('Cancer treatment', 'List of EC numbers (EC 2)'): 0.06, ('Cancer treatment', 'List of EC numbers (EC 3)'): 0.08, ('Cancer treatment', 'List of EC numbers (EC 4)'): 0.06, ('Cancer treatment', 'List of EC numbers (EC 5)'): 0.06, ('Cancer treatment', 'List of EC numbers (EC 6)'): 0.06, ('Cancer treatment', 'List of EC numbers (EC 7)'): 0.06, ('Cancer treatment', 'List of enzymes'): 0.06, ('Cancer treatment', 'Lyase'): 0.06, ('Cancer treatment', 'MRNA capping enzyme'): 0.03, ('Cancer treatment', 'Mevalonate kinase'): 0.03, ('Cancer treatment', 'Michaelis–Menten kinetics'): 0.06, ('Cancer treatment', 'Mitochondrial DNA'): 0.03, ('Cancer treatment', 'Mitogen-activated protein kinase'): 0.06, ('Cancer treatment', 'Monosaccharide'): 0.03, ('Cancer treatment', 'N-acetylglucosamine-1-phosphate transferase'): 0.03, ('Cancer treatment', 'NAD+ kinase'): 0.03, ('Cancer treatment', 'Neuroblastoma'): 0.1, ('Cancer treatment', 'Nitrogen'): 0.03, ('Cancer treatment', 'Nucleoside-diphosphate kinase'): 0.03, ('Cancer treatment', 'Nucleoside-phosphate kinase'): 0.03, ('Cancer treatment', 'Nucleoside monophosphate'): 0.03, ('Cancer treatment', 'Nucleotide'): 0.03, ('Cancer treatment', 'Nucleotidyltransferase'): 0.03, ('Cancer treatment', 'Oligosaccharide'): 0.03, ('Cancer treatment', 'Oxidoreductase'): 0.06, ('Cancer treatment', 'Oxyanion hole'): 0.06, ('Cancer treatment', 'PFKL'): 0.03, ('Cancer treatment', 'PFKM'): 0.03, ('Cancer treatment', 'PFKP'): 0.03, ('Cancer treatment', 'PFP (enzyme)'): 0.03, ('Cancer treatment', 'POLG'): 0.03, ('Cancer treatment', 'POLI'): 0.03, ('Cancer treatment', 'POLK'): 0.03, ('Cancer treatment', 'POLQ'): 0.03, ('Cancer treatment', 'POLRMT'): 0.03, ('Cancer treatment', 'PRIM1'): 0.03, ('Cancer treatment', 'PRIM2'): 0.03, ('Cancer treatment', 'Pantothenate kinase'): 0.03, ('Cancer treatment', 'Pfu DNA polymerase'): 0.03, ('Cancer treatment', 'Phosphatase'): 0.06, ('Cancer treatment', 'Phosphatases'): 0.03, ('Cancer treatment', 'Phosphate'): 0.03, ('Cancer treatment', 'Phosphatidylcholine synthase'): 0.03, ('Cancer treatment', 'Phosphatidylinositol'): 0.03, ('Cancer treatment', 'Phosphatidylinositol-4,5-bisphosphate 3-kinase'): 0.03, ('Cancer treatment', 'Phosphatidylinositol-4-phosphate 3-kinase'): 0.03, ('Cancer treatment', 'Phosphatidylinositol 3,4,5-trisphosphate'): 0.03, ('Cancer treatment', 'Phosphatidylinositol 3,4-bisphosphate'): 0.03, ('Cancer treatment', 'Phosphatidylinositol 3-phosphate'): 0.03, ('Cancer treatment', 'Phosphatidylinositol phosphate kinases'): 0.03, ('Cancer treatment', 'Phosphoanhydride'): 0.03, ('Cancer treatment', 'Phosphoenolpyruvate'): 0.03, ('Cancer treatment', 'Phosphofructokinase'): 0.03, ('Cancer treatment', 'Phosphofructokinase 1'): 0.03, ('Cancer treatment', 'Phosphofructokinase 2'): 0.06, ('Cancer treatment', 'Phosphoglycerate'): 0.03, ('Cancer treatment', 'Phosphoglycerate kinase'): 0.03, ('Cancer treatment', 'Phospholipase C'): 0.06, ('Cancer treatment', 'Phospholipid'): 0.03, ('Cancer treatment', 'Phosphomevalonate kinase'): 0.03, ('Cancer treatment', 'Phosphoprotein'): 0.03, ('Cancer treatment', 'Phosphorolysis'): 0.03, ('Cancer treatment', 'Phosphorus'): 0.03, ('Cancer treatment', 'Phosphorylase'): 0.03, ('Cancer treatment', 'Phosphotransferase'): 0.03, ('Cancer treatment', 'Polyadenylation'): 0.03, ('Cancer treatment', 'Polymerase'): 0.03, ('Cancer treatment', 'Polynucleotide adenylyltransferase'): 0.03, ('Cancer treatment', 'Polynucleotide phosphorylase'): 0.03, ('Cancer treatment', 'PrimPol'): 0.03, ('Cancer treatment', 'Primase'): 0.03, ('Cancer treatment', 'Prokaryote'): 0.03, ('Cancer treatment', 'Protein-histidine pros-kinase'): 0.03, ('Cancer treatment', 'Protein-histidine tele-kinase'): 0.03, ('Cancer treatment', 'Protein kinase'): 0.03, ('Cancer treatment', 'Protein superfamily'): 0.06, ('Cancer treatment', 'Pyruvate dehydrogenase'): 0.03, ('Cancer treatment', 'Pyruvate kinase'): 0.03, ('Cancer treatment', 'REV3L'): 0.03, ('Cancer treatment', 'RNA polymerase I'): 0.03, ('Cancer treatment', 'RNA polymerase III'): 0.03, ('Cancer treatment', 'RNA polymerase IV'): 0.03, ('Cancer treatment', 'RNA polymerase V'): 0.03, ('Cancer treatment', 'RNase PH'): 0.03, ('Cancer treatment', 'Raf kinase'): 0.03, ('Cancer treatment', 'Ras subfamily'): 0.03, ('Cancer treatment', 'Recombinase'): 0.03, ('Cancer treatment', 'Redox cofactor'): 0.03, ('Cancer treatment', 'Reverse transcriptase'): 0.03, ('Cancer treatment', 'Rho family of GTPases'): 0.03, ('Cancer treatment', 'Riboflavin'): 0.03, ('Cancer treatment', 'Riboflavin kinase'): 0.03, ('Cancer treatment', 'Ribose-phosphate diphosphokinase'): 0.03, ('Cancer treatment', 'Secretory pathway'): 0.03, ('Cancer treatment', 'Serine/threonine-specific protein kinase'): 0.06, ('Cancer treatment', 'Shikimate'): 0.03, ('Cancer treatment', 'Shikimate kinase'): 0.03, ('Cancer treatment', 'Sphingosine'): 0.03, ('Cancer treatment', 'Sphingosine-1-phosphate'): 0.03, ('Cancer treatment', 'Sphingosine kinase'): 0.03, ('Cancer treatment', 'Spinocerebellar ataxia'): 0.06, ('Cancer treatment', 'Substrate (biochemistry)'): 0.03, ('Cancer treatment', 'Substrate (biology)'): 0.03, ('Cancer treatment', 'T7 DNA polymerase'): 0.03, ('Cancer treatment', 'T7 RNA polymerase'): 0.03, ('Cancer treatment', 'Taq polymerase'): 0.03, ('Cancer treatment', \"Tarui's disease\"): 0.03, ('Cancer treatment', 'Terminal deoxynucleotidyl transferase'): 0.03, ('Cancer treatment', 'Thiamine-diphosphate kinase'): 0.03, ('Cancer treatment', 'Thiamine diphosphokinase'): 0.03, ('Cancer treatment', 'Thymidine diphosphate'): 0.03, ('Cancer treatment', 'Thymidine kinase'): 0.03, ('Cancer treatment', 'Thymidine kinase in clinical chemistry'): 0.03, ('Cancer treatment', 'Thymidine monophosphate'): 0.03, ('Cancer treatment', 'Thymidine triphosphate'): 0.03, ('Cancer treatment', 'Thymidylate kinase'): 0.03, ('Cancer treatment', 'Transcription (genetics)'): 0.06, ('Cancer treatment', 'Transesterification'): 0.06, ('Cancer treatment', 'Transferase'): 0.06, ('Cancer treatment', 'Translation (biology)'): 0.03, ('Cancer treatment', 'Translocase'): 0.06, ('Cancer treatment', 'Transposase'): 0.03, ('Cancer treatment', 'UMP kinase'): 0.03, ('Cancer treatment', 'UTP—glucose-1-phosphate uridylyltransferase'): 0.03, ('Cancer treatment', 'Wall-associated kinase'): 0.03, ('Cancer treatment', 'Chondrosarcoma'): 0.06, ('Cancer treatment', 'DNA methylation in cancer'): 0.05, ('Cancer treatment', 'Genome instability'): 0.07, ('Cancer treatment', 'Thyroid cancer'): 0.1, ('Cancer treatment', 'Choriocarcinoma'): 0.07, ('Cancer treatment', 'G1 phase'): 0.05, ('Cancer treatment', 'Germ cell tumor'): 0.07, ('Cancer treatment', 'Mitosis'): 0.05, ('Cancer treatment', 'Small-cell carcinoma'): 0.05, ('Cancer treatment', 'Clinical outcome'): 0.02, ('Cancer treatment', 'Synergy'): 0.02, ('Cancer treatment', 'Fetal alcohol spectrum disorder'): 0.05, ('Cancer treatment', 'Pruritus'): 0.06, ('Cancer treatment', 'Restless legs syndrome'): 0.05, ('Cancer treatment', 'Suppository'): 0.05, ('Cancer treatment', 'Urinary retention'): 0.05, ('Cancer treatment', 'Senescence'): 0.05, ('Cancer treatment', 'Sirtuin 1'): 0.05, ('Cancer treatment', 'Epithelium'): 0.05, ('Cancer treatment', 'Serine/threonine kinase'): 0.05, ('Cancer treatment', 'Ageing'): 0.05, ('Cancer treatment', 'American Association for the Advancement of Science'): 0.02, ('Cancer treatment', 'Diagnosis'): 0.05, ('Cancer treatment', 'Doctor of Philosophy'): 0.02, ('Cancer treatment', 'Harvey Mudd College'): 0.02, ('Cancer treatment', 'Insurance'): 0.02, ('Cancer treatment', 'Longitudinal data'): 0.02, ('Cancer treatment', 'Mathematics Genealogy Project'): 0.02, ('Cancer treatment', 'Professor emerita'): 0.02, ('Cancer treatment', 'Spatial variability'): 0.02, ('Cancer treatment', 'Thesis'): 0.02, ('Cancer treatment', 'University of California, Los Angeles'): 0.02, ('Cancer treatment', 'Wilfrid Dixon'): 0.02, ('Cancer treatment', 'C. Gordon Zubrod'): 0.02, ('Cancer treatment', 'Cancer patient'): 0.02, ('Cancer treatment', 'David A. Karnofsky'): 0.02, ('Cancer treatment', 'Diagnostic and Statistical Manual of Mental Disorders'): 0.02, ('Cancer treatment', 'Eastern Cooperative Oncology Group'): 0.02, ('Cancer treatment', 'Global Assessment of Functioning'): 0.02, ('Cancer treatment', 'Joseph H. Burchenal'): 0.02, ('Cancer treatment', 'Randomized controlled trial'): 0.02, ('Cancer treatment', 'Exponential distribution'): 0.02, ('Cancer treatment', 'Huldah Bancroft'): 0.02, ('Cancer treatment', 'Survival function'): 0.02, ('Cancer treatment', 'University of Chicago'): 0.02, ('Cancer treatment', 'University of Minnesota'): 0.02, ('Cancer treatment', 'Robot-assisted surgery'): 0.05, ('Cancer treatment', 'Brain tumor'): 0.05, ('Cancer treatment', 'Dysgerminoma'): 0.05, ('Cancer treatment', 'Embryonal carcinoma'): 0.05, ('Cancer treatment', 'Endodermal sinus tumor'): 0.05, ('Cancer treatment', 'Hepatocellular carcinoma'): 0.05, ('Cancer treatment', 'Sertoli–Leydig cell tumour'): 0.05, ('Cancer treatment', 'Surface epithelial-stromal tumor'): 0.05, ('Cancer treatment', 'Small molecule'): 0.07, ('Cancer treatment', 'Amyotrophic lateral sclerosis'): 0.05, ('Cancer treatment', 'Intervertebral disc'): 0.05, ('Cancer treatment', \"Parkinson's disease\"): 0.05, ('Cancer treatment', 'Brain transplant'): 0.05, ('Cancer treatment', 'Head transplant'): 0.05, ('Cancer treatment', 'Arthralgia'): 0.03, ('Cancer treatment', 'Calvin Bridges'): 0.03, ('Cancer treatment', 'Drosophila melanogaster'): 0.03, ('Cancer treatment', 'Evolutionary capacitance'): 0.03, ('Cancer treatment', 'Forward genetics'): 0.03, ('Cancer treatment', 'Genetic screen'): 0.03, ('Cancer treatment', 'KDM1A'): 0.03, ('Cancer treatment', 'Phenotype'): 0.03, ('Cancer treatment', 'Polymerase chain reaction'): 0.03, ('Cancer treatment', 'Reverse genetics'): 0.03, ('Cancer treatment', 'Robustness (evolution)'): 0.03, ('Cancer treatment', 'Synthetic genetic array'): 0.03, ('Cancer treatment', 'Synthetic rescue'): 0.03, ('Cancer treatment', 'Theodore Dobzhansky'): 0.03, ('Cancer treatment', 'Tumor suppressor'): 0.03, ('Cancer treatment', 'Abortion'): 0.02, ('Cancer treatment', 'E. Donnall Thomas'): 0.05, ('Breast cancer', 'Base excision repair'): 0.02, ('Central nervous system', 'Antiemetics'): 0.02, ('Chemotherapy', 'Antiemetics'): 0.02, ('Chemotherapy', 'Axitinib'): 0.02, ('Chemotherapy', 'Cancer cell'): 0.02, ('Colon cancer', 'Synthetic lethality'): 0.02, ('Constipation', 'Antiemetics'): 0.02, ('Diarrhea', 'Antiemetics'): 0.02, ('Human brain', 'Antiemetics'): 0.02, ('Human brain', 'BRCA1'): 0.02, ('Human brain', 'Base excision repair'): 0.01, ('Human brain', 'Cancer cell'): 0.01, ('Human brain', 'Synthetic lethality'): 0.01, ('Lymph node', 'Cancer cell'): 0.02, ('Medical Subject Headings', 'Cancer cell'): 0.07, ('Medical Subject Headings', 'Synthetic lethality'): 0.05, ('Medication', 'Antiemetics'): 0.02, ('Medication', 'Axitinib'): 0.02, ('Nausea', 'Antiemetics'): 0.02, ('Neoplasm', 'BRCA1'): 0.02, ('Neoplasm', 'Synthetic lethality'): 0.03, ('Prostate cancer', 'Base excision repair'): 0.02, ('Prostate cancer', 'Cancer cell'): 0.02, ('Radiotherapy', 'Cancer cell'): 0.02, ('Therapy', 'Base excision repair'): 0.03, ('Therapy', 'Cancer cell'): 0.03, ('Therapy', 'Synthetic lethality'): 0.04, ('Vomiting', 'Antiemetics'): 0.02, ('7S seed storage protein', 'Cancer cell'): 0.02, ('11S globulin family', 'Cancer cell'): 0.02, ('2S albumin', 'Cancer cell'): 0.02, ('Afamin', 'Cancer cell'): 0.02, ('Albumin (disambiguation)', 'Cancer cell'): 0.02, ('Alpha-2-Macroglobulin', 'Cancer cell'): 0.02, ('Alpha-fetoprotein', 'Cancer cell'): 0.02, ('Alpha-lactalbumin', 'Cancer cell'): 0.02, ('Alpha 1-antichymotrypsin', 'Cancer cell'): 0.02, ('Alpha 1-antitrypsin', 'Cancer cell'): 0.02, ('Alpha 2-antiplasmin', 'Cancer cell'): 0.02, ('Alpha globulin', 'Cancer cell'): 0.02, ('Angiostatin', 'Cancer cell'): 0.02, ('Antibody', 'Cancer cell'): 0.02, ('Antithrombin', 'Cancer cell'): 0.02, ('Avidin', 'Cancer cell'): 0.02, ('Beta-2 microglobulin', 'Cancer cell'): 0.02, ('Beta-lactoglobulin', 'Cancer cell'): 0.02, ('Beta globulins', 'Cancer cell'): 0.02, ('Biliprotein', 'Cancer cell'): 0.02, ('Bilirubin', 'Cancer cell'): 0.02, ('Blood plasma', 'Cancer cell'): 0.02, ('Blood proteins', 'Cancer cell'): 0.02, ('Bovine serum albumin', 'Cancer cell'): 0.02, ('C-reactive protein', 'Cancer cell'): 0.02, ('CITES', 'Cancer cell'): 0.02, ('Carrier protein', 'Cancer cell'): 0.02, ('Ceruloplasmin', 'Cancer cell'): 0.02, ('Chromoprotein', 'Cancer cell'): 0.02, ('Chromosome 4', 'Cancer cell'): 0.02, ('Coagulate', 'Cancer cell'): 0.02, ('Cohn process', 'Cancer cell'): 0.02, ('Conalbumin', 'Cancer cell'): 0.02, ('Denaturation (biochemistry)', 'Cancer cell'): 0.02, ('Edestin', 'Cancer cell'): 0.02, ('Egg white', 'Cancer cell'): 0.02, ('Encyclopædia Britannica Eleventh Edition', 'Cancer cell'): 0.02, ('Extracellular matrix protein 1', 'Cancer cell'): 0.02, ('Factor H', 'Cancer cell'): 0.02, ('Fatty acid', 'Cancer cell'): 0.02, ('Fetal fibronectin', 'Cancer cell'): 0.02, ('Fibronectin', 'Cancer cell'): 0.02, ('Gamma globulin', 'Cancer cell'): 0.02, ('Genetically modified rice', 'Cancer cell'): 0.02, ('Globular protein', 'Cancer cell'): 0.02, ('Globulin', 'Cancer cell'): 0.02, ('Glycosylation', 'Cancer cell'): 0.02, ('Haptoglobin', 'Cancer cell'): 0.02, ('Hemopexin', 'Cancer cell'): 0.02, ('Hemp protein', 'Cancer cell'): 0.02, ('Heparin cofactor II', 'Cancer cell'): 0.02, ('Human serum albumin', 'Cancer cell'): 0.02, ('InterPro', 'Cancer cell'): 0.02, ('Isoelectric point', 'Cancer cell'): 0.02, ('Lactalbumin', 'Cancer cell'): 0.02, ('Lactoferrin', 'Cancer cell'): 0.02, ('Latin', 'Cancer cell'): 0.04, ('Ligand', 'Cancer cell'): 0.02, ('Lipocalin', 'Cancer cell'): 0.02, ('List of proteins', 'Cancer cell'): 0.02, ('Macroglobulin', 'Cancer cell'): 0.02, ('Membrane protein', 'Cancer cell'): 0.04, ('Microglobulin', 'Cancer cell'): 0.02, ('Oncotic pressure', 'Cancer cell'): 0.02, ('Orosomucoid', 'Cancer cell'): 0.02, ('Ovalbumin', 'Cancer cell'): 0.02, ('PDBsum', 'Cancer cell'): 0.02, ('PROSITE', 'Cancer cell'): 0.02, ('Parvalbumin', 'Cancer cell'): 0.02, ('Pfam', 'Cancer cell'): 0.02, ('Photoreceptor protein', 'Cancer cell'): 0.02, ('Phycobiliprotein', 'Cancer cell'): 0.02, ('Phylogeny', 'Cancer cell'): 0.02, ('Phytochrome', 'Cancer cell'): 0.02, ('Plasmin', 'Cancer cell'): 0.02, ('Post-translational modification', 'Cancer cell'): 0.02, ('Properdin', 'Cancer cell'): 0.02, ('Proteasome', 'Cancer cell'): 0.02, ('Protein', 'Base excision repair'): 0.02, ('Protein', 'Cancer cell'): 0.04, ('Protein', 'Synthetic lethality'): 0.03, ('Protein Data Bank', 'Base excision repair'): 0.02, ('Protein Data Bank', 'Cancer cell'): 0.04, ('Protein Data Bank', 'Synthetic lethality'): 0.03, ('Protein biosynthesis', 'Cancer cell'): 0.02, ('Protein domain', 'Cancer cell'): 0.02, ('Protein family', 'Cancer cell'): 0.02, ('Protein folding', 'Cancer cell'): 0.02, ('Protein methods', 'Cancer cell'): 0.02, ('Protein structure', 'Cancer cell'): 0.02, ('Protein targeting', 'Cancer cell'): 0.02, ('Proteome', 'Cancer cell'): 0.02, ('Retinol binding protein', 'Cancer cell'): 0.02, ('Ricin', 'Cancer cell'): 0.02, ('Scleroprotein', 'Cancer cell'): 0.02, ('Seed', 'Cancer cell'): 0.02, ('Serpin', 'Cancer cell'): 0.02, ('Serum albumin', 'Cancer cell'): 0.02, ('Sex hormone-binding globulin', 'Cancer cell'): 0.02, ('Simple Modular Architecture Research Tool', 'Cancer cell'): 0.02, ('Solubility', 'Cancer cell'): 0.02, ('Storage protein', 'Cancer cell'): 0.02, ('Structural Classification of Proteins', 'Cancer cell'): 0.02, ('Thyroglobulin', 'Cancer cell'): 0.02, ('Traditional Chinese medicine', 'Cancer cell'): 0.02, ('Transcobalamin', 'Cancer cell'): 0.02, ('Transcortin', 'Cancer cell'): 0.02, ('Transferrin', 'Cancer cell'): 0.02, ('Transthyretin', 'Cancer cell'): 0.02, ('Unified atomic mass unit', 'Cancer cell'): 0.02, ('Vertebrates', 'Cancer cell'): 0.02, ('Vitamin D-binding protein', 'Cancer cell'): 0.02, ('Whey protein', 'Cancer cell'): 0.02, ('Wikisource', 'Cancer cell'): 0.02, ('Wnt protein', 'Cancer cell'): 0.02, ('Alternative medicine', 'Base excision repair'): 0.03, ('Alternative medicine', 'Cancer cell'): 0.03, ('Alternative medicine', 'Synthetic lethality'): 0.04, ('Cancer', 'Antiemetics'): 0.02, ('Cancer', 'Axitinib'): 0.02, ('Cancer', 'Base excision repair'): 0.02, ('Cancer', 'Synthetic lethality'): 0.03, ('DNA repair', 'Synthetic lethality'): 0.05, ('DNA replication', 'Synthetic lethality'): 0.05, ('Epigenetics', 'Cancer cell'): 0.02, ('Epigenetics', 'Synthetic lethality'): 0.05, ('History of medicine', 'Base excision repair'): 0.03, ('History of medicine', 'Cancer cell'): 0.03, ('History of medicine', 'Synthetic lethality'): 0.04, ('Immune system', 'Antiemetics'): 0.02, ('Medical cannabis', 'Antiemetics'): 0.02, ('Medicine', 'Base excision repair'): 0.03, ('Medicine', 'Cancer cell'): 0.03, ('Medicine', 'Synthetic lethality'): 0.04, ('Mutational', 'Base excision repair'): 0.02, ('Mutational', 'Cancer cell'): 0.02, ('Mutational', 'Synthetic lethality'): 0.03, ('Palliative care', 'Base excision repair'): 0.03, ('Palliative care', 'Cancer cell'): 0.03, ('Palliative care', 'Synthetic lethality'): 0.04, ('Public health', 'Base excision repair'): 0.03, ('Public health', 'Cancer cell'): 0.03, ('Public health', 'Synthetic lethality'): 0.04, ('Radiation therapy', 'Base excision repair'): 0.03, ('Radiation therapy', 'Synthetic lethality'): 0.04, ('Traditional medicine', 'Base excision repair'): 0.03, ('Traditional medicine', 'Cancer cell'): 0.03, ('Traditional medicine', 'Synthetic lethality'): 0.04, ('United Kingdom', 'Antiemetics'): 0.02, ('Pain management', 'Base excision repair'): 0.03, ('Pain management', 'Cancer cell'): 0.03, ('Pain management', 'Synthetic lethality'): 0.04, ('Anatomical pathology', 'Base excision repair'): 0.02, ('Anatomical pathology', 'Cancer cell'): 0.02, ('Anatomical pathology', 'Synthetic lethality'): 0.03, ('AmeriPath', 'BRCA1'): 0.02, ('AmeriPath', 'Base excision repair'): 0.01, ('AmeriPath', 'Cancer cell'): 0.01, ('AmeriPath', 'Synthetic lethality'): 0.01, ('Addiction medicine', 'Antiemetics'): 0.02, ('Addiction medicine', 'Base excision repair'): 0.03, ('Addiction medicine', 'Cancer cell'): 0.03, ('Addiction medicine', 'Synthetic lethality'): 0.04, ('Addiction psychiatry', 'Base excision repair'): 0.03, ('Addiction psychiatry', 'Cancer cell'): 0.03, ('Addiction psychiatry', 'Synthetic lethality'): 0.04, ('Adolescent medicine', 'Base excision repair'): 0.03, ('Adolescent medicine', 'Cancer cell'): 0.03, ('Adolescent medicine', 'Synthetic lethality'): 0.04, ('Allergy', 'Base excision repair'): 0.03, ('Allergy', 'Cancer cell'): 0.03, ('Allergy', 'Synthetic lethality'): 0.04, ('Allied health professions', 'Base excision repair'): 0.03, ('Allied health professions', 'Cancer cell'): 0.03, ('Allied health professions', 'Synthetic lethality'): 0.04, ('American Board of Pathology', 'BRCA1'): 0.02, ('American Board of Pathology', 'Base excision repair'): 0.01, ('American Board of Pathology', 'Cancer cell'): 0.01, ('American Board of Pathology', 'Synthetic lethality'): 0.01, ('American Osteopathic Board of Pathology', 'BRCA1'): 0.02, ('American Osteopathic Board of Pathology', 'Base excision repair'): 0.01, ('American Osteopathic Board of Pathology', 'Cancer cell'): 0.01, ('American Osteopathic Board of Pathology', 'Synthetic lethality'): 0.01, ('Andrology', 'Base excision repair'): 0.03, ('Andrology', 'Cancer cell'): 0.03, ('Andrology', 'Synthetic lethality'): 0.04, ('Anesthesiology', 'Base excision repair'): 0.03, ('Anesthesiology', 'Cancer cell'): 0.03, ('Anesthesiology', 'Synthetic lethality'): 0.04, ('Angiology', 'Base excision repair'): 0.03, ('Angiology', 'Cancer cell'): 0.03, ('Angiology', 'Synthetic lethality'): 0.04, ('Apoptosis', 'BRCA1'): 0.02, ('Apoptosis', 'Base excision repair'): 0.01, ('Apoptosis', 'Synthetic lethality'): 0.01, ('Atrophy', 'BRCA1'): 0.02, ('Atrophy', 'Base excision repair'): 0.01, ('Atrophy', 'Cancer cell'): 0.01, ('Atrophy', 'Synthetic lethality'): 0.01, ('Autopsy', 'BRCA1'): 0.02, ('Autopsy', 'Base excision repair'): 0.01, ('Autopsy', 'Cancer cell'): 0.01, ('Autopsy', 'Synthetic lethality'): 0.01, ('Aviation medicine', 'Base excision repair'): 0.03, ('Aviation medicine', 'Cancer cell'): 0.03, ('Aviation medicine', 'Synthetic lethality'): 0.04, ('Bachelor of Medical Sciences', 'Base excision repair'): 0.03, ('Bachelor of Medical Sciences', 'Cancer cell'): 0.03, ('Bachelor of Medical Sciences', 'Synthetic lethality'): 0.04, ('Bachelor of Medicine, Bachelor of Surgery', 'Base excision repair'): 0.03, ('Bachelor of Medicine, Bachelor of Surgery', 'Cancer cell'): 0.03, ('Bachelor of Medicine, Bachelor of Surgery', 'Synthetic lethality'): 0.04, ('Basic research', 'BRCA1'): 0.02, ('Basic research', 'Base excision repair'): 0.01, ('Basic research', 'Cancer cell'): 0.01, ('Basic research', 'Synthetic lethality'): 0.01, ('Biopsy', 'BRCA1'): 0.02, ('Biopsy', 'Base excision repair'): 0.01, ('Biopsy', 'Cancer cell'): 0.03, ('Biopsy', 'Synthetic lethality'): 0.01, ('Blood bank', 'BRCA1'): 0.02, ('Blood bank', 'Base excision repair'): 0.01, ('Blood bank', 'Cancer cell'): 0.01, ('Blood bank', 'Synthetic lethality'): 0.01, ('Blood banking', 'BRCA1'): 0.02, ('Blood banking', 'Base excision repair'): 0.01, ('Blood banking', 'Cancer cell'): 0.01, ('Blood banking', 'Synthetic lethality'): 0.01, ('Bodily fluid', 'BRCA1'): 0.02, ('Bodily fluid', 'Base excision repair'): 0.01, ('Bodily fluid', 'Cancer cell'): 0.01, ('Bodily fluid', 'Synthetic lethality'): 0.01, ('Cardiac surgery', 'Base excision repair'): 0.03, ('Cardiac surgery', 'Cancer cell'): 0.03, ('Cardiac surgery', 'Synthetic lethality'): 0.04, ('Cardiology', 'Base excision repair'): 0.03, ('Cardiology', 'Cancer cell'): 0.03, ('Cardiology', 'Synthetic lethality'): 0.04, ('Cardiothoracic surgery', 'Base excision repair'): 0.03, ('Cardiothoracic surgery', 'Cancer cell'): 0.03, ('Cardiothoracic surgery', 'Synthetic lethality'): 0.04, ('Caseous necrosis', 'BRCA1'): 0.02, ('Caseous necrosis', 'Base excision repair'): 0.01, ('Caseous necrosis', 'Cancer cell'): 0.01, ('Caseous necrosis', 'Synthetic lethality'): 0.01, ('Cause (medicine)', 'BRCA1'): 0.02, ('Cause (medicine)', 'Base excision repair'): 0.01, ('Cause (medicine)', 'Cancer cell'): 0.01, ('Cause (medicine)', 'Synthetic lethality'): 0.01, ('Cell biology', 'BRCA1'): 0.02, ('Cell biology', 'Base excision repair'): 0.01, ('Cell biology', 'Cancer cell'): 0.01, ('Cell biology', 'Synthetic lethality'): 0.01, ('Cell damage', 'BRCA1'): 0.02, ('Cell damage', 'Base excision repair'): 0.01, ('Cell damage', 'Cancer cell'): 0.01, ('Cell damage', 'Synthetic lethality'): 0.01, ('Cell death', 'BRCA1'): 0.02, ('Cell death', 'Base excision repair'): 0.01, ('Cell death', 'Cancer cell'): 0.01, ('Cell death', 'Synthetic lethality'): 0.01, ('Cellular adaptation', 'BRCA1'): 0.02, ('Cellular adaptation', 'Base excision repair'): 0.01, ('Cellular adaptation', 'Cancer cell'): 0.01, ('Cellular adaptation', 'Synthetic lethality'): 0.01, ('Chief physician', 'Base excision repair'): 0.03, ('Chief physician', 'Cancer cell'): 0.03, ('Chief physician', 'Synthetic lethality'): 0.04, ('Chromatography', 'BRCA1'): 0.02, ('Chromatography', 'Base excision repair'): 0.01, ('Chromatography', 'Cancer cell'): 0.01, ('Chromatography', 'Synthetic lethality'): 0.01, ('Chromosomal translocation', 'BRCA1'): 0.02, ('Chromosomal translocation', 'Base excision repair'): 0.01, ('Chromosomal translocation', 'Cancer cell'): 0.01, ('Chromosomal translocation', 'Synthetic lethality'): 0.01, ('Clinical Pathology', 'BRCA1'): 0.02, ('Clinical Pathology', 'Base excision repair'): 0.01, ('Clinical Pathology', 'Cancer cell'): 0.01, ('Clinical Pathology', 'Synthetic lethality'): 0.01, ('Clinical chemistry', 'Base excision repair'): 0.03, ('Clinical chemistry', 'Cancer cell'): 0.03, ('Clinical chemistry', 'Synthetic lethality'): 0.04, ('Clinical neurophysiology', 'Base excision repair'): 0.03, ('Clinical neurophysiology', 'Cancer cell'): 0.03, ('Clinical neurophysiology', 'Synthetic lethality'): 0.04, ('Clinical pathology', 'Base excision repair'): 0.03, ('Clinical pathology', 'Cancer cell'): 0.03, ('Clinical pathology', 'Synthetic lethality'): 0.04, ('Clinical research', 'BRCA1'): 0.02, ('Clinical research', 'Base excision repair'): 0.01, ('Clinical research', 'Cancer cell'): 0.01, ('Clinical research', 'Synthetic lethality'): 0.01, ('Coagulative necrosis', 'BRCA1'): 0.02, ('Coagulative necrosis', 'Base excision repair'): 0.01, ('Coagulative necrosis', 'Cancer cell'): 0.01, ('Coagulative necrosis', 'Synthetic lethality'): 0.01, ('Colon (anatomy)', 'BRCA1'): 0.02, ('Colon (anatomy)', 'Base excision repair'): 0.01, ('Colon (anatomy)', 'Cancer cell'): 0.01, ('Colon (anatomy)', 'Synthetic lethality'): 0.01, ('Colorectal polyp', 'BRCA1'): 0.02, ('Colorectal polyp', 'Base excision repair'): 0.01, ('Colorectal polyp', 'Cancer cell'): 0.01, ('Colorectal polyp', 'Synthetic lethality'): 0.01, ('Colorectal surgery', 'Base excision repair'): 0.03, ('Colorectal surgery', 'Cancer cell'): 0.03, ('Colorectal surgery', 'Synthetic lethality'): 0.04, ('Cytogenetics', 'BRCA1'): 0.02, ('Cytogenetics', 'Base excision repair'): 0.01, ('Cytogenetics', 'Cancer cell'): 0.01, ('Cytogenetics', 'Synthetic lethality'): 0.01, ('Cytopathology', 'Base excision repair'): 0.03, ('Cytopathology', 'Cancer cell'): 0.03, ('Cytopathology', 'Synthetic lethality'): 0.04, ('DNA', 'Base excision repair'): 0.03, ('DNA', 'Synthetic lethality'): 0.04, ('Dentistry', 'Base excision repair'): 0.03, ('Dentistry', 'Cancer cell'): 0.03, ('Dentistry', 'Synthetic lethality'): 0.04, ('Dermatologist', 'BRCA1'): 0.02, ('Dermatologist', 'Base excision repair'): 0.01, ('Dermatologist', 'Cancer cell'): 0.01, ('Dermatologist', 'Synthetic lethality'): 0.01, ('Dermatology', 'Base excision repair'): 0.03, ('Dermatology', 'Cancer cell'): 0.03, ('Dermatology', 'Synthetic lethality'): 0.04, ('Digestive system surgery', 'Base excision repair'): 0.03, ('Digestive system surgery', 'Cancer cell'): 0.03, ('Digestive system surgery', 'Synthetic lethality'): 0.04, ('Digital pathology', 'BRCA1'): 0.02, ('Digital pathology', 'Base excision repair'): 0.01, ('Digital pathology', 'Cancer cell'): 0.01, ('Digital pathology', 'Synthetic lethality'): 0.01, ('Disaster medicine', 'Base excision repair'): 0.03, ('Disaster medicine', 'Cancer cell'): 0.03, ('Disaster medicine', 'Synthetic lethality'): 0.04, ('Disease', 'BRCA1'): 0.02, ('Disease', 'Base excision repair'): 0.01, ('Disease', 'Cancer cell'): 0.01, ('Disease', 'Synthetic lethality'): 0.01, ('Diving medicine', 'Base excision repair'): 0.03, ('Diving medicine', 'Cancer cell'): 0.03, ('Diving medicine', 'Synthetic lethality'): 0.04, ('Doctor of Medicine', 'Base excision repair'): 0.03, ('Doctor of Medicine', 'Cancer cell'): 0.03, ('Doctor of Medicine', 'Synthetic lethality'): 0.04, ('Doctor of Osteopathic Medicine', 'Base excision repair'): 0.03, ('Doctor of Osteopathic Medicine', 'Cancer cell'): 0.03, ('Doctor of Osteopathic Medicine', 'Synthetic lethality'): 0.04, ('Ductal carcinoma', 'BRCA1'): 0.02, ('Ductal carcinoma', 'Base excision repair'): 0.01, ('Ductal carcinoma', 'Cancer cell'): 0.01, ('Ductal carcinoma', 'Synthetic lethality'): 0.01, ('Dura Mater', 'BRCA1'): 0.02, ('Dura Mater', 'Base excision repair'): 0.01, ('Dura Mater', 'Cancer cell'): 0.01, ('Dura Mater', 'Synthetic lethality'): 0.01, ('Dysplasia', 'Base excision repair'): 0.03, ('Dysplasia', 'Synthetic lethality'): 0.04, ('Economies of scale', 'BRCA1'): 0.02, ('Economies of scale', 'Base excision repair'): 0.01, ('Economies of scale', 'Cancer cell'): 0.01, ('Economies of scale', 'Synthetic lethality'): 0.01, ('Electron microscope', 'BRCA1'): 0.02, ('Electron microscope', 'Base excision repair'): 0.01, ('Electron microscope', 'Cancer cell'): 0.01, ('Electron microscope', 'Synthetic lethality'): 0.01, ('Electron microscopy', 'BRCA1'): 0.02, ('Electron microscopy', 'Base excision repair'): 0.01, ('Electron microscopy', 'Cancer cell'): 0.01, ('Electron microscopy', 'Synthetic lethality'): 0.01, ('Emergency medicine', 'Base excision repair'): 0.03, ('Emergency medicine', 'Cancer cell'): 0.03, ('Emergency medicine', 'Synthetic lethality'): 0.04, ('Endocrine surgery', 'Base excision repair'): 0.03, ('Endocrine surgery', 'Cancer cell'): 0.03, ('Endocrine surgery', 'Synthetic lethality'): 0.04, ('Endocrinology', 'Base excision repair'): 0.03, ('Endocrinology', 'Cancer cell'): 0.03, ('Endocrinology', 'Synthetic lethality'): 0.04, ('Enzyme assay', 'BRCA1'): 0.02, ('Enzyme assay', 'Base excision repair'): 0.01, ('Enzyme assay', 'Cancer cell'): 0.01, ('Enzyme assay', 'Synthetic lethality'): 0.01, ('Eosin', 'BRCA1'): 0.02, ('Eosin', 'Base excision repair'): 0.01, ('Eosin', 'Cancer cell'): 0.01, ('Eosin', 'Synthetic lethality'): 0.01, ('Evolutionary medicine', 'Base excision repair'): 0.03, ('Evolutionary medicine', 'Cancer cell'): 0.03, ('Evolutionary medicine', 'Synthetic lethality'): 0.04, ('Eye surgery', 'Base excision repair'): 0.03, ('Eye surgery', 'Cancer cell'): 0.03, ('Eye surgery', 'Synthetic lethality'): 0.04, ('Family medicine', 'Base excision repair'): 0.03, ('Family medicine', 'Cancer cell'): 0.03, ('Family medicine', 'Synthetic lethality'): 0.04, ('Fat necrosis', 'BRCA1'): 0.02, ('Fat necrosis', 'Base excision repair'): 0.01, ('Fat necrosis', 'Cancer cell'): 0.01, ('Fat necrosis', 'Synthetic lethality'): 0.01, ('Fibrinoid necrosis', 'BRCA1'): 0.02, ('Fibrinoid necrosis', 'Base excision repair'): 0.01, ('Fibrinoid necrosis', 'Cancer cell'): 0.01, ('Fibrinoid necrosis', 'Synthetic lethality'): 0.01, ('Fine-needle aspiration', 'BRCA1'): 0.02, ('Fine-needle aspiration', 'Base excision repair'): 0.01, ('Fine-needle aspiration', 'Cancer cell'): 0.01, ('Fine-needle aspiration', 'Synthetic lethality'): 0.01, ('Flow cytometry', 'BRCA1'): 0.02, ('Flow cytometry', 'Base excision repair'): 0.01, ('Flow cytometry', 'Cancer cell'): 0.01, ('Flow cytometry', 'Synthetic lethality'): 0.01, ('Fluorescence in situ hybridization', 'BRCA1'): 0.02, ('Fluorescence in situ hybridization', 'Base excision repair'): 0.01, ('Fluorescence in situ hybridization', 'Cancer cell'): 0.01, ('Fluorescence in situ hybridization', 'Synthetic lethality'): 0.01, ('Fluorescent', 'BRCA1'): 0.02, ('Fluorescent', 'Base excision repair'): 0.01, ('Fluorescent', 'Cancer cell'): 0.01, ('Fluorescent', 'Synthetic lethality'): 0.01, ('Fluorescent in situ hybridization', 'BRCA1'): 0.02, ('Fluorescent in situ hybridization', 'Base excision repair'): 0.01, ('Fluorescent in situ hybridization', 'Cancer cell'): 0.01, ('Fluorescent in situ hybridization', 'Synthetic lethality'): 0.01, ('Forensic pathology', 'BRCA1'): 0.02, ('Forensic pathology', 'Base excision repair'): 0.01, ('Forensic pathology', 'Cancer cell'): 0.01, ('Forensic pathology', 'Synthetic lethality'): 0.01, ('Forlì', 'BRCA1'): 0.02, ('Forlì', 'Base excision repair'): 0.01, ('Forlì', 'Cancer cell'): 0.01, ('Forlì', 'Synthetic lethality'): 0.01, ('Gangrene', 'BRCA1'): 0.02, ('Gangrene', 'Base excision repair'): 0.01, ('Gangrene', 'Cancer cell'): 0.01, ('Gangrene', 'Synthetic lethality'): 0.01, ('Gastroenterology', 'Base excision repair'): 0.03, ('Gastroenterology', 'Cancer cell'): 0.03, ('Gastroenterology', 'Synthetic lethality'): 0.04, ('Genentech', 'BRCA1'): 0.02, ('Genentech', 'Base excision repair'): 0.01, ('Genentech', 'Cancer cell'): 0.01, ('Genentech', 'Synthetic lethality'): 0.01, ('General pathology', 'BRCA1'): 0.02, ('General pathology', 'Base excision repair'): 0.01, ('General pathology', 'Cancer cell'): 0.01, ('General pathology', 'Synthetic lethality'): 0.01, ('General practice', 'Base excision repair'): 0.03, ('General practice', 'Cancer cell'): 0.03, ('General practice', 'Synthetic lethality'): 0.04, ('General surgery', 'Base excision repair'): 0.03, ('General surgery', 'Cancer cell'): 0.03, ('General surgery', 'Synthetic lethality'): 0.04, ('Genetic testing', 'Base excision repair'): 0.03, ('Genetic testing', 'Cancer cell'): 0.03, ('Genetic testing', 'Synthetic lethality'): 0.04, ('Geriatrics', 'Base excision repair'): 0.03, ('Geriatrics', 'Cancer cell'): 0.03, ('Geriatrics', 'Synthetic lethality'): 0.04, ('Giovan Battista Morgagni', 'BRCA1'): 0.02, ('Giovan Battista Morgagni', 'Base excision repair'): 0.01, ('Giovan Battista Morgagni', 'Cancer cell'): 0.01, ('Giovan Battista Morgagni', 'Synthetic lethality'): 0.01, ('Glandular metaplasia', 'BRCA1'): 0.02, ('Glandular metaplasia', 'Base excision repair'): 0.01, ('Glandular metaplasia', 'Cancer cell'): 0.01, ('Glandular metaplasia', 'Synthetic lethality'): 0.01, ('Gross examination', 'BRCA1'): 0.02, ('Gross examination', 'Base excision repair'): 0.01, ('Gross examination', 'Cancer cell'): 0.01, ('Gross examination', 'Synthetic lethality'): 0.01, ('Gross processing', 'BRCA1'): 0.02, ('Gross processing', 'Base excision repair'): 0.01, ('Gross processing', 'Cancer cell'): 0.01, ('Gross processing', 'Synthetic lethality'): 0.01, ('Gynaecology', 'Base excision repair'): 0.03, ('Gynaecology', 'Cancer cell'): 0.03, ('Gynaecology', 'Synthetic lethality'): 0.04, ('Gynecologic oncology', 'Base excision repair'): 0.03, ('Gynecologic oncology', 'Cancer cell'): 0.03, ('Gynecologic oncology', 'Synthetic lethality'): 0.04, ('HMO', 'BRCA1'): 0.02, ('HMO', 'Base excision repair'): 0.01, ('HMO', 'Cancer cell'): 0.01, ('HMO', 'Synthetic lethality'): 0.01, ('Haematoxylin', 'BRCA1'): 0.02, ('Haematoxylin', 'Base excision repair'): 0.01, ('Haematoxylin', 'Cancer cell'): 0.01, ('Haematoxylin', 'Synthetic lethality'): 0.01, ('Hand surgery', 'Base excision repair'): 0.03, ('Hand surgery', 'Cancer cell'): 0.03, ('Hand surgery', 'Synthetic lethality'): 0.04, ('Hematology', 'Base excision repair'): 0.03, ('Hematology', 'Cancer cell'): 0.03, ('Hematology', 'Synthetic lethality'): 0.04, ('Hematopathology', 'BRCA1'): 0.02, ('Hematopathology', 'Base excision repair'): 0.01, ('Hematopathology', 'Cancer cell'): 0.01, ('Hematopathology', 'Synthetic lethality'): 0.01, ('Hemodynamics', 'BRCA1'): 0.02, ('Hemodynamics', 'Base excision repair'): 0.01, ('Hemodynamics', 'Cancer cell'): 0.01, ('Hemodynamics', 'Synthetic lethality'): 0.01, ('Hemosiderin', 'BRCA1'): 0.02, ('Hemosiderin', 'Base excision repair'): 0.01, ('Hemosiderin', 'Cancer cell'): 0.01, ('Hemosiderin', 'Synthetic lethality'): 0.01, ('Hepatology', 'Base excision repair'): 0.03, ('Hepatology', 'Cancer cell'): 0.03, ('Hepatology', 'Synthetic lethality'): 0.04, ('Her2neu', 'BRCA1'): 0.02, ('Her2neu', 'Base excision repair'): 0.01, ('Her2neu', 'Cancer cell'): 0.01, ('Her2neu', 'Synthetic lethality'): 0.01, ('Histochemistry', 'BRCA1'): 0.02, ('Histochemistry', 'Base excision repair'): 0.01, ('Histochemistry', 'Cancer cell'): 0.01, ('Histochemistry', 'Synthetic lethality'): 0.01, ('Histology', 'BRCA1'): 0.02, ('Histology', 'Base excision repair'): 0.01, ('Histology', 'Synthetic lethality'): 0.01, ('Histopathology', 'BRCA1'): 0.02, ('Histopathology', 'Base excision repair'): 0.01, ('Histopathology', 'Cancer cell'): 0.01, ('Histopathology', 'Synthetic lethality'): 0.01, ('History of pathology', 'BRCA1'): 0.02, ('History of pathology', 'Base excision repair'): 0.01, ('History of pathology', 'Cancer cell'): 0.01, ('History of pathology', 'Synthetic lethality'): 0.01, ('Hospital medicine', 'Base excision repair'): 0.03, ('Hospital medicine', 'Cancer cell'): 0.03, ('Hospital medicine', 'Synthetic lethality'): 0.04, ('Human lung', 'BRCA1'): 0.02, ('Human lung', 'Base excision repair'): 0.01, ('Human lung', 'Cancer cell'): 0.01, ('Human lung', 'Synthetic lethality'): 0.01, ('Hyperplasia', 'BRCA1'): 0.02, ('Hyperplasia', 'Base excision repair'): 0.01, ('Hyperplasia', 'Synthetic lethality'): 0.01, ('Hypertrophy', 'BRCA1'): 0.02, ('Hypertrophy', 'Base excision repair'): 0.01, ('Hypertrophy', 'Cancer cell'): 0.01, ('Hypertrophy', 'Synthetic lethality'): 0.01, ('Immotile cilia syndrome', 'BRCA1'): 0.02, ('Immotile cilia syndrome', 'Base excision repair'): 0.01, ('Immotile cilia syndrome', 'Cancer cell'): 0.01, ('Immotile cilia syndrome', 'Synthetic lethality'): 0.01, ('Immunoassay', 'BRCA1'): 0.02, ('Immunoassay', 'Base excision repair'): 0.01, ('Immunoassay', 'Cancer cell'): 0.01, ('Immunoassay', 'Synthetic lethality'): 0.01, ('Immunofluorescence', 'BRCA1'): 0.02, ('Immunofluorescence', 'Base excision repair'): 0.01, ('Immunofluorescence', 'Cancer cell'): 0.01, ('Immunofluorescence', 'Synthetic lethality'): 0.01, ('Immunohistochemistry', 'BRCA1'): 0.02, ('Immunohistochemistry', 'Base excision repair'): 0.01, ('Immunohistochemistry', 'Cancer cell'): 0.01, ('Immunohistochemistry', 'Synthetic lethality'): 0.01, ('Immunology', 'Base excision repair'): 0.03, ('Immunology', 'Cancer cell'): 0.03, ('Immunology', 'Synthetic lethality'): 0.04, ('Immunopathology', 'BRCA1'): 0.02, ('Immunopathology', 'Base excision repair'): 0.01, ('Immunopathology', 'Cancer cell'): 0.01, ('Immunopathology', 'Synthetic lethality'): 0.01, ('Immunophenotype', 'BRCA1'): 0.02, ('Immunophenotype', 'Base excision repair'): 0.01, ('Immunophenotype', 'Cancer cell'): 0.01, ('Immunophenotype', 'Synthetic lethality'): 0.01, ('In situ hybridization', 'BRCA1'): 0.02, ('In situ hybridization', 'Base excision repair'): 0.01, ('In situ hybridization', 'Cancer cell'): 0.01, ('In situ hybridization', 'Synthetic lethality'): 0.01, ('Infection', 'Antiemetics'): 0.02, ('Infection', 'BRCA1'): 0.02, ('Infection', 'Base excision repair'): 0.01, ('Infection', 'Cancer cell'): 0.01, ('Infection', 'Synthetic lethality'): 0.01, ('Infectious diseases (medical specialty)', 'Base excision repair'): 0.03, ('Infectious diseases (medical specialty)', 'Cancer cell'): 0.03, ('Infectious diseases (medical specialty)', 'Synthetic lethality'): 0.04, ('Inflammation', 'Axitinib'): 0.02, ('Inflammation', 'BRCA1'): 0.02, ('Inflammation', 'Base excision repair'): 0.01, ('Inflammation', 'Cancer cell'): 0.01, ('Inflammation', 'Synthetic lethality'): 0.01, ('Intensive care medicine', 'Base excision repair'): 0.03, ('Intensive care medicine', 'Cancer cell'): 0.03, ('Intensive care medicine', 'Synthetic lethality'): 0.04, ('Internal medicine', 'Base excision repair'): 0.03, ('Internal medicine', 'Cancer cell'): 0.03, ('Internal medicine', 'Synthetic lethality'): 0.04, ('Interventional radiologist', 'BRCA1'): 0.02, ('Interventional radiologist', 'Base excision repair'): 0.01, ('Interventional radiologist', 'Cancer cell'): 0.01, ('Interventional radiologist', 'Synthetic lethality'): 0.01, ('Interventional radiology', 'Base excision repair'): 0.03, ('Interventional radiology', 'Cancer cell'): 0.03, ('Interventional radiology', 'Synthetic lethality'): 0.04, ('Ischemia', 'Axitinib'): 0.02, ('Ischemia', 'BRCA1'): 0.02, ('Ischemia', 'Base excision repair'): 0.01, ('Ischemia', 'Cancer cell'): 0.01, ('Ischemia', 'Synthetic lethality'): 0.01, ('Italy', 'BRCA1'): 0.02, ('Italy', 'Base excision repair'): 0.01, ('Italy', 'Cancer cell'): 0.01, ('Italy', 'Synthetic lethality'): 0.01, ('Karyolysis', 'BRCA1'): 0.02, ('Karyolysis', 'Base excision repair'): 0.01, ('Karyolysis', 'Cancer cell'): 0.01, ('Karyolysis', 'Synthetic lethality'): 0.01, ('Karyorrhexis', 'BRCA1'): 0.02, ('Karyorrhexis', 'Base excision repair'): 0.01, ('Karyorrhexis', 'Cancer cell'): 0.01, ('Karyorrhexis', 'Synthetic lethality'): 0.01, ('Kidney', 'BRCA1'): 0.02, ('Kidney', 'Base excision repair'): 0.01, ('Kidney', 'Cancer cell'): 0.01, ('Kidney', 'Synthetic lethality'): 0.01, ('Laser capture microdissection', 'BRCA1'): 0.02, ('Laser capture microdissection', 'Base excision repair'): 0.01, ('Laser capture microdissection', 'Cancer cell'): 0.01, ('Laser capture microdissection', 'Synthetic lethality'): 0.01, ('Leukemia', 'BRCA1'): 0.02, ('Leukemia', 'Base excision repair'): 0.01, ('Leukemia', 'Synthetic lethality'): 0.01, ('Lipochrome', 'BRCA1'): 0.02, ('Lipochrome', 'Base excision repair'): 0.01, ('Lipochrome', 'Cancer cell'): 0.01, ('Lipochrome', 'Synthetic lethality'): 0.01, ('Lipofuscin', 'BRCA1'): 0.02, ('Lipofuscin', 'Base excision repair'): 0.01, ('Lipofuscin', 'Cancer cell'): 0.01, ('Lipofuscin', 'Synthetic lethality'): 0.01, ('Liquefactive necrosis', 'BRCA1'): 0.02, ('Liquefactive necrosis', 'Base excision repair'): 0.01, ('Liquefactive necrosis', 'Cancer cell'): 0.01, ('Liquefactive necrosis', 'Synthetic lethality'): 0.01, ('List of pathologists', 'BRCA1'): 0.02, ('List of pathologists', 'Base excision repair'): 0.01, ('List of pathologists', 'Cancer cell'): 0.01, ('List of pathologists', 'Synthetic lethality'): 0.01, ('Lymphoma', 'BRCA1'): 0.02, ('Lymphoma', 'Base excision repair'): 0.01, ('Lymphoma', 'Synthetic lethality'): 0.01, ('MD–PhD', 'Base excision repair'): 0.03, ('MD–PhD', 'Cancer cell'): 0.03, ('MD–PhD', 'Synthetic lethality'): 0.04, ('Magnifying glass', 'BRCA1'): 0.02, ('Magnifying glass', 'Base excision repair'): 0.01, ('Magnifying glass', 'Cancer cell'): 0.01, ('Magnifying glass', 'Synthetic lethality'): 0.01, ('Mass gathering medicine', 'Base excision repair'): 0.03, ('Mass gathering medicine', 'Cancer cell'): 0.03, ('Mass gathering medicine', 'Synthetic lethality'): 0.04, ('Mass spectrometry', 'BRCA1'): 0.02, ('Mass spectrometry', 'Base excision repair'): 0.01, ('Mass spectrometry', 'Cancer cell'): 0.01, ('Mass spectrometry', 'Synthetic lethality'): 0.01, ('Master of Medicine', 'Base excision repair'): 0.03, ('Master of Medicine', 'Cancer cell'): 0.03, ('Master of Medicine', 'Synthetic lethality'): 0.04, ('Master of Surgery', 'Base excision repair'): 0.03, ('Master of Surgery', 'Cancer cell'): 0.03, ('Master of Surgery', 'Synthetic lethality'): 0.04, ('Maternal–fetal medicine', 'Base excision repair'): 0.03, ('Maternal–fetal medicine', 'Cancer cell'): 0.03, ('Maternal–fetal medicine', 'Synthetic lethality'): 0.04, ('Medical Scientist Training Program', 'Base excision repair'): 0.03, ('Medical Scientist Training Program', 'Cancer cell'): 0.03, ('Medical Scientist Training Program', 'Synthetic lethality'): 0.04, ('Medical diagnosis', 'Base excision repair'): 0.03, ('Medical diagnosis', 'Cancer cell'): 0.03, ('Medical diagnosis', 'Synthetic lethality'): 0.04, ('Medical education', 'Base excision repair'): 0.03, ('Medical education', 'Cancer cell'): 0.03, ('Medical education', 'Synthetic lethality'): 0.04, ('Medical genetics', 'Base excision repair'): 0.03, ('Medical genetics', 'Cancer cell'): 0.03, ('Medical genetics', 'Synthetic lethality'): 0.04, ('Medical laboratory', 'BRCA1'): 0.02, ('Medical laboratory', 'Base excision repair'): 0.01, ('Medical laboratory', 'Cancer cell'): 0.01, ('Medical laboratory', 'Synthetic lethality'): 0.01, ('Medical license', 'BRCA1'): 0.02, ('Medical license', 'Base excision repair'): 0.01, ('Medical license', 'Cancer cell'): 0.01, ('Medical license', 'Synthetic lethality'): 0.01, ('Medical microbiology', 'Base excision repair'): 0.03, ('Medical microbiology', 'Cancer cell'): 0.03, ('Medical microbiology', 'Synthetic lethality'): 0.04, ('Medical school', 'Base excision repair'): 0.03, ('Medical school', 'Cancer cell'): 0.03, ('Medical school', 'Synthetic lethality'): 0.04, ('Medical specialty', 'Base excision repair'): 0.03, ('Medical specialty', 'Cancer cell'): 0.03, ('Medical specialty', 'Synthetic lethality'): 0.04, ('Medical students', 'BRCA1'): 0.02, ('Medical students', 'Base excision repair'): 0.01, ('Medical students', 'Cancer cell'): 0.01, ('Medical students', 'Synthetic lethality'): 0.01, ('Medicare (United States)', 'BRCA1'): 0.02, ('Medicare (United States)', 'Base excision repair'): 0.01, ('Medicare (United States)', 'Cancer cell'): 0.01, ('Medicare (United States)', 'Synthetic lethality'): 0.01, ('Melanin', 'BRCA1'): 0.02, ('Melanin', 'Base excision repair'): 0.01, ('Melanin', 'Cancer cell'): 0.01, ('Melanin', 'Synthetic lethality'): 0.01, ('Meningitis', 'BRCA1'): 0.02, ('Meningitis', 'Base excision repair'): 0.01, ('Meningitis', 'Cancer cell'): 0.01, ('Meningitis', 'Synthetic lethality'): 0.01, ('Metaplasia', 'BRCA1'): 0.02, ('Metaplasia', 'Base excision repair'): 0.01, ('Metaplasia', 'Cancer cell'): 0.01, ('Metaplasia', 'Synthetic lethality'): 0.01, ('Microbiological culture', 'BRCA1'): 0.02, ('Microbiological culture', 'Base excision repair'): 0.01, ('Microbiological culture', 'Cancer cell'): 0.01, ('Microbiological culture', 'Synthetic lethality'): 0.01, ('Microscope', 'BRCA1'): 0.02, ('Microscope', 'Base excision repair'): 0.01, ('Microscope', 'Cancer cell'): 0.01, ('Microscope', 'Synthetic lethality'): 0.01, ('Molecular oncology', 'Base excision repair'): 0.03, ('Molecular oncology', 'Cancer cell'): 0.03, ('Molecular oncology', 'Synthetic lethality'): 0.04, ('Molecular pathology', 'BRCA1'): 0.02, ('Molecular pathology', 'Base excision repair'): 0.01, ('Molecular pathology', 'Cancer cell'): 0.01, ('Molecular pathology', 'Synthetic lethality'): 0.01, ('Myocytolysis', 'BRCA1'): 0.02, ('Myocytolysis', 'Base excision repair'): 0.01, ('Myocytolysis', 'Cancer cell'): 0.01, ('Myocytolysis', 'Synthetic lethality'): 0.01, ('Nanomedicine', 'Base excision repair'): 0.03, ('Nanomedicine', 'Cancer cell'): 0.03, ('Nanomedicine', 'Synthetic lethality'): 0.04, ('Narcology', 'Base excision repair'): 0.03, ('Narcology', 'Cancer cell'): 0.03, ('Narcology', 'Synthetic lethality'): 0.04, ('Necrosis', 'BRCA1'): 0.02, ('Necrosis', 'Base excision repair'): 0.01, ('Necrosis', 'Cancer cell'): 0.01, ('Necrosis', 'Synthetic lethality'): 0.01, ('Neonatology', 'Base excision repair'): 0.03, ('Neonatology', 'Cancer cell'): 0.03, ('Neonatology', 'Synthetic lethality'): 0.04, ('Nephrology', 'Base excision repair'): 0.03, ('Nephrology', 'Cancer cell'): 0.03, ('Nephrology', 'Synthetic lethality'): 0.04, ('Neurology', 'Base excision repair'): 0.03, ('Neurology', 'Cancer cell'): 0.03, ('Neurology', 'Synthetic lethality'): 0.04, ('Neuroradiology', 'Base excision repair'): 0.03, ('Neuroradiology', 'Cancer cell'): 0.03, ('Neuroradiology', 'Synthetic lethality'): 0.04, ('Neurosurgery', 'Base excision repair'): 0.03, ('Neurosurgery', 'Cancer cell'): 0.03, ('Neurosurgery', 'Synthetic lethality'): 0.04, ('Neurosurgical anesthesia', 'Base excision repair'): 0.03, ('Neurosurgical anesthesia', 'Cancer cell'): 0.03, ('Neurosurgical anesthesia', 'Synthetic lethality'): 0.04, ('Nuclear medicine', 'Base excision repair'): 0.03, ('Nuclear medicine', 'Cancer cell'): 0.03, ('Nuclear medicine', 'Synthetic lethality'): 0.04, ('Obstetric anesthesiology', 'Base excision repair'): 0.03, ('Obstetric anesthesiology', 'Cancer cell'): 0.03, ('Obstetric anesthesiology', 'Synthetic lethality'): 0.04, ('Obstetrics', 'Base excision repair'): 0.03, ('Obstetrics', 'Cancer cell'): 0.03, ('Obstetrics', 'Synthetic lethality'): 0.04, ('Obstetrics and gynaecology', 'Base excision repair'): 0.03, ('Obstetrics and gynaecology', 'Cancer cell'): 0.03, ('Obstetrics and gynaecology', 'Synthetic lethality'): 0.04, ('Occupational medicine', 'Base excision repair'): 0.03, ('Occupational medicine', 'Cancer cell'): 0.03, ('Occupational medicine', 'Synthetic lethality'): 0.04, ('Oncology', 'Base excision repair'): 0.03, ('Oncology', 'Synthetic lethality'): 0.04, ('Ophthalmology', 'Antiemetics'): 0.02, ('Ophthalmology', 'Base excision repair'): 0.03, ('Ophthalmology', 'Cancer cell'): 0.03, ('Ophthalmology', 'Synthetic lethality'): 0.04, ('Optical microscope', 'BRCA1'): 0.02, ('Optical microscope', 'Base excision repair'): 0.01, ('Optical microscope', 'Cancer cell'): 0.01, ('Optical microscope', 'Synthetic lethality'): 0.01, ('Oral and maxillofacial pathology', 'BRCA1'): 0.02, ('Oral and maxillofacial pathology', 'Base excision repair'): 0.01, ('Oral and maxillofacial pathology', 'Cancer cell'): 0.01, ('Oral and maxillofacial pathology', 'Synthetic lethality'): 0.01, ('Oral and maxillofacial surgery', 'Base excision repair'): 0.03, ('Oral and maxillofacial surgery', 'Cancer cell'): 0.03, ('Oral and maxillofacial surgery', 'Synthetic lethality'): 0.04, ('Oral medicine', 'Base excision repair'): 0.03, ('Oral medicine', 'Cancer cell'): 0.03, ('Oral medicine', 'Synthetic lethality'): 0.04, ('Organ (anatomy)', 'BRCA1'): 0.02, ('Organ (anatomy)', 'Base excision repair'): 0.01, ('Organ (anatomy)', 'Cancer cell'): 0.01, ('Organ (anatomy)', 'Synthetic lethality'): 0.01, ('Organ transplantation', 'Base excision repair'): 0.03, ('Organ transplantation', 'Cancer cell'): 0.03, ('Organ transplantation', 'Synthetic lethality'): 0.04, ('Organelles', 'BRCA1'): 0.02, ('Organelles', 'Base excision repair'): 0.01, ('Organelles', 'Cancer cell'): 0.01, ('Organelles', 'Synthetic lethality'): 0.01, ('Orthopedic surgery', 'Base excision repair'): 0.03, ('Orthopedic surgery', 'Cancer cell'): 0.03, ('Orthopedic surgery', 'Synthetic lethality'): 0.04, ('Otorhinolaryngology', 'Base excision repair'): 0.03, ('Otorhinolaryngology', 'Cancer cell'): 0.03, ('Otorhinolaryngology', 'Synthetic lethality'): 0.04, ('Outline of medicine', 'Base excision repair'): 0.03, ('Outline of medicine', 'Cancer cell'): 0.03, ('Outline of medicine', 'Synthetic lethality'): 0.04, ('Pap smear', 'BRCA1'): 0.02, ('Pap smear', 'Base excision repair'): 0.01, ('Pap smear', 'Cancer cell'): 0.01, ('Pap smear', 'Synthetic lethality'): 0.01, ('Pap test', 'BRCA1'): 0.02, ('Pap test', 'Base excision repair'): 0.01, ('Pap test', 'Cancer cell'): 0.01, ('Pap test', 'Synthetic lethality'): 0.01, ('Pathogenesis', 'BRCA1'): 0.02, ('Pathogenesis', 'Base excision repair'): 0.01, ('Pathogenesis', 'Cancer cell'): 0.01, ('Pathogenesis', 'Synthetic lethality'): 0.01, ('Pathological Society', 'BRCA1'): 0.02, ('Pathological Society', 'Base excision repair'): 0.01, ('Pathological Society', 'Cancer cell'): 0.01, ('Pathological Society', 'Synthetic lethality'): 0.01, ('Pathology', 'Base excision repair'): 0.03, ('Pathology', 'Cancer cell'): 0.03, ('Pathology', 'Synthetic lethality'): 0.04, ('Pediatric surgery', 'Base excision repair'): 0.03, ('Pediatric surgery', 'Cancer cell'): 0.03, ('Pediatric surgery', 'Synthetic lethality'): 0.04, ('Pediatrics', 'Base excision repair'): 0.03, ('Pediatrics', 'Cancer cell'): 0.03, ('Pediatrics', 'Synthetic lethality'): 0.04, ('Personalized medicine', 'Base excision repair'): 0.03, ('Personalized medicine', 'Cancer cell'): 0.03, ('Personalized medicine', 'Synthetic lethality'): 0.04, ('Pharmacy', 'Base excision repair'): 0.03, ('Pharmacy', 'Cancer cell'): 0.03, ('Pharmacy', 'Synthetic lethality'): 0.04, ('Phlebologist', 'Base excision repair'): 0.03, ('Phlebologist', 'Cancer cell'): 0.03, ('Phlebologist', 'Synthetic lethality'): 0.04, ('Physical medicine and rehabilitation', 'Base excision repair'): 0.03, ('Physical medicine and rehabilitation', 'Cancer cell'): 0.03, ('Physical medicine and rehabilitation', 'Synthetic lethality'): 0.04, ('Physical therapy', 'Base excision repair'): 0.03, ('Physical therapy', 'Cancer cell'): 0.03, ('Physical therapy', 'Synthetic lethality'): 0.04, ('Physician', 'Base excision repair'): 0.03, ('Physician', 'Cancer cell'): 0.03, ('Physician', 'Synthetic lethality'): 0.04, ('Pigment', 'BRCA1'): 0.02, ('Pigment', 'Base excision repair'): 0.01, ('Pigment', 'Cancer cell'): 0.01, ('Pigment', 'Synthetic lethality'): 0.01, ('Plastic surgery', 'Base excision repair'): 0.03, ('Plastic surgery', 'Cancer cell'): 0.03, ('Plastic surgery', 'Synthetic lethality'): 0.04, ('Podiatry', 'Base excision repair'): 0.03, ('Podiatry', 'Cancer cell'): 0.03, ('Podiatry', 'Synthetic lethality'): 0.04, ('Preventive healthcare', 'Base excision repair'): 0.03, ('Preventive healthcare', 'Cancer cell'): 0.03, ('Preventive healthcare', 'Synthetic lethality'): 0.04, ('Prison healthcare', 'Base excision repair'): 0.03, ('Prison healthcare', 'Cancer cell'): 0.03, ('Prison healthcare', 'Synthetic lethality'): 0.04, ('Programmed cell death', 'BRCA1'): 0.02, ('Programmed cell death', 'Base excision repair'): 0.01, ('Programmed cell death', 'Cancer cell'): 0.01, ('Programmed cell death', 'Synthetic lethality'): 0.01, ('Psychiatry', 'Base excision repair'): 0.03, ('Psychiatry', 'Cancer cell'): 0.03, ('Psychiatry', 'Synthetic lethality'): 0.04, ('Pulmonary fibrosis', 'BRCA1'): 0.02, ('Pulmonary fibrosis', 'Base excision repair'): 0.01, ('Pulmonary fibrosis', 'Cancer cell'): 0.01, ('Pulmonary fibrosis', 'Synthetic lethality'): 0.01, ('Pulmonology', 'Base excision repair'): 0.03, ('Pulmonology', 'Cancer cell'): 0.03, ('Pulmonology', 'Synthetic lethality'): 0.04, ('Pyknosis', 'BRCA1'): 0.02, ('Pyknosis', 'Base excision repair'): 0.01, ('Pyknosis', 'Cancer cell'): 0.01, ('Pyknosis', 'Synthetic lethality'): 0.01, ('RCPA', 'BRCA1'): 0.02, ('RCPA', 'Base excision repair'): 0.01, ('RCPA', 'Cancer cell'): 0.01, ('RCPA', 'Synthetic lethality'): 0.01, ('RNA', 'BRCA1'): 0.02, ('RNA', 'Base excision repair'): 0.01, ('RNA', 'Cancer cell'): 0.01, ('RNA', 'Synthetic lethality'): 0.01, ('Radiology', 'Base excision repair'): 0.03, ('Radiology', 'Cancer cell'): 0.03, ('Radiology', 'Synthetic lethality'): 0.04, ('Reproductive endocrinology and infertility', 'Base excision repair'): 0.03, ('Reproductive endocrinology and infertility', 'Cancer cell'): 0.03, ('Reproductive endocrinology and infertility', 'Synthetic lethality'): 0.04, ('Reproductive medicine', 'Base excision repair'): 0.03, ('Reproductive medicine', 'Cancer cell'): 0.03, ('Reproductive medicine', 'Synthetic lethality'): 0.04, ('Reproductive surgery', 'Base excision repair'): 0.03, ('Reproductive surgery', 'Cancer cell'): 0.03, ('Reproductive surgery', 'Synthetic lethality'): 0.04, ('Residency (medicine)', 'BRCA1'): 0.02, ('Residency (medicine)', 'Base excision repair'): 0.01, ('Residency (medicine)', 'Cancer cell'): 0.01, ('Residency (medicine)', 'Synthetic lethality'): 0.01, ('Rheumatology', 'Base excision repair'): 0.03, ('Rheumatology', 'Cancer cell'): 0.03, ('Rheumatology', 'Synthetic lethality'): 0.04, ('Rural health', 'Base excision repair'): 0.03, ('Rural health', 'Cancer cell'): 0.03, ('Rural health', 'Synthetic lethality'): 0.04, ('Serology', 'BRCA1'): 0.02, ('Serology', 'Base excision repair'): 0.01, ('Serology', 'Cancer cell'): 0.01, ('Serology', 'Synthetic lethality'): 0.01, ('Sexual medicine', 'Base excision repair'): 0.03, ('Sexual medicine', 'Cancer cell'): 0.03, ('Sexual medicine', 'Synthetic lethality'): 0.04, ('Sleep medicine', 'Base excision repair'): 0.03, ('Sleep medicine', 'Cancer cell'): 0.03, ('Sleep medicine', 'Synthetic lethality'): 0.04, ('Sports medicine', 'Base excision repair'): 0.03, ('Sports medicine', 'Cancer cell'): 0.03, ('Sports medicine', 'Synthetic lethality'): 0.04, ('Squamous metaplasia', 'BRCA1'): 0.02, ('Squamous metaplasia', 'Base excision repair'): 0.01, ('Squamous metaplasia', 'Cancer cell'): 0.01, ('Squamous metaplasia', 'Synthetic lethality'): 0.01, ('Steatosis', 'BRCA1'): 0.02, ('Steatosis', 'Base excision repair'): 0.01, ('Steatosis', 'Cancer cell'): 0.01, ('Steatosis', 'Synthetic lethality'): 0.01, ('Subspecialty', 'Base excision repair'): 0.03, ('Subspecialty', 'Cancer cell'): 0.03, ('Subspecialty', 'Synthetic lethality'): 0.04, ('Surgeon', 'BRCA1'): 0.02, ('Surgeon', 'Base excision repair'): 0.01, ('Surgeon', 'Cancer cell'): 0.01, ('Surgeon', 'Synthetic lethality'): 0.01, ('Surgery', 'Base excision repair'): 0.03, ('Surgery', 'Cancer cell'): 0.03, ('Surgery', 'Synthetic lethality'): 0.04, ('Surgical oncology', 'Base excision repair'): 0.03, ('Surgical oncology', 'Cancer cell'): 0.03, ('Surgical oncology', 'Synthetic lethality'): 0.04, ('Surgical pathology', 'BRCA1'): 0.02, ('Surgical pathology', 'Base excision repair'): 0.01, ('Surgical pathology', 'Cancer cell'): 0.01, ('Surgical pathology', 'Synthetic lethality'): 0.01, ('Telepathology', 'BRCA1'): 0.02, ('Telepathology', 'Base excision repair'): 0.01, ('Telepathology', 'Cancer cell'): 0.01, ('Telepathology', 'Synthetic lethality'): 0.01, ('Tissue (biology)', 'BRCA1'): 0.02, ('Tissue (biology)', 'Base excision repair'): 0.01, ('Tissue (biology)', 'Cancer cell'): 0.01, ('Tissue (biology)', 'Synthetic lethality'): 0.01, ('Transfusion medicine', 'Base excision repair'): 0.03, ('Transfusion medicine', 'Cancer cell'): 0.03, ('Transfusion medicine', 'Synthetic lethality'): 0.04, ('Translational research', 'BRCA1'): 0.02, ('Translational research', 'Base excision repair'): 0.01, ('Translational research', 'Cancer cell'): 0.01, ('Translational research', 'Synthetic lethality'): 0.01, ('Trauma surgery', 'Base excision repair'): 0.03, ('Trauma surgery', 'Cancer cell'): 0.03, ('Trauma surgery', 'Synthetic lethality'): 0.04, ('Travel medicine', 'Base excision repair'): 0.03, ('Travel medicine', 'Cancer cell'): 0.03, ('Travel medicine', 'Synthetic lethality'): 0.04, ('Tropical medicine', 'Base excision repair'): 0.03, ('Tropical medicine', 'Cancer cell'): 0.03, ('Tropical medicine', 'Synthetic lethality'): 0.04, ('United States and Canadian Academy of Pathology', 'BRCA1'): 0.02, ('United States and Canadian Academy of Pathology', 'Base excision repair'): 0.01, ('United States and Canadian Academy of Pathology', 'Cancer cell'): 0.01, ('United States and Canadian Academy of Pathology', 'Synthetic lethality'): 0.01, ('Urogynecology', 'Base excision repair'): 0.03, ('Urogynecology', 'Cancer cell'): 0.03, ('Urogynecology', 'Synthetic lethality'): 0.04, ('Urology', 'Base excision repair'): 0.03, ('Urology', 'Cancer cell'): 0.03, ('Urology', 'Synthetic lethality'): 0.04, ('Vascular surgery', 'Base excision repair'): 0.03, ('Vascular surgery', 'Cancer cell'): 0.03, ('Vascular surgery', 'Synthetic lethality'): 0.04, ('Venereology', 'Base excision repair'): 0.03, ('Venereology', 'Cancer cell'): 0.03, ('Venereology', 'Synthetic lethality'): 0.04, ('Veterinary medicine', 'Base excision repair'): 0.03, ('Veterinary medicine', 'Cancer cell'): 0.03, ('Veterinary medicine', 'Synthetic lethality'): 0.04, ('Veterinary pathology', 'BRCA1'): 0.02, ('Veterinary pathology', 'Base excision repair'): 0.01, ('Veterinary pathology', 'Cancer cell'): 0.01, ('Veterinary pathology', 'Synthetic lethality'): 0.01, ('Wound healing', 'Axitinib'): 0.02, ('Wound healing', 'BRCA1'): 0.02, ('Wound healing', 'Base excision repair'): 0.01, ('Wound healing', 'Cancer cell'): 0.01, ('Wound healing', 'Synthetic lethality'): 0.01, ('AC133', 'Axitinib'): 0.02, ('Aerobic exercise', 'Axitinib'): 0.02, ('Alpha-5 beta-1', 'Axitinib'): 0.02, ('Alpha-v beta-3', 'Axitinib'): 0.02, ('Alpha-v beta-5', 'Axitinib'): 0.02, (\"Alzheimer's disease\", 'Axitinib'): 0.02, ('Anatomical terminology', 'Axitinib'): 0.02, ('Anatomical terminology', 'Cancer cell'): 0.02, ('Ang1', 'Axitinib'): 0.02, ('Ang2', 'Axitinib'): 0.02, ('Angioblast', 'Axitinib'): 0.02, ('Angiogenesis inhibitor', 'Axitinib'): 0.02, ('Angiogenin', 'Axitinib'): 0.02, ('Angiopoietins', 'Axitinib'): 0.02, ('Anterior cardinal vein', 'Axitinib'): 0.02, ('Aorta', 'Axitinib'): 0.02, ('Aortic arches', 'Axitinib'): 0.02, ('Aortic sac', 'Axitinib'): 0.02, ('Aorticopulmonary septum', 'Axitinib'): 0.02, ('Arteriogenesis', 'Axitinib'): 0.02, ('Atrioventricular canal', 'Axitinib'): 0.02, ('BFGF', 'Axitinib'): 0.02, ('Basement membrane', 'Axitinib'): 0.02, ('Bilayer', 'Axitinib'): 0.02, ('Blood islands', 'Axitinib'): 0.02, ('Blood vessel', 'Axitinib'): 0.02, ('Blood vessel', 'Cancer cell'): 0.02, ('Blood vessels', 'Axitinib'): 0.02, ('Bulbus cordis', 'Axitinib'): 0.02, ('CCL2', 'Axitinib'): 0.02, ('CD31', 'Axitinib'): 0.02, ('COX-2', 'Axitinib'): 0.02, ('Capillaries', 'Axitinib'): 0.02, ('Cardiovascular diseases', 'Axitinib'): 0.02, ('Cell growth', 'Axitinib'): 0.02, ('Cell junction', 'Axitinib'): 0.02, ('Cell signaling', 'Axitinib'): 0.02, ('Chorion', 'Axitinib'): 0.02, ('Circulating tumor cell', 'Axitinib'): 0.02, ('Circulatory system', 'Antiemetics'): 0.02, ('Circulatory system', 'Axitinib'): 0.02, ('Circulatory system', 'Cancer cell'): 0.02, ('Coalescent angiogenesis', 'Axitinib'): 0.02, ('Collagen', 'Axitinib'): 0.02, ('Collagen, type IV, alpha 1', 'Axitinib'): 0.02, ('Common cardinal veins', 'Axitinib'): 0.02, ('Concentration', 'Axitinib'): 0.02, ('Connecting stalk', 'Axitinib'): 0.02, ('DLL4', 'Axitinib'): 0.02, ('Diet (nutrition)', 'Axitinib'): 0.02, ('Dorsal aorta', 'Axitinib'): 0.02, ('Drug resistance', 'Axitinib'): 0.02, ('Ductus arteriosus', 'Axitinib'): 0.02, ('Ductus venosus', 'Axitinib'): 0.02, ('Edema', 'Axitinib'): 0.02, ('Embryo', 'Axitinib'): 0.02, ('Embryogenesis', 'Axitinib'): 0.02, ('Endocardial cushions', 'Axitinib'): 0.02, ('Endoglin', 'Axitinib'): 0.02, ('Endothelial', 'Axitinib'): 0.02, ('Endothelial cell', 'Axitinib'): 0.02, ('Endothelial cells', 'Axitinib'): 0.02, ('Endothelial cells', 'Cancer cell'): 0.02, ('Endothelium', 'Axitinib'): 0.02, ('Endothelium', 'Cancer cell'): 0.02, ('Endurance exercise', 'Axitinib'): 0.02, ('Enzyme', 'Axitinib'): 0.02, ('Extracellular matrix', 'Axitinib'): 0.02, ('FGF-1', 'Axitinib'): 0.02, ('FGF-2', 'Axitinib'): 0.02, ('Fetal circulation', 'Axitinib'): 0.02, ('Fibrosis', 'Axitinib'): 0.02, ('Foramen ovale (heart)', 'Axitinib'): 0.02, ('Foramen secundum', 'Axitinib'): 0.02, ('Gene knockout', 'Axitinib'): 0.02, ('Gene therapy', 'Axitinib'): 0.02, ('Granulation tissue', 'Axitinib'): 0.02, ('Growth factor', 'Axitinib'): 0.02, ('Growth factor', 'Base excision repair'): 0.02, ('Growth factor', 'Cancer cell'): 0.02, ('Growth factor', 'Synthetic lethality'): 0.03, ('Growth factors', 'Axitinib'): 0.02, ('Haematopoiesis', 'Axitinib'): 0.02, ('Haematopoiesis', 'Cancer cell'): 0.02, ('Heart', 'Axitinib'): 0.02, ('Heart development', 'Axitinib'): 0.02, ('Heart disease', 'Axitinib'): 0.02, ('Histamine', 'Axitinib'): 0.02, ('Hyperaemia', 'Axitinib'): 0.02, ('Hypoxia (medical)', 'Axitinib'): 0.02, ('ID1', 'Axitinib'): 0.02, ('ID3 (gene)', 'Axitinib'): 0.02, ('Immunogenicity', 'Axitinib'): 0.02, ('Inferior vena cava', 'Axitinib'): 0.02, ('Integrin', 'Axitinib'): 0.02, ('Intussusceptive angiogenesis', 'Axitinib'): 0.02, ('John Hunter (surgeon)', 'Axitinib'): 0.02, ('Judah Folkman', 'Axitinib'): 0.02, ('Junctional molecule', 'Axitinib'): 0.02, ('Lumen (anatomy)', 'Axitinib'): 0.02, ('Lymph sacs', 'Axitinib'): 0.02, ('Lymphangiogenesis', 'Axitinib'): 0.02, ('Lymphocyte', 'Axitinib'): 0.02, ('Lymphocyte', 'Cancer cell'): 0.02, ('MRNA', 'Axitinib'): 0.02, ('Macular degeneration', 'Axitinib'): 0.02, ('Maggot therapy', 'Axitinib'): 0.02, ('Malignant', 'Antiemetics'): 0.02, ('Malignant', 'Axitinib'): 0.02, ('Malignant tumor', 'Axitinib'): 0.02, ('Matrix (biology)', 'Axitinib'): 0.02, ('Matrix macromolecules', 'Axitinib'): 0.02, ('Matrix metalloproteinase', 'Axitinib'): 0.02, ('Mechanism of action', 'Axitinib'): 0.02, ('Mesoderm', 'Axitinib'): 0.02, ('Metastasis', 'Axitinib'): 0.02, ('Microcirculation', 'Axitinib'): 0.02, ('Mutation', 'Axitinib'): 0.02, ('Mutation', 'Synthetic lethality'): 0.05, ('Myofibroblast', 'Axitinib'): 0.02, ('NRP-1', 'Axitinib'): 0.02, ('Neonatal', 'Axitinib'): 0.02, ('Neovascularization', 'Axitinib'): 0.02, ('Neuroangiogenesis', 'Axitinib'): 0.02, ('Neuropilin', 'Axitinib'): 0.02, ('Nitric oxide', 'Axitinib'): 0.02, ('Nitric oxide synthase', 'Axitinib'): 0.02, ('Notch family of receptors', 'Axitinib'): 0.02, ('Oncogenesis', 'Axitinib'): 0.02, ('Oxygen', 'Axitinib'): 0.02, ('Perforated', 'Axitinib'): 0.02, ('Perfusion', 'Axitinib'): 0.02, ('Pericyte', 'Axitinib'): 0.02, ('Phosphorylation', 'Axitinib'): 0.02, ('Placenta', 'Axitinib'): 0.02, ('Plasminogen activator', 'Axitinib'): 0.02, ('Plasminogen activator inhibitor-1', 'Axitinib'): 0.02, ('Platelet-derived growth factor', 'Base excision repair'): 0.02, ('Platelet-derived growth factor', 'Cancer cell'): 0.02, ('Platelet-derived growth factor', 'Synthetic lethality'): 0.03, ('Platelet derived growth factor', 'Axitinib'): 0.02, ('Posterior cardinal vein', 'Axitinib'): 0.02, ('Presentation (medical)', 'Axitinib'): 0.02, ('Primary interatrial foramen', 'Axitinib'): 0.02, ('Primary interventricular foramen', 'Axitinib'): 0.02, ('Primitive atrium', 'Axitinib'): 0.02, ('Primitive ventricle', 'Axitinib'): 0.02, ('Protease', 'Axitinib'): 0.02, ('Proteases in angiogenesis', 'Axitinib'): 0.02, ('Protein replacement therapy', 'Axitinib'): 0.02, ('Protein signalling in heart development', 'Axitinib'): 0.02, ('Proteinase', 'Axitinib'): 0.02, ('Proteolysis', 'Axitinib'): 0.02, ('Proteolytic', 'Axitinib'): 0.02, ('Pulmonary artery', 'Axitinib'): 0.02, ('Receptor (biochemistry)', 'Axitinib'): 0.02, ('Receptor (biochemistry)', 'Base excision repair'): 0.02, ('Receptor (biochemistry)', 'Cancer cell'): 0.02, ('Receptor (biochemistry)', 'Synthetic lethality'): 0.03, ('Retina', 'Axitinib'): 0.02, ('Scar', 'Axitinib'): 0.02, ('Semaphorin', 'Axitinib'): 0.02, ('Septum intermedium', 'Axitinib'): 0.02, ('Septum primum', 'Axitinib'): 0.02, ('Septum secundum', 'Axitinib'): 0.02, ('Shear stress', 'Axitinib'): 0.02, ('Sinus venosus', 'Axitinib'): 0.02, ('Smooth muscle cell', 'Axitinib'): 0.02, ('Space', 'Axitinib'): 0.02, ('Stem cell', 'Axitinib'): 0.02, ('Tandem', 'Axitinib'): 0.02, ('The Angiogenesis Foundation', 'Axitinib'): 0.02, ('Tie-1', 'Axitinib'): 0.02, ('Tie-2', 'Axitinib'): 0.02, ('Time', 'Axitinib'): 0.02, ('Transdifferentiation', 'Axitinib'): 0.02, ('Transforming growth factor beta', 'Axitinib'): 0.02, ('Truncus arteriosus', 'Axitinib'): 0.02, ('Tubular heart', 'Axitinib'): 0.02, ('Tumor', 'Axitinib'): 0.02, ('Tyrosine kinases', 'Axitinib'): 0.02, ('Umbilical artery', 'Axitinib'): 0.02, ('Umbilical cord', 'Axitinib'): 0.02, ('Umbilical cord', 'Cancer cell'): 0.02, ('Umbilical vein', 'Axitinib'): 0.02, ('VE-cadherin', 'Axitinib'): 0.02, ('VEGF', 'Axitinib'): 0.02, ('VEGF-A', 'Axitinib'): 0.02, ('VEGFR', 'Axitinib'): 0.02, ('Vascular remodelling in the embryo', 'Axitinib'): 0.02, ('Vasculature', 'Axitinib'): 0.02, ('Vasculature', 'Cancer cell'): 0.02, ('Vasculogenesis', 'Axitinib'): 0.02, ('Vasculogenic mimicry', 'Axitinib'): 0.02, ('Vitelline arteries', 'Axitinib'): 0.02, ('Vitelline veins', 'Axitinib'): 0.02, ('Western world', 'Axitinib'): 0.02, ('Yolk sac', 'Axitinib'): 0.02, ('5-HT3 antagonist', 'Antiemetics'): 0.02, ('ACE inhibitor', 'Antiemetics'): 0.02, ('ATC code A', 'Antiemetics'): 0.02, ('ATC code A04', 'Antiemetics'): 0.02, ('ATC code B', 'Antiemetics'): 0.02, ('ATC code C', 'Antiemetics'): 0.02, ('ATC code D', 'Antiemetics'): 0.02, ('ATC code D09', 'Antiemetics'): 0.02, ('ATC code G', 'Antiemetics'): 0.02, ('ATC code H', 'Antiemetics'): 0.02, ('ATC code J', 'Antiemetics'): 0.02, ('ATC code L', 'Antiemetics'): 0.02, ('ATC code M', 'Antiemetics'): 0.02, ('ATC code N', 'Antiemetics'): 0.02, ('ATC code P', 'Antiemetics'): 0.02, ('ATC code R', 'Antiemetics'): 0.02, ('ATC code S', 'Antiemetics'): 0.02, ('ATC code V', 'Antiemetics'): 0.02, ('ATCvet code QI', 'Antiemetics'): 0.02, ('Adverse effect (medicine)', 'Antiemetics'): 0.02, ('Agonist', 'Antiemetics'): 0.02, ('Ajwain', 'Antiemetics'): 0.02, ('Alizapride', 'Antiemetics'): 0.02, ('Alkylating antineoplastic agent', 'Antiemetics'): 0.02, ('Alosetron', 'Antiemetics'): 0.02, ('Amisulpride', 'Antiemetics'): 0.02, ('Anabolic steroid', 'Antiemetics'): 0.02, ('Analgesic', 'Antiemetics'): 0.02, ('Anatomical Therapeutic Chemical Classification System', 'Antiemetics'): 0.02, ('Anesthetic', 'Antiemetics'): 0.02, ('Angiotensin II receptor antagonist', 'Antiemetics'): 0.02, ('Anorectic', 'Antiemetics'): 0.02, ('Antacid', 'Antiemetics'): 0.02, ('Anthelmintic', 'Antiemetics'): 0.02, ('Anti-inflammatory', 'Antiemetics'): 0.02, ('Anti-obesity medication', 'Antiemetics'): 0.02, ('Antianginal', 'Antiemetics'): 0.02, ('Antiarrhythmic agent', 'Antiemetics'): 0.02, ('Antibacterial', 'Antiemetics'): 0.02, ('Anticholinergic', 'Antiemetics'): 0.02, ('Anticoagulant', 'Antiemetics'): 0.02, ('Anticonvulsant', 'Antiemetics'): 0.02, ('Antidementia drug', 'Antiemetics'): 0.02, ('Antidepressant', 'Antiemetics'): 0.02, ('Antidiarrhoeal', 'Antiemetics'): 0.02, ('Antidote', 'Antiemetics'): 0.02, ('Antifibrinolytic', 'Antiemetics'): 0.02, ('Antifungal drug', 'Antiemetics'): 0.02, ('Antihemorrhagic', 'Antiemetics'): 0.02, ('Antihistamine', 'Antiemetics'): 0.02, ('Antihyperkinetic', 'Antiemetics'): 0.02, ('Antihypertensive drug', 'Antiemetics'): 0.02, ('Antimetabolite', 'Antiemetics'): 0.02, ('Antimicrobial', 'Antiemetics'): 0.02, ('Antimigraine drug', 'Antiemetics'): 0.02, ('Antimycobacterial', 'Antiemetics'): 0.02, ('Antineoplastic', 'Antiemetics'): 0.02, ('Antiparasitic', 'Antiemetics'): 0.02, ('Antiplatelet drug', 'Antiemetics'): 0.02, ('Antipropulsive', 'Antiemetics'): 0.02, ('Antiprotozoal agent', 'Antiemetics'): 0.02, ('Antipruritic', 'Antiemetics'): 0.02, ('Antipsoriatic', 'Antiemetics'): 0.02, ('Antipsychotic', 'Antiemetics'): 0.02, ('Antisemitism', 'Antiemetics'): 0.02, ('Antithrombotic', 'Antiemetics'): 0.02, ('Antithyroid agent', 'Antiemetics'): 0.02, ('Antiviral drug', 'Antiemetics'): 0.02, ('Anxiolytic', 'Antiemetics'): 0.02, ('Aphrodisiac', 'Antiemetics'): 0.02, ('Aprepitant', 'Antiemetics'): 0.02, ('Atropine', 'Antiemetics'): 0.02, ('Azasetron', 'Antiemetics'): 0.02, ('Bemesetron', 'Antiemetics'): 0.02, ('Benzodiazepines', 'Antiemetics'): 0.02, ('Beta blocker', 'Antiemetics'): 0.02, ('Bile acid sequestrant', 'Antiemetics'): 0.02, ('Bisphosphonate', 'Antiemetics'): 0.02, ('Blood', 'Antiemetics'): 0.02, ('Bone', 'Antiemetics'): 0.02, ('Bone', 'Cancer cell'): 0.02, ('Bromopride', 'Antiemetics'): 0.02, ('Bronchodilator', 'Antiemetics'): 0.02, ('CB1 receptor', 'Antiemetics'): 0.02, ('Cachexia', 'Antiemetics'): 0.02, ('Calcium channel blocker', 'Antiemetics'): 0.02, ('Cancer and nausea', 'Antiemetics'): 0.02, ('Cannabinoid', 'Antiemetics'): 0.02, ('Cannabis (drug)', 'Antiemetics'): 0.02, ('Cardiac glycoside', 'Antiemetics'): 0.02, ('Cardiac stimulant', 'Antiemetics'): 0.02, ('Casopitant', 'Antiemetics'): 0.02, ('Cerium oxalate', 'Antiemetics'): 0.02, ('Chemoreceptor trigger zone', 'Antiemetics'): 0.02, ('Chlorpromazine', 'Antiemetics'): 0.02, ('Cicatrizant', 'Antiemetics'): 0.02, ('Cilansetron', 'Antiemetics'): 0.02, ('Cinnarizine', 'Antiemetics'): 0.02, ('Clebopride', 'Antiemetics'): 0.02, ('Clozapine', 'Antiemetics'): 0.02, ('Coagulation', 'Antiemetics'): 0.02, ('Compazine', 'Antiemetics'): 0.02, ('Contrast medium', 'Antiemetics'): 0.02, ('Controlled Substances Act', 'Antiemetics'): 0.02, ('Corticosteroid', 'Antiemetics'): 0.02, ('Cough medicine', 'Antiemetics'): 0.02, ('Cyclizine', 'Antiemetics'): 0.02, ('Cyproheptadine', 'Antiemetics'): 0.02, ('Dazopride', 'Antiemetics'): 0.02, ('Decongestant', 'Antiemetics'): 0.02, ('Deliriant', 'Antiemetics'): 0.02, ('Depressant', 'Antiemetics'): 0.02, ('Dexamethasone', 'Antiemetics'): 0.02, ('Diabetes medication', 'Antiemetics'): 0.02, ('Dietary mineral', 'Antiemetics'): 0.02, ('Dimenhydrinate', 'Antiemetics'): 0.02, ('Diphenhydramine', 'Antiemetics'): 0.02, ('Disease-modifying antirheumatic drug', 'Antiemetics'): 0.02, ('Dissociative', 'Antiemetics'): 0.02, ('Diuretic', 'Antiemetics'): 0.02, ('Dolasetron', 'Antiemetics'): 0.02, ('Domperidone', 'Antiemetics'): 0.02, ('Dopamine antagonist', 'Antiemetics'): 0.02, ('Doxylamine', 'Antiemetics'): 0.02, ('Dressing (medical)', 'Antiemetics'): 0.02, ('Dronabinol', 'Antiemetics'): 0.02, ('Droperidol', 'Antiemetics'): 0.02, ('Ectoparasiticide', 'Antiemetics'): 0.02, ('Emetic', 'Antiemetics'): 0.02, ('Emetrol', 'Antiemetics'): 0.02, ('Emollient', 'Antiemetics'): 0.02, ('Endocrine system', 'Antiemetics'): 0.02, ('Entactogen', 'Antiemetics'): 0.02, ('Entheogen', 'Antiemetics'): 0.02, ('Eritrea', 'Antiemetics'): 0.02, ('Ethiopia', 'Antiemetics'): 0.02, ('Euphoria', 'Antiemetics'): 0.02, ('Eur J Pharmacol', 'Antiemetics'): 0.02, ('Extrapyramidal system', 'Antiemetics'): 0.02, ('Fatigue (medical)', 'Antiemetics'): 0.02, ('Fertility medication', 'Antiemetics'): 0.02, ('Fibrate', 'Antiemetics'): 0.02, ('Fosaprepitant', 'Antiemetics'): 0.02, ('Galanolactone', 'Antiemetics'): 0.02, ('Gastroenteritis', 'Antiemetics'): 0.02, ('Gastrointestinal tract', 'Antiemetics'): 0.02, ('General anaesthetic', 'Antiemetics'): 0.02, ('Genitourinary system', 'Antiemetics'): 0.02, ('Ginger', 'Antiemetics'): 0.02, ('Gingerol', 'Antiemetics'): 0.02, ('Glucocorticoid', 'Antiemetics'): 0.02, ('Granisetron', 'Antiemetics'): 0.02, ('H1 antagonist', 'Antiemetics'): 0.02, ('H2 antagonist', 'Antiemetics'): 0.02, ('Haloperidol', 'Antiemetics'): 0.02, ('Histamine antagonist', 'Antiemetics'): 0.02, ('Histamine receptor', 'Antiemetics'): 0.02, ('Hormonal contraception', 'Antiemetics'): 0.02, ('Human gastrointestinal tract', 'Antiemetics'): 0.02, ('Human skin', 'Antiemetics'): 0.02, ('Hydroxyzine', 'Antiemetics'): 0.02, ('Hyoscine hydrobromide', 'Antiemetics'): 0.02, ('Hyoscyamine', 'Antiemetics'): 0.02, ('Hyperemesis gravidarum', 'Antiemetics'): 0.02, ('Hypnotic', 'Antiemetics'): 0.02, ('Hypolipidemic agent', 'Antiemetics'): 0.02, ('Hypothalamic–pituitary hormone', 'Antiemetics'): 0.02, ('Immunomodulator', 'Antiemetics'): 0.02, ('Immunostimulant', 'Antiemetics'): 0.02, ('Immunosuppressive drug', 'Antiemetics'): 0.02, ('India', 'Antiemetics'): 0.02, ('Intravenous immunoglobulin', 'Antiemetics'): 0.02, ('Itopride', 'Antiemetics'): 0.02, ('JWH cannabinoids', 'Antiemetics'): 0.02, ('Joint', 'Antiemetics'): 0.02, ('Laxative', 'Antiemetics'): 0.02, ('Lerisetron', 'Antiemetics'): 0.02, ('Local anesthetic', 'Antiemetics'): 0.02, ('Lorazepam', 'Antiemetics'): 0.02, (\"Management of Parkinson's disease\", 'Antiemetics'): 0.02, ('Maropitant', 'Antiemetics'): 0.02, ('Meclizine', 'Antiemetics'): 0.02, ('Metabolism', 'Antiemetics'): 0.02, ('Metoclopramide', 'Antiemetics'): 0.02, ('Metopimazine', 'Antiemetics'): 0.02, ('Mianserin', 'Antiemetics'): 0.02, ('Midazolam', 'Antiemetics'): 0.02, ('Mineralocorticoid', 'Antiemetics'): 0.02, ('Mirtazapine', 'Antiemetics'): 0.02, ('Mood stabilizer', 'Antiemetics'): 0.02, ('Morning sickness', 'Antiemetics'): 0.02, ('Motion sickness', 'Antiemetics'): 0.02, ('Muscarinic acetylcholine receptor', 'Antiemetics'): 0.02, ('Muscimol', 'Antiemetics'): 0.02, ('Muscle', 'Antiemetics'): 0.02, ('Muscle relaxant', 'Antiemetics'): 0.02, ('Muscle spasms', 'Antiemetics'): 0.02, ('NK1 receptor antagonist', 'Antiemetics'): 0.02, ('Nabilone', 'Antiemetics'): 0.02, ('Nervous system', 'Antiemetics'): 0.02, ('Netupitant', 'Antiemetics'): 0.02, ('Netupitant/palonosetron', 'Antiemetics'): 0.02, ('Neuroprotective', 'Antiemetics'): 0.02, ('Neurotoxin', 'Antiemetics'): 0.02, ('Non-steroidal anti-inflammatory drug', 'Antiemetics'): 0.02, ('Nootropic', 'Antiemetics'): 0.02, ('Olanzapine', 'Antiemetics'): 0.02, ('Ondansetron', 'Antiemetics'): 0.02, ('Opioid', 'Antiemetics'): 0.02, ('Orexigenic', 'Antiemetics'): 0.02, ('Otology', 'Antiemetics'): 0.02, ('Palonosetron', 'Antiemetics'): 0.02, ('Peppermint', 'Antiemetics'): 0.02, ('Platelet', 'Antiemetics'): 0.02, ('Platelet', 'Cancer cell'): 0.02, ('Prochlorperazine', 'Antiemetics'): 0.02, ('Promethazine', 'Antiemetics'): 0.02, ('Propofol', 'Antiemetics'): 0.02, ('Proton-pump inhibitor', 'Antiemetics'): 0.02, ('Psychedelic drug', 'Antiemetics'): 0.02, ('Psychedelics, dissociatives and deliriants', 'Antiemetics'): 0.02, ('Psychomotor agitation', 'Antiemetics'): 0.02, ('Quetiapine', 'Antiemetics'): 0.02, ('Radiopharmacology', 'Antiemetics'): 0.02, ('Ramosetron', 'Antiemetics'): 0.02, ('Receptor Antagonist', 'Antiemetics'): 0.02, ('Renin inhibitor', 'Antiemetics'): 0.02, ('Renin–angiotensin system', 'Antiemetics'): 0.02, ('Respiratory system', 'Antiemetics'): 0.02, ('Ricasetron', 'Antiemetics'): 0.02, ('Risperidone', 'Antiemetics'): 0.02, ('Rolapitant', 'Antiemetics'): 0.02, ('Sativex', 'Antiemetics'): 0.02, ('Schedule II Controlled Substance', 'Antiemetics'): 0.02, ('Scopolamine', 'Antiemetics'): 0.02, ('Sedative', 'Antiemetics'): 0.02, ('Selective estrogen receptor modulator', 'Antiemetics'): 0.02, ('Senotherapeutics', 'Antiemetics'): 0.02, ('Sense', 'Antiemetics'): 0.02, ('Serenic', 'Antiemetics'): 0.02, ('Serotonin', 'Antiemetics'): 0.02, ('Serotonin antagonist', 'Antiemetics'): 0.02, ('Sex steroid', 'Antiemetics'): 0.02, ('Shogaol', 'Antiemetics'): 0.02, ('Spindle poison', 'Antiemetics'): 0.02, ('Statin', 'Antiemetics'): 0.02, ('Steroid', 'Antiemetics'): 0.02, ('Stimulant', 'Antiemetics'): 0.02, ('Synthetic cannabinoids', 'Antiemetics'): 0.02, ('Tetrahydrocannabinol', 'Antiemetics'): 0.02, ('The New York Times', 'Antiemetics'): 0.02, ('The New York Times', 'Base excision repair'): 0.02, ('The New York Times', 'Cancer cell'): 0.02, ('The New York Times', 'Synthetic lethality'): 0.03, ('Thiethylperazine', 'Antiemetics'): 0.02, ('Thrombolytic drug', 'Antiemetics'): 0.02, ('Thyroid hormone', 'Antiemetics'): 0.02, ('Topoisomerase inhibitor', 'Antiemetics'): 0.02, ('Trimethobenzamide', 'Antiemetics'): 0.02, ('Tropisetron', 'Antiemetics'): 0.02, ('Vaccine', 'Antiemetics'): 0.02, ('Vasodilation', 'Antiemetics'): 0.02, ('Vitamin', 'Antiemetics'): 0.02, ('Wakefulness-promoting agent', 'Antiemetics'): 0.02, ('Xerostomia', 'Antiemetics'): 0.02, ('Zatosetron', 'Antiemetics'): 0.02, ('Ziprasidone', 'Antiemetics'): 0.02, ('Brain-derived neurotrophic factor', 'Synthetic lethality'): 0.02, ('C-Met', 'Base excision repair'): 0.02, ('C-Met', 'Cancer cell'): 0.02, ('C-Met', 'Synthetic lethality'): 0.03, ('CD117', 'Base excision repair'): 0.02, ('CD117', 'Cancer cell'): 0.02, ('CD117', 'Synthetic lethality'): 0.03, ('CD135', 'Base excision repair'): 0.02, ('CD135', 'Cancer cell'): 0.02, ('CD135', 'Synthetic lethality'): 0.03, ('Epidermal growth factor receptor', 'Base excision repair'): 0.02, ('Epidermal growth factor receptor', 'Cancer cell'): 0.02, ('Epidermal growth factor receptor', 'Synthetic lethality'): 0.03, ('ErbB', 'Base excision repair'): 0.02, ('ErbB', 'Cancer cell'): 0.02, ('ErbB', 'Synthetic lethality'): 0.03, ('HER2/neu', 'Base excision repair'): 0.02, ('HER2/neu', 'Cancer cell'): 0.02, ('HER2/neu', 'Synthetic lethality'): 0.03, ('Hedgehog signaling pathway', 'Base excision repair'): 0.02, ('Hedgehog signaling pathway', 'Cancer cell'): 0.02, ('Hedgehog signaling pathway', 'Synthetic lethality'): 0.03, ('Hepatocyte growth factor', 'Base excision repair'): 0.02, ('Hepatocyte growth factor', 'Cancer cell'): 0.02, ('Hepatocyte growth factor', 'Synthetic lethality'): 0.03, ('Lymphatic system', 'Cancer cell'): 0.02, ('RET proto-oncogene', 'Base excision repair'): 0.02, ('RET proto-oncogene', 'Cancer cell'): 0.02, ('RET proto-oncogene', 'Synthetic lethality'): 0.03, ('Receptor tyrosine kinase', 'Base excision repair'): 0.02, ('Receptor tyrosine kinase', 'Cancer cell'): 0.02, ('Receptor tyrosine kinase', 'Synthetic lethality'): 0.03, ('Wnt signaling pathway', 'Base excision repair'): 0.02, ('Wnt signaling pathway', 'Cancer cell'): 0.02, ('Wnt signaling pathway', 'Synthetic lethality'): 0.03, ('B cell', 'Cancer cell'): 0.02, ('AKT', 'Base excision repair'): 0.02, ('AKT', 'Cancer cell'): 0.02, ('AKT', 'Synthetic lethality'): 0.03, ('AKT1', 'Base excision repair'): 0.02, ('AKT1', 'Cancer cell'): 0.02, ('AKT1', 'Synthetic lethality'): 0.03, ('AP-1 transcription factor', 'Base excision repair'): 0.02, ('AP-1 transcription factor', 'Cancer cell'): 0.02, ('AP-1 transcription factor', 'Synthetic lethality'): 0.03, ('ATF1', 'Base excision repair'): 0.02, ('ATF1', 'Cancer cell'): 0.02, ('ATF1', 'Synthetic lethality'): 0.03, ('Abl gene', 'Base excision repair'): 0.02, ('Abl gene', 'Cancer cell'): 0.02, ('Abl gene', 'Synthetic lethality'): 0.03, ('Acetaldehyde', 'Base excision repair'): 0.02, ('Acetaldehyde', 'Cancer cell'): 0.02, ('Acetaldehyde', 'Synthetic lethality'): 0.03, ('Adenomatosis polyposis coli', 'Base excision repair'): 0.02, ('Adenomatosis polyposis coli', 'Cancer cell'): 0.02, ('Adenomatosis polyposis coli', 'Synthetic lethality'): 0.03, ('Akt/PKB signaling pathway', 'Base excision repair'): 0.02, ('Akt/PKB signaling pathway', 'Cancer cell'): 0.02, ('Akt/PKB signaling pathway', 'Synthetic lethality'): 0.03, ('Allele', 'Base excision repair'): 0.02, ('Allele', 'Cancer cell'): 0.02, ('Allele', 'Synthetic lethality'): 0.03, ('Alpha-helices', 'Base excision repair'): 0.02, ('Alpha-helices', 'Cancer cell'): 0.02, ('Alpha-helices', 'Synthetic lethality'): 0.03, ('Alpha helix', 'Base excision repair'): 0.02, ('Alpha helix', 'Cancer cell'): 0.02, ('Alpha helix', 'Synthetic lethality'): 0.03, ('Androgen receptor', 'Base excision repair'): 0.02, ('Androgen receptor', 'Cancer cell'): 0.02, ('Androgen receptor', 'Synthetic lethality'): 0.03, ('Ashkenazi Jews', 'Base excision repair'): 0.02, ('Ashkenazi Jews', 'Cancer cell'): 0.02, ('Ashkenazi Jews', 'Synthetic lethality'): 0.03, ('Association for Molecular Pathology v. Myriad Genetics', 'Base excision repair'): 0.02, ('Association for Molecular Pathology v. Myriad Genetics', 'Cancer cell'): 0.02, ('Association for Molecular Pathology v. Myriad Genetics', 'Synthetic lethality'): 0.03, ('Ataxia telangiectasia and Rad3 related', 'Base excision repair'): 0.02, ('Ataxia telangiectasia and Rad3 related', 'Cancer cell'): 0.02, ('Ataxia telangiectasia and Rad3 related', 'Synthetic lethality'): 0.03, ('Ataxia telangiectasia mutated', 'Base excision repair'): 0.02, ('Ataxia telangiectasia mutated', 'Cancer cell'): 0.02, ('BACH1', 'Base excision repair'): 0.02, ('BACH1', 'Cancer cell'): 0.02, ('BACH1', 'Synthetic lethality'): 0.03, ('BARD1', 'Base excision repair'): 0.02, ('BARD1', 'Cancer cell'): 0.02, ('BARD1', 'Synthetic lethality'): 0.03, ('BRCA1 protein', 'Base excision repair'): 0.02, ('BRCA1 protein', 'Cancer cell'): 0.02, ('BRCA1 protein', 'Synthetic lethality'): 0.03, ('BRCA2', 'Base excision repair'): 0.02, ('BRCA2', 'Cancer cell'): 0.02, ('BRCA mutation', 'Base excision repair'): 0.02, ('BRCA mutation', 'Cancer cell'): 0.02, ('BRCA mutation', 'Synthetic lethality'): 0.03, ('BRCC3', 'Base excision repair'): 0.02, ('BRCC3', 'Cancer cell'): 0.02, ('BRCC3', 'Synthetic lethality'): 0.03, ('BRCT domain', 'Base excision repair'): 0.02, ('BRCT domain', 'Cancer cell'): 0.02, ('BRCT domain', 'Synthetic lethality'): 0.03, ('BRE (gene)', 'Base excision repair'): 0.02, ('BRE (gene)', 'Cancer cell'): 0.02, ('BRE (gene)', 'Synthetic lethality'): 0.03, ('BRIP1', 'Cancer cell'): 0.02, ('BRIP1', 'Synthetic lethality'): 0.05, ('Base pair', 'Base excision repair'): 0.02, ('Base pair', 'Cancer cell'): 0.02, ('Base pair', 'Synthetic lethality'): 0.03, ('Bcl-2', 'Base excision repair'): 0.02, ('Bcl-2', 'Cancer cell'): 0.02, ('Bcl-2', 'Synthetic lethality'): 0.03, ('Beta-catenin', 'Base excision repair'): 0.02, ('Beta-catenin', 'Cancer cell'): 0.02, ('Beta-catenin', 'Synthetic lethality'): 0.03, ('Beta-sheet', 'Base excision repair'): 0.02, ('Beta-sheet', 'Cancer cell'): 0.02, ('Beta-sheet', 'Synthetic lethality'): 0.03, ('Biological patent', 'Base excision repair'): 0.02, ('Biological patent', 'Cancer cell'): 0.02, ('Biological patent', 'Synthetic lethality'): 0.03, ('Breast', 'Base excision repair'): 0.02, ('Breast', 'Cancer cell'): 0.02, ('Breast', 'Synthetic lethality'): 0.03, ('Breast cancer classification', 'Base excision repair'): 0.02, ('Breast cancer classification', 'Cancer cell'): 0.02, ('Breast cancer classification', 'Synthetic lethality'): 0.03, ('C-Fos', 'Base excision repair'): 0.02, ('C-Fos', 'Cancer cell'): 0.02, ('C-Fos', 'Synthetic lethality'): 0.03, ('C-Raf', 'Base excision repair'): 0.02, ('C-Raf', 'Cancer cell'): 0.02, ('C-Raf', 'Synthetic lethality'): 0.03, ('C-jun', 'Base excision repair'): 0.02, ('C-jun', 'Cancer cell'): 0.02, ('C-jun', 'Synthetic lethality'): 0.03, ('C-terminus', 'Base excision repair'): 0.02, ('C-terminus', 'Cancer cell'): 0.02, ('C-terminus', 'Synthetic lethality'): 0.03, ('CBL (gene)', 'Base excision repair'): 0.02, ('CBL (gene)', 'Cancer cell'): 0.02, ('CBL (gene)', 'Synthetic lethality'): 0.03, ('CDH1 (gene)', 'Base excision repair'): 0.02, ('CDH1 (gene)', 'Cancer cell'): 0.02, ('CDH1 (gene)', 'Synthetic lethality'): 0.03, ('CHEK2', 'Base excision repair'): 0.02, ('CHEK2', 'Cancer cell'): 0.02, ('CHEK2', 'Synthetic lethality'): 0.03, ('CLSPN', 'Base excision repair'): 0.02, ('CLSPN', 'Cancer cell'): 0.02, ('CLSPN', 'Synthetic lethality'): 0.03, ('CREB-binding protein', 'Base excision repair'): 0.02, ('CREB-binding protein', 'Cancer cell'): 0.02, ('CREB-binding protein', 'Synthetic lethality'): 0.03, ('CSNK2B', 'Base excision repair'): 0.02, ('CSNK2B', 'Cancer cell'): 0.02, ('CSNK2B', 'Synthetic lethality'): 0.03, ('CSTF2', 'Base excision repair'): 0.02, ('CSTF2', 'Cancer cell'): 0.02, ('CSTF2', 'Synthetic lethality'): 0.03, ('Caretaker gene', 'Base excision repair'): 0.02, ('Caretaker gene', 'Cancer cell'): 0.02, ('Caretaker gene', 'Synthetic lethality'): 0.03, ('Cell cycle', 'Base excision repair'): 0.02, ('Cell cycle', 'Cancer cell'): 0.02, ('Cell cycle', 'Synthetic lethality'): 0.03, ('Cell nucleus', 'Base excision repair'): 0.02, ('Cell nucleus', 'Synthetic lethality'): 0.03, ('Chelation', 'Base excision repair'): 0.02, ('Chelation', 'Cancer cell'): 0.02, ('Chelation', 'Synthetic lethality'): 0.03, ('Chromosome', 'Base excision repair'): 0.02, ('Chromosome', 'Synthetic lethality'): 0.03, ('Chromosome 17 (human)', 'Base excision repair'): 0.02, ('Chromosome 17 (human)', 'Cancer cell'): 0.02, ('Chromosome 17 (human)', 'Synthetic lethality'): 0.03, ('Cofactor of BRCA1', 'Base excision repair'): 0.02, ('Cofactor of BRCA1', 'Cancer cell'): 0.02, ('Cofactor of BRCA1', 'Synthetic lethality'): 0.03, ('Comparative genomic hybridization', 'Base excision repair'): 0.02, ('Comparative genomic hybridization', 'Cancer cell'): 0.02, ('Comparative genomic hybridization', 'Synthetic lethality'): 0.03, ('Cyclin-dependent kinase 2', 'Base excision repair'): 0.02, ('Cyclin-dependent kinase 2', 'Cancer cell'): 0.02, ('Cyclin-dependent kinase 2', 'Synthetic lethality'): 0.03, ('Cyclin-dependent kinase 4', 'Base excision repair'): 0.02, ('Cyclin-dependent kinase 4', 'Cancer cell'): 0.02, ('Cyclin-dependent kinase 4', 'Synthetic lethality'): 0.03, ('Cyclin D', 'Base excision repair'): 0.02, ('Cyclin D', 'Cancer cell'): 0.02, ('Cyclin D', 'Synthetic lethality'): 0.03, ('Cyclin E', 'Base excision repair'): 0.02, ('Cyclin E', 'Cancer cell'): 0.02, ('Cyclin E', 'Synthetic lethality'): 0.03, ('Cysteine', 'Base excision repair'): 0.02, ('Cysteine', 'Cancer cell'): 0.02, ('Cysteine', 'Synthetic lethality'): 0.03, ('DHX9', 'Base excision repair'): 0.02, ('DHX9', 'Cancer cell'): 0.02, ('DHX9', 'Synthetic lethality'): 0.03, ('DNA damage', 'Base excision repair'): 0.02, ('DNA damage', 'Cancer cell'): 0.02, ('DNA damage', 'Synthetic lethality'): 0.03, ('DNA methylation', 'Cancer cell'): 0.02, ('DNA mismatch repair', 'Cancer cell'): 0.02, ('Double-strand break repair model', 'Base excision repair'): 0.02, ('Double-strand break repair model', 'Cancer cell'): 0.02, ('Double-strand break repair model', 'Synthetic lethality'): 0.03, ('Double-strand breaks', 'Base excision repair'): 0.02, ('Double-strand breaks', 'Cancer cell'): 0.02, ('Double-strand breaks', 'Synthetic lethality'): 0.03, ('ELK4', 'Base excision repair'): 0.02, ('ELK4', 'Cancer cell'): 0.02, ('ELK4', 'Synthetic lethality'): 0.03, ('EP300', 'Base excision repair'): 0.02, ('EP300', 'Cancer cell'): 0.02, ('EP300', 'Synthetic lethality'): 0.03, ('ERBB3', 'Base excision repair'): 0.02, ('ERBB3', 'Cancer cell'): 0.02, ('ERBB3', 'Synthetic lethality'): 0.03, ('Ensembl', 'Cancer cell'): 0.02, ('Ensembl', 'Synthetic lethality'): 0.05, ('Ensembl genome database project', 'Base excision repair'): 0.02, ('Ensembl genome database project', 'Cancer cell'): 0.02, ('Ensembl genome database project', 'Synthetic lethality'): 0.03, ('Entrez', 'Cancer cell'): 0.02, ('Entrez', 'Synthetic lethality'): 0.05, ('Estrogen receptor', 'Base excision repair'): 0.02, ('Estrogen receptor', 'Cancer cell'): 0.02, ('Estrogen receptor', 'Synthetic lethality'): 0.03, ('Estrogen receptor alpha', 'Base excision repair'): 0.02, ('Estrogen receptor alpha', 'Cancer cell'): 0.02, ('Estrogen receptor alpha', 'Synthetic lethality'): 0.03, ('Eva Y.-H. P. Lee', 'Base excision repair'): 0.02, ('Eva Y.-H. P. Lee', 'Cancer cell'): 0.02, ('Eva Y.-H. P. Lee', 'Synthetic lethality'): 0.03, ('FANCA', 'Cancer cell'): 0.02, ('FANCA', 'Synthetic lethality'): 0.05, ('FANCD2', 'Cancer cell'): 0.02, ('FHL2', 'Base excision repair'): 0.02, ('FHL2', 'Cancer cell'): 0.02, ('FHL2', 'Synthetic lethality'): 0.03, ('Fallopian tube', 'Base excision repair'): 0.02, ('Fallopian tube', 'Cancer cell'): 0.02, ('Fallopian tube', 'Synthetic lethality'): 0.03, ('Fanconi anemia', 'Base excision repair'): 0.02, ('Fanconi anemia', 'Cancer cell'): 0.02, ('Fanconi anemia', 'Synthetic lethality'): 0.03, ('Federal Court of Australia', 'Base excision repair'): 0.02, ('Federal Court of Australia', 'Cancer cell'): 0.02, ('Federal Court of Australia', 'Synthetic lethality'): 0.03, ('Formaldehyde', 'Base excision repair'): 0.02, ('Formaldehyde', 'Cancer cell'): 0.02, ('Formaldehyde', 'Synthetic lethality'): 0.03, ('Gene', 'Base excision repair'): 0.02, ('Gene', 'Synthetic lethality'): 0.03, ('GeneCards', 'Cancer cell'): 0.02, ('GeneCards', 'Synthetic lethality'): 0.05, ('Gene expression', 'Base excision repair'): 0.02, ('Gene expression', 'Cancer cell'): 0.02, ('Gene expression', 'Synthetic lethality'): 0.03, ('Gene nomenclature', 'Cancer cell'): 0.02, ('Gene nomenclature', 'Synthetic lethality'): 0.05, ('Gene ontology', 'Base excision repair'): 0.02, ('Gene ontology', 'Cancer cell'): 0.02, ('Gene ontology', 'Synthetic lethality'): 0.03, ('Germline mutation', 'Base excision repair'): 0.02, ('Germline mutation', 'Cancer cell'): 0.02, ('Germline mutation', 'Synthetic lethality'): 0.03, ('H2AFX', 'Base excision repair'): 0.02, ('H2AFX', 'Cancer cell'): 0.02, ('H2AFX', 'Synthetic lethality'): 0.03, ('HRAS', 'Base excision repair'): 0.02, ('HRAS', 'Cancer cell'): 0.02, ('HRAS', 'Synthetic lethality'): 0.03, ('Hereditary breast–ovarian cancer syndrome', 'Base excision repair'): 0.02, ('Hereditary breast–ovarian cancer syndrome', 'Cancer cell'): 0.02, ('Hereditary breast–ovarian cancer syndrome', 'Synthetic lethality'): 0.03, ('Heterodimerization', 'Base excision repair'): 0.02, ('Heterodimerization', 'Cancer cell'): 0.02, ('Heterodimerization', 'Synthetic lethality'): 0.03, ('High Court of Australia', 'Base excision repair'): 0.02, ('High Court of Australia', 'Cancer cell'): 0.02, ('High Court of Australia', 'Synthetic lethality'): 0.03, ('Hippo signaling pathway', 'Base excision repair'): 0.02, ('Hippo signaling pathway', 'Cancer cell'): 0.02, ('Hippo signaling pathway', 'Synthetic lethality'): 0.03, ('Histidine', 'Base excision repair'): 0.02, ('Histidine', 'Cancer cell'): 0.02, ('Histidine', 'Synthetic lethality'): 0.03, ('Histone deacetylase', 'Base excision repair'): 0.02, ('Histone deacetylase', 'Cancer cell'): 0.02, ('Histone deacetylase', 'Synthetic lethality'): 0.03, ('HomoloGene', 'Base excision repair'): 0.02, ('HomoloGene', 'Cancer cell'): 0.02, ('HomoloGene', 'Synthetic lethality'): 0.03, ('Homology directed repair', 'Cancer cell'): 0.02, ('Homology directed repair', 'Synthetic lethality'): 0.05, ('Human genome', 'Base excision repair'): 0.02, ('Human genome', 'Cancer cell'): 0.02, ('Human genome', 'Synthetic lethality'): 0.03, ('Hypomorphic', 'Base excision repair'): 0.02, ('Hypomorphic', 'Cancer cell'): 0.02, ('Hypomorphic', 'Synthetic lethality'): 0.03, ('In vitro', 'Base excision repair'): 0.02, ('In vitro', 'Cancer cell'): 0.04, ('In vitro', 'Synthetic lethality'): 0.03, ('In vivo', 'Base excision repair'): 0.02, ('In vivo', 'Cancer cell'): 0.04, ('In vivo', 'Synthetic lethality'): 0.03, ('Inhibitor of apoptosis', 'Base excision repair'): 0.02, ('Inhibitor of apoptosis', 'Cancer cell'): 0.02, ('Inhibitor of apoptosis', 'Synthetic lethality'): 0.03, ('Intracellular signaling peptides and proteins', 'Base excision repair'): 0.02, ('Intracellular signaling peptides and proteins', 'Cancer cell'): 0.02, ('Intracellular signaling peptides and proteins', 'Synthetic lethality'): 0.03, ('Invasive lobular carcinoma', 'Base excision repair'): 0.02, ('Invasive lobular carcinoma', 'Cancer cell'): 0.02, ('Invasive lobular carcinoma', 'Synthetic lethality'): 0.03, ('Invertebrate', 'Base excision repair'): 0.02, ('Invertebrate', 'Cancer cell'): 0.02, ('Invertebrate', 'Synthetic lethality'): 0.03, ('JAK-STAT signaling pathway', 'Base excision repair'): 0.02, ('JAK-STAT signaling pathway', 'Cancer cell'): 0.02, ('JAK-STAT signaling pathway', 'Synthetic lethality'): 0.03, ('JUNB', 'Base excision repair'): 0.02, ('JUNB', 'Cancer cell'): 0.02, ('JUNB', 'Synthetic lethality'): 0.03, ('James G. Herman', 'Base excision repair'): 0.02, ('James G. Herman', 'Cancer cell'): 0.02, ('James G. Herman', 'Synthetic lethality'): 0.03, ('JunD', 'Base excision repair'): 0.02, ('JunD', 'Cancer cell'): 0.02, ('JunD', 'Synthetic lethality'): 0.03, ('KLF6', 'Base excision repair'): 0.02, ('KLF6', 'Cancer cell'): 0.02, ('KLF6', 'Synthetic lethality'): 0.03, ('LMO4', 'Base excision repair'): 0.02, ('LMO4', 'Cancer cell'): 0.02, ('LMO4', 'Synthetic lethality'): 0.03, ('Laboratory mouse', 'Base excision repair'): 0.02, ('Laboratory mouse', 'Cancer cell'): 0.02, ('Laboratory mouse', 'Synthetic lethality'): 0.03, ('Ligand (biochemistry)', 'Base excision repair'): 0.02, ('Ligand (biochemistry)', 'Cancer cell'): 0.02, ('Ligand (biochemistry)', 'Synthetic lethality'): 0.03, ('Locus (genetics)', 'Base excision repair'): 0.02, ('Locus (genetics)', 'Cancer cell'): 0.02, ('Locus (genetics)', 'Synthetic lethality'): 0.03, ('MAP3K3', 'Base excision repair'): 0.02, ('MAP3K3', 'Cancer cell'): 0.02, ('MAP3K3', 'Synthetic lethality'): 0.03, ('MAPK/ERK pathway', 'Base excision repair'): 0.02, ('MAPK/ERK pathway', 'Cancer cell'): 0.02, ('MAPK/ERK pathway', 'Synthetic lethality'): 0.03, ('MED1', 'Base excision repair'): 0.02, ('MED1', 'Cancer cell'): 0.02, ('MED1', 'Synthetic lethality'): 0.03, ('MED17', 'Base excision repair'): 0.02, ('MED17', 'Cancer cell'): 0.02, ('MED17', 'Synthetic lethality'): 0.03, ('MED21', 'Base excision repair'): 0.02, ('MED21', 'Cancer cell'): 0.02, ('MED21', 'Synthetic lethality'): 0.03, ('MED24', 'Base excision repair'): 0.02, ('MED24', 'Cancer cell'): 0.02, ('MED24', 'Synthetic lethality'): 0.03, ('MRE11A', 'Base excision repair'): 0.02, ('MRE11A', 'Cancer cell'): 0.02, ('MSH2', 'Cancer cell'): 0.02, ('MSH2', 'Synthetic lethality'): 0.05, ('MSH3', 'Base excision repair'): 0.02, ('MSH3', 'Cancer cell'): 0.02, ('MSH3', 'Synthetic lethality'): 0.03, ('MSH6', 'Base excision repair'): 0.02, ('MSH6', 'Cancer cell'): 0.02, ('MSH6', 'Synthetic lethality'): 0.03, ('Mary-Claire King', 'Base excision repair'): 0.02, ('Mary-Claire King', 'Cancer cell'): 0.02, ('Mary-Claire King', 'Synthetic lethality'): 0.03, ('Maspin', 'Base excision repair'): 0.02, ('Maspin', 'Cancer cell'): 0.02, ('Maspin', 'Synthetic lethality'): 0.03, ('Mdm2', 'Base excision repair'): 0.02, ('Mdm2', 'Cancer cell'): 0.02, ('Mdm2', 'Synthetic lethality'): 0.03, ('Meiosis', 'Base excision repair'): 0.02, ('Meiosis', 'Synthetic lethality'): 0.03, ('Mendelian Inheritance in Man', 'Base excision repair'): 0.02, ('Mendelian Inheritance in Man', 'Cancer cell'): 0.02, ('Mendelian Inheritance in Man', 'Synthetic lethality'): 0.03, ('Merlin (protein)', 'Base excision repair'): 0.02, ('Merlin (protein)', 'Cancer cell'): 0.02, ('Merlin (protein)', 'Synthetic lethality'): 0.03, ('Methylation', 'Base excision repair'): 0.02, ('Methylation', 'Cancer cell'): 0.02, ('Methylation', 'Synthetic lethality'): 0.03, ('MiRNA', 'Base excision repair'): 0.02, ('MiRNA', 'Cancer cell'): 0.02, ('MiRNA', 'Synthetic lethality'): 0.03, ('MicroRNA', 'Base excision repair'): 0.02, ('MicroRNA', 'Cancer cell'): 0.02, ('MicroRNA', 'Synthetic lethality'): 0.03, ('Mir-17 microRNA precursor family', 'Base excision repair'): 0.02, ('Mir-17 microRNA precursor family', 'Cancer cell'): 0.02, ('Mir-17 microRNA precursor family', 'Synthetic lethality'): 0.03, ('Mir-30 microRNA precursor', 'Base excision repair'): 0.02, ('Mir-30 microRNA precursor', 'Cancer cell'): 0.02, ('Mir-30 microRNA precursor', 'Synthetic lethality'): 0.03, ('Missense mutation', 'Base excision repair'): 0.02, ('Missense mutation', 'Cancer cell'): 0.02, ('Missense mutation', 'Synthetic lethality'): 0.03, ('Mitochondrion', 'Base excision repair'): 0.02, ('Mitochondrion', 'Synthetic lethality'): 0.03, ('Mothers against decapentaplegic homolog 2', 'Base excision repair'): 0.02, ('Mothers against decapentaplegic homolog 2', 'Cancer cell'): 0.02, ('Mothers against decapentaplegic homolog 2', 'Synthetic lethality'): 0.03, ('Mothers against decapentaplegic homolog 4', 'Base excision repair'): 0.02, ('Mothers against decapentaplegic homolog 4', 'Cancer cell'): 0.02, ('Mothers against decapentaplegic homolog 4', 'Synthetic lethality'): 0.03, ('Mouse Genome Informatics', 'Base excision repair'): 0.02, ('Mouse Genome Informatics', 'Cancer cell'): 0.02, ('Mouse Genome Informatics', 'Synthetic lethality'): 0.03, ('Mre11-Rad50-Nbs1', 'Base excision repair'): 0.02, ('Mre11-Rad50-Nbs1', 'Cancer cell'): 0.02, ('Mre11-Rad50-Nbs1', 'Synthetic lethality'): 0.03, ('Multiplex ligation-dependent probe amplification', 'Base excision repair'): 0.02, ('Multiplex ligation-dependent probe amplification', 'Cancer cell'): 0.02, ('Multiplex ligation-dependent probe amplification', 'Synthetic lethality'): 0.03, ('Myc', 'Base excision repair'): 0.02, ('Myc', 'Cancer cell'): 0.02, ('Myc', 'Synthetic lethality'): 0.03, ('Myriad Genetics', 'Base excision repair'): 0.02, ('Myriad Genetics', 'Cancer cell'): 0.02, ('Myriad Genetics', 'Synthetic lethality'): 0.03, ('N-myc-interactor', 'Base excision repair'): 0.02, ('N-myc-interactor', 'Cancer cell'): 0.02, ('N-myc-interactor', 'Synthetic lethality'): 0.03, ('NPM1', 'Base excision repair'): 0.02, ('NPM1', 'Cancer cell'): 0.02, ('NPM1', 'Synthetic lethality'): 0.03, ('NUFIP1', 'Base excision repair'): 0.02, ('NUFIP1', 'Cancer cell'): 0.02, ('NUFIP1', 'Synthetic lethality'): 0.03, ('Negative elongation factor', 'Base excision repair'): 0.02, ('Negative elongation factor', 'Cancer cell'): 0.02, ('Negative elongation factor', 'Synthetic lethality'): 0.03, ('Neurofibromin 1', 'Base excision repair'): 0.02, ('Neurofibromin 1', 'Cancer cell'): 0.02, ('Neurofibromin 1', 'Synthetic lethality'): 0.03, ('Nibrin', 'Base excision repair'): 0.02, ('Nibrin', 'Cancer cell'): 0.02, ('Nibrin', 'Synthetic lethality'): 0.03, ('Non-homologous end joining', 'Cancer cell'): 0.02, ('Notch signaling', 'Base excision repair'): 0.02, ('Notch signaling', 'Cancer cell'): 0.02, ('Notch signaling', 'Synthetic lethality'): 0.03, ('Nuclear export signal', 'Base excision repair'): 0.02, ('Nuclear export signal', 'Cancer cell'): 0.02, ('Nuclear export signal', 'Synthetic lethality'): 0.03, ('Nuclear localization signal', 'Base excision repair'): 0.02, ('Nuclear localization signal', 'Cancer cell'): 0.02, ('Nuclear localization signal', 'Synthetic lethality'): 0.03, ('Nuclear receptor coactivator 2', 'Base excision repair'): 0.02, ('Nuclear receptor coactivator 2', 'Cancer cell'): 0.02, ('Nuclear receptor coactivator 2', 'Synthetic lethality'): 0.03, ('Oncogene', 'Base excision repair'): 0.02, ('Oncogene', 'Synthetic lethality'): 0.03, ('Ortholog', 'Base excision repair'): 0.02, ('Ortholog', 'Cancer cell'): 0.02, ('Ortholog', 'Synthetic lethality'): 0.03, ('Orthologs', 'Cancer cell'): 0.02, ('Orthologs', 'Synthetic lethality'): 0.05, ('Ovarian cancer', 'Base excision repair'): 0.02, ('Ovarian cancer', 'Cancer cell'): 0.02, ('Ovarian cancer', 'Synthetic lethality'): 0.03, ('P14arf', 'Base excision repair'): 0.02, ('P14arf', 'Cancer cell'): 0.02, ('P14arf', 'Synthetic lethality'): 0.03, ('P16 (gene)', 'Base excision repair'): 0.02, ('P16 (gene)', 'Cancer cell'): 0.02, ('P16 (gene)', 'Synthetic lethality'): 0.03, ('P53', 'Cancer cell'): 0.02, ('PALB2', 'Cancer cell'): 0.02, ('POLR2A', 'Base excision repair'): 0.02, ('POLR2A', 'Cancer cell'): 0.02, ('POLR2A', 'Synthetic lethality'): 0.03, ('PPP1CA', 'Base excision repair'): 0.02, ('PPP1CA', 'Cancer cell'): 0.02, ('PPP1CA', 'Synthetic lethality'): 0.03, ('PTCH1', 'Base excision repair'): 0.02, ('PTCH1', 'Cancer cell'): 0.02, ('PTCH1', 'Synthetic lethality'): 0.03, ('PTEN (gene)', 'Base excision repair'): 0.02, ('PTEN (gene)', 'Cancer cell'): 0.02, ('PTEN (gene)', 'Synthetic lethality'): 0.03, ('Paralogy', 'Base excision repair'): 0.02, ('Paralogy', 'Cancer cell'): 0.02, ('Paralogy', 'Synthetic lethality'): 0.03, ('Penetrance', 'Base excision repair'): 0.02, ('Penetrance', 'Cancer cell'): 0.02, ('Penetrance', 'Synthetic lethality'): 0.03, ('Poly (ADP-ribose) polymerase', 'Base excision repair'): 0.02, ('Poly (ADP-ribose) polymerase', 'Cancer cell'): 0.02, ('Poly (ADP-ribose) polymerase', 'Synthetic lethality'): 0.03, ('Progesterone receptor', 'Base excision repair'): 0.02, ('Progesterone receptor', 'Cancer cell'): 0.02, ('Progesterone receptor', 'Synthetic lethality'): 0.03, ('Promoter (biology)', 'Base excision repair'): 0.02, ('Promoter (biology)', 'Cancer cell'): 0.02, ('Promoter (biology)', 'Synthetic lethality'): 0.03, ('Prophylactic surgery', 'Base excision repair'): 0.02, ('Prophylactic surgery', 'Cancer cell'): 0.02, ('Prophylactic surgery', 'Synthetic lethality'): 0.03, ('Protein–protein interaction', 'Base excision repair'): 0.02, ('Protein–protein interaction', 'Cancer cell'): 0.02, ('Protein–protein interaction', 'Synthetic lethality'): 0.03, ('Proto-oncogene tyrosine-protein kinase Src', 'Base excision repair'): 0.02, ('Proto-oncogene tyrosine-protein kinase Src', 'Cancer cell'): 0.02, ('Proto-oncogene tyrosine-protein kinase Src', 'Synthetic lethality'): 0.03, ('PubMed', 'Cancer cell'): 0.02, ('PubMed', 'Synthetic lethality'): 0.05, ('Quantitative PCR', 'Base excision repair'): 0.02, ('Quantitative PCR', 'Cancer cell'): 0.02, ('Quantitative PCR', 'Synthetic lethality'): 0.03, ('RAD51', 'Cancer cell'): 0.02, ('RBBP4', 'Base excision repair'): 0.02, ('RBBP4', 'Cancer cell'): 0.02, ('RBBP4', 'Synthetic lethality'): 0.03, ('RBBP7', 'Base excision repair'): 0.02, ('RBBP7', 'Cancer cell'): 0.02, ('RBBP7', 'Synthetic lethality'): 0.03, ('RBBP8', 'Base excision repair'): 0.02, ('RBBP8', 'Cancer cell'): 0.02, ('RBBP8', 'Synthetic lethality'): 0.03, ('RELA', 'Base excision repair'): 0.02, ('RELA', 'Cancer cell'): 0.02, ('RELA', 'Synthetic lethality'): 0.03, ('RING finger domain', 'Base excision repair'): 0.02, ('RING finger domain', 'Cancer cell'): 0.02, ('RING finger domain', 'Synthetic lethality'): 0.03, ('RNA polymerase II', 'Base excision repair'): 0.02, ('RNA polymerase II', 'Cancer cell'): 0.02, ('RNA polymerase II', 'Synthetic lethality'): 0.03, ('RPL31', 'Base excision repair'): 0.02, ('RPL31', 'Cancer cell'): 0.02, ('RPL31', 'Synthetic lethality'): 0.03, ('Rad50', 'Base excision repair'): 0.02, ('Rad50', 'Cancer cell'): 0.02, ('Rad50', 'Synthetic lethality'): 0.03, ('Ras (protein)', 'Base excision repair'): 0.02, ('Ras (protein)', 'Cancer cell'): 0.02, ('Ras (protein)', 'Synthetic lethality'): 0.03, ('Retinoblastoma-like protein 1', 'Base excision repair'): 0.02, ('Retinoblastoma-like protein 1', 'Cancer cell'): 0.02, ('Retinoblastoma-like protein 1', 'Synthetic lethality'): 0.03, ('Retinoblastoma-like protein 2', 'Base excision repair'): 0.02, ('Retinoblastoma-like protein 2', 'Cancer cell'): 0.02, ('Retinoblastoma-like protein 2', 'Synthetic lethality'): 0.03, ('Retinoblastoma protein', 'Base excision repair'): 0.02, ('Retinoblastoma protein', 'Cancer cell'): 0.02, ('Retinoblastoma protein', 'Synthetic lethality'): 0.03, ('SDHB', 'Base excision repair'): 0.02, ('SDHB', 'Cancer cell'): 0.02, ('SDHB', 'Synthetic lethality'): 0.03, ('SDHD', 'Base excision repair'): 0.02, ('SDHD', 'Cancer cell'): 0.02, ('SDHD', 'Synthetic lethality'): 0.03, ('SMARCA4', 'Base excision repair'): 0.02, ('SMARCA4', 'Cancer cell'): 0.02, ('SMARCA4', 'Synthetic lethality'): 0.03, ('SMARCB1', 'Base excision repair'): 0.02, ('SMARCB1', 'Cancer cell'): 0.02, ('SMARCB1', 'Synthetic lethality'): 0.03, ('STAT1', 'Base excision repair'): 0.02, ('STAT1', 'Cancer cell'): 0.02, ('STAT1', 'Synthetic lethality'): 0.03, ('Sequence homology', 'Base excision repair'): 0.02, ('Sequence homology', 'Cancer cell'): 0.02, ('Sequence homology', 'Synthetic lethality'): 0.03, ('Signal transduction', 'Base excision repair'): 0.02, ('Signal transduction', 'Cancer cell'): 0.02, ('Signal transduction', 'Synthetic lethality'): 0.03, ('Sister chromatid', 'Base excision repair'): 0.02, ('Sister chromatid', 'Cancer cell'): 0.02, ('Sister chromatid', 'Synthetic lethality'): 0.03, ('Stathmin', 'Base excision repair'): 0.02, ('Stathmin', 'Cancer cell'): 0.02, ('Stathmin', 'Synthetic lethality'): 0.03, ('Stephen B. Baylin', 'Base excision repair'): 0.02, ('Stephen B. Baylin', 'Cancer cell'): 0.02, ('Stephen B. Baylin', 'Synthetic lethality'): 0.03, ('Supreme Court of the United States', 'Base excision repair'): 0.02, ('Supreme Court of the United States', 'Cancer cell'): 0.02, ('Supreme Court of the United States', 'Synthetic lethality'): 0.03, ('Sydney Morning Herald', 'Base excision repair'): 0.02, ('Sydney Morning Herald', 'Cancer cell'): 0.02, ('Sydney Morning Herald', 'Synthetic lethality'): 0.03, ('TGF beta receptor 2', 'Base excision repair'): 0.02, ('TGF beta receptor 2', 'Cancer cell'): 0.02, ('TGF beta receptor 2', 'Synthetic lethality'): 0.03, ('TGF beta signaling pathway', 'Base excision repair'): 0.02, ('TGF beta signaling pathway', 'Cancer cell'): 0.02, ('TGF beta signaling pathway', 'Synthetic lethality'): 0.03, ('TOPBP1', 'Base excision repair'): 0.02, ('TOPBP1', 'Cancer cell'): 0.02, ('TOPBP1', 'Synthetic lethality'): 0.03, ('Tandem repeat', 'Base excision repair'): 0.02, ('Tandem repeat', 'Synthetic lethality'): 0.03, ('The Guardian', 'Base excision repair'): 0.02, ('The Guardian', 'Cancer cell'): 0.02, ('The Guardian', 'Synthetic lethality'): 0.03, ('Three prime untranslated region', 'Base excision repair'): 0.02, ('Three prime untranslated region', 'Cancer cell'): 0.02, ('Three prime untranslated region', 'Synthetic lethality'): 0.03, ('Transcription factor', 'Base excision repair'): 0.02, ('Transcription factor', 'Cancer cell'): 0.02, ('Transcription factor', 'Synthetic lethality'): 0.03, ('Transcriptional regulation', 'Base excision repair'): 0.02, ('Transcriptional regulation', 'Cancer cell'): 0.02, ('Transcriptional regulation', 'Synthetic lethality'): 0.03, ('Triple-negative breast cancer', 'Base excision repair'): 0.02, ('Triple-negative breast cancer', 'Cancer cell'): 0.02, ('Triple-negative breast cancer', 'Synthetic lethality'): 0.03, ('Tumor suppressor gene', 'Base excision repair'): 0.02, ('Tumor suppressor gene', 'Synthetic lethality'): 0.03, ('UBE2D1', 'Base excision repair'): 0.02, ('UBE2D1', 'Cancer cell'): 0.02, ('UBE2D1', 'Synthetic lethality'): 0.03, ('USF2', 'Base excision repair'): 0.02, ('USF2', 'Cancer cell'): 0.02, ('USF2', 'Synthetic lethality'): 0.03, ('Ubiquitin', 'Base excision repair'): 0.02, ('Ubiquitin', 'Cancer cell'): 0.02, ('Ubiquitin', 'Synthetic lethality'): 0.03, ('Ubiquitin ligase', 'Base excision repair'): 0.02, ('Ubiquitin ligase', 'Cancer cell'): 0.02, ('Ubiquitin ligase', 'Synthetic lethality'): 0.03, ('UniProt', 'Cancer cell'): 0.02, ('UniProt', 'Synthetic lethality'): 0.05, ('University of California, Berkeley', 'Base excision repair'): 0.02, ('University of California, Berkeley', 'Cancer cell'): 0.02, ('University of California, Berkeley', 'Synthetic lethality'): 0.03, ('Valosin-containing protein', 'Base excision repair'): 0.02, ('Valosin-containing protein', 'Cancer cell'): 0.02, ('Valosin-containing protein', 'Synthetic lethality'): 0.03, ('Vertebrate', 'Base excision repair'): 0.02, ('Vertebrate', 'Cancer cell'): 0.02, ('Vertebrate', 'Synthetic lethality'): 0.03, ('Von Hippel–Lindau tumor suppressor', 'Base excision repair'): 0.02, ('Von Hippel–Lindau tumor suppressor', 'Cancer cell'): 0.02, ('Von Hippel–Lindau tumor suppressor', 'Synthetic lethality'): 0.03, ('WT1', 'Base excision repair'): 0.02, ('WT1', 'Cancer cell'): 0.02, ('WT1', 'Synthetic lethality'): 0.03, ('Wayback Machine', 'Base excision repair'): 0.02, ('Wayback Machine', 'Synthetic lethality'): 0.03, ('Wikidata', 'Cancer cell'): 0.02, ('Wikidata', 'Synthetic lethality'): 0.05, ('XIST (gene)', 'Base excision repair'): 0.02, ('XIST (gene)', 'Cancer cell'): 0.02, ('XIST (gene)', 'Synthetic lethality'): 0.03, ('ZNF350', 'Base excision repair'): 0.02, ('ZNF350', 'Cancer cell'): 0.02, ('ZNF350', 'Synthetic lethality'): 0.03, ('Zn finger', 'Base excision repair'): 0.02, ('Zn finger', 'Cancer cell'): 0.02, ('Zn finger', 'Synthetic lethality'): 0.03, ('3-methyladenine', 'Synthetic lethality'): 0.02, ('APE1', 'Synthetic lethality'): 0.02, ('APE2', 'Synthetic lethality'): 0.02, ('Apn1', 'Synthetic lethality'): 0.02, ('Apn2', 'Synthetic lethality'): 0.02, ('Endonuclease IV', 'Synthetic lethality'): 0.02, ('5-Methylcytosine', 'Synthetic lethality'): 0.02, ('5-hydroxymethylcytosine', 'Synthetic lethality'): 0.02, ('5-methylcytosine', 'Synthetic lethality'): 0.02, ('7-methylguanosine', 'Synthetic lethality'): 0.02, (\"8-Oxo-2'-deoxyguanosine\", 'Synthetic lethality'): 0.02, ('8-Oxoguanine', 'Synthetic lethality'): 0.02, ('8-oxoguanine', 'Synthetic lethality'): 0.02, ('APOBEC3G', 'Synthetic lethality'): 0.02, ('AP endonuclease', 'Synthetic lethality'): 0.02, ('AP lyase', 'Synthetic lethality'): 0.02, ('AP site', 'Synthetic lethality'): 0.02, ('Adaptive response', 'Synthetic lethality'): 0.02, ('Adenine', 'Synthetic lethality'): 0.02, ('Biochemistry', 'Synthetic lethality'): 0.02, ('Bloom syndrome protein', 'Synthetic lethality'): 0.02, ('CRY1', 'Synthetic lethality'): 0.02, ('CRY2', 'Synthetic lethality'): 0.02, ('Cancer epigenetics', 'Synthetic lethality'): 0.02, ('Carcinogenesis', 'Synthetic lethality'): 0.02, ('Cognition', 'Synthetic lethality'): 0.02, ('CpG site', 'Synthetic lethality'): 0.02, ('Cytosine', 'Synthetic lethality'): 0.02, ('DDB1', 'Synthetic lethality'): 0.02, ('DNA-3-methyladenine glycosylase', 'Synthetic lethality'): 0.02, ('DNA Polymerase', 'Synthetic lethality'): 0.02, ('DNA base flipping', 'Synthetic lethality'): 0.02, ('DNA demethylation', 'Synthetic lethality'): 0.02, ('DNA glycosylase', 'Synthetic lethality'): 0.02, ('DNA ligase', 'Synthetic lethality'): 0.02, ('DNA oxidation', 'Synthetic lethality'): 0.02, ('DNA polymerase', 'Synthetic lethality'): 0.02, ('DNA polymerase beta', 'Synthetic lethality'): 0.02, ('DNA polymerase lambda', 'Synthetic lethality'): 0.02, ('Deamination', 'Synthetic lethality'): 0.02, ('Deletion (genetics)', 'Synthetic lethality'): 0.02, ('Directionality (molecular biology)', 'Synthetic lethality'): 0.02, ('Downregulation and upregulation', 'Synthetic lethality'): 0.02, ('ERCC1', 'Synthetic lethality'): 0.02, ('ERCC2', 'Synthetic lethality'): 0.02, ('ERCC4', 'Synthetic lethality'): 0.02, ('ERCC5', 'Synthetic lethality'): 0.02, ('ERCC6', 'Synthetic lethality'): 0.02, ('ERCC8 (gene)', 'Synthetic lethality'): 0.02, ('Excinuclease', 'Synthetic lethality'): 0.02, ('Excision repair', 'Synthetic lethality'): 0.02, ('Excision repair cross-complementing', 'Synthetic lethality'): 0.02, ('Exonuclease III', 'Synthetic lethality'): 0.02, ('FANCB', 'Synthetic lethality'): 0.02, ('FANCE', 'Synthetic lethality'): 0.02, ('FANCF', 'Synthetic lethality'): 0.02, ('FANCG', 'Synthetic lethality'): 0.02, ('FANCI', 'Synthetic lethality'): 0.02, ('FANCL', 'Synthetic lethality'): 0.02, ('FANCM', 'Synthetic lethality'): 0.02, ('FANC proteins', 'Synthetic lethality'): 0.02, ('FEN1', 'Synthetic lethality'): 0.02, ('Fanconi anemia, complementation group C', 'Synthetic lethality'): 0.02, ('Fear conditioning', 'Synthetic lethality'): 0.02, ('Flap endonuclease', 'Synthetic lethality'): 0.02, ('Gene promoter', 'Synthetic lethality'): 0.02, ('Gene silencing', 'Synthetic lethality'): 0.02, ('Genetics', 'Synthetic lethality'): 0.02, ('Glycosidic bond', 'Synthetic lethality'): 0.02, ('Helicase', 'Synthetic lethality'): 0.02, ('Hippocampus', 'Synthetic lethality'): 0.02, ('Hoogsteen base pair', 'Synthetic lethality'): 0.02, ('Host-cell reactivation', 'Synthetic lethality'): 0.02, ('Hydantoin', 'Synthetic lethality'): 0.02, ('Hypoxanthine', 'Synthetic lethality'): 0.02, ('Intron', 'Synthetic lethality'): 0.02, ('Ku (protein)', 'Synthetic lethality'): 0.02, ('MBD4', 'Synthetic lethality'): 0.02, ('MLH1', 'Synthetic lethality'): 0.02, ('MUTYH', 'Synthetic lethality'): 0.02, ('Meiotic recombination checkpoint', 'Synthetic lethality'): 0.02, ('Memory', 'Synthetic lethality'): 0.02, ('Messenger RNA', 'Synthetic lethality'): 0.02, ('Microhomology-mediated end joining', 'Synthetic lethality'): 0.02, ('NEIL1', 'Synthetic lethality'): 0.02, ('Neurobiological effects of physical exercise', 'Synthetic lethality'): 0.02, ('Nucleotide excision repair', 'Synthetic lethality'): 0.02, ('O-6-methylguanine-DNA methyltransferase', 'Synthetic lethality'): 0.02, ('Okazaki fragment', 'Synthetic lethality'): 0.02, ('Oxoguanine glycosylase', 'Synthetic lethality'): 0.02, ('PCNA', 'Synthetic lethality'): 0.02, ('PNKP', 'Synthetic lethality'): 0.02, ('PcrA', 'Synthetic lethality'): 0.02, ('Photolyase', 'Synthetic lethality'): 0.02, ('Poly ADP ribose polymerase', 'Synthetic lethality'): 0.02, ('Postreplication repair', 'Synthetic lethality'): 0.02, ('Proliferating cell nuclear antigen', 'Synthetic lethality'): 0.02, ('Protein O-GlcNAc transferase', 'Synthetic lethality'): 0.02, ('Pyrimidine', 'Synthetic lethality'): 0.02, ('RAD23A', 'Synthetic lethality'): 0.02, ('RAD23B', 'Synthetic lethality'): 0.02, ('RecA', 'Synthetic lethality'): 0.02, ('RecF pathway', 'Synthetic lethality'): 0.02, ('Replication protein A', 'Synthetic lethality'): 0.02, ('SMUG1', 'Synthetic lethality'): 0.02, ('SOS box', 'Synthetic lethality'): 0.02, ('SOS response', 'Synthetic lethality'): 0.02, ('Sgs1', 'Synthetic lethality'): 0.02, ('Single-nucleotide polymorphism', 'Synthetic lethality'): 0.02, ('Slx4', 'Synthetic lethality'): 0.02, ('TRAMP complex', 'Synthetic lethality'): 0.02, ('Tet methylcytosine dioxygenase 1', 'Synthetic lethality'): 0.02, ('Tet methylcytosine dioxygenase 2', 'Synthetic lethality'): 0.02, ('Tet methylcytosine dioxygenase 3', 'Synthetic lethality'): 0.02, ('Thymidine', 'Synthetic lethality'): 0.02, ('Thymine', 'Synthetic lethality'): 0.02, ('Thymine-DNA glycosylase', 'Synthetic lethality'): 0.02, ('Thymine glycol', 'Synthetic lethality'): 0.02, ('Transcription-coupled repair', 'Synthetic lethality'): 0.02, ('Transition (genetics)', 'Synthetic lethality'): 0.02, ('Uracil', 'Synthetic lethality'): 0.02, ('Uracil-DNA glycosylase', 'Synthetic lethality'): 0.02, ('White blood cell', 'Cancer cell'): 0.02, ('White blood cell', 'Synthetic lethality'): 0.02, ('XPA', 'Synthetic lethality'): 0.02, ('XPB', 'Synthetic lethality'): 0.02, ('XPC (gene)', 'Synthetic lethality'): 0.02, ('Xanthine', 'Synthetic lethality'): 0.02, ('Adipocyte', 'Cancer cell'): 0.02, ('Adipose tissue', 'Cancer cell'): 0.02, ('Allogenic', 'Cancer cell'): 0.02, ('Anemia', 'Cancer cell'): 0.02, ('Antiretroviral', 'Cancer cell'): 0.02, ('Aplastic anemia', 'Cancer cell'): 0.02, ('Appendicular skeleton', 'Cancer cell'): 0.02, ('Aquaporin', 'Cancer cell'): 0.02, ('Autologous', 'Cancer cell'): 0.02, ('Axial skeleton', 'Cancer cell'): 0.02, ('Band cell', 'Cancer cell'): 0.02, ('Basophil granulocyte', 'Cancer cell'): 0.02, ('Basophilic normoblast', 'Cancer cell'): 0.02, ('Beta cell', 'Cancer cell'): 0.02, ('Biological tissue', 'Cancer cell'): 0.02, ('Blood cell', 'Cancer cell'): 0.02, ('Bone canaliculus', 'Cancer cell'): 0.02, ('Bone marrow (food)', 'Cancer cell'): 0.02, ('Bone marrow aspiration', 'Cancer cell'): 0.02, ('Bone marrow examination', 'Cancer cell'): 0.02, ('Bone mineral', 'Cancer cell'): 0.02, ('Cartilage', 'Cancer cell'): 0.02, ('Cellular compartment', 'Cancer cell'): 0.02, ('Cellular differentiation', 'Cancer cell'): 0.02, ('Chemical precursor', 'Cancer cell'): 0.02, ('Chondroblast', 'Cancer cell'): 0.02, ('Chondrocyte', 'Cancer cell'): 0.02, ('Colony stimulating factors', 'Cancer cell'): 0.02, ('Computed tomography', 'Cancer cell'): 0.02, ('Condyle', 'Cancer cell'): 0.02, ('Cords of Billroth', 'Cancer cell'): 0.02, ('Devonian', 'Cancer cell'): 0.02, ('Diaphysis', 'Cancer cell'): 0.02, ('Elastic cartilage', 'Cancer cell'): 0.02, ('Endochondral ossification', 'Cancer cell'): 0.02, ('Endosteum', 'Cancer cell'): 0.02, ('Endothelial stem cell', 'Cancer cell'): 0.02, ('Enthesis', 'Cancer cell'): 0.02, ('Eosinophil', 'Cancer cell'): 0.02, ('Eosinophil granulocyte', 'Cancer cell'): 0.02, ('Eosinophilic band cell', 'Cancer cell'): 0.02, ('Eosinophilic metamyelocyte', 'Cancer cell'): 0.02, ('Eosinophilic myelocyte', 'Cancer cell'): 0.02, ('Epicondyle', 'Cancer cell'): 0.02, ('Epiphyseal line', 'Cancer cell'): 0.02, ('Epiphyseal plate', 'Cancer cell'): 0.02, ('Epiphysis', 'Cancer cell'): 0.02, ('Erythrocytes', 'Cancer cell'): 0.02, ('Erythroid', 'Cancer cell'): 0.02, ('Erythropoiesis', 'Cancer cell'): 0.02, ('European Synchrotron Radiation Facility', 'Cancer cell'): 0.02, ('Eusthenopteron', 'Cancer cell'): 0.02, ('Femur', 'Cancer cell'): 0.02, ('Fibroblasts', 'Cancer cell'): 0.02, ('Fibrocartilage', 'Cancer cell'): 0.02, ('Fibrocartilage callus', 'Cancer cell'): 0.02, ('Flat bone', 'Cancer cell'): 0.02, ('Foundational Model of Anatomy', 'Cancer cell'): 0.02, ('General anesthesia', 'Cancer cell'): 0.02, ('Germinal center', 'Cancer cell'): 0.02, ('Gift of Life Marrow Registry', 'Cancer cell'): 0.02, ('Glycophorin', 'Cancer cell'): 0.02, ('Granulocytes', 'Cancer cell'): 0.02, ('Gut-associated lymphoid tissue', 'Cancer cell'): 0.02, ('HIV', 'Cancer cell'): 0.02, (\"Hassall's corpuscles\", 'Cancer cell'): 0.02, ('Haversian canal', 'Cancer cell'): 0.02, ('Hematopoiesis', 'Cancer cell'): 0.02, ('Hematopoietic stem cell', 'Cancer cell'): 0.02, ('Hematopoietic stem cell transplantation', 'Cancer cell'): 0.02, ('Hematopoietic system', 'Cancer cell'): 0.02, ('Hemoglobin', 'Cancer cell'): 0.02, ('High endothelial venules', 'Cancer cell'): 0.02, ('Human skull', 'Cancer cell'): 0.02, ('Human sternum', 'Cancer cell'): 0.02, ('Humerus', 'Cancer cell'): 0.02, ('Hyaline cartilage', 'Cancer cell'): 0.02, ('Iliac crest', 'Cancer cell'): 0.02, ('Inflammatory bowel disease', 'Cancer cell'): 0.02, ('Intramembranous ossification', 'Cancer cell'): 0.02, ('Intravenous therapy', 'Cancer cell'): 0.02, ('Ionizing radiation', 'Cancer cell'): 0.02, ('Iron', 'Cancer cell'): 0.02, ('Irregular bone', 'Cancer cell'): 0.02, ('LOC100272216', 'Cancer cell'): 0.02, ('Lacuna (histology)', 'Cancer cell'): 0.02, ('Latin language', 'Cancer cell'): 0.02, ('Lingual tonsils', 'Cancer cell'): 0.02, ('List of distinct cell types in the adult human body', 'Cancer cell'): 0.02, ('Lizard', 'Cancer cell'): 0.02, ('Lobe-finned fish', 'Cancer cell'): 0.02, ('Local anesthesia', 'Cancer cell'): 0.02, ('Long bone', 'Cancer cell'): 0.02, ('Long bones', 'Cancer cell'): 0.02, ('Lymphatic fluid', 'Cancer cell'): 0.02, ('Lymphatic vessel', 'Cancer cell'): 0.02, ('Lymphocytes', 'Cancer cell'): 0.02, ('Magnetic resonance imaging', 'Cancer cell'): 0.02, ('Mammal', 'Cancer cell'): 0.02, ('Mantle zone', 'Cancer cell'): 0.02, ('Marginal zone', 'Cancer cell'): 0.02, ('Marrow Adipose Tissue', 'Cancer cell'): 0.02, ('Marrow adipose tissue', 'Cancer cell'): 0.02, ('Mast cell', 'Cancer cell'): 0.02, ('Medullary cavity', 'Cancer cell'): 0.02, ('Megakaryocyte', 'Cancer cell'): 0.02, ('Mesenchymal stem cell', 'Cancer cell'): 0.02, ('Mesenchymal stem cells', 'Cancer cell'): 0.02, ('Metamyelocyte', 'Cancer cell'): 0.02, ('Metaphysis', 'Cancer cell'): 0.02, ('Milan', 'Cancer cell'): 0.02, ('Monash University', 'Cancer cell'): 0.02, ('Monocyte', 'Cancer cell'): 0.02, ('Mucosa-associated lymphoid tissue', 'Cancer cell'): 0.02, ('Multiple myeloma', 'Cancer cell'): 0.02, ('Multipotent', 'Cancer cell'): 0.02, ('Myeloblast', 'Cancer cell'): 0.02, ('Myelofibrosis', 'Cancer cell'): 0.02, ('Myelogenous leukemia', 'Cancer cell'): 0.02, ('Myeloid cell', 'Cancer cell'): 0.02, ('Myeloid tissue', 'Cancer cell'): 0.02, ('Myelomonocyte', 'Cancer cell'): 0.02, ('Myelonecrosis', 'Cancer cell'): 0.02, ('Myelopoiesis', 'Cancer cell'): 0.02, ('Myocyte', 'Cancer cell'): 0.02, ('National Marrow Donor Program', 'Cancer cell'): 0.02, ('Nature Publishing Group', 'Cancer cell'): 0.02, ('Neutrophilic band cell', 'Cancer cell'): 0.02, ('Neutrophilic metamyelocyte', 'Cancer cell'): 0.02, ('Neutrophilic myelocyte', 'Cancer cell'): 0.02, ('Organ system', 'Cancer cell'): 0.02, ('Orthochromatic', 'Cancer cell'): 0.02, ('Orthochromatic normoblast', 'Cancer cell'): 0.02, ('Ossein', 'Cancer cell'): 0.02, ('Ossification', 'Cancer cell'): 0.02, ('Ossobuco', 'Cancer cell'): 0.02, ('Osteoblast', 'Cancer cell'): 0.02, ('Osteoblasts', 'Cancer cell'): 0.02, ('Osteoclast', 'Cancer cell'): 0.02, ('Osteoclasts', 'Cancer cell'): 0.02, ('Osteocyte', 'Cancer cell'): 0.02, ('Osteoid', 'Cancer cell'): 0.02, ('Osteon', 'Cancer cell'): 0.02, ('Outpatient surgery', 'Cancer cell'): 0.02, ('Palatine tonsil', 'Cancer cell'): 0.02, ('Pancytopenia', 'Cancer cell'): 0.02, ('Pelvis', 'Cancer cell'): 0.02, ('Periarteriolar lymphoid sheaths', 'Cancer cell'): 0.02, ('Perichondrium', 'Cancer cell'): 0.02, ('Periosteum', 'Cancer cell'): 0.02, ('Peripheral blood', 'Cancer cell'): 0.02, ('Peripheral venous catheter', 'Cancer cell'): 0.02, (\"Peyer's patch\", 'Cancer cell'): 0.02, ('Pharyngeal tonsil', 'Cancer cell'): 0.02, ('Plasma cell', 'Cancer cell'): 0.02, ('Platelets', 'Cancer cell'): 0.02, ('Pluripotential hematopoietic stem cell', 'Cancer cell'): 0.02, ('Polychromatic normoblast', 'Cancer cell'): 0.02, ('Polycythemia', 'Cancer cell'): 0.02, ('Primary bone', 'Cancer cell'): 0.02, ('Primary lymphoid organs', 'Cancer cell'): 0.02, ('Progenitor cell', 'Cancer cell'): 0.02, ('Promyelocyte', 'Cancer cell'): 0.02, ('Pronormoblast', 'Cancer cell'): 0.02, ('Prussian blue', 'Cancer cell'): 0.02, ('Radiation poisoning', 'Cancer cell'): 0.02, ('Radiograph', 'Cancer cell'): 0.02, ('Red blood cell', 'Cancer cell'): 0.02, ('Red pulp', 'Cancer cell'): 0.02, ('Reference range', 'Cancer cell'): 0.02, ('Reticular cell', 'Cancer cell'): 0.02, ('Reticular connective tissue', 'Cancer cell'): 0.02, ('Rib cage', 'Cancer cell'): 0.02, ('Ribs', 'Cancer cell'): 0.02, ('Scapulae', 'Cancer cell'): 0.02, ('Secondary lymphoid organs', 'Cancer cell'): 0.02, ('Segmented neutrophil', 'Cancer cell'): 0.02, ('Sesamoid bone', 'Cancer cell'): 0.02, (\"Sharpey's fibres\", 'Cancer cell'): 0.02, ('Short bone', 'Cancer cell'): 0.02, ('Sinusoid blood vessel', 'Cancer cell'): 0.02, ('Sinusoids', 'Cancer cell'): 0.02, ('Spleen', 'Cancer cell'): 0.02, ('Splenic hilum', 'Cancer cell'): 0.02, ('Spongy bone', 'Cancer cell'): 0.02, ('Sternum', 'Cancer cell'): 0.02, ('Stromal cell', 'Cancer cell'): 0.02, ('Suction (medicine)', 'Cancer cell'): 0.02, ('T1-weighted MRI', 'Cancer cell'): 0.02, ('T cell', 'Cancer cell'): 0.02, ('Terminologia Anatomica', 'Cancer cell'): 0.02, ('Tetrapod', 'Cancer cell'): 0.02, ('Thalassemia', 'Cancer cell'): 0.02, ('Thymus', 'Cancer cell'): 0.02, ('Tibia', 'Cancer cell'): 0.02, ('Tonsil', 'Cancer cell'): 0.02, ('Tonsillar crypts', 'Cancer cell'): 0.02, ('Trabecula', 'Cancer cell'): 0.02, ('Trabeculae of spleen', 'Cancer cell'): 0.02, ('Trabecular arteries', 'Cancer cell'): 0.02, ('Trabecular veins', 'Cancer cell'): 0.02, ('Tubal tonsil', 'Cancer cell'): 0.02, ('Tuberculosis', 'Cancer cell'): 0.02, ('Uppsala University', 'Cancer cell'): 0.02, ('Valve', 'Cancer cell'): 0.02, ('Venipuncture', 'Cancer cell'): 0.02, ('Vertebra', 'Cancer cell'): 0.02, ('Vertebrae', 'Cancer cell'): 0.02, (\"Volkmann's canals\", 'Cancer cell'): 0.02, ('Wake Forest Baptist Medical Center', 'Cancer cell'): 0.02, (\"Waldeyer's tonsillar ring\", 'Cancer cell'): 0.02, ('White pulp', 'Cancer cell'): 0.02, (\"Wright's stain\", 'Cancer cell'): 0.02, ('X-ray microtomography', 'Cancer cell'): 0.02}\n"
     ]
    }
   ],
   "source": [
    "print(missing_links)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "e6f84e92",
   "metadata": {},
   "outputs": [],
   "source": [
    "# We get the top 20 missing links based on their scores\n",
    "top_missing_links = get_top_n_links(missing_links, n=20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "a8b93629",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Top 20 missing links:\n",
      "Cancer treatment <-0.59-> Breast cancer\n",
      "Cancer treatment <-0.56-> Medical Subject Headings\n",
      "Cancer treatment <-0.39-> Apoptosis\n",
      "Cancer treatment <-0.32-> Gene\n",
      "Cancer treatment <-0.31-> Protein Data Bank\n",
      "Cancer treatment <-0.31-> Mutation\n",
      "Cancer treatment <-0.3-> Neoplasm\n",
      "Cancer treatment <-0.3-> Protein\n",
      "Cancer treatment <-0.3-> DNA repair\n",
      "Cancer treatment <-0.29-> Oncogene\n",
      "Cancer treatment <-0.29-> P53\n",
      "Cancer treatment <-0.28-> Inflammation\n",
      "Cancer treatment <-0.28-> Ensembl\n",
      "Cancer treatment <-0.28-> Entrez\n",
      "Cancer treatment <-0.28-> GeneCards\n",
      "Cancer treatment <-0.28-> Gene expression\n",
      "Cancer treatment <-0.28-> Gene nomenclature\n",
      "Cancer treatment <-0.28-> Orthologs\n",
      "Cancer treatment <-0.28-> PubMed\n",
      "Cancer treatment <-0.28-> UniProt\n"
     ]
    }
   ],
   "source": [
    "print(\"Top 20 missing links:\")\n",
    "for nodes, link_strength in top_missing_links.items():\n",
    "    node1, node2 = nodes\n",
    "    print(f'{node1} <-{link_strength}-> {node2}')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
